
<SEC-DOCUMENT>0001095435-14-000064.txt : 20140731
<SEC-HEADER>0001095435-14-000064.hdr.sgml : 20140731
<ACCEPTANCE-DATETIME>20140730190921
ACCESSION NUMBER:
CONFORMED SUBMISSION TYPE:
PUBLIC DOCUMENT COUNT:
CONFORMED PERIOD OF REPORT:
FILED AS OF DATE:
DATE AS OF CHANGE:
20-F
10
20140730
0001095435-14-000064
20140730
20140731
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME:
CENTRAL INDEX KEY:
STANDARD INDUSTRIAL CLASSIFICATION: CRUDE PETROLEUM & NATURAL GAS
PORTAGE BIOTECH INC.
0001095435
[1311]
IRS NUMBER:
STATE OF INCORPORATION:
FISCAL YEAR END:
000000000
A6
0331
FILING VALUES:
FORM TYPE:
SEC ACT:
SEC FILE NUMBER: 000-30314
FILM NUMBER:
20-F
1934 Act
141004115
BUSINESS ADDRESS:
STREET 1:
STREET 2:
CITY:
STATE:
ZIP:
BUSINESS PHONE:
47 AVENUE ROAD
SUITE 200
TORONTO
A6
M5R 2G3
416-929-1806
MAIL ADDRESS:
STREET 1:
STREET 2:
CITY:
STATE:
ZIP:
47 AVENUE ROAD
SUITE 200
TORONTO
A6
M5R 2G3
FORMER COMPANY:
FORMER CONFORMED NAME: BONTAN CORP INC
DATE OF NAME CHANGE:
20030421
FORMER COMPANY:
FORMER CONFORMED NAME: DEALCHECK COM INC
DATE OF NAME CHANGE:
19990921
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>pf2014.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<html>
<head>
    <title>pf2014.htm</title>
    <!--Licensed to: bontan94-->
    <!--Document Created using EDGARizer 2020 5.4.0.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;UNITED 
STATES</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE 
COMMISSION</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">WASHINGTON, D.C. 20549</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">FORM 20-F</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE 
SECURITIES EXCHANGE ACT OF 1934</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 180pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">OR</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-
DECORATION: underline">X</font>&#160;&#160;&#160;ANNUAL REPORT PURSUANT TO 
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the fiscal year ended March 31, 
2014</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 180pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">OR</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">OR</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE 
SECURITIES EXCHANGE ACT OF 1934</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Date of event requiring this shell company 
report______________</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>For the 
transition period from ______________ to __________________</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Commission file number: 0-30314</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 12pt; FONT-WEIGHT: bold">Portage Biotech Inc.</font></div>
</td>
</tr></table>
</div>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">(Exact name of Registrant as specified in its 
charter)</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Inapplicable</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(Translation 
of Registrant&#8217;s name into English)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">British Virgin Islands</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(Jurisdiction 
of incorporation or organization)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">47 Avenue Road, Suite 200, Toronto, Ontario,
Canada, M5R 2G3</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(Address of 
principal executive offices)</font></div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Kam Shah, 
416.929.1806,ks@portagebiotech.com, Fax: 416.929.6612</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">47 Avenue Road, Suite 200, Toronto, Ontario,
Canada M5R 2G3</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">(Name, telephone, e-mail and/or facsimile number and Address of
Company Contact Person)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Securities registered or to be registered pursuant to Section 
12(b) of the Act:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Title of each 
class&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;Name of each exchange on which registered</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Not 
applicable&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Not 
applicable</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Securities registered or to be registered pursuant to Section 
12(g) of the Act.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common shares without par value</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">(Title of Class)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Securities for which there is a reporting obligation pursuant 
to Section 15(d) of the Act:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Not applicable</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">(Title of Class)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Indicate the number of outstanding shares of each of the 
Issuer&#8217;s classes of capital or common stock as of the close of the period 
covered by the annual report.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common shares without par value &#8211; 
180,775,790 as at March 31, 2014</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Indicate by check mark if the registrant is a well-known 
seasoned issuer, as defined in Rule 405 of the Securities 
Act&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;&#160;Yes ___&#160;&#160;&#160;&#160;&#160;&#160;&#160;No <font 
style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: 
underline">X</font><font style="DISPLAY: inline; TEXT-DECORATION: 
underline">__</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">If this report is an annual or transition report, indicate by 
check mark if the registrant is not required to file reports pursuant to Section
13 or 15(d) of the Securities Exchange Act of 
1934.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;Yes____&#160;&#160;&#160;&#160;&#160;&#160;No<font id="TAB1" 
style="MARGIN-LEFT: 12pt"></font><font style="DISPLAY: inline; FONT-WEIGHT: 
bold; TEXT-DECORATION: underline">X</font><font id="TAB2" style="LETTER-SPACING:
3pt; COLOR: black">&#160;</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Note &#8211; Checking the box above will not relieve any 
registrant required to file reports pursuant to Section 13 or 15(d) of the 
Securities Exchange Act of 1934 from their obligations under those 
Sections.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange 
Act of 1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such report) and (2) has been subject to such 
filing requirements for the past 90 days.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 288pt"></font>Yes <font 
style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: 
underline">X</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;&#160;&#160;No</font></div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Indicate by check mark whether the registrant has submitted 
electronically and posted on its corporate Web site, if any, every Interactive 
Data File required to be submitted and posted pursuant to Rule 405 of Regulation
S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such 
shorter period that the registrant was required to submit and post such 
files).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Indicate by 
checkmark&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; 
FONT-WEIGHT: bold; TEXT-DECORATION: 
underline">X</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;No_______</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a large 
accelerated filer, an accelerated filer, or a non-accelerated filer. See 
definition of &#8220;accelerated filer and large accelerated filer&#8221; in 
Rule 12b-2 of the Exchange Act. (Check one):</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Large accelerated filer___Accelerated filer____ Non-accelerated
filer&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-
DECORATION: 
underline">X</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Indicate by check mark which basis of accounting the registrant
has used to prepare the financial statements included in this 
filing:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">U.S. GAAP___&#160;&#160;&#160;&#160;International Financial
Reporting&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other 
__</font></div>
<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Standards as issued by the International <font style="DISPLAY: 
inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">X</font></font></div>
<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Accounting Standards Board</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">If &#8220;Other&#8221; has been checked in response to the 
previous question, indicate by check mark which financial statement item the 
registrant has elected to follow</font></div>
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Item 17<font style="DISPLAY: inline; FONT-WEIGHT: 
bold">:&#160;&#160;&#160;&#160;&#160;</font>Item 18 <font style="DISPLAY: 
inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">X</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">If this is an annual report, indicate by check mark whether the
registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 
Yes__ No <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: 
underline">X</font></font></div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">TABLE OF CONTENTS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="63%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Page 
No.</font></font></div>
</td>
</tr><tr>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="63%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" colspan="2" valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Forward-looking statements</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td align="left" colspan="2" valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Foreign Private Issuer Status and Reporting 
currency</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2</font></div>
</td>
</tr><tr>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="63%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Part 
I</font></font></div>
</td>
<td valign="top" width="63%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="63%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 1.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Identity of Directors, Senior Management and 
Advisors</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 2.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Offer Statistics and Expected Timetable</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 3.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Key Information</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 4.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Information on the Company</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">9</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 5.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Operating and Financial Review and Prospects</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">14</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 6.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Directors, Senior Management and Employees</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">19</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 7.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Major Shareholders and Related Party Transactions</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">24</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 8.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Financial Information</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">25</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 9.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">The Offer and Listing</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">26</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 10.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Additional Information</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">27</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 11.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Quantitative and Qualitative Disclosures about Market 
Risk</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">39</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 12.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Description of Securities Other than Equity 
Securities</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">40</font></div>
</td>
</tr><tr>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="63%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Part 
II</font></font></div>
</td>
<td valign="top" width="63%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="63%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 13.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Defaults, Dividend Arrearages and Delinquencies</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">40</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 14.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Material Modifications to the Rights of Security Holders and 
Use of Proceeds</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">40</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 15.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Controls and Procedures</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">41</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 16.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Audit Committee, Code of Ethics, and Principal 
Accountant&#8217;s Fees and Services</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">42</font></div>
</td>
</tr><tr>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="63%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="63%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Part 
III</font></font></div>
</td>
<td valign="top" width="63%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="63%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 17.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Financial Statements</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">42</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 18.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Financial Statements</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">43</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Item 19.</font></div>
</td>
<td align="left" valign="top" width="63%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Exhibits</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">43</font></div>
</td>
</tr></table>
</div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">FORWARD LOOKING STATEMENTS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">This annual report includes &#8220;forward looking 
statements&#8221;. All statements, other than statements of historical facts, 
included herein or incorporated by reference herein, including without 
limitation, statements regarding our business strategy, plans and objectives of 
management for future operations and those statements preceded by, followed by 
or that otherwise include the words &#8220;believe&#8221;, 
&#8220;expects&#8221;, &#8220;anticipates&#8221;, &#8220;intends&#8221;, 
&#8220;estimates&#8221; or similar expressions or variations on such expressions
are forward-looking statements. We can give no assurances that such forward-
looking statements will prove to be correct.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Each forward-looking statement reflects our current view of 
future events and is subject to risks, uncertainties and other factors that 
could cause actual results to differ materially from any results expressed or 
implied by our forward-looking statements.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Risks and uncertainties include, but are not limited 
to:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 27pt"><font style="DISPLAY: inline; 
FONT-FAMILY: symbol, serif; FONT-SIZE: 10pt">&#183;</font><font id="TAB2" 
style="LETTER-SPACING: 9pt; COLOR: black">&#160;</font><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">our plans and ability to 
develop and commercialize product candidates and the timing of these development
programs;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td colspan="2" valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 27pt"><font style="DISPLAY: inline; 
FONT-FAMILY: symbol, serif; FONT-SIZE: 10pt">&#183;</font><font id="TAB2" 
style="LETTER-SPACING: 9pt; COLOR: black">&#160;</font><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">clinical development of 
our product candidates, including the results of current and future clinical 
trials;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
</td>
</tr><tr>
<td colspan="2" valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 27pt"><font style="DISPLAY: inline; 
FONT-FAMILY: symbol, serif; FONT-SIZE: 10pt">&#183;</font><font id="TAB2" 
style="LETTER-SPACING: 9pt; COLOR: black">&#160;</font><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">the benefits and risks of
our product candidates as compared to others;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
</td>
</tr><tr>
<td colspan="2" valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 27pt"><font style="DISPLAY: inline; 
FONT-FAMILY: symbol, serif; FONT-SIZE: 10pt">&#183;</font><font id="TAB2" 
style="LETTER-SPACING: 9pt; COLOR: black">&#160;</font><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">our maintenance and 
establishment of intellectual property rights in our product 
candidates;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
</td>
</tr><tr>
<td colspan="2" valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 27pt"><font style="DISPLAY: inline; 
FONT-FAMILY: symbol, serif; FONT-SIZE: 10pt">&#183;</font><font id="TAB2" 
style="LETTER-SPACING: 9pt; COLOR: black">&#160;</font><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">our need for additional 
financing and our estimates regarding our capital requirements and future 
revenues and profitability;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
</td>
</tr><tr>
<td colspan="2" valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 27pt"><font style="DISPLAY: inline; 
FONT-FAMILY: symbol, serif; FONT-SIZE: 10pt">&#183;</font><font id="TAB2" 
style="LETTER-SPACING: 9pt; COLOR: black">&#160;</font><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">our estimates of the size
of the potential markets for our product candidates;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
</td>
</tr><tr>
<td colspan="2" valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 27pt"><font style="DISPLAY: inline; 
FONT-FAMILY: symbol, serif; FONT-SIZE: 10pt">&#183;</font><font id="TAB2" 
style="LETTER-SPACING: 9pt; COLOR: black">&#160;</font><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">our selection and 
licensing of product candidates;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">These statements are based on assumptions and analyses made by 
us in light of our experience and our perception of historical trends, current 
conditions and expected future developments based on the change in the focus of
our business activities to Biotechnology , as well as other factors we believe 
are appropriate in particular circumstances. However, whether actual results and
developments will meet our expectations and predictions depends on a number of 
risks and uncertainties, which could cause actual results to differ materially 
from our expectations, including the risks set forth in "Item 3-Key Information-
Risk Factors."</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We do not currently have the marketing expertise needed to 
commercialize our products; we will be primarily a pharmaceutical development 
business subject to all of the risks of a pharmaceutical development 
business;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Consequently, all of the forward-looking statements made in 
this annual report are qualified by these cautionary statements. We cannot 
assure you that the actual results or developments anticipated by us will be 
realized or, even if substantially realized, that they will have the expected 
effect on us or our business or operations.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Unless the context indicates otherwise the terms "Portage 
Biotech Inc." the "Company&#8221;, "Portage", &#8220;we&#8221;, 
&#8220;us&#8221;, &#8220;our&#8221; are used interchangeably in this Annual 
Report and mean Portage Biotech Inc.. and its subsidiaries.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">FOREIGN PRIVATE ISSUER STATUS AND REPORTING 
CURRENCY</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Foreign Private Issuer Status:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Portage Biotech Inc., which changed its name from Bontan 
Corporation inc. on July 5, 2014,moved its jurisdiction from the Province of 
Ontario, Canada to the British Virgin Islands (BVI) as per the certificate of 
Continuance issued by the Registrar of Corporate Affairs of the BVI on July 5, 
2014. Approximately 40% of its common stock was held by non-United States 
citizens and residents as of September 30, 2013 being its latest second quarter 
end. However, our business is administered principally outside the United States
and all our assets are located outside the United States; As a result, we 
believe that we qualify as a "foreign private issuer" for continuing to report 
regarding the registration of our common
stock using this Form 20-F annual report format.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Currency</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The financial information presented in this Annual Report is 
expressed in US dollars ("US $") and the financial data in this Annual Report is
presented in accordance with the International Financial Reporting Standards as 
issued by the International Accounting Standards Board (&#8220;IFRS&#8221;) and 
interpretations of the International Financial Reporting Interpretations 
Committee.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">All dollar 
amounts set forth in this report are in US dollars, except where otherwise 
indicated.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">PART I</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 1 &#8211; IDENTITY OF DIRECTORS, SENIOR MANAGEMENT 
AND ADVISORS</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Not required since this is an annual report.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 2 &#8211; OFFER STATISTICS AND EXPECTED 
TIMETABLE</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Not required since this is an annual report</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 3 &#8211; KEY INFORMATION</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A) SELECTED FINANCIAL DATA</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">On June 4, 2013, the Company completed an acquisition with 
Portage Pharma Ltd, incorporated in the British Virgin Islands on May 23, 2012, 
through exchange of shares as further explained later in this report. The 
transaction was treated as reverse acquisition for accounting 
purposes.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">As a result, the selected financial data, presented below, 
represents financial data for the fiscal year 2014 and for the period from May 
23, 2012 to March 31, 2013 relating to Portage Pharma Ltd., prepared in 
accordance with IFRS issued by IASB.&#160;&#160;Selected financial data for the 
earlier fiscal years are not presented since they related to Bontan Corporation 
Inc., which was an accounting acquiree under the reverse acquisition 
transaction.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">SUMMARY OF FINANCIAL INFORMATION 
IN THE COMPANY FINANCIAL STATEMENTS (US $)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Operating data 
&#8211;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="33%" style="BORDER-BOTTOM: black 4px double; BORDER-TOP:
black 1.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 4px 
double; BORDER-TOP: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended March 31, 2014</font></div>
</td>
<td align="right" valign="top" width="14%" style="BORDER-BOTTOM: black 4px 
double; BORDER-TOP: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Period from May 23, 2012 to March 31,
2013</font></div>
</td>
</tr><tr>
<td valign="top" width="33%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Revenue</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Loss before non-controlling interests</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$(6,626,630)</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$(29,486)</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Non-controlling interests</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$(321,683)</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$&#160;&
#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-
</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Net Loss attributable to shareholders</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$(6,304,947)</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$(29,486)</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Net loss per share (1)</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">($0.04)</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">($0.00)</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Working capital</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$2,067,319</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$474,009</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Total assets</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$5,263,413</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$486,401</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Capital stock</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$7,256,715</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$503,495</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Warrants</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$1,108,402</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-
</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Stock option reserve</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$362,440</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;-</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Shareholders' equity</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$2,393,124</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$474,009</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 4px 
double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Weighted average number of shares outstanding</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 4px 
double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">161,977,171</font></div>
</td>
<td align="right" valign="top" width="14%" style="BORDER-BOTTOM: black 4px 
double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">81,759,076</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">1. The effect of potential share issuances pursuant to the 
exercise of options and warrants would be anti-dilutive and, therefore, basic 
and diluted losses per share are the same.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company has not declared or paid any dividends in any of 
the financial periods.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exchange Rates</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">In this Annual Report on Form 20-F, unless otherwise specified,
all monetary amounts are expressed in US dollars. One of the Company&#8217;s 
subsidiaries maintains its books in Canadian dollars. The exchange rates used 
herein were obtained from Bank of Canada; however, they cannot be 
guaranteed.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">On July 24, 2014, the exchange rate, based on the noon buying 
rates, for the conversion of Canadian dollars into United States dollars (the
&#8220;Noon Rate of Exchange&#8221;) was approximately CDN$1 = 
US$0.93.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The following table sets out the high and low exchange rates in
US dollar for one Canadian dollar for each of the last six months</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">June</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">May</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">April</font></div>
</td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">March</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">February</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">January</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">High for period</font></div>
</td>
<td valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$0.94</font></div>
</td>
<td valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$0.92</font></div>
</td>
<td valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$0.92</font></div>
</td>
<td valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$0.91</font></div>
</td>
<td valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$0.91</font></div>
</td>
<td valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$.94</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Low for period</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$0.91</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$0.91</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$0.90</font></div>
</td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$0.89</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$0.89</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$0.89</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The following table sets out the average exchange rates in US 
dollar for one Canadian dollar for the five most recent financial years 
calculated by using the average of the Noon Rate of Exchange on the last day of 
each month during the period.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="6" valign="top" width="50%" style="BORDER-BOTTOM: black 2px solid; 
BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year Ended March 31,</font></div>
</td>
</tr><tr>
<td valign="top" width="17%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="left" valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td align="left" valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td align="left" valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td align="left" valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2011</font></div>
</td>
<td align="left" valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2010</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="17%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Average for the year</font></div>
</td>
<td align="left" valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.95</font></div>
</td>
<td align="left" valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1.00</font></div>
</td>
<td align="left" valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1.01</font></div>
</td>
<td align="left" valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.98</font></div>
</td>
<td align="left" valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.92</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">(B)&#160;&#160;CAPITALIZATION AND 
INDEBTEDNESS</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Not applicable</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(C)&#160;&#160;REASONS FOR THE OFFER AND USE
OF PROCEEDS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Not applicable</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(D)&#160;&#160;RISK FACTORS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The following is a brief discussion of those distinctive or 
special characteristics of the Company&#8217;s operations and industry that may 
have a material impact on, or constitute risk factors in respect of, the 
Company&#8217;s future financial performance.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">Risks Related to our Business</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We have a history 
of operating losses and may never achieve profitability in the 
future.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We have not generated any business income since fiscal 2010 and
have an accumulated deficit of approximately $6 million as at March 31, 2014. 
While our management and the Board consist of persons with significant 
experience in the biotechnology industry, we have no product sales and have no 
established sales and distribution network.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We expect to be involved in research and development to 
identify and validate new drug targets that could become marketed drugs for 
several years to come and will be requiring significant financial resources 
without any income. We expect these expenses to result in continuing operating 
losses in the near future.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Our ability to generate future revenue or achieve profitable 
operations is largely dependent upon our ability to attract and maintain the 
experienced management and know-how to develop new drug candidates and to 
partner with major pharmaceutical companies to successfully commercialize the 
drug candidates. It takes many years and significant financial resources to 
successfully develop pre-clinical or early clinical drug candidate into a 
marketable drug and we cannot assure you that we will be able to successfully 
achieve these objectives.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We will be 
primarily in a pharmaceutical development business and will be subject to all of
the risks of a pharmaceutical development business.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">As a result, our business must be evaluated in light of the 
problems, delays, uncertainties and complications encountered in connection with
establishing a pharmaceutical development business.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">There is a possibility that none of our drug candidates that 
may be under development in future will be found to be safe and effective, that 
we will be unable to receive necessary regulatory approvals in order to 
commercialize them, or that we will obtain regulatory approvals that are too 
narrow to be commercially viable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Any failure to successfully develop and obtain regulatory 
approval for products would have a material adverse effect on our business, 
financial condition and results of operations.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Clinical trials for
our potential product candidates will be expensive and time consuming, and their
outcome uncertain.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Before we can obtain regulatory approval for the commercial
sale of any product candidate or attract major pharmaceutical company to 
collaborate with, we will be required to complete extensive clinical trials to 
demonstrate its safety and efficacy. Clinical trials are very expensive, and are
difficult to design and implement. The clinical trial process is also time-
consuming and can often be subject to unexpected delays.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The timing of the commencement, 
continuation and completion of clinical trials may be subject to significant 
delays relating to various causes, including:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">our inability to manufacture or obtain sufficient quantities of
materials for use in clinical trials;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">delays arising from our collaborative 
partnerships;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">delays in obtaining regulatory approvals to commence a study, 
or government intervention to suspend or terminate a study;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">delays, suspension, or termination of the clinical trials due 
to the institutional review board or independent ethics board responsible for 
overseeing the study to protect research subjects at a particular study 
site;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">delays in identifying and reaching agreement on acceptable 
terms with prospective clinical trial sites;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">slower than expected rates of patient recruitment and 
enrollment;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">uncertain dosing issues;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol,
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">inability or unwillingness of medical investigators to follow 
our clinical protocols;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">variability in the number and types of subjects available for 
each study and resulting difficulties in identifying and enrolling subjects who 
meet trial eligibility criteria;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">scheduling conflicts with participating clinicians and clinical
institutions;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol,
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">difficulty in maintaining contact with subjects after 
treatment, which results in incomplete data;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">unforeseen safety issues or side effects;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">lack of efficacy during the clinical trials;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">our reliance on clinical research organizations to conduct 
clinical trials, which may not conduct those trials with good clinical or 
laboratory practices; or</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">other regulatory delays.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The results of pre-
clinical studies and initial clinical trials are not necessarily predictive of 
future results, and our potential product candidates may not have favourable 
results in later trials or in the commercial setting.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Pre-clinical tests and Phase 1 and Phase 2 clinical trials are 
primarily designed to test safety, to study pharmacokinetics and 
pharmacodynamics and to understand the side effects of product candidates and 
explore efficacy at various doses and schedules. Success in pre-clinical or 
animal studies and early clinical trials does not ensure that later large-scale 
efficacy trials will be successful nor does it predict final results; favourable
results in early trials may not be repeated in later trials.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">A number of companies in the life sciences industry have 
suffered significant setbacks in advanced clinical trials, even after positive 
results in earlier trials. Clinical results are frequently susceptible to 
varying interpretations that may delay, limit or prevent regulatory approvals. 
Negative or inconclusive results or adverse medical events during a clinical 
trial could cause a clinical trial to be delayed, repeated or terminated. In 
addition, failure to construct appropriate clinical trial protocols could result
in the test or control group experiencing a disproportionate number of adverse 
events and could cause a clinical trial to be repeated or 
terminated.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">There is typically an extremely high rate of attrition from the
failure of product candidates proceeding through clinical and post-approval 
trials.</font><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: 
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our success will be 
dependent upon our corporate collaborations with third parties in connection 
with services we will need for the development, marketing and commercialization 
of our products.</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The success of our business will be largely dependent on our 
ability to enter into corporate collaborations regarding the development, 
clinical testing, regulatory approval and commercialization of our potential 
product candidates. We may not be able to find new collaborative partners to 
support our future development, marketing and commercialization of our products,
which may require us to undertake</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">research and development and/or commercialization activities 
ourselves, and may result in a material adverse effect on our business, 
financial condition, prospects and results of operations.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Even if we are able to find new collaborative partners, our 
success is highly dependent upon the performance of these new corporate
collaborators. The amount and timing of resources to be devoted to activities by
future corporate collaborators, if any, are not within our direct control and, 
as a result, we cannot assure you that any future corporate collaborators will 
commit sufficient resources to our research and development projects or the 
commercialization of our potential product candidates. Any future corporate 
collaborators might not perform its obligations as expected and might pursue 
existing or other development-stage products or alternative technologies in 
preference to those being developed in
collaboration with us, or may terminate particular development programs, or the 
agreement governing such development programs.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">In addition, if any future collaborators fail to comply with 
applicable regulatory requirements, the FDA, the European Medicines Agency 
(&#8220;EMA&#8221;), the Therapeutic Products Directorate (&#8220;TPD&#8221;) or
other authorities could take enforcement action that could jeopardize our 
ability to develop and commercialize our potential product candidates. Despite 
our best efforts to limit them, disputes may arise with respect to ownership of 
technology developed under any such corporate collaboration.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; 
FONT-WEIGHT: bold">We will rely on proprietary technology, the protection of 
which can be unpredictable and costly.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Our success will depend in part upon our ability to obtain 
patent protection or patent licenses for our future technology and products. 
Obtaining such patent protection or patent licenses can be costly and the 
outcome of any application for patent protection and patent licenses can be 
unpredictable. In addition, any breach of confidentiality by a third party by 
premature disclosure may preclude us from obtaining appropriate patent 
protection, thereby affecting the development and commercial value of our 
technology and products.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Some of our future 
products may rely on licenses of proprietary technology owned by third parties 
and we may not be able to maintain these licenses on favourable 
terms.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The manufacture and sale of some of the products we hope to 
develop may involve the use of processes, products, or information, the rights
to which are owned by third parties. Such licenses frequently provide for 
limited periods of exclusivity that may be extended only with the consent of the
licensor. If licenses or other rights related to the use of such processes, 
products or information are crucial for marketing purposes, and we are not able 
to obtain them on favourable terms, or at all, the commercial value of our 
products will be significantly impaired. If we experience delays in developing 
our products and extensions are not granted on any or all of such licenses, our 
ability to realize the benefits of our
efforts may be limited.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We will have 
additional future capital needs and there are uncertainties as to our ability to
raise additional funding.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">&#160;</font><br>
&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We believes that the proceeds from the current offering 
together with cash on hand will be adequate to cover our operational and 
developmental costs for the next eighteen months. However, We may require 
substantial additional capital resources to develop potential product 
candidates, obtain regulatory approvals and ultimately to commercialize such 
product candidates.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">In addition, our future cash requirements may vary materially 
from those now expected. For example, our future capital requirements may 
increase if:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">we experience scientific progress sooner than expected in our 
future discovery, research and development projects, if we expand the magnitude 
and scope of these activities, or if we modify our focus as a result of our 
discoveries;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">we experience setbacks in our progress with pre-clinical 
studies and clinical trials are delayed;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">we experience delays or unexpected increased costs in 
connection with obtaining regulatory approvals;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">we are required to perform additional pre-clinical studies and 
clinical trials;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">we experience unexpected or increased costs relating to 
preparing, filing, prosecuting, maintaining, defending and enforcing patent 
claims; or</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">we elect to develop, acquire or license new technologies and 
products.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">If sufficient capital is not available, we may be required to 
delay, reduce the scope of, eliminate or divest of one or more of our research 
or development projects, any of which could have a material adverse effect on 
our business, financial condition, prospects or results of 
operations.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We will be subject 
to risks associated with doing business globally.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">As a pharmaceutical company our operations are likely to expand
in the European Union and worldwide, we will be subject to political, economic, 
operational, legal, regulatory and other risks that are inherent in conducting 
business globally. These risks include foreign exchange fluctuations, exchange 
controls, capital controls, new laws or regulations or changes in the 
interpretation or enforcement of existing laws or regulations, political 
instability, macroeconomic changes, including recessions and inflationary or 
deflationary pressures, increases in prevailing interest rates by central banks 
or financial services companies, economic uncertainty, which may reduce the 
demand for our potential products or reduce
the prices that our potential customers will be willing to pay for our products,
import or export restrictions, tariff increases, price controls, nationalization
and expropriation, changes in taxation, diminished or insufficient protection of
intellectual property, lack of access to impartial court systems, violations of 
law, including the U.S. Foreign Corrupt Practices Act and the U.K. Bribery Act, 
disruption or destruction of operations or changes to the Company&#8217;s 
business position, regardless of cause, including war, terrorism, riot, civil 
insurrection, social unrest, strikes and natural or man-made disasters, 
including famine, flood, fire, earthquake, storm or disease. The impact of any 
of these developments, either individually or cumulatively, could have a 
material adverse effect on our business, financial condition and results of 
operations.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may face 
exposure to adverse movements in foreign currency exchange rates while 
completing international clinical trials and when our products will be 
commercialized.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We intend to generate revenue and expenses internationally that
are likely to be primarily denominated in U.S., Euros and other foreign 
currencies. Our intended international business will be subject to risks typical
of an international business including, but not limited to, differing tax 
structures, a myriad of regulations and restrictions, and general foreign 
exchange rate volatility. A decrease in the value of such foreign currencies 
relative to the Canadian dollar could result in losses in revenues from currency
exchange rate fluctuations. Conversely, an increase in the value of such foreign
currencies relative to the Canadian dollar could negatively impact our operating
expenses. To date, we have not hedged
against risks associated with foreign exchange rate exposure. We cannot be sure 
that any hedging techniques we may implement in the future will be successful or
that our business, results of operations, financial condition and cash flows 
will not be materially adversely affected by exchange rate 
fluctuations.</font></div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">&#160;</div>
</div>
<div id="HDR"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-
SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: 
underline">Risks Related to Ownership of our shares</font></font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">There is currently 
a limited trading market for our Common Shares.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">There currently is a limited public market for our Common 
Shares. Further, although our Common Shares are currently traded on the OTCQB 
marketplace (PTGEF) and are also listed and traded on the Canadian 
Securities&#160;&#160;Exchange.&#160;&#160;Trading of our Common Shares is 
currently extremely sporadic. As a result, an investor may find it difficult to 
sell, or to obtain accurate quotations of the price of our Common Shares. There 
can be no assurance that a more active trading market for our Common Shares will
develop. Accordingly, investors must assume they may have to bear the economic 
risk of an investment in our Common Shares for an indefinite period of 
time.</font><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="FONT-STYLE: italic; 
DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">Risks related to penny stocks.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Our Common Shares are subject to regulations prescribed by the 
SEC relating to &#8220;penny stock.&#8221; These regulations impose additional 
sales practice requirements on broker-dealers who sell such securities to 
persons other than established customers and accredited investors (as defined in
Rule 501 of the U.S. Securities Act). These regulations could adversely impact 
market demand for our shares and adversely impact our trading volume and 
price.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The issuance of 
Common Shares upon the exercise of our outstanding warrants and options will 
dilute the ownership interest of existing shareholders and increase the number 
of shares eligible for future resale.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The exercise of some or all of our outstanding warrants and 
options could significantly dilute the ownership interests of our existing 
shareholders. As of March 31, 2014, we had outstanding warrants to purchase an 
aggregate of approximately 114 million Common Shares and outstanding options to 
purchase an aggregate of approximately 5 million Common Shares. To the extent 
the warrants and options are exercised, additional Common Shares will be issued 
and that issuance will increase the number of shares eligible for resale in the 
public market. The sale of a significant number of shares by our shareholders, 
or the perception that such sales could occur, could have a depressive effect on
the public market price of our
Common Shares.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The Company has not
registered the securities or the shares issuable upon exercise of the warrants, 
which will limit your ability to resell them</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Neither the Units nor the shares issuable upon conversion of 
the warrants to be issued under this private placement have been or will be 
registered under the U.S. Securities Act or any state securities laws. As a 
result, they may only be offered or sold if an applicable exemption from the 
registration requirements of the U.S. Securities Act and applicable state laws 
applies to the circumstances of the sale</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-STYLE: italic; DISPLAY:
inline">Your investment return may be reduced if we lose our foreign private 
issuer status</font>.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We are a &#8220;foreign private issuer,&#8221; as such term is 
defined in Rule 405 under the U.S. Securities Act, and, therefore, we are not 
required to file quarterly reports on Form 10-Q or current reports on Form 8-K 
with the SEC. In addition, the proxy rules and Section 16 reporting and short-
swing profit recapture rules are not applicable to us. If we lose our status as 
a foreign private issuer by our election or otherwise, we will be subject to 
additional reporting obligations under the Exchange Act which would increase our
SEC compliance costs.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may be treated 
as a passive foreign investment company for U.S. tax purposes, which could 
subject United States investors to significant adverse tax 
consequences.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">A foreign corporation will be treated as a passive foreign 
investment company, or PFIC, for U.S. federal income taxation purposes, if in 
any taxable year either: (a) 75% or more of its gross income consists of passive
income; or (b) 50% or more of the value of the company&#8217;s assets is 
attributable to assets that produce, or are held for the production of, passive 
income. Based on our current income and assets and our anticipated future 
operations, we believe that we currently are not a PFIC.U.S. stockholders of a 
PFIC are subject to a disadvantageous U.S. income tax regime with respect to the
income derived by the PFIC, the distributions they receive from the PFIC, and 
the gain, if any, they derive from the
sale or other disposition of their shares in the PFIC. Because PFIC status is a 
fact-intensive determination made on an annual basis, no assurance can be given 
that we are not or will not become classified as a PFIC. The PFIC rules are 
extremely complex. A U.S. person is encouraged to consult his or her U.S. tax 
advisor before making an investment in our shares.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-STYLE: italic; DISPLAY: 
inline">U.S. shareholders may not be able to enforce civil liabilities against 
us</font>.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We are a corporation organized under the laws of the British 
Virgin Islands. Most of our directors and executive officers are non-residents 
of the United States. Because a substantial portion of their assets and 
currently all of our assets are located outside the United States, it may be 
difficult for investors to effect service of process within the United States 
upon us or those persons.</font><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our
corporate affairs will be governed by our Memorandum and Articles of 
Association, the BVI Business Companies Act, and the common law of the British 
Virgin Islands. The rights of shareholders to take action against the directors,
actions by minority shareholders and the fiduciary responsibilities of our 
directors to us under British Virgin Islands law are to a large extent governed 
by the common law of the British Virgin Islands. The common law of the British 
Virgin Islands is derived in part from comparatively limited judicial precedent 
in the British Virgin Islands, as well as from English common law, the decisions
of whose courts are considered persuasive authority but are not binding on a 
court in the British Virgin Islands. The rights of our shareholders and the 
fiduciary responsibilities of our
directors under British Virgin Islands law are not as clearly established as 
they would be under statutes or judicial precedent in some jurisdictions in the 
United States. In particular, the British Virgin Islands has a less developed 
body of securities laws as compared to the United States, and some states, such 
as Delaware, have more fully </font><font style="DISPLAY: inline; FONT-FAMILY: 
Times New Roman; FONT-SIZE: 10pt">developed and judicially interpreted bodies of
corporate law. In addition, British Virgin Islands companies may not have 
standing to initiate a shareholder derivative action in a federal court of the 
United States.</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The British Virgin Islands courts are also 
unlikely:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">to recognize or enforce against us judgments of U.S. courts 
based on certain civil liability provisions of U.S. securities laws; 
and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">to impose liabilities against us, in original actions brought 
in the British Virgin Islands, based on certain civil liability provisions of 
U.S. securities laws that are penal in nature.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">There is no statutory recognition in the British Virgin Islands
of judgments obtained in the United States. We have been advised by Forbes Hare,
our counsel as to British Virgin Islands law, that (i) they are unaware of any 
proceedings that have been brought in the British Virgin Islands to enforce 
judgments of the U.S. courts or to impose liabilities based on the civil 
liability provisions of the U.S. federal or state securities laws; (ii) a final 
and conclusive judgment in the federal or state courts of the United States 
under which a sum of money is payable, other than a sum payable in respect of 
taxes, fines, penalties or similar charges, may be subject to enforcement 
proceedings as a debt in the courts of the
British Virgin Islands under the common law doctrine of obligation; and (iii) 
because it is uncertain whether a British Virgin Islands court would determine 
that a judgment of a U.S. court based on the civil liability provisions of the 
U.S. federal or state securities laws is in the nature of a penalty, it is 
uncertain whether such a liability judgment would be enforceable in the British 
Virgin Islands.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 4 &#8211; INFORMATION ON THE 
COMPANY</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 45pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">(A)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">HISTORY AND DEVELOPMENT OF THE 
COMPANY</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">The Company was 
originally incorporated in Ontario in 1973. It was inactive until 1985. Between 
1986 and 2009 , it was engaged in variety of businesses including development of
a new technology for the marine propulsion business, distribution and 
manufacture of a snack food, emerging technology-based businesses and natural 
resource involving diamond mining and oil &amp; gas exploration. In 2010, the 
company acquired an indirect interest in two drilling licenses in Israel, which 
was disposed of for US$ 5 million under a settlement agreement on June 29, 2012 
with our minority partner on this project. During the period, the Company went 
through several name changes
ending with Bontan Corporation Inc. ( Bontan).</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">In December 
2012, the Company decided to change the focus of its business activities from 
oil and gas to biotechnology mainly due to the increasing difficulty in getting 
access to viable oil &amp; gas projects and also due to the potentially more 
profitable business opportunities which existed in the biotechnology sector. On 
March 21, 2013, the Company signed a letter of intent with Portage Pharma Ltd, a
biotech private limited company formed under the laws of the British Virgin 
Islands to acquire Portage Pharma Ltd through exchange of shares. The 
transaction was completed on June 4, 2013 and accounted for as a reverse 
acquisition.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">On July 5, 2013, the Company changed its name to Portage 
Biotech Inc. and moved its jurisdiction to the British Virgin Islands 
( BVI)&#160;&#160;under a certificate of Continuance issued by the Registrar of 
Corporate Affairs of BVI.</font><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-
SIZE: 10pt">The Company now continues as a BVI incorporated company with its 
registered office located at FH Chambers, P.O. Box 4649, Road Town, Tortola, 
BVI. Its Toronto agent is located at 47 Avenue Road, Suite 200, Toronto, 
Ontario, M5R 2G3, Canada.</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company continues to be a reporting issuer with Ontario 
Securities Commission and US Securities and Exchange Commission and its shares 
trade on the Quotation Board of the OTC Markets under the trading symbol 
&#8220;PTGEF,&#8221; effective August 23, 2013. Prior to this date, it was 
trading as Bontan Corporation Inc. under the trading symbol 
&#8220;BNTNF&#8221;.&#160;&#160;Effective October 28, 2013, the Company&#8217;s 
shares are also listed for trading in US currency on the Canadian Securities 
Exchange (formerly, Canadian National Stock Exchange) under the symbol 
&#8220;PBT.U&#8221;.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(B)&#160;&#160;BUSINESS 
OVERVIEW</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Portage develops pharmaceutical &amp; biotech products through 
to clinical &#8220;proof of concept&#8221; focussing on unmet clinical needs. 
Following proof of concept, Portage will look to sell or license the products to
large pharmaceutical companies for further development through to
commercialization.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Portage seeks products &amp; co-development partners in cancer,
infectious disease, neurology and psychiatry with novel targeted therapies, or 
reformulations that can be patented.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Portage will work with a wide range of partners, in all phases 
of development. The collaboration may include direct funding or investing human 
capital/sweat equity from our extensive pool of talented scientists and 
physicians to value-add by mitigating risks, clinical trial design and 
regulatory expertise.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">Our 
research and development work is primarily carried out through two 
subsidiaries:</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font 
style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">Portage pharmaceuticals Ltd (
PPL)</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">On 
June 4, 2013, following the acquisition of Portage Pharma Ltd, the 
Company&#8217;s wholly owned subsidiary, Portage Acquisition Inc. and Portage 
Pharma Ltd amalgamated. The amalgamated company was named PPL, which has been 
incorporated in the BVI..</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: 
inline">PPL&#8217;s focus is in discovering and developing innovative cell 
permeable peptide therapies to normalize gene expression, restore function and 
improve medical outcomes. Its core technology involves delivering biologically 
active &#8220;cargo&#8221; to intracellular and intranuclear targets to 
normalize cell and tissue function, improve the immunogenicity of vaccines and 
enable better treatment of intracellular pathogens.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">PPL 
holds exclusive license in non-oncology fields for patents relating to the use 
and know how of Antennapedia cell permeable peptide. PPL has also patented in 
June 2013 proprietary structures in human-derived cell permeable peptides with 
demonstrated in vitro and in vivo activity and no therapeutic 
area.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">In May 2014, PPL has entered into a Collaborative Research 
Agreement with Yale University to study the biological activity and cell 
penetrating properties of peptides developed by Portage and by Professor Alanna 
Schepartz of Yale&#8217;s Department of Chemistry.&#160;&#160;These studies will
compare the ability of these peptides to cross cell membranes and deliver 
biologically active cargo to an intracellular target.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">In May 2014, PPL also has entered into a materials 
collaborative research and development agreement (M-CRADA) with the National Eye
Institute, one of the National Institutes of Health.&#160;&#160;&#160;PPL will 
provide its lead cell permeable peptide targeting inflammatory diseases to Dr. 
Robert B. Nussenblatt to investigate its efficacy in animal models of 
uveitis.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">In July 2014, PPL has successfully validated a new proprietary 
cell permeable peptide platform technology derived from human genes. This 
proprietary platform technology has been shown to efficiently deliver an active 
pharmacological agent or cargo into a cell without disrupting the cell 
membrane.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Along with demonstrating that the delivery system is capable of
carrying biologically active cargo to intracellular sites of action, the 
platform has favorable pharmaceutical properties simplifying formulation 
development for systemic and locally administered conjugates which will allow 
more rapid development of drug products.</font><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR"><br>
<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">PPL
has converted its previously filed provisional patent application for this 
delivery system to an international patent application that includes a variety 
of structures utilizing cargos that address important areas of medical 
need.</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">PPL has prioritized inflammation as an area with a large 
therapeutic opportunity.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Using a cargo peptide against an anti-inflammatory target, PPL 
has demonstrated not only cell penetration but also convincing in-vitro and in-
vivo pharmacological effects mediated intracellularly. The lead compound is 
being evaluated in several animal models of human inflammatory disease that will
determine its first indication.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Biohaven Pharmaceutical 
Holding Company Limited (Biohaven)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">On January 6, 2014, the Company acquired approximately 54% 
equity in Biohaven, a private corporation incorporated on September 25, 2013 
under the laws of the British Virgin Islands for $3.5 million, payable as $ 1.75
million upfront and the balance in three instalments over the next eleven 
months. Biohaven&#8217;s founder shareholders include originators at Yale 
University who discovered the therapeutic potential of glutamate modulation in 
anxiety and depression and have track record of successful registrational 
trials..</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: 
inline">Biohaven is engaged in the development of clinical stage neuroscience 
compounds targeting the glutamatergic system. The company obtained a license 
from Yale University regarding intellectual property for the use of certain 
glutamate modulating agents in the treatment of neuropsychiatric 
disorders.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">The 
first drug candidate being developed is for treatment-resistant mood and anxiety
disorders. The lead drug candidate is a Phase 2 ready compound and will enter 
clinical testing for treatment-resistant mood or anxiety disorders next 
year.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: 
inline">&#160;A second unique drug candidate also targets the glutamatergic 
system with a well-established safety profile. Biohaven will begin optimization 
of its formulation in 2014.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">In July 2014, the U.S. Patent and Trademark Office 
(&#8220;USPTO&#8221;)issued Patent No. 8,778,979B2 related to Biohaven&#8217;s 
intellectual property licensed from Yale University (U.S. Patent Application No.
11/399,188).&#160;&#160;The patent claims cover the use of certain glutamate 
modulating agents in the treatment of Generalized Anxiety Disorder 
(GAD).&#160;&#160;Patent protection under 8,778,979 B2 extends until April 27, 
2029. Biohaven has exclusive rights to all divisionals or continuations stemming
from the parent-US Patent Application No. 11/399,188.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">GAD affects approximately 6.8 million adults or 3% of the U.S. 
population. GAD is characterized by excessive anxiety and uncontrollable worry 
that interferes with an individual&#8217;s daily functioning. Anxiety symptoms 
are often accompanied by restlessness, fatigue, difficulty concentrating, 
irritability, muscle tension and increased sleep. GAD is more common in women 
than men and is often characterized by a chronic course.&#160;&#160;Current 
medication treatments are fully effective in only half of patients. Preclinical 
and clinical studies suggest that dysfunction in glutamatergic neurotransmission
plays a central role in the pathophysiology of mood and anxiety disorders. 
Directly targeting the glutamatergic
system may lead to more effective treatments for mood and anxiety disorders that
fail to respond to current monoamine based therapies.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The patent being issued by the USPTO will provide strong IP 
protection for Biohaven&#8217;s lead candidate in GAD. Biohaven expects to enter
initial clinical studies within a year.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We also have&#160;&#160;a wholly owned subsidiary, Portage 
Services Ltd.,(PSL) which was incorporated in Ontario, Canada under the name 
1843343 Ontario Inc. and changed its name to the present name on July 11, 2013. 
PSL acts as a local agent for the Company as per the requirements of the Ontario
Securities Commission. PSL maintains an office in Toronto, Canada and looks 
after all corporate, financials and regulatory matters.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We have developed a comprehensive website &#8211; <font 
style="DISPLAY: inline; TEXT-DECORATION: 
underline">www.portagebiotech.com</font>&#160;&#160;&#160;which provide 
information on our people, activities and other corporate details.</font><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; 
FONT-WEIGHT: bold">(C) ORGANIZATIONAL STRUCTURE</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Following diagram reflects our current organization 
structure:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><img src="flowchart2014.jpg" 
alt=""><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="left">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since the change of business 
strategy and acquisition of Portage Pharma Ltd in June 2013, as discussed in 
this report, the Company&#8217;s organizational structure changed 
significantly.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Effective June 4, 2013, Dr. Declan Doogan became the Chief 
Executive Officer (CEO), replacing Mr. Kam Shah who continues as Chief Financial
Officer. The two existing directors &#8211;Mr. Dean Bradley and Mr. Brett Rees 
resigned and were replaced by three new directors; Dr. Declan Doogan, Dr. 
Gregory Bailey and Mr. James Mellon. Mr. Kam Shah continues as the fourth 
director. These four directors were re-appointed in the shareholders annual and 
special meeting of March 7, 2014.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Effective June 4, 2013, a wholly owned subsidiary, PPL was 
created from merger of two subsidiaries.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">PPL management consisted of DR. Bruce Littman as CEO , Dr. 
Frank Marcoux as Chief Scientific Officer (CSO) and Mr. Kam Shah as CFO. The PPL
management reports to the PPL Board of directors comprising Dr. Doogan as 
Chairman, Dr. Bailey, Mr. Shah, Dr. Littman and DR. Marcoux. PPL also created a 
scientific advisory board (SAB) consisting of Dr. Sankar Ghosh, DR. Michael 
Caplan and DR. Burt Adelman. In addition, PPL has seven consultants comprising 
scientists and researchers.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Biohaven where the Company has approximately 54% has 
independent management comprising Dr. Declan Doogan&#160;&#160;as Executive 
Chairman and Dr. Robert Burman as CMO. Its board of directors comprise Dr. 
Doogan as Chairman, Dr. Bailey , Mr. Shah, Dr. Vlad Coric and Mr. Childs. Mr. 
Mellon and Dr. Berman are alternative directors. The SAB comprise Dr. John 
Krystal and Dr. Gerard Sanacora and Dr. Maurizio Fava.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">PSL is a Canadian subsidiary which provides regulatory and 
corporate services to the Company. Mr. Shah who is based in Toronto looks after 
all the services and was assisted by an assistant controller who resigned in 
July 2014. Mr. Shah works with Dr. Bailey and Dr. Doogan who provide the duel 
control on the operational matters.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">A brief biodata of the key&#160;&#160;people in our 
organization is provided below:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Declan Doogan M.D. &#8211; Director and 
CEO</font></div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Has more than 30 years&#8217; experience in the global 
pharmaceutical industry.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">He joined Pfizer in 1982, where he held a number of senior 
positions in R&amp;D in the USA, UK and Japan. He retired from Pfizer in 2007 as
the Senior VP Head of World Development. Subsequently</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Was interim CEO and CMO at Amarin.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Holds visiting professorships at Glasgow, Kitasato (Tokyo) and 
Cork Universities . He received his Medical degree from Glasgow 
University.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Kam Shah CA, CPA (CANADA), CPA (US), CGMA 
(US) &#8211;CFO and Director</font></div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Senior financial executive with over 25 years of corporate 
finance,</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Was senior manager with two of the largest accounting firms, 
Ernst &amp; Young and Price Waterhouse Coopers</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Worked in industry under various&#160;&#160;roles from an 
office manager to CEO, CFO of public companies.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gregory Bailey M.D. &#8211; 
Chairman</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Former director and financier of Medivation Inc. (MDVN: 
NASDAQ).</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Co-founder, of Ascent Healthcare Solutions: VirnetX Inc 
internet security (VHC: AMEX) and Duramedic Inc. a medical products 
company.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Has Medical Doctorate from the University of Western 
Ontario.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Jim Mellon &#8211; Director</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Director of multiple public companies: In the biopharma sector 
Miraculins, Plethora Solutions, and the Summit Corporation.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Chairman of AIM listed Port Erin Biopharma Investments, a fund 
specialising in biopharma investments</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The author of the best-selling book &#8220;Cracking the 
Code.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Other listed company directorships include chairman of Manx 
Financial Group and Speymill, co-chairman of both Regent Pacific Group and West 
African Mining Corporation, and a board member of Brazilian Gold Corporation, 
Charlemagne Capital and Condor Resources.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Bruce H. 
Littman, </font>MD &#8211; CEO</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Former Pfizer VP Global Translational Medicine</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Over 30 years pharmaceutical company and academic research 
experience</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Frank W. 
Marcoux</font>, Ph.D. - CSO</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Former Pfizer VP Quantitative and Innovative Medicine WW 
Development and former VP Biology Discipline WW Discovery</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Over 25 years pharmaceutical company and academic 
research</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Vlad Coric, 
MD&#160;&#160;</font>&#8211; Director</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Has over 14 years of clinical trial experience as the Chief of 
Inpatient Services at the Yale Clinical Neuroscience Research Unit.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">An Associate Clinical Professor of Psychiatry at the 
Yale</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">A co-inventor of Yale intellectual property related to the use 
of glutamate modulating agents</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Earned his medical degree at Wake Forest University School of 
Medicine, and received his BS from University of Connecticut in Physiology and 
Neurobiology.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Has over 45 peer-reviewed journal and book 
publications.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Robert 
Berman , MD - </font>CMO</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Almost 30 years of neuroscience research</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">13 years of clinical development experience (Pfizer and 
Bristol-Myers Squibb)</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Professor of Psychiatry (Adjunct), Yale School of 
Medicine</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Over 60 peer-reviewed publications &#8211;&#160;&#160;including
first clinical trial with ketamine in patients with depression and 
leading&#160;&#160;the registrational program to obtain the first indication for
a neuroleptic in the adjunctive treatment of major depressive 
disorder</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">BA, Molecular Biophysics and Biochemistry, Yale 
University</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">M.D., Mount Sinai School of Medicine</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">John Krystal, 
M.D.</font></div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Chairman of Psychiatry and Professor, Yale School of 
Medicine.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Expert in the areas of psychopharmacology, glutamatergic 
neurotransmission, alcoholism, schizophrenia, and post-traumatic stress 
disorders.&#160;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gerard Sanacora, M.D., Ph.D.</font></div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Professor of Psychiatry and Director of the Yale Depression 
Research Clinic</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Expert in elucidating the pathophysiological mechanisms 
associated with mood and other neuropsychiatric disorders.&#160;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Maurizio Fava M.D.</font></div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Director, MGH Clinical Research Program (CRP), Executive Vice 
Chair for the MGH Department of Psychiatry, Executive Director, MGH Clinical 
Trials Network and Institute, Director, and Slater Family Professor of 
Psychiatry at Harvard Medical School</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Expert in affective disorders and clinical trial design &#8211;
with over 600 original articles</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(D) PROPERTY PLANTS AND 
EQUIPMENT</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Our subsidiary, Portage Services Ltd., currently leases office 
space at 47 Avenue Road, Suite 200, and Toronto, Ontario, Canada for 
approximately $2,300 per month. The leased area is approximately 950 square 
feet. Our current lease agreement is a month to month arrangement.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 4A &#8211; UNRESOLVED STAFF 
COMMENTS</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">None.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 5 &#8211; OPERATING AND FINANCIAL REVIEW AND 
PROSPECTS</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A)&#160;&#160;OPERATING 
RESULTS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The following discussion should be read in conjunction with the
Audited Financial Statements of the Company and notes thereto contained 
elsewhere in this report.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Results of operations</font></div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="29%" style="BORDER-BOTTOM: black 4px double"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="top" width="19%" style="BORDER-BOTTOM: black 4px 
double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">March 31,2014</font></div>
</td>
<td align="right" valign="top" width="20%" style="BORDER-BOTTOM: black 4px 
double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">May 23, 2012 to</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">March 31, 2013</font></div>
</td>
<td valign="top" width="19%" style="BORDER-BOTTOM: black 4px double"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
</tr><tr>
<td valign="top" width="29%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="19%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">in 000' US $</font></div>
</td>
<td align="right" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">in 000' US $</font></div>
</td>
<td valign="top" width="19%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="29%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Expenses</font></div>
</td>
<td align="right" valign="top" width="19%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(6,627)</font></div>
</td>
<td align="right" valign="top" width="20%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">(29)</font></div>
</td>
<td valign="top" width="19%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
</tr><tr>
<td valign="top" width="29%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="19%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(6,627)</font></div>
</td>
<td align="right" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">(29)</font></div>
</td>
<td valign="top" width="19%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="29%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Non-controlling interests</font></div>
</td>
<td align="right" valign="top" width="19%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(322)</font></div>
</td>
<td align="right" valign="top" width="20%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="19%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
</tr><tr>
<td align="left" valign="top" width="29%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Net loss attributable to shareholders</font></div>
</td>
<td align="right" valign="top" width="19%" style="BORDER-BOTTOM: black 4px 
double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(6,305)</font></div>
</td>
<td align="right" valign="top" width="20%" style="BORDER-BOTTOM: black 4px 
double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">(29)</font></div>
</td>
<td valign="top" width="19%" style="BORDER-BOTTOM: black 4px double"><font
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
</tr><tr>
<td align="left" valign="top" width="29%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Deficit at end of year</font></div>
</td>
<td align="right" valign="top" width="19%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(6,334)</font></div>
</td>
<td align="right" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">(29)</font></div>
</td>
<td valign="top" width="19%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Overview</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Significant changes in the business strategy and organizational
changes are explained&#160;&#160;under item 4 (B) and (C) of this report. Three 
other operational matters consisted of&#160;&#160;reverse acquisition 
transaction, change in the functional and reporting currency and investment in 
Biohaven. These are further elaborated below:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="FONT-STYLE: italic; 
DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Reverse 
Acquisition Transaction</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">On June 4, 2013, the Company completed an acquisition with PPL 
pursuant to which a wholly owned subsidiary of the Company, Portage Acquisition 
Inc. and PPL amalgamated, resulting in the Company owning all of the issued and 
outstanding shares of the amalgamated entity.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Pursuant to a Share Exchange Agreement, Bontan issued 
81,759,076 common shares and 71,456,420 warrants to PPL shareholders in exchange
for PPL shareholders transferring all their shares in favour of Portage 
Acquisition Inc. Warrants can be exercised within two years at an exercise price
of US$0.29 to acquire an equal number of common shares of the Company. In 
addition, Bontan also issued 9,811,091 shares to a company as compensation for 
financial advisory services rendered in connection with the transaction. The 
fair value of these shares of $ 3,826,325 was expensed.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Although the transaction resulted in PPL becoming a wholly 
owned subsidiary of the Company, the transaction constitutes a reverse 
acquisition in as much as the shareholders of PPL own a substantial majority of 
the outstanding common shares of the Company and three out of four members of 
the Board of Directors of the Company are PPL shareholders. As a result, PPL 
controls the Company.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The transaction has therefore been accounted for as a reverse 
acquisition in accordance with guidance provided in International Financial 
Reporting Standards (&#8220;IFRS&#8221;) 3 <font style="FONT-STYLE: italic; 
DISPLAY: inline">Business Combinations</font> and IFRS 10 <font style="FONT-
STYLE: italic; DISPLAY: inline">Consolidated Financial 
Statements</font>.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">These consolidated financial statements include:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 0pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">a.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The assets and liabilities of PPL at their pre-acquisition 
carrying amounts as at&#160;&#160;March 31, 2014 and expenses for the year ended
on that date</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 0pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">b.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The assets and liabilities of Bontan as at March 31, 2014 and 
expenses from June 4, 2013 to March 31, 2014.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 0pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">c.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Share capital representing the total number of shares issued by
the Company.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 0pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">d.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Value of the share capital was computed by adding to the value 
of the share capital of PPL on the date of acquisition, June 4, 2013, the fair 
value of Bontan as allocated to shares issued on the date of acquisition, and 
adjusted to any exercise or issuance of shares, warrants and options during the 
year ended March 31, 2014.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 0pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">e.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Comparative figures are those of PPL.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The fair value of the consideration is determined based on the 
fair value of net assets acquired by PPL, which was computed as $2,869,815, as 
follows:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><br>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="38%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Cash</font></div>
</td>
<td align="right" valign="bottom" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;$3,006,593</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="38%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Office equipment and furniture</font></div>
</td>
<td align="right" valign="bottom" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;5,286</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="38%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;Other assets</font></div>
</td>
<td align="right" valign="bottom" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;153,963</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="38%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Liabilities</font></div>
</td>
<td align="right" valign="bottom" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;(296,027)</font></div>
</td>
</tr><tr>
<td valign="bottom" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="38%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Fair value of consideration</font></div>
</td>
<td align="right" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;2,869,815</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The fair value
of the consideration was allocated:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>To shares 
issued&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$1,761,413
</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>To warrants 
issued&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$1,108,402</font></div>
<br>
<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="FONT-STYLE: italic; 
DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Functional and 
presentation currency</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">On June 4, 2013, the Company did an analysis applying the 
primary and secondary indicators in IAS 21 and determined that, as a result of 
the reverse acquisition transaction discussed in Note 2 and change of its 
jurisdiction to BVI; its economic circumstances have changed. The Company is 
expected to incur substantially all expenses in US Dollars and expects future 
revenues in US Dollars.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The management therefore concluded that the US Dollar is the 
most appropriate functional currency for all operations. The Company has also 
decided to change its presentation currency to the US Dollar.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The effect of the above change in functional currency has been 
accounted for prospectively as provided under IAS 21 <font style="FONT-STYLE: 
italic; DISPLAY: inline">the effect of changes in foreign exchange rates</font>.
Accordingly, all Non-US dollar items were translated into US dollars using the 
exchange rate as of June 4, 2013. The resulting translated amounts for non-
monetary items were treated at their historical costs.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt">Investment in Biohaven</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Biohaven was incorporated in the British Virgin Island on 
September 25, 2013. Biohaven is engaged in the identification and development of
clinical stage neuroscience compounds targeting the glutamatergic system. 
Biohaven founders who held a worldwide license from Yale University to use 
intellectual property relating to the use of certain glutamate modulating agents
in the treatment of neuropsychiatric disorders, transferred it to Biohaven and 
acquired 9,400 shares of common stock of Biohaven.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">On January 6, 2014, the Company entered into Securities 
Purchase agreement and Stockholders agreement with Biohaven. Under the terms of 
these agreements, Portage was issued 11,504 shares&#160;&#160;at $304.24 per 
share for a total price of $ 3.5 million. Biohaven agreed to allow Portage to 
pay the purchase price in four installments - $1,750,000 on signing, $ 750,000 
on August 1, 2014, $ 500,000 on December 3, 2014 and the balance $ 500,000 on 
February 4, 2015. The first payment was made upon signing. The remaining 
payments, if not made on time, will result in Portage having to surrender its 
Biohaven shares proportionately.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">A new board of directors was appointed effective January 6, 
2014 which comprised five members, three of whom, Dr. Doogan, Dr. Bailey 
and&#160;&#160;Mr. Shah are the directors of&#160;&#160;Portage. Dr. 
Doogan&#160;&#160;is one of the founding shareholders of Biohaven.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Given that as at March 31, 2014, Portage held 11,504 shares out
of total issued shares of 21,304 &#8211; 54% equity and has three of its 
directors forming majority of directors on the board of Biohaven, the Company 
consolidated the results of Biohaven.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The consolidated expenses include Biohaven expenses of 
approximately $700,000 of which 46%&#160;&#160;or approximately $ 322,000 was 
attributed to non-controlling interest.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Interest of the non-controlling interests on the date of 
acquisition was valued at $ 3 million based on the their 46% equity being valued
on the basis of the price we paid for 54% equity in Biohaven. In absence of any 
net tangible assets in Biohaven on the date of the acquisition, the entire 
amount was treated as goodwill as per <font style="FONT-STYLE: italic; DISPLAY: 
inline">IFRS 3 &#8211; business combinations</font>.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Changes in the fair value of goodwill&#160;&#160;that result 
from additional information obtained during the measurement period (maximum one 
year from the acquisition date) about facts and circumstances that existed at 
the acquisition date will be adjusted retrospectively against goodwill. nO such 
adjustment was considered necessary as at March 31, 2014.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Expenses</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The overall analysis of the expenses is as follows: ( in 
000&#8217;$)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="39%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: 
black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="14%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended March 31, 2014</font></div>
</td>
<td align="right" valign="top" width="17%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">May 23, 2012 to March 31, 2013</font></div>
</td>
</tr><tr>
<td valign="top" width="39%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Acquisition related costs</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">3,839</font></div>
</td>
<td align="right" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Consulting fees</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-0.55pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1,162</font></div>
</td>
<td align="right" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-0.55pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Research &amp; development</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">$&#160;&#160;&#160;&#160;&#160;1,136</font></div>
</td>
<td align="right" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;27</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Professional fees</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">336</font></div>
</td>
<td align="right" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Other costs</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">154</font></div>
</td>
<td align="right" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2</font></div>
</td>
</tr><tr>
<td valign="bottom" width="39%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="14%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">$&#160;&#160;&#160;&#160;&#160;6,627</font></div>
</td>
<td align="right" valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;29</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Acquisition related 
costs</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Acquisition related costs include approximately $ 3.8 million 
paid to a company&#160;&#160;as compensation for financial advisory services 
rendered in connection the acquisition of Portage Pharma Ltd., detailed under 
Overview section of this report. This consists of issuance of approximately 9.8
million common shares of the Company on June 4, 2013 valued at $0.39 being the 
quoted market price of the common shares on the date of their 
issuance.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Approximately $ 13,000 fee was paid in cash to various 
independent consultant for due diligence on Biohaven, detailed under Overview 
section of this report<font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
WEIGHT: bold">&#160;</font>and other potential investment targets.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The cost was expensed as per IFRS 3.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consulting 
fees</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Fees include cash fee, shares and options issued to key 
management, directors and others as detailed in Note 11 to the consolidated 
financial statements for the year ended March 31, 2014.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">CFO was paid cash fee of $102,458. He along with the CEO and 
the chairman who provided business development and investor relations services 
were issued 4 million common shares valued at $691,000 based on the quoted 
market price of the shares on the dates of their issuance.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Four directors of the Company were also issued 2.9 million 
options , valid for five years and are convertible into equal number of common 
shares at a conversion price of $0.20 and are to be vested in equal monthly 
instalments over the year ending December 31, 2014. These options were valued 
at&#160;&#160;approximately&#160;&#160;$232,000 based on a Black-Scholes option 
pricing model.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Key management opted to accept shares and options instead of 
cash fee to ensure cash is available for outside consultants and for research 
and development costs.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research &amp; 
development</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">These costs comprised the following:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="46%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Year ended March 31, 2014</font></div>
</td>
<td valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">May 23, 2012 to March 31, 2013</font></div>
</td>
</tr><tr>
<td valign="top" width="46%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="19%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">in 000$</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">licenses fee</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">26</font></div>
</td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">patent registration (a)</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">29</font></div>
</td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Consulting fee ( c)</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">365</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">27</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">fee paid by Biohaven under a service contract (b)</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">500</font></div>
</td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Other outside services - lab tseting, peptide production 
etc.</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">215</font></div>
</td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="46%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$&#160;&#160;1,135</font></div>
</td>
<td align="right" valign="top" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$&#160;&#160;&#160;&#160;27</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(a)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Company&#8217;s subsidiary PPL paid the license fee to a non 
related entity in respect of ANTP license under License Agreement dated January 
25, 2013.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(b)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Biohaven has signed a Master Service Agreement on January 31, 
2014, as subsequently amended in April 2014, with Biohaven Pharmaceuticals Inc, 
a private Delaware incorporated research and development company 
(&#8220;BPI&#8221;). BPI is owned by non-controlling shareholders of Biohaven 
and is engaged by Biohaven to conduct, on behalf of Biohaven, research and 
development services relating to identification and development of clinical 
stage neuroscience compounds targeting the glutamatergic system.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE:
10pt">(c)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Consulting fee includes fees totaling to approximately $306,000
paid to the CEO and CSO of PPL . Fee includes value of the vested options of 
approximately $57,000 and balance in cash.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Professional 
fees</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Professional fees consisted of Audit and related fee of 
approximately $47,000 and legal fee of approximately $289,000. There were no 
legal fees during the period from May 23, 2012 to March 31, 2013.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Legal fee includes approximately $181,000 relating to legal 
work charged to Biohaven.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">A relatively high legal fee for the year ended March 31, 2014 
was largely due to costs of incorporations in the British Virgin Islands, 
jurisdictional changes, initiations of various documents relating to acquisitons
and service contracts, which had to go through several amendments and extensive 
negotiations and general regulatory services.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Liqui
dity and Capital Resources</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Working 
Capital</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">As at March 31, 2014, the Company had a net working capital of 
approximately $2.1 million compared to a working capital of 
approximately&#160;&#160;$470,000 as at March 31, 2013. The increase in working 
capital is largely due to cash of approximately $ 3 million received on 
acquisition accounted for as reverse acquisition as explained under Overview 
section of this report.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Operating cash 
flow</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">During the fiscal year 2014, operating activities required a 
net cash outflow of approximately $1.9 million, which primarily include research
and development costs of approximately $ 1.1 million incurred by its operating 
subsidiaries &#8211; PPL and Biohaven. The balance comprised mainly legal costs 
and consulting.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">During the fiscal period May 23, 2012 to March 31, 2013, 
operating activities required a net cash outflow of approximately $17,000 mainly
due to consulting fee.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Operating costs were met from the cash received on acquisition 
as explained above.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company is in pre-clinical stage and is required to perform
further research and development and also fulfil its financial obligation of $ 
1,750,000 to Its subsidiary, Biohaven to retain its 54% equity in Biohaven. The 
Company has not yet determined whether costs incurred and to be incurred are 
economically recoverable. The Company's continuing operations are dependent upon
any one of:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">1. the existence of economically recoverable medical or 
industrial solutions;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">2. the ability of the Company to obtain the necessary financing
to complete the research; or</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">3. future profitable production from, or proceeds from the 
disposition of intellectual property.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Although there are no assurances that management's plan will be
realized, management believes the Company will be able to secure the necessary 
financing to continue operations into the future. However, the consolidated 
financial statements for the year ended March 31, 2014 includes a going concern 
note which reflects need for further financing to continue our planned research 
and development work and operating needs of all our subsidiaries.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Investing cash 
flows</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">There were no investing activities in the reporting 
periods.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financing cash 
flows</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">During the year ended March 31, 2014, the Company had a net 
cash inflow of approximately $3.8 million from its financing 
activities.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Approximately $ 3 million was received as a result of 
acquisition as more fully explained under Overview section of this report. The 
Company also realized approximately $ 295,000 from the PPL shareholders towards 
their capital commitment made in prior period and $ 474,000 were received from 
exercise of options and warrants by the Company&#8217;s 
shareholders.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The net cash inflow during the period from May 23, 2012 to 
March 31, 2013 was approximately $ 208,000&#160;&#160;representing capital 
contribution by the PPL shareholders.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;
(C)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;RESEARCH 
AND DEVELOPMENT, PATENTS AND LICENSES</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">From May 23, 2012 to date , the Company through its operating 
subsidiaries is engaged in pre-clinical studies as detailed under Item 4 (B) 
business overview of this report. Research and development expenses analysis and
details are provided under Item 5 (A) of this report. All research and 
development expenses are expensed as they are incurred.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">PPL holds <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: 
inline">an exclusive licence in non-oncology fields under patents granted in the
USA, Australia, Israel and New Zealand and patents applied for in Japan and 
Canada, and an exclusive worldwide licence in non-oncology fields and the know-
how relating to the Antennapedia protein (ANTP) transduction technology 
developed by Trojantec for non-oncology products, treatments or 
medications.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">PPL also filed the following two patents during the fiscal year
2014:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(a)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Cargo Peptides and Uses for Antennapedia Homeodomain-based 
Protein Biological Drugs &#8211; new provisional patent for Antennapedia 
structures and indications.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(b)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Structure, Manufacturing and uses of Human-derived Cell-
Permeable Peptides Conjugated with Special Biologically Active Cargo Peptides 
&#8211; Converted 2013 provisional patent into an international patent for our 
own proprietary human-derived cell permeable peptides to maintain June 11, 2013 
priority date with addition of more specific examples with supporting animal 
data, new specific structures, indications and manufacturing 
details.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Biohaven holds an exclusive license from Yale University 
regarding the use of certain glutamate modulating agents in neuropsychiatric 
disorders.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">In May 2014, Biohaven has been issued by the U.S. Patent and 
Trademark Office (&#8220;USPTO&#8221;) a notice of allowance related to 
Biohaven&#8217;s intellectual property licensed from Yale University (U.S. 
Patent Application No. 11/399,188).&#160;&#160;The patent claims cover the use 
of certain glutamate modulating agents in the treatment of Generalized Anxiety 
Disorder (GAD).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">D)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;TREND 
INFORMATION</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">There are no other trends, commitments, events or uncertainties
presently known to management that are reasonably expected to have a material 
effect on the Company&#8217;s business, financial condition or results of 
operation other than as disclosed elsewhere in this report (Refer to the heading
entitled &#8220;Risk Factors&#8221;).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">(E)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;OFF-
BALANCE SHEET ARRANGEMENTS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">At March 31, 2014, and 2013, the Company did not have any off 
balance sheet arrangements, including any relationships with unconsolidated 
entities or financial partnership to enhance perceived liquidity.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">(F)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CONTR
ACTUAL OBLIGATIONS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">None.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">(G)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SAFE 
HARBOUR</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Not applicable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 6 &#8211; DIRECTORS, SENIOR MANAGEMENT AND 
EMPLOYEES</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A)&#160;&#160;DIRECTORS AND SENIOR 
MANAGEMENT</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The following sets forth the names and province or state and 
country of residence of our directors and executive officers, the offices held 
by them in the Corporation, their current principal occupations, all as of July 
24, 2014, the date of this report, their principal occupations during the last 
five years and the month and year in which they became directors or officers. 
The term of each director expires on the date of our next annual 
meeting.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="17%" style="BORDER-BOTTOM: black 2px solid;
BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Name, Province/State and Country of Residence and Present 
Position with Portage (1)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
<td valign="top" width="20%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: 
black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Date became Director/Officer</font></div>
</td>
<td valign="top" width="42%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: 
black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Principal Occupation Last five years</font></div>
</td>
</tr><tr>
<td valign="top" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Dr. Gregory Bailey (2)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">London, UK</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Chairman of the Board of Director</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
<td valign="top" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">June 4, 2013</font></div>
</td>
<td valign="top" width="42%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">See brief biography below</font></div>
</td>
</tr><tr>
<td valign="top" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Dr. Declan Doogan</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Stonington, CT, USA</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Chief Executive Officer and Director</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
<td valign="top" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">June 4, 2013</font></div>
</td>
<td valign="top" width="42%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">See brief biography below</font></div>
</td>
</tr><tr>
<td valign="top" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Mr. Jim Mellon (2) (3)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Isle of Man</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Director</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
<td valign="top" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">June 4, 2013</font></div>
</td>
<td valign="top" width="42%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">See brief biography below</font></div>
</td>
</tr><tr>
<td valign="top" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Mr. Kam Shah (2)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Ontario, Canada</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Director and Chief Financial Officer</font></div>
</td>
<td valign="top" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">January 3, 1999</font></div>
</td>
<td valign="top" width="42%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">May 17, 2004 &#8211; June 4, 2013 &#8211; Chief Executive 
Officer of Bontan,</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">March 9, 2010 till date &#8211; Sole director, CEO/CFO of ZD 
Ventures Corporation</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(1)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Neither age nor date of birth of directors or executive 
officers is required to be reported in our home country nor otherwise publicly 
disclosed.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(2)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Member of the Audit and Compensation Committee. Mr. Jim Mellon 
is the Chair of this Committee.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(3)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Independent directors</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The following are short biographies of our directors and 
executive officers:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Gregory Bailey
M.D. </font>is a co-founder and Chief Business Officer of Portage Pharma Ltd. 
Co-founder of Ascent Healthcare Solutions, the #1 re-processor of used surgical 
equipment; VirnetX Inc. (VHC: AMEX), internet security; and Duramedic Inc., a 
medical products company. He is a former financier of Medivation Inc. (MDVN: 
NASDAQ) and was a director from 2005 to 2012.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Declan Doogan 
M.D. </font>is the co-founder and Chairman of Portage Pharma Ltd., Previously 
the CEO and Head of R&amp;D at Amarin Inc. (AMRN:NASDAQ) and the former Head of 
Worldwide Drug Development at Pfizer Inc. He has held Visiting Professorships at
Harvard School of Public Health, Glasgow University Medical School and Kitasato 
University (Tokyo) and sits on the boards of Pulmonary Vascular Research 
Institute UK, Sosei (Japan Biotech), Trojantec (UK, oncology) and Spinifex 
(Melbourne). He continues to provide medical advice to Amarin Inc.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Jim 
Mellon</font>: co-founder of Portage Pharma Ltd. Jim holds directorships in a 
number of publicly quoted companies, many of which are in the biopharma sector 
including Miraculins, Plethora Solutions, and the Summit Corporation. He is also
chairman of AIM listed Port Erin Biopharma Investments, a fund specialising in 
biopharma investments and is the author of the best-selling book &#8220;Cracking
the Code&#8221; which charts the developments within the biotech industry. 
Jim&#8217;s other listed company directorships include chairman of Manx 
Financial Group and Speymill, co-chairman of both Regent Pacific Group and West 
African Mining Corporation, and a board member
of Brazilian Gold Corporation, Charlemagne Capital and Condor 
Resources.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Kam 
Shah</font> worked with PricewaterhouseCoopers LLP and Ernst &amp; Young. He is 
a US Certified Public Accountant and a Canadian Chartered 
Accountant.&#160;&#160;He has over fifteen years of international experience in 
corporate financial analysis, mergers &amp; acquisitions.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Family 
Relationships</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">There are no family relationships between the directors and
executive officers.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other Relationships</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">There are no arrangements or understandings between any major 
shareholder, customer, supplier or others, pursuant<font style="DISPLAY: inline;
FONT-FAMILY: Times New Roman">&#160;</font>to which any of the above-named 
persons were selected as directors or members of senior management except that 
as per the terms of the Share Exchange Agreement with Portage Pharma 
Ltd&#160;&#160;dated&#160;&#160;May 21, 2013. Board of Director of Portage will 
nominate Mr. Kam Shah as director for at least three years and Mr. Shah will be 
employed as CFO for the term of two years and in a mutually acceptable capacity 
for the third year.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(B)&#160;&#160;COMPENSATION</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The compensation payable to directors and officers of the 
Company and its subsidiary is summarized below:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Genera
l</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company does not compensate directors for acting solely as 
directors. Except as described below, the Company does not have any arrangements
pursuant to which directors are remunerated by the Company or its subsidiary for
their services in their capacity as directors, other than options to purchase 
shares of the Company which may be granted to the Company&#8217;s directors from
time to time and the reimbursement of direct expenses.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company does not have any pension plans.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Statem
ent of Executive Compensation</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The following table and accompanying notes set forth all 
compensation paid by the Company to its directors, senior management and key 
consultants for the fiscal years ended March 31, 2014, 2013. Since the 
acquisition of Portage Pharma Ltd has been accounted as reverse acquisition as 
explained earlier in this report, details for the prior period related to 
Portage pharma Ltd which was incorporated on May 23, 2012</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 1pt solid"><font style="DISPLAY: inline; FONT-FAMILY: 
times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="4" valign="bottom" width="25%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 1pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">ANNUAL COMPENSATION</font></div>
</td>
<td colspan="3" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 1pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">LONG-TERM COMPENSATION</font></div>
</td>
<td align="left" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 1pt solid"><font style="DISPLAY: inline; FONT-FAMILY: 
times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td align="left" valign="bottom" width="3%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE:
10pt">&#160; </font></td>
<td align="left" valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td align="left" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td align="left" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Awards</font></div>
</td>
<td align="left" valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Payouts</font></div>
</td>
<td align="left" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
</tr><tr>
<td align="left" valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Name and principal position</font></div>
</td>
<td align="left" valign="bottom" width="3%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year</font></div>
</td>
<td align="left" valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fee (3)</font></div>
</td>
<td align="left" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Bonus</font></div>
</td>
<td align="left" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other annual compensation(6)</font></div>
</td>
<td align="left" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Securities under options/SARs Granted (1)
&amp; (4)</font></div>
</td>
<td align="left" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shares or units subject to resale 
restrictions (4)</font></div>
</td>
<td align="left" valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">LTIP (2) payouts</font></div>
</td>
<td align="left" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">all other compensation (5)</font></div>
</td>
<td align="left" valign="middle" width="8%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total compensation</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td align="left" valign="bottom" width="3%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td align="left" valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">($)</font></div>
</td>
<td align="left" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">($)</font></div>
</td>
<td align="left" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">($)</font></div>
</td>
<td align="left" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="left" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">($)</font></div>
</td>
<td align="left" valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">($)</font></div>
</td>
<td align="left" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">($)</font></div>
</td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">($)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Declan Doogan</font></div>
</td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">CEO</font></div>
</td>
<td align="right" valign="middle" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2014</font></div>
</td>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td valign="middle" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">135,743</font></div>
</td>
<td align="right" valign="middle" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">270,000</font></div>
</td>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">405,743</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">CEO</font></div>
</td>
<td align="right" valign="middle" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2013</font></div>
</td>
<td align="right" valign="middle" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;-</font></div>
</td>
<td valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Kam Shah</font></div>
</td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">CFO</font></div>
</td>
<td align="right" valign="bottom" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2014</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">253,458</font></div>
</td>
<td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">67,871</font></div>
</td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">321,329</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gregory Bailey</font></div>
</td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Chairman/Business development</font></div>
</td>
<td align="right" valign="bottom" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2014</font></div>
</td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">135,743</font></div>
</td>
<td align="right" valign="bottom" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">270,000</font></div>
</td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">405,743</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Chairman/business development</font></div>
</td>
<td align="right" valign="bottom" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2013</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;-</font></div>
</td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">James Mellon</font></div>
</td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Independent director</font></div>
</td>
<td align="right" valign="bottom" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2014</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">54,297</font></div>
</td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">54,297</font></div>
</td>
</tr><tr>
<td valign="bottom" width="17%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt">Notes:</font></div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New 
Roman; FONT-SIZE: 10pt">1.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: 
Times New Roman; FONT-SIZE: 10pt">&#8220;SAR&#8221; means stock appreciation 
rights. The Company never issued any SARs</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New 
Roman; FONT-SIZE: 10pt">2.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: 
Times New Roman; FONT-SIZE: 10pt">&#8220;LTIP&#8221; means long term incentive 
plan.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New 
Roman; FONT-SIZE: 10pt">3.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: 
Times New Roman; FONT-SIZE: 10pt">Fee includes issuance of 1 million shares to 
Mr. Shah valued at $151,000.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New 
Roman; FONT-SIZE: 10pt">4.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: 
Times New Roman; FONT-SIZE: 10pt">Consists of 1.5 million restricted shares each
to Dr. Doogan and Dr. Bailey valued at $270,000 each for services rendered. 
Restrictive legend can only be removed by either filing a registration statement
or seeking exemption under Rule 144 of the Securities Act.</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New 
Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">5.</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Total of 2.9 
million options were issued to the four key executives. One million each to Dr. 
Doogan and Dr. Bailey, 500,000 to Mr. Shah and 400,000 to Mr. Mellon. 
</font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">. </font><font style="FONT-STYLE: italic; DISPLAY: 
inline">These options are valid for five years and are convertible into equal 
number of common shares of the Company at an exercise price of $0.20 per common 
share. The Options were registered with the US Securities and Exchange 
Commission on December 19, 2013 and will vest in equal instalment over the 
twelve months ending December 31, 2014.</font></font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Long Term Incentive Plan (LTIP) 
Awards</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company does not have a LTIP, pursuant to which cash or 
non-cash compensation intended to serve as an incentive for performance (whereby
performance is measured by reference to financial performance or the price of 
the Company&#8217;s securities) was paid or distributed to the Named Executive 
Officers during the most recently completed financial year.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Defined Benefit or Actuarial Plan 
Disclosure</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">There is no pension plan or retirement benefit plan that has 
been instituted by the Company and none are proposed at this time.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Indebtedness of Directors, Executive 
Officers and Senior Officers</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">None.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Directors&#8217; and Officers&#8217; 
Liability Insurance</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company has purchased, at its expense, directors and 
officers liability insurance policy to provide insurance against possible 
liabilities incurred by them in their capacity as directors and officers of the 
Company.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(C)&#160;&#160;BOARD PRACTICES</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Directors may be appointed at any time in accordance with the 
by-laws of the Company and then re-elected annually by the shareholders of the 
Company. Directors receive no compensation for serving as such, other than stock
option and reimbursement of direct expenses. Officers are elected annually by 
the Board of Directors of the Company and serve at the discretion of the Board 
of Directors.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company has not set aside or accrued any amount for 
retirement or similar benefits to the directors.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Mandate of the Board</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Board has adopted a mandate, in which it has explicitly 
assumed responsibility for the stewardship of Portage. In carrying out its 
mandate the Board holds at least one meeting every month. The frequency of 
meetings, as well as the nature of the matters dealt with, will vary from year 
to year depending on the state of our business and the opportunities or risks, 
which we face from time to time. The Board held a total of 12 meetings, mostly 
by way of conference calls, during our financial year ended March 31, 2014. 
&#160;To assist in the discharge of its responsibilities, the Board has 
designated one standing committee: an Audit and Compensation Committee effective
June 27, 2013.as more particularly discussed
below.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Audit and Compensation Committee 
(&#8220;ACC&#8221;)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The members of the ACC consist of Jim Mellon, Greg Bailey and 
Kam Shah. Jim Mellon and Greg Bailey are the independent directors and Kam Shah 
is an executive director. Jim Mellon is the chairman of the Committee. The ACC 
was approved in the board meeting on June 27, 2013.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Two new Charters were adopted on June 27, 2013 &#8211; Charter 
of the ACC relating to compensation matters and Charter of the ACC relating to 
Audit matters. These Charters are included in the Exhibits to this 
report.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The ACC relating to audit matters&#160;&#160;is charged with 
overseeing the Company's accounting and financial reporting policies, practices 
and internal controls. The committee reviews significant financial and 
accounting issues and the services performed by and the reports of our 
independent auditors and makes recommendations to our Board of Directors with 
respect to these and related matters.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Audit Committee charter assists the Board in fulfilling its 
responsibilities for our accounting and financial reporting practices 
by:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">reviewing the quarterly and annual consolidated financial 
statements and management discussion and analyses;</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">meeting at least annually with our external 
auditor;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">reviewing the adequacy of the system of internal controls in 
consultation with the chief executive and financial officer;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">reviewing any relevant accounting and financial matters 
including reviewing our public disclosure of information extracted or derived 
from our financial statements;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">establishing procedures for the receipt, retention and 
treatment of complaints received by us regarding accounting, internal controls 
or auditing matters and the confidential, anonymous submission by employees of 
concerns regarding questionable accounting or auditing matters;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">pre-approving all non-audit services and recommending the 
appointment of external auditors; and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">reviewing and approving our hiring policies regarding personnel
of our present and former external auditor</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Reviewing and approving all employee and consultants contracts,
bonuses and other compensation matters</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">A CC Charter relating to compensation matters will monitor 
incentive and equity based compensation plans for the executives based on their 
periodic performance evaluation.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Corporate Governance Committee</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company does not have a separate corporate governance 
committee. The management in conjunction with the ACC has developed and updated 
corporate governance practices and policies, code of ethics and corporate 
disclosure policy which form part of our internal control over financial 
reporting manual. The goal is to provide a mechanism that can assist in our 
operations, including but not limited to, the monitoring of the implementation 
of policies, strategies and programs and the development, continuing assessment 
and execution of the Company&#8217;s strategic plan.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(D)&#160;&#160;EMPLOYEES</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company presently has no&#160;&#160;employee. It uses the 
services of consultants from time to time.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(E)&#160;&#160;SHARE OWNERSHIP</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company usually creates two Plans, Consultants Stock 
Compensation Plan and Stock Option Plan.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">As at July 24, 2014, the date of this report, the Company had 
one active Consultants Stock Compensation Plan and two active Stock Option 
Plans.&#160;&#160;Details of these Plans and movements therein during the fiscal
2014 are given in Notes 6(e) and 7(b) respectively to the consolidated financial
statements for the fiscal 2014.&#160;&#160;As of the date of this report, there 
were 4,061,667 common shares registered under the Consultants Stock Compensation
Plan and not yet allotted, and 5,010,000 outstanding options under the Stock 
Option Plans.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The objective of these stock plans is to provide for and 
encourage ownership of our common shares by our directors, officers, consultants
and employees and those of any subsidiary companies so that such persons may 
increase their stake in our company and benefit from increases in the value of 
the common shares. The Plans are designed to be competitive with the benefit 
programs of other companies in the</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">natural resource industry. It is the view of management that 
the plans are a significant incentive for the directors, officers, consultants 
and employees to continue and to increase their efforts in promoting our 
operations to the mutual benefit of both our company and such individuals and 
also allows us to avail of the services of experienced persons with minimum cash
outlay.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The following table sets forth the share ownership of our 
executive officers and directors as at July 24, 2014:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="bottom" width="22%" style="BORDER-BOTTOM: black 4px 
double; BORDER-TOP: black 1pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common Shares</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Beneficially Owned</font></div>
</td>
<td valign="bottom" width="2%" style="BORDER-TOP: black 1pt solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td colspan="5" valign="bottom" width="38%" style="BORDER-BOTTOM: black 4px 
double; BORDER-TOP: black 1pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Options and Warrants 
Exercisable</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">for Common Shares</font></div>
</td>
</tr><tr>
<td valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Name</font></div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number</font></div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Percentage *</font></div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number</font></div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;
</font></td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exercise price - in US$</font></div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Expiry date(s)</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="15%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Kam Shah</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2,359,131</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1.31%</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">200,000</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">O</font></div>
</td>
<td align="right" valign="middle" width="13%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.35</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">18-Aug-15</font></div>
</td>
</tr><tr>
<td valign="middle" width="15%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="10%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="10%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">500,000</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">O</font></div>
</td>
<td align="right" valign="middle" width="13%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.20</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">12-Dec-18</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="15%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Declan Doogan</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">27,711,068</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">15.33%</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">22,908,149</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">W</font></div>
</td>
<td align="right" valign="middle" width="13%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.29</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">06- June- 15</font></div>
</td>
</tr><tr>
<td valign="middle" width="15%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="10%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="10%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1,000,000</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">O</font></div>
</td>
<td align="right" valign="middle" width="13%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.20</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">12-Dec-18</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="15%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Greg Bailey</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">27,711,068</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">15.33%</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">22,908,149</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">W</font></div>
</td>
<td align="right" valign="middle" width="13%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.29</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">06- June- 15</font></div>
</td>
</tr><tr>
<td valign="middle" width="15%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="10%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="10%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1,000,000</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">O</font></div>
</td>
<td align="right" valign="middle" width="13%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.20</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">12-Dec-18</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="15%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">James Mellon</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">26,211,068</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">14.50%</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">22,908,149</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="13%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.29</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">06- June- 15</font></div>
</td>
</tr><tr>
<td valign="middle" width="15%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="10%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="10%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">400,000</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">O</font></div>
</td>
<td align="right" valign="middle" width="13%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.20</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">12-Dec-18</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">* Based on 180,775,790 issued and outstanding common shares at 
July 24, 2014</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">O = Options and W= warrants</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">All shares and options held by the above persons carry same 
rights as the other holders of the Common shares of the Company.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 7 &#8211; MAJOR SHAREHOLDERS AND RELATED PARTY 
TRANSACTIONS</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A)&#160;&#160;MAJOR 
SHAREHOLDERS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company's securities are recorded on the books of its 
transfer agent in registered form. The majority of such shares are, however, 
registered in the name of intermediaries such as brokerage houses and clearing-
houses on behalf of their respective clients. The Company does not have 
knowledge of all the beneficial owners thereof.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">As at July 24, 2014, Intermediaries like CDS &amp; Co, Toronto,
Canada and Cede &amp; Co of New York, USA held approximately 44% of the issued 
and outstanding common shares of the company on behalf of several beneficial 
shareholders whose individual holdings details were not available.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At July 24, 2014, the Company had
180,775,790 shares of common stock outstanding, which, as per the details 
provided by the Transfer Agents, were held by 95 record holders excluding the 
beneficial shareholders held through the intermediaries.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The following table sets forth persons known by us to be 
beneficial owners of more than 5% of our common shares as of July 24, 2014.<font
style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#160;</font>Beneficial 
ownership of shares is determined under rules of the SEC and generally includes 
any shares over which a person exercises sole or shared voting or investment 
power. Shares subject to options and warrants that are currently exercisable or 
exercisable within 60&#160;days of the date of this prospectus are deemed to be
outstanding and beneficially owned by the person holding the option and 
warrant.&#160;&#160;These shares, however, are not deemed outstanding for the 
purpose of computing the percentage
ownership of any other person.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="20%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Name of 
Beneficial Owner</font></font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">No. of 
Shares</font></font></div>
</td>
<td valign="top" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Percentage of 
Shares</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Declan Doogan</font></div>
</td>
<td align="left" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">51,202,548 (1)</font></div>
</td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">20%</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Greg Bailey</font></div>
</td>
<td align="left" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">51,202,548 (1)</font></div>
</td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">20%</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">James Mellon</font></div>
</td>
<td align="left" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">49,352,548 (2)</font></div>
</td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">20%</font></div>
</td>
</tr><tr>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(1)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Includes&#160;&#160;23,491,480&#160;&#160;shares issuable
upon exercise of warrants and vested options</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(2)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Includes&#160;&#160;23,141,480&#160;&#160;shares issuable upon 
exercise of warrants and vested options</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company is a publicly owned BVI corporation, the shares of 
which are owned by Canadian residents, US residents, and residents of other 
countries. The Company is not owned or controlled directly or indirectly by 
another corporation or any foreign government. There are no arrangements, known 
to the Company, the operation of which may at a subsequent date result in a 
change of control of the Company.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(B) RELATED PARTY TRANSACTIONS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Transactions with related parties are incurred in the normal 
course of business and are measured at the exchange amount, which is the amount 
of consideration established and agreed to between the related parties. Related 
party transactions and balances have been listed below, unless they have been 
disclosed elsewhere in the consolidated financial statements for the year ended 
March 31, 2014.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 27pt; MARGIN-LEFT: 27pt"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i)</font><font id="TAB2" 
style="LETTER-SPACING: 9pt; COLOR: black">&#160;</font><font style="DISPLAY: 
inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Business expenses of 
$12,786 were reimbursed to directors of the Company.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 27pt; MARGIN-LEFT: 27pt"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii)</font><font id="TAB2"
style="LETTER-SPACING: 9pt; COLOR: black">&#160;</font><font style="DISPLAY: 
inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consulting fees include 
cash fee paid to key management for services of $102,458</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(C) INTERESTS OF EXPERTS AND 
COUNSEL</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Not applicable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 8 &#8211; FINANCIAL INFORMATION</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A) CONSOLIDATED STATEMENTS AND OTHER 
FINANCIAL INFORMATION</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financial Statements</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Information regarding our financial statements is contained 
under Item18 of this Annual Report.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Legal Proceedings</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company has no pending legal claims as of 
today.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Dividend 
Policy</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Since its incorporation, the Company has not declared or paid, 
and has no present intention to declare or to pay in the foreseeable future, any
cash dividends with respect to its Common Shares. Earnings will be retained to 
finance further growth and development of the business of the Company. However, 
if the Board of Directors declares dividends; all Common Shares will participate
equally in the dividends, and, in the event of liquidation, in the net assets, 
of the Company.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(B)&#160;&#160;SIGNIFICANT 
CHANGES</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Subsequent events have been evaluated through July 24, 2014, 
the date of this report. There were no major events which could have any bearing
on the consolidated financial statements for the eyar ended March 31, 
2014.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 9 - THE OFFER AND LISTING</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A)&#160;&#160;OFFER AND LISTING 
DETAILS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The following tables set forth the reported high and low sale 
prices for our common shares as quoted on OTC Quotation Board.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The following table outlines the annual high and low market 
prices for the five most recent fiscal years:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="54%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Fiscal year 
ended March 31</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2014</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">High</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: 
inline">(US$)</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.42</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Low</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: 
inline">(US$)</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.06</font></div>
</td>
</tr><tr>
<td valign="middle" width="54%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2013</font></div>
</td>
<td valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.16</font></div>
</td>
<td valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.01</font></div>
</td>
</tr><tr>
<td valign="middle" width="54%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2012</font></div>
</td>
<td valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.18</font></div>
</td>
<td valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.02</font></div>
</td>
</tr><tr>
<td valign="middle" width="54%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="middle" width="54%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2011</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2010</font></div>
</td>
<td valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.40</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.45</font></div>
</td>
<td valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.07</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.06</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The following table outlines the high and low market prices for
each fiscal financial quarter for the two most recent fiscal periods and any 
subsequent period:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="34%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline">Fiscal Quarter 
ended</font></font></div>
</td>
<td valign="middle" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">High</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Low</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="34%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline">In US$</font></font></div>
</td>
<td valign="middle" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline">In US$</font></font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">June 30, 2014</font></div>
</td>
<td valign="middle" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.12</font></div>
</td>
<td valign="middle" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.09</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">March 31, 2014</font></div>
</td>
<td valign="middle" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.23</font></div>
</td>
<td valign="middle" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.08</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">December 31, 2013</font></div>
</td>
<td valign="middle" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.30</font></div>
</td>
<td valign="middle" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.16</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">September 30, 2013</font></div>
</td>
<td valign="middle" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.38</font></div>
</td>
<td valign="middle" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.22</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">June 30, 2013</font></div>
</td>
<td valign="middle" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.42</font></div>
</td>
<td valign="middle" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.15</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">March 31, 2013</font></div>
</td>
<td valign="middle" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.16</font></div>
</td>
<td valign="middle" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.07</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">December 31, 2012</font></div>
</td>
<td valign="middle" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.11</font></div>
</td>
<td valign="middle" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.04</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">September 31, 2012</font></div>
</td>
<td valign="middle" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.06</font></div>
</td>
<td valign="middle" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.01</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">June 30, 2012</font></div>
</td>
<td valign="middle" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.04</font></div>
</td>
<td valign="middle" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.02</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The following table outlines the high and low market prices for
each of the most recent six months:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="37%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline">Month</font></font></div>
</td>
<td align="left" valign="middle" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">High</font></div>
</td>
<td align="left" valign="middle" width="12%" style="BORDER-BOTTOM: black 2px
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Low</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="37%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline">In US$</font></font></div>
</td>
<td align="left" valign="middle" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline">In US$</font></font></div>
</td>
</tr><tr>
<td valign="middle" width="37%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="37%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">June 2014</font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.11</font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.09</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="37%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">May 2014</font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.11</font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.09</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="37%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">April 2014</font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.<font style="DISPLAY: inline; FONT-FAMILY: times new 
roman">12</font></font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.<font style="DISPLAY: inline; FONT-FAMILY: times new 
roman">09</font></font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="37%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">March 2014</font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.17</font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.<font style="DISPLAY: inline; FONT-FAMILY: times new 
roman">06</font></font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="37%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">February 2014</font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.19</font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.13</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="37%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">January 2014</font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.<font style="DISPLAY: inline; FONT-FAMILY: times new 
roman">24</font></font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.<font style="DISPLAY: inline; FONT-FAMILY: times new 
roman">13</font></font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><br>
&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(B)&#160;&#160;PLAN OF 
DISTRIBUTION</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Not applicable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(C)&#160;&#160;MARKETS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company&#8217;s common shares currently trade in two 
places</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">On OTC Quotation Board under the trading symbol 
&#8220;PTGEF&#8221;. The shares have been traded on OTCQB since 
2000.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Effective October 28, 2013, the Company&#8217;s shares are also
listed for trading in US currency on the Canadian Securities Exchange (formerly,
Canadian National Stock Exchange) under the symbol 
&#8220;PBT.U&#8221;.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(D)&#160;&#160;SELLING 
SHAREHOLDERS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Not applicable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(E)&#160;&#160;DILUTION</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Not applicable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(F)&#160;&#160;EXPENSES OF THE 
ISSUE</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Not applicable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 10 &#8211; ADDITIONAL 
INFORMATION</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A)&#160;&#160;SHARE CAPITAL</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">This Form 20F is being filed as an Annual Report under the 
Exchange Act and, as such, there is no requirement to provide any information 
under this section.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(B)&#160;&#160;MEMORANDUM AND ARTICLES
OF ASSOCIATION</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">General</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Effective July 5, 2013, The Company moved its jurisdiction from
Ontario to British Virgin Islands.&#160;&#160;our affairs are therefore governed
by the provisions of our memorandum of association and articles of association, 
as adopted on becoming a BVI corporation, and by the provisions of applicable 
British Virgin Islands law.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Pursuant to our Memorandum and Articles of Association, 
we are authorized to issue a unlimited number of ordinary shares of no par value
of which 180,775,790 shares are issued and outstanding.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The following are summaries of material terms and provisions of
our Memorandum and Articles of Association and the BVI&#160;Act, insofar as they
relate to the material terms of our ordinary shares. Unless otherwise stated, 
the following summaries are of the terms of our shares as of the date of this 
annual report. This summary is not intended to be complete, and you should read 
the form of our Memorandum and Articles of Association, which has been filed as 
an exhibits to this report.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Meetings of shareholders</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">If our shareholders want us to hold a meeting of shareholders 
of the company, they may requisition the directors to hold one upon the written 
request of shareholders entitled to exercise at least 10% of the voting rights
in respect of the matter for which the meeting is requested. Under British 
Virgin Islands law, we may not increase the required percentage to call a 
meeting above 10%.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Subject to our Memorandum and Articles of Association, a 
meeting of shareholders of the company will be called by not less than twenty 
one days' written notice. Notice of every meeting of shareholders may be 
delivered electronically and will be given to all of our shareholders. However, 
the inadvertent failure of the convener or conveners of a meeting of 
shareholders to give notice of the meeting to a shareholder, or the fact that a 
shareholder has not received the notice, does not invalidate the 
meeting.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;A meeting may be called by shorter notice than that 
mentioned above, but, subject to our articles of association, it will be deemed 
to have been duly called if shareholders holding at least 90% of the total 
voting rights on all the matters to be considered at the meeting have waived 
notice of the meeting and, for this purpose, the presence of a shareholder at 
the meeting shall constitute a waiver in relation to all the shares which that 
shareholder holds.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;A meeting of shareholders is duly constituted if, at the 
commencement of the meeting, there are present in person or by proxy two or more
shareholders entitled to vote at the meeting. Shareholders.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Rights attaching to 
shares</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Voting rights</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Holders of our ordinary shares have identical rights, 
including dividend and liquidation rights, provided that, except as otherwise 
expressly provided in our Amended Memorandum and Articles of Association or 
required by applicable law, on any matter that is submitted to a vote of our 
shareholders, holders of our ordinary shares are entitled to one vote per 
ordinary share.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Under the BVI&#160;Act, the ordinary shares are deemed to
be issued when the name of the shareholder is entered in our register of 
members. Our register of members is maintained by our transfer agent, Equity 
Transfer Services Inc., which enters the names of our shareholders in our 
register of members. If (a)&#160;information that is required to be entered in 
the register of shareholders is omitted from the register or is inaccurately 
entered in the register, or (b)&#160;there is unreasonable delay in entering 
information in the register, a shareholder of the company, or any person who is 
aggrieved by the omission, inaccuracy or delay, may apply to the British Virgin 
Islands courts for an order that the register
be rectified, and the court may either refuse the application or order the
rectification of the register, and may direct the company to pay all costs of 
the application and any damages the applicant may have sustained.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Subject to any rights or restrictions attached to any 
shares, at any general meeting on a show of hands every shareholder of record 
who is present in person (or, in the case of a shareholder being a corporation, 
by its duly authorized representative) or by proxy shall have one vote and on a 
poll every shareholder present in person (or, in the case of a shareholder being
a corporation, by its duly appointed representative) or by proxy shall have one 
vote for each share which such shareholder is the holder. Voting at any meeting 
of the shareholders is by show of hands unless a poll is demanded. A poll may be
demanded by shareholders present in person or by proxy if the shareholder 
disputes the outcome of the vote
on a proposed resolution and the chairman shall cause a poll to be 
taken.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;No shareholder shall be entitled to vote or be reckoned 
in a quorum, in respect of any share, unless such shareholder is registered as 
our shareholder at the applicable record date for that meeting. Shareholders of 
record may also pass written resolutions without a meeting.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Protection of minority 
shareholders</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Under the laws of the British Virgin Islands, there is little 
statutory law for the protection of minority shareholders other than the 
provisions of the BVI&#160;Act dealing with shareholder remedies. The principal 
protection under statutory law is that shareholders may bring an action to 
enforce the BVI&#160;Act or the constituent documents of the corporation, our 
Memorandum and Articles of Association. Shareholders are entitled to have our 
affairs conducted in accordance with the BVI&#160;Act and the Memorandum and 
Articles of Association.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">There are common law rights for the protection of shareholders 
that may be invoked, largely dependent on English company law, since the common 
law of the British Virgin Islands is limited. Under the general rule pursuant to
English company law known as the rule in Foss v. Harbottle, a court will 
generally refuse to interfere with the management of a company at the insistence
of a minority of its shareholders who express dissatisfaction with the conduct 
of the company's affairs by the majority or the board of directors. However, 
every shareholder is entitled to have the affairs of the company conducted 
properly according to British Virgin Islands law and the constituent documents 
of the company. As such, if those
who control the company have persistently disregarded the requirements of 
company law or the provisions of the company's Memorandum and Articles of 
Association, then the courts may grant relief. Generally, the</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">areas in which the courts will intervene are the following: 
(1)&#160;an act complained of which is outside the scope of the authorized 
business or is illegal or not capable of ratification by the majority; 
(2)&#160;acts that constitute fraud on the minority where the wrongdoers control
the company; (3)&#160;acts that infringe or are about to infringe on the 
personal rights of the shareholders, such as the right to vote; and 
(4)&#160;where the company has not complied with provisions requiring approval 
of a special or extraordinary majority of shareholders, which are more limited 
than the rights afforded minority shareholders under the laws of many states in 
the U.S.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pre-emption rights</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">British Virgin Islands law does not make a distinction between 
public and private companies and some of the protections and safeguards (such as
statutory pre-emption rights, save to the extent that they are expressly 
provided for in the Memorandum and Articles of Association) that investors may 
expect to find in relation to a public company are not provided for under 
British Virgin Islands law. There are no pre-emption rights applicable to the 
issuance of new shares under either British Virgin Islands law or our Amended 
Memorandum and Articles of Association.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liquidation rights</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">As permitted by British Virgin Islands law and our Memorandum 
and Articles of Association, we may be voluntarily liquidated under 
Part&#160;XII of the BVI Act if we have no liabilities or we are able to pay our
debts as they fall due and the value of our assets equals or exceeds our 
liabilities by resolution of directors and resolution of 
shareholders.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Modification of rights</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;As permitted by British Virgin Islands law, and our 
Memorandum and Articles of Association, we may vary the rights attached to our 
ordinary shares only with the consent in writing of or by a resolution passed at
a meeting by the holders of not less than 50% of the issued shares of a 
particular class of shares.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Transfer of shares</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Subject to any applicable restrictions set forth in our 
Memorandum and Articles of Association, any of our shareholders may transfer all
or any of his or her shares by a written instrument of transfer in the usual or 
common form or in any other form which our directors may approve.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Our board of directors may, in its absolute discretion, resolve
to refuse or delay the registration of any transfer of any share for reasons 
that shall be specified in the Resolution of Directors. If our directors refuse 
or delay the registration of a transfer they shall, as soon as practicable, send
to each of the transferor and the transferee notice of such refusal or delay in 
the agreed form.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Changes in authorized ordinary 
shares</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">By resolution of our shareholders or resolution of our 
directors we may (i)&#160;consolidate and divide all or any of our unissued 
authorized shares into shares of larger amount than our existing shares; 
(ii)&#160;sub-divide our existing ordinary shares, or any of them into shares of
smaller amount than is fixed by our memorandum of association, subject 
nevertheless to the provisions of the BVI Act; (iii)&#160;cancel any ordinary 
shares which, at the date of the passing of the resolution, have not been taken 
or agreed to be taken by any person; or (iv)&#160;create new classes of shares 
with preferences to be determined by the board of directors at the time of 
authorization, although any such new classes of shares may
only be created with prior shareholder approval.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Share repurchase</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">As permitted by the BVI Act and our Memorandum and Articles of 
Association, shares may be repurchased, redeemed or otherwise acquired by 
us.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Dividends</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Subject to the BVI Act and our Memorandum and Articles of 
Association, our directors may, by resolution, authorize a distribution to 
shareholders at such time and of such an amount as they think fit, if they are 
satisfied, on reasonable grounds, that, immediately after the distribution, we 
will satisfy the 'solvency test'. A company will satisfy the solvency test if 
(i)&#160;the value of the company's assets exceeds its liabilities; and 
(ii)&#160;the company is able to pay its debts as they fall due. Where a 
distribution is made to a shareholder at a time when the company did not, 
immediately after the distribution, satisfy the solvency test, it may be 
recovered by the company from the shareholder unless (i)&#160;the
shareholder received the distribution in good faith and without knowledge of the
company's failure to satisfy the solvency test; (ii)&#160;the shareholder has 
altered his position in reliance on the validity of the distribution; and 
(iii)&#160;it would be unfair to require repayment in full or at 
all.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Untraceable shareholders</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;We are entitled to sell any shares of a shareholder who 
is untraceable, as long as:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">all checks, not being less than three in total number, for any 
sums payable in cash to the holder of such shares have remained uncashed for a 
period of 12&#160;years;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">we have not during that time or before the expiry of the three-
month period referred to in the following point received any indication of the 
existence of the shareholder or person entitled to such shares by death, 
bankruptcy or operation of law; and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, 
serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">upon expiration of the twelve-year period, we have caused an 
advertisement to be published in newspapers, giving notice of our intention to 
sell these shares, and a period of three months or such shorter period has 
elapsed since the date of such advertisement.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The net proceeds of any such sale shall belong to us, and when 
we receive these net proceeds we shall become indebted to the former shareholder
for an amount equal to such net proceeds.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline;
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Board of directors</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;We are managed by a board of directors which currently 
consists of four directors.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Our shareholders may, pursuant to our Memorandum and Articles 
of Association, at any time remove any director before the expiration of his or 
her period of office for cause, and may, pursuant to our Memorandum and Articles
of Association, elect another person in his or her stead. Subject to our 
Memorandum and Articles of Association, the directors will have power at any 
time and from time to time to appoint any person to be a director, either as an 
addition to the existing directors or to fill a vacancy as long as the total 
number of directors (exclusive of alternate directors) does not at any time 
exceed the maximum number fixed by or in accordance with our Amended Memorandum 
and Articles of Association (if
any).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline;
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are no share ownership 
qualifications for directors.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Meetings of our board of directors may be convened at any
time deemed necessary by any of our directors.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;&#160;A meeting of our board of directors will be 
competent to make lawful and binding decisions if at least one 
half&#160;&#160;of the directors are present or represented. unless there are 
only two directors, in which case, the quorum shall be two. At any meeting of 
our directors, each director, whether by his or her presence or by his or her 
alternate, is entitled to one vote.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Questions arising at a meeting of our board of directors are 
required to be decided by simple majority votes of the directors present or 
represented at the meeting. In the case of a tie vote, the chairman of the 
meeting shall not have a second or deciding vote. Our board of directors may 
also pass unanimous written resolutions without a meeting.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;The remuneration to be paid to the directors shall be 
such remuneration as the directors shall determine. Under our Memorandum and 
Articles of Association, the independent directors shall also be entitled to 
reimbursement of out-of-pocket expenses in connection with the performance of 
their duties as director.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Issuance of additional ordinary 
shares</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Our Memorandum and Articles of Association authorize our board 
of directors to issue additional ordinary shares from time to time as our board 
of directors shall determine, to the extent of available authorized but unissued
shares.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;&#160;Our Memorandum and Articles of Association 
authorize our board of directors from time to time to issue ordinary shares to 
the extent permitted by the BVI Act.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Changes in authorized shares</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">We are authorized to issue unlimited number 
of&#160;&#160;ordinary shares without par value,&#160;&#160;which will be 
subject to the same provisions with reference to the payment of calls, liens, 
transfers, transmissions, forfeitures and otherwise as the shares in issue. We 
may by resolution:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">o&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">consolidate and divide all or any of our unissued authorized 
shares into shares of a larger amount than our existing shares;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">o&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">sub-divide our existing ordinary shares, or any of them into 
shares of smaller amount than is fixed by our memorandum of association, subject
nevertheless to the provisions of the BVI Act;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">o&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#8226;cancel any ordinary shares that, at the date of the 
passing of the resolution, have not been taken or agreed to be taken by any 
person; or</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">o&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">create new classes of shares with preferences to be determined
by the board of directors at the time of authorization, although any such new 
classes of shares may only be created with prior shareholder 
approval.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inspection of books and records</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Under British Virgin Islands law holders of our ordinary shares
will be entitled, on giving written notice to us, to inspect and make copies or 
take extracts of our: (a)&#160; Memorandum and Articles of Association; 
(b)&#160;register of shareholders; (c)&#160;register of directors; and 
(d)&#160;minutes of meetings and resolutions of shareholders and those classes 
of shareholders of which he is a shareholder.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subject to our Memorandum and 
Articles of Association, our board of directors may, if they are satisfied that 
it would be contrary to our interest to allow a shareholder to inspect any 
document, or part of a document as referenced above, refuse to permit the 
shareholder to inspect the document or limit the inspection of the document, 
including limiting the making of copies or the taking of extracts from the 
records. Where our directors exercise their powers in these circumstances, they 
shall notify the shareholder as soon as reasonably practicable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Differences in corporate law</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">We are now&#160;&#160;incorporated under, and are governed by, 
the laws of the British Virgin Islands. The flexibility available under British 
Virgin Islands law has enabled us to adopt the memorandum and articles of 
association that will provide shareholders with rights that do not vary in any 
material respect from those they enjoyed under the Ontario Companies 
laws.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Conflicts of interest</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;&#160;Pursuant to the BVI Act and the company's 
memorandum and articles of association, a director of a company who has an 
interest in a transaction and who has declared such interest to the other 
directors, may:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">vote on a matter relating to the transaction;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">attend a meeting of directors at which a matter relating to the
transaction arises and be included among the directors present at the meeting 
for the purposes of a quorum; and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">sign a document on behalf of the company, or do any other thing
in his capacity as a director, that relates to the transaction.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Anti-money laundering laws</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">In order to comply with legislation or regulations aimed at the
prevention of money laundering we are required to adopt and maintain anti-money 
laundering procedures, and may require subscribers to provide evidence to verify
their identity. Where permitted, and subject to certain conditions, we may also 
delegate the maintenance of our anti-money laundering procedures (including the 
acquisition of due diligence information) to a suitable person.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;We reserve the right to request such information as is 
necessary to verify the identity of a subscriber. In the event of delay or 
failure on the part of the subscriber in producing any information required for 
verification purposes, we may refuse to accept the application, in which case 
any funds received will be returned without interest to the account from which 
they were originally debited.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;If any person resident in the British Virgin Islands 
knows or suspects that another person is engaged in money laundering or 
terrorist financing and the information for that knowledge or suspicion came to 
their attention in the course of their business, the person will be required to 
report his belief or suspicion to the Financial Investigation Agency of the 
British Virgin Islands, pursuant to the Proceeds of Criminal Conduct Act 1997 
(as amended). Such a report shall not be treated as a breach of confidence or of
any restriction upon the disclosure of information imposed by any enactment or 
otherwise.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Duties of directors</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">British Virgin Islands law provides that every director of the 
company in exercising his powers or performing his duties shall act honestly and
in good faith and in what the director believes to be in the best interests of 
the company. Additionally, the director shall exercise the care, diligence, and 
skill that a reasonable director would exercise in the same circumstances taking
into account the nature of the company, the nature of the decision and the 
position of the director and his responsibilities. In addition, British Virgin 
Islands law provides that a director shall exercise his powers as a director for
a proper purpose and shall not act, or agree to the company acting, in a manner 
that contravenes British
Virgin Islands law or the memorandum and articles of association of the 
company.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><br>
&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Anti-takeover provisions</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;The BVI Act does not prevent companies from adopting a 
wide range of defensive measures, such as staggered boards, blank check 
preferred shares, removal of directors only for cause and provisions that 
restrict the rights of shareholders to call meetings and submit shareholder 
proposals.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Interested directors</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;The BVI Act provides that a director shall, after 
becoming aware that he is interested in a transaction entered into or to be 
entered into by the company, disclose that interest to the board of directors of
the company. The failure of a director to disclose that interest does not affect
the validity of a transaction entered into by the director or the company, so 
long as the director's interest was disclosed to the board prior to the 
company's entry into the transaction or was not required to be disclosed (for 
example where the transaction is between the company and the director himself or
is otherwise in the ordinary course of business and on the usual terms and 
conditions). As permitted by British Virgin
Islands law and our Memorandum and Articles of Association, a director 
interested in a particular transaction may vote on it, attend meetings at which 
it is considered, and sign documents on our behalf which relate to the 
transaction.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Voting rights and quorum 
requirements</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Under British Virgin Islands law, the voting rights of 
shareholders are regulated by the company's Memorandum and Articles of 
Association and, in certain circumstances, the BVI Act. The articles of 
association will govern matters such as quorum for the transaction of business, 
rights of shares, and majority votes required to approve any action or 
resolution at a meeting of the shareholders or board of directors. Unless the 
articles of association otherwise provide, the requisite majority is usually a 
simple majority of votes cast.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Mergers and similar 
arrangements</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Under the BVI Act, two or more companies may merge or 
consolidate in accordance with the statutory provisions. A merger means the 
merging of two or more constituent companies into one of the constituent 
companies, and a consolidation means the uniting of two or more constituent 
companies into a new company. In order to merge or consolidate, the directors of
each constituent company must approve a written plan of merger or consolidation 
which must be authorized by a resolution approved at a duly convened and 
constituted meeting of the shareholders of the Company by the affirmative vote 
of a <font style="DISPLAY: inline; TEXT-DECORATION: underline">majority of two 
thirds
(</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; 
TEXT-DECORATION: underline">2</font><font style="DISPLAY: inline; TEXT-
DECORATION: underline">/3) or more of the votes of the shares entitled to vote 
thereon which were present</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">at the meeting and voted, or a resolution consented to in 
writing by the same number of the votes of the Shares entitled to vote 
thereon.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Shareholders not otherwise entitled to vote on the merger or 
consolidation may still acquire the right to vote if the plan or merger or 
consolidation contains any provision which, if proposed as an amendment to the 
memorandum of amended association and articles of association, would entitle 
them to vote as a class or series on the proposed amendment. In any event, all 
shareholders must be given a copy of the plan of merger or consolidation 
irrespective of whether they are entitled to vote at the meeting or consent to 
the written resolution to approve the plan of merger or 
consolidation.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shareholder suits</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">We are not aware of any reported class action or derivative 
action having been brought against the company in a British Virgin Islands 
court.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Under the BVI Act, if a company or a director of a 
company engages in, or proposes to engage in, conduct that contravenes the BVI 
Act or the memorandum of association or articles of the company, the BVI Court 
may, on the application of a shareholder or a director of the company, make an 
order directing the company or director to comply with, or restraining the 
company or director from engaging in that conduct.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">In addition, under the BVI Act, the BVI Court may, on the 
application of a shareholder of a company, grant leave to that shareholder to 
bring proceedings in the name and on behalf of that company or to intervene in 
proceedings to which the company is a party for the purpose of continuing, 
defending or discontinuing the proceedings on behalf of the company. In 
determining whether to grant leave for such derivative actions, the Court must
take into account certain matters, including whether the shareholder is acting 
in good faith, whether the derivative action is in the interests of the company 
taking account of the views of the company's directors on commercial matters and
whether an alternative remedy to the
derivative claim is available.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">A shareholder of a company may bring an action against the 
company for breach of a duty owed by the company to him as a shareholder. The 
BVI Act also includes provisions for actions based on oppression, and for 
representative actions where the interests of the claimant are substantially the
same as those of other shareholders.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Corporate governance</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;British Virgin Islands laws do not restrict transactions 
with directors, requiring only that directors exercise a duty to act honestly, 
in good faith and in what the directors believe to be in the best interests to 
the companies for which they serve.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Indemnification</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">British Virgin Islands law does not limit the extent to which a
company's articles of association may provide for indemnification of officers 
and directors, except to the extent any such provision may be held by the 
British Virgin Islands courts to be contrary to public policy, such as to 
provide indemnification against civil fraud or the consequences of committing a 
crime. Our articles of association provide for the indemnification of our 
directors against all losses or liabilities incurred or sustained by him or her 
as a director of our company in defending any proceedings, whether civil or 
criminal and this indemnity only applies if he or she acted honestly and in good
faith with a view to our best interests and,
with respect to any criminal action, he or she must have had no reasonable cause
to believe his or her conduct was unlawful.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Insofar as indemnification for liabilities arising under the 
Securities Act may be permitted for directors, officers or persons controlling 
us under the foregoing provisions, we have been advised that, in the opinion of 
the U.S. Securities and Exchange Commission, such indemnification is against 
public policy as expressed in the Securities Act and therefore is 
unenforceable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Staggered board of directors</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;The BVI Act does not contain statutory provisions that 
require staggered board arrangements for a British Virgin Islands company and 
our articles of association do not provide for a staggered board.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">(C) MATERIAL 
CONTRACTS</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company had no material contract, other than contracts 
entered into in the ordinary course of business, to which we or any of our 
subsidiaries is a party, for the year immediately preceding the filing of this 
report.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(D) EXCHANGE 
CONTROLS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">There is no income or other tax of the British Virgin Islands 
imposed by withholding or otherwise on any payment to be made by 
us.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We are free to acquire, hold and sell foreign currency and 
securities without restriction. There is no exchange control legislation under 
British Virgin Islands law and accordingly there are no exchange control 
regulations imposed under British Virgin Islands law that would prevent us from 
paying dividends to shareholders in United States Dollars or any other 
currencies, and all such dividends may be freely transferred out of the British
Virgin Islands, clear of any income or other tax of the British Virgin Islands 
imposed by withholding or otherwise without the necessity of obtaining any 
consent of any government or authority of the British Virgin 
Islands.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;</font><br>
&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(E)&#160;&#160;TAXATION</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font 
style="DISPLAY: inline; TEXT-DECORATION: underline">British Virgin Islands Tax 
Consequences</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Under the law of the British Virgin Islands as currently in 
effect, a holder of shares of the Company who is not a resident of the British 
Virgin Islands is not liable for British Virgin Islands income tax on dividends 
paid with respect to the shares of the Company, and all holders of securities of
the Company are not liable to the British Virgin Islands for income tax on gains
realized on the sale or disposal of such securities. The British Virgin Islands 
does not impose a withholding tax on dividends paid by a company incorporated or
re-registered under the BCA.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">There are no capital gains, gift or inheritance taxes levied by
the British Virgin Islands on companies incorporated or re-registered under the 
BCA. In addition, securities of companies incorporated or re-registered under 
the BCA are not subject to transfer taxes, stamp duties or similar 
charges.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">There is no income tax treaty or convention currently in effect
between (i) the United States and the British Virgin Islands or (ii) Canada and 
the British Virgin Islands, although a Tax Information Exchange Agreement is in 
force between the United States and the BVI and Canada and the BVI</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font 
style="DISPLAY: inline; TEXT-DECORATION: underline">U.S. Federal Income Tax 
Consequences</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;&#160;The following discussion sets forth the material 
U.S. federal income tax consequences to U.S. Holders (as defined below) of 
owning, and disposing of our ordinary shares as of the date hereof. This 
discussion is not a complete analysis or listing of all of the possible tax 
consequences and does not address all tax considerations that may be relevant to
investors in light of their particular circumstances. This summary applies only 
to U.S. Holders that hold Class&#160;A ordinary shares as capital assets for 
U.S. federal income tax purposes (generally, property held for investment), and
it does not describe all of the U.S. federal income tax consequences that may be
relevant to U.S. Holders subject to
special rules, such as:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">banks and other financial institutions;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">insurance companies;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">regulated investment companies;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">real estate investment trusts;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">dealers and traders in securities that use mark-to-market 
accounting for U.S. federal income tax purposes;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">U.S. Holders holding Class&#160;A ordinary shares as part of a 
hedging transaction, straddle, conversion transaction or other integrated
transaction;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">U.S. Holders whose functional currency for U.S. federal income 
tax purposes is not the U.S. dollar;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">U.S. Holders liable for the alternative minimum 
tax;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">tax-exempt organizations or entities, including an "individual 
retirement account" or "Roth IRA" as defined in Section&#160;408 or 408A of the 
Code, respectively;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">U.S. Holders that received the Class&#160;A ordinary shares as 
compensation for the performance of services;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">U.S. Holders holding Class&#160;A ordinary shares that own or 
are deemed to own 10% or more of the voting shares of the Company; 
or</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE:
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">former citizens and residents of the United States subject to 
tax as expatriates.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">This summary is based on the Internal Revenue Code of 1986, as 
amended (the "Code"), administrative pronouncements, judicial decisions and 
final, temporary and proposed Treasury regulations, all as currently in effect 
and available. These authorities are subject to change, possibly with 
retroactive effect. U.S. Holders should consult their own tax advisers 
concerning the U.S. federal, state, local, and foreign tax consequences of 
owning and disposing of Class&#160;A ordinary shares in their particular 
circumstances.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;For purposes of this summary, a "U.S. Holder" is a 
beneficial owner of ordinary shares who is, for U.S. federal income tax 
purposes:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">a citizen or individual resident of the United 
States;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">a corporation, or other entity taxable as a corporation for 
U.S. federal income tax purposes, created or organized in or under the laws of 
the United States, any state thereof or the District of Columbia;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">an estate, the income of which is subject to U.S. federal 
income taxation regardless of its source; or</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">a trust that (1)&#160;is subject to the primary supervision of 
a U.S. court and one or more U.S. persons that have the authority to control all
substantial decisions of the trust or (2)&#160;has a valid election in effect 
under applicable Treasury regulations to be treated as a U.S. 
person.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">If a partnership (or other entity treated as a partnership for 
U.S. federal income tax purposes) holds the ordinary shares, the tax treatment 
of a partner in such partnership generally will depend upon the status of the 
partner and upon the activities of the partnership. Prospective investors who 
are partners in a partnership should consult their tax advisers as to the 
particular U.S. federal income tax consequences of owning and disposing of 
Class&#160;A ordinary shares in their particular circumstances.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Unless otherwise indicated, this discussion assumes that the 
Company is not, and will not become, a "passive foreign investment company," or 
a PFIC, for U.S. federal income tax purposes.. Further, this summary does not 
address the U.S. federal estate and gift, state, local or non-U.S. tax 
consequences to U.S. Holders of owning, and disposing of Class&#160;A ordinary 
shares. Prospective investors should consult their own tax advisors regarding 
the U.S. federal, state and local, as well as non-U.S. income and other tax 
consequences of owning and disposing of Class&#160;A ordinary shares in their 
particular circumstances.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline;
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Taxation of 
distributions</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Distributions paid on ordinary shares will be treated as 
dividends to the extent paid out of our current or accumulated earnings and 
profits (as determined under U.S. federal income tax principles). Such dividends
paid to a U.S. Holder with respect to ordinary shares generally will be taxable 
as ordinary income at the time of receipt by a U.S. Holder. Distributions in 
excess of our current and accumulated earnings and profits will be treated first
as a non-taxable return of capital, thereby reducing such U.S. Holder's adjusted
tax basis in ordinary shares (but not below zero), and thereafter as either 
long-term or short-term capital gain depending upon whether the U.S. Holder has 
held ordinary shares for more
than one year as of the time such distribution is received. Because we do not 
maintain calculations of our earnings and profits under U.S. federal income tax 
principles, it is expected that distributions generally will be reported to U.S.
Holders as dividends. Distributions of additional ordinary shares to U.S. 
Holders that are part of a pro rata distribution to all of our shareholders 
generally will not be subject to U.S. federal income tax. The amount of any 
distribution of property other than cash will be the fair market value of such 
property on the date of distribution. As used below, the term "dividend" means a
distribution that constitutes a dividend for U.S. federal income tax 
purposes.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;With respect to non-corporate U.S. Holders, dividends 
received may be subject to reduced rates of taxation provided that our ordinary 
shares are readily tradable on a qualifying U.S. securities market and that 
(i)&#160;such U.S. Holder holds such ordinary shares for 61&#160;days or more 
during the 121-day period beginning on the date which is 60&#160;days before the
date on which such shares become ex-dividend with respect to such dividends and 
(ii)&#160;the U.S. Holder is not under an obligation (whether pursuant to a 
short sale or otherwise) to make related payments with respect to existing or 
substantially similar or related property. Our ordinary shares currently trade 
on the OTCQB and are also listed an
dtraded on Canadian Securities Exchange , which may be&#160;&#160;treated as a 
qualifying securities market. However, there is no assurance that our ordinary 
shares will remain "readily tradable" and, additionally, such reduced rate will 
not apply if we are a PFIC for the taxable year in which we pay a dividend or 
were a PFIC for the preceding taxable year.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Dividends received on the ordinary shares will be treated
as foreign source income and will not be eligible for the dividends-received 
deduction generally allowed to U.S. corporations under the Code.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Sale or other 
taxable disposition of shares</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">For U.S. federal income tax purposes, gain or loss realized on 
the sale or other taxable disposition of ordinary shares will be capital gain or
loss, and will be long-term capital gain or loss if a U.S. Holder held ordinary 
shares for more than one year. Non-corporate U.S. Holders may be eligible for 
preferential rates of U.S. federal income tax in respect of long-term capital 
gains. The deductibility of capital losses is subject to limitations under the 
Code.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;The amount of the gain or loss realized will be equal to 
the difference between a U.S. Holder's adjusted tax basis in the ordinary shares
disposed of and the amount realized on the sale or other taxable disposition. A 
U.S. Holder's initial tax basis in its ordinary shares will be the amount paid 
for ordinary shares. Such gain or loss generally will be U.S.-source gain or
loss for U.S. foreign tax credit purposes.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Passive foreign investment 
company considerations</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Special U.S. federal income tax rules apply to U.S. persons 
owning shares of a PFIC. A non-U.S. corporation will be classified as a PFIC in 
any taxable year in which, either:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">at least 75% of its gross income is "passive income"; 
or</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#8226;</font>&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">at least 50% of the average quarterly value of its total gross
assets (which may be determined, in part, by the market value of our ordinary 
shares, which is subject to change) is attributable to assets that produce 
"passive income" or are held for the production of passive income.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Passive income for this purpose generally includes, among other
things, dividends, interest, royalties, rents and gains from commodities (other 
than gains that arise out of commodity hedging transactions, or that are foreign
currency gains attributable to any section&#160;988 transactions, or gains from 
commodities sold in an active trade or business) and securities transactions. If
a non-United States corporation owns at least 25% by value of the stock of 
another corporation, the non-United States corporation is treated 
for</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">purposes of the PFIC tests as owning its proportionate share of
the assets of the other corporation and as receiving directly its proportionate 
share of the other corporation's income.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Based on our financial statements, relevant market data 
and the projected composition of our income and the valuation of our assets, we 
do not expect to be a PFIC for the taxable year ending March&#160;31, 2015. 
Because PFIC status is based on our income, assets and activities for the entire
taxable year, it is not possible to determine whether we will be characterized 
as a PFIC for the 2015 taxable year until after the close of the year. Moreover,
we must determine our PFIC status annually based on tests which are factual in 
nature, and our status in future years will depend on our income, assets and 
activities in those years. In addition, because the market price of our ordinary
shares is likely to fluctuate
and because that market price may affect the determination of whether we will be
considered a PFIC, there can be no assurance that we will not be considered a 
PFIC for any taxable year.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;If, however, we were a PFIC for any taxable year during 
which a U.S. Holder held ordinary shares, gain recognized by a U.S. Holder upon 
a disposition (including, under certain circumstances, a pledge) of ordinary 
shares would be allocated ratably over the U.S. Holder's holding period for such
shares. The amounts allocated to the taxable year of disposition and to years 
before we became a PFIC would be taxed as ordinary income. The amount allocated 
to each other taxable year would be subject to tax at the highest rate in effect
for that taxable year for individuals or corporations, as appropriate, and an 
interest charge would be imposed on the tax attributable to the allocated 
amount. Further, to the extent that
any distribution received by a U.S. Holder on ordinary shares exceeds 125% of 
the average of the annual distributions on such shares received during the 
preceding three years or the U.S. Holder's holding period, whichever is shorter,
that distribution would be subject to taxation in the same manner as gain, 
described immediately above. Certain elections may be available that would 
result in alternative treatments (such as mark-to-market treatment) of ordinary 
shares. We do not intend to provide information necessary for U.S. Holders to 
make qualified electing fund elections if, contrary to our expectation, we are 
classified as a PFIC. U.S. Holders should consult their tax advisers to 
determine whether any of these elections would be available and if so, what the 
consequences of the alternative treatments would be in their particular 
circumstances.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">&#160;If we are determined to be a PFIC, the general tax 
treatment for U.S. Holders described in this paragraph would apply to indirect 
distributions and gains deemed to be realized by U.S. Holders in respect of any 
of our subsidiaries that also may be determined to be PFICs.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;If a U.S. Holder owns ordinary shares during any year in 
which the Company is a PFIC, the U.S. Holder generally will be required to file 
an IRS Form&#160;8621 with respect to the Company, generally, with the U.S. 
Holder's federal income tax return for that year. If the Company were classified
as a PFIC for a given taxable year, then holders should consult their tax 
advisers concerning their annual filing requirements.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;U.S. Holders should consult their tax advisers regarding 
whether we are a PFIC and the potential application of the PFIC 
rules.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Medicare tax</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Certain U.S. Holders that are individuals, estates or trusts 
are subject to a 3.8% tax on all or a portion of their "net investment income," 
which may include all or a portion of their dividend income and net gains from 
the disposition of ordinary shares. Each U.S. Holder that is an individual, 
estate or trust is urged to consult its tax advisors regarding the applicability
of the Medicare tax to its income and gains in respect of its investment in the 
ordinary shares.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Information reporting and 
backup withholding</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Payments of dividends and proceeds from the sale or other
taxable disposition that are made within the United States or through certain 
U.S.-related financial intermediaries generally are subject to information 
reporting, and may be subject to backup withholding, unless (1)&#160;the U.S. 
Holder is a corporation or other exempt recipient or (2)&#160;in the case of 
backup withholding, the U.S. Holder provides a correct taxpayer identification 
number and certifies that it is not subject to backup withholding.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;The amount of any backup withholding from a payment to a 
U.S. Holder will be allowed as a credit against a U.S. Holder's U.S. federal 
income tax liability and may entitle such holder to a refund, provided that the 
required information is timely furnished to the United States Internal Revenue 
Service.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Foreign asset 
reporting</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;Certain U.S. Holders who are individuals are required to 
report information relating to an interest in ordinary shares, subject to 
certain exceptions (including an exception for ordinary shares held in accounts 
maintained by U.S. financial institutions). U.S. Holders are urged to consult 
their tax advisors regarding their information reporting obligations, if any, 
with respect to their ownership and disposition of ordinary shares.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(F)&#160;&#160;DIVIDEND AND PAYING 
AGENTS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Not applicable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(G)&#160;&#160;STATEMENT BY 
EXPERTS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Not 
applicable.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(H)&#160;&#160;DOCUMENTS ON 
DISPLAY</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">We are currently subject to the informational requirements of 
the Exchange Act applicable to foreign private issuers. We fulfill these 
requirements by filing annual, quarterly and current reports and other 
information with the SEC, which you can access using the means described above. 
As a foreign private issuer, we are exempt from the rules under the Exchange Act
relating to the furnishing and content of proxy statements, and our officers, 
directors and principal shareholders will be exempt from the reporting and short
swing profit recovery provisions contained in Section&#160;16 of the Exchange 
Act. In addition, we are not required under the Exchange Act to file periodic 
reports and financial statements with the
Securities and Exchange Commission as frequently or as promptly as U.S. 
companies whose securities are registered under the Exchange Act. However, we 
are required to file with the Securities and</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Exchange Commission, within four months after the end of our 
fiscal year ended March&#160;31, 2014 and each subsequent fiscal year, an annual
report on Form&#160;20-F containing financial statements which will be examined 
and reported on, with an opinion expressed, by an independent public accounting 
firm. We also intend to file with the Securities and Exchange Commission reports
on Form&#160;6-K containing unaudited financial information for the first three 
quarters of each fiscal year, within 90&#160;days after the end of each 
quarter.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">You may read and copy any document we file with the SEC without
charge at the SEC's public reference room at 100&#160;F&#160;Street, N.E., 
Room&#160;1580, Washington, D.C. 20549. You may also obtain copies of the 
documents at prescribed rates by writing to the Public Reference Section of the 
SEC at 100&#160;F&#160;Street, N.E., Washington, D.C. 20549. Please call the SEC
at 1&#160;800 SEC 0330 for further information on the public reference room. The
SEC also maintains an Internet site that contains reports and other information 
regarding issuers that file electronically with the SEC. Our filings with the 
SEC are also available to the public through this web site at
<font style="DISPLAY: inline; TEXT-DECORATION: 
underline">http://www.sec.gov.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(I)&#160;&#160;SUBSIDIARY 
INFORMATION</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The documents concerning the Company&#8217;s subsidiaries 
referred to in this Annual Report may be inspected at the Company's office at 47
Avenue Road, Suite 200, Toronto, Ontario, Canada, M5R 2G3.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 11 &#8211; QUANTITATIVE AND QUALITATIVE DISCLOSURES 
ABOUT MARKET RISK</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company is exposed in varying degrees to a number of risks 
arising from financial instruments. Management&#8217;s close involvement in the 
operations allows for the identification of risks and variances from 
expectations. The Company does not participate in the use of financial 
instruments to mitigate these risks and has no designated hedging transactions. 
The Board approves and monitors the risk management processes. The Board&#8217;s
main objectives for managing risks are to ensure liquidity, the fulfilment 
of</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">obligations, the continuation of the Company&#8217;s search for
new business participation opportunities, and limited exposure to credit and 
market risks while ensuring greater returns on the surplus funds on hand. There 
were no changes to the objectives or the process from the prior 
year.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">A summary of the Company&#8217;s risk exposures as it relates 
to financial instruments are reflected below:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New 
Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">a)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: 
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair value of financial 
instruments</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company&#8217;s financial assets and liabilities are 
comprised of cash, amounts receivable, prepaid expenses, accounts payable and 
accrued liabilities.</font></div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 35.45pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company classifies the fair value of these transactions 
according to the following fair value hierarchy based on the amount of 
observable inputs used to value the instrument:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 36pt; MARGIN-LEFT: 36pt"><font style="DISPLAY: inline;
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font><font id="TAB2" 
style="LETTER-SPACING: 9pt; COLOR: black">&#160;</font><font style="DISPLAY: 
inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 1 &#8211; Values 
are based on unadjusted quoted prices available in active markets for identical 
assets or liabilities as of the reporting date.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 36pt; MARGIN-LEFT: 36pt"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font><font id="TAB2" 
style="LETTER-SPACING: 9pt; COLOR: black">&#160;</font><font style="DISPLAY: 
inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 2 &#8211; Values 
are based on inputs, including quoted forward prices for commodities, time value
and volatility factors, which can be substantially observed or corroborated in 
the marketplace. Prices in Level 2 are either directly or indirectly observable 
as of the reporting date.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 36pt; MARGIN-LEFT: 36pt"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font><font id="TAB2" 
style="LETTER-SPACING: 9pt; COLOR: black">&#160;</font><font style="DISPLAY: 
inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 3 &#8211; Values 
are based on prices or valuation techniques that are not based on observable 
market data.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Assessment of the significance of a particular input to the 
fair value measurement requires judgment and may affect the placement within the
fair value hierarchy.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company&#8217;s financial instruments are exposed to 
certain financial risks: credit risk, liquidity risk, other price risk and 
market risk.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Credit risk</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Credit risk is the risk of loss associated with a counter-
party&#8217;s inability to fulfill its payment obligations. The credit risk is 
attributable to various financial instruments, as noted below. The credit risk 
is limited to the carrying value amount carried on the statement of financial 
position.</font></div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">a.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Cash&#8211; Cash is held with a major international financial 
institution in Canada and a major law firm in the USA and therefore the risk of 
loss is minimal.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">b.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Other receivable &#8211; The Company is not exposed to major 
credit risk attributable to customers. A significant portion of this amount is 
prepaid to BPI under a master service agreement.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">c)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liquidity risk</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Liquidity risk is the risk that the Company will encounter 
difficulty in satisfying financial obligations as they become due.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company&#8217;s approach to managing liquidity is to 
ensure, as far as possible, that it will have sufficient liquidity to meet its 
liabilities when due, under both normal and stressed conditions without 
incurring unacceptable losses or risking harm to the Company&#8217;s reputation.
The Company holds sufficient cash to satisfy obligations under accounts payable
and accruals.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company is in pre-clinical stage and is required to perform
further research and development and also fulfil its financial obligation of $ 
1,750,000 to Its subsidiary, Biohaven to retain its 54% equity in Biohaven. The 
Company has not yet determined whether costs incurred and to be incurred are 
economically recoverable. The Company's continuing operations are dependent upon
any one of:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">1. the existence of economically recoverable medical or 
industrial solutions;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">2. the ability of the Company to obtain the necessary financing
to complete the research; or</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">3. future profitable production from, or proceeds from the 
disposition of intellectual property.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">However, as a biotech company at an early stage of development 
and without significant internally generated cash flows, there are inherent 
liquidity risks, including the possibility that additional financing may not be 
available to the Company, or that actual drug development expenditures may 
exceed those</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">planned. The current uncertainty in global markets could have 
an impact on the Company&#8217;s future ability to access capital on terms that 
are acceptable to the Company. There can be no assurance that required financing
will be available to the Company.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 12 &#8211; DESCRIPTION OF SECURITIES OTHER THAN 
EQUITY SECURITIES</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Not applicable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">PART II</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 13 &#8211; DEFAULTS, DIVIDEND ARREARAGES AND 
DELINQUENCIES</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">None.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 14 &#8211; MATERIAL MODIFICATIONS TO THE RIGHTS OF 
SECURITY HOLDERS AND USE OF PROCEEDS</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">None</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 15 - CONTROLS AND PROCEDURES</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Disclosure Controls and 
Procedures</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Our chief executive officer and chief financial officer have 
evaluated the effectiveness of our disclosure controls and procedures (as 
defined in Rules 13a-15(e) of the Exchange Act) as of March 31, 2014 covered by 
this annual report. Our management has concluded that our disclosure controls 
and procedures as of the end of the Year ended March 31, 2014 were
effective.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Management&#8217;s Annual Report on Internal
Control over Financial Reporting</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Our management is responsible for establishing and maintaining 
adequate internal control over financial reporting, as such term is defined in 
Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over 
financial reporting is a process designed to provide reasonable assurance 
regarding the reliability of financial reporting and the preparation of 
consolidated financial statements in accordance with the International Financial
Reporting Standards (&#8220;IFRS&#8221;) issued by the International Accounting 
Standards Board (&#8220;IASB&#8221;), and interpretations of the International 
Financial Reporting Interpretations Committee. Internal control over financial 
reporting includes those policies and
procedures that (1)&#160;pertain to the maintenance of records that, in 
reasonable detail, accurately and fairly reflect the transactions and 
dispositions of a company&#8217;s assets, (2)&#160;provide reasonable assurance 
that transactions are recorded as necessary to permit preparation of 
consolidated financial statements in accordance with generally accepted 
accounting principles, and that a company&#8217;s receipts and expenditures are 
being made only in accordance with authorizations of a company&#8217;s 
management and directors and (3)&#160;provide reasonable assurance regarding 
prevention or timely detection of unauthorized acquisition, use or disposition 
of a company&#8217;s assets that could have a material effect on the 
consolidated financial statements.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Because of its inherent limitations, a system of internal 
control over financial reporting can provide only reasonable assurance with 
respect to consolidated financial statement preparation and presentation, and 
may not prevent or detect misstatements. Also, projections of any evaluation of 
effectiveness to future periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree of compliance 
with the policies and procedures may deteriorate.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">We have conducted an evaluation of the effectiveness of 
internal control over financial reporting based on the framework in <font 
style="FONT-STYLE: italic; DISPLAY: inline">Internal Control &#8212; Integrated 
Framework </font>(1992)&#160;issued by the Committee of Sponsoring Organizations
of the Treadway Commission , or COSO. Based on this evaluation, management 
concluded that internal control over financial reporting was effective as of 
March 31, 2014&#160;&#160;based on criteria in <font style="FONT-STYLE: italic; 
DISPLAY: inline">Internal Control &#8212; Integrated Framework</font>
(1992)&#160;issued by the COSO.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The CEO has instituted a system of disclosure controls for the 
Company to ensure proper and complete disclosure of material information. The 
limited number of consultants and direct involvement of the CEO and CFO 
facilitates access to real time information about developments in the business 
for drafting disclosure documents. All documents are circulated to the board of 
directors and audit committee according to the disclosure time-
lines.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><a name="guide_to_coso"><!--EFPlaceholder--></a><font 
style="DISPLAY: inline; TEXT-DECORATION: underline">c) Attestation report of the
registered public accounting firm</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Not applicable since we are neither an accelerated filer nor a 
large accelerated filer as defined in Rule 12b-2 under the Securities Exchange 
Act of 1934.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">d) 
Changes in Internal Controls</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">In prior period, here was a lack of segregation of duties since
Chief executive and financial officer handled accounting records and was also a 
sole signatory to bank accounts. However, effective June 4, 2013, we appointed a
new CEO and segregated management functions between the CEO and CFO. Further, we
also introduced dual signatories to all our bank accounts and independent review
of bank reconciliations and other related controls. Our audit committee &#8211; 
now known as audit and compensation committee - now comprise three members two 
of whom are independent.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We believe that the above changes have mitigated significantly 
any potential risks arising from the earlier weakness of lack of segregation of 
duties.</font></div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font 
style="DISPLAY: inline; TEXT-DECORATION: underline">ITEM 16(A) AUDIT COMMITTEE 
FINANCIAL EXPERTS</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">the Board of Directors has determined that Mr. James Mellon is 
an audit committee financial expert as such term is defined in Rule&#160;10A-
3(b)(1) under the Exchange Act&#160;.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 16 (B) CODES OF ETHICS</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We have adopted a Code of Ethics, which applies to all 
employees, consultants, officers and directors. A copy of our current code of 
ethics is included in the exhibits to this annual report .</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">A copy of our Code of Ethics can be obtained by writing to our
corporate office at 47 Avenue Road, Suite 200, Toronto, ON M5R 2G3 attention: 
Chief Financial&#160;&#160;Officer.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 16 (C) PRINCIPAL ACCOUNTANT&#8217;S FEES AND 
SERVICES</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The following outlines the expenditures for accounting fees for
the last two fiscal periods ended:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="28%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">March 31,</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2014</font></div>
</td>
<td align="right" valign="top" width="15%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2013</font></div>
</td>
</tr><tr>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Audit fee</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$45,000</font></div>
</td>
<td align="right" valign="top" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Other services</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2,413</font></div>
</td>
<td align="right" valign="top" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Under our existing policies, the audit committee must approve 
all audit and non-audit related services provided by the auditors.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 16 (D) - EXEMPTIONS FROM THE LISTING STANDARDS FOR 
AUDIT COMMITTEES</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Not applicable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 16 (E) - PURCHASES OF EQUITY SECURITIES BY THE 
ISSUER AND AFFILIATED PURCHASERS</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">We did not, nor did any affiliated purchaser, purchase any of 
our equity securities during the fiscal year 2013.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 16 (F) &#8211; CHANGE IN REGISTRANT&#8217;S 
CERTIFYING ACCOUNTANT</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Not applicable.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 16 (G) &#8211; CORPORATE 
GOVERNANCE</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our securities are listed on the 
OTC QB and on Canadian Securities Exchange. There are no significant ways in 
which our corporate governance practices differ from those followed by domestic 
companies under the listing standards of that exchange except for proxy delivery
requirements. As a foreign private issuer, the Company is exempt from the proxy 
rules set forth in Sections 14(a), 14(b), 14(c) and 14(f) of the Act. The 
Company solicits proxies in accordance with applicable rules and regulations in 
British Virgin Islands and requirements of Ontario Securities Commission and 
applicable CSE rules.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">PART III</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 17 - FINANCIAL STATEMENTS</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Refer to Item 18 - Financial Statements</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 18 - FINANCIAL STATEMENTS</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">See the Financial Statements and Exhibits listed in Item 19 
hereof and filed as part of this Annual Report.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-
DECORATION: underline">ITEM 19 - EXHIBITS</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">(a)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financial Statements</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="58%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline">Description of 
Document</font></font></div>
</td>
<td align="left" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline">Page No.</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="58%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Cover Sheet</font></div>
</td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="58%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Index</font></div>
</td>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">F1</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="58%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Report of Independent Registered Public Accounting
Firm</font></div>
</td>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">F2</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="58%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Consolidated Statements of Financial Position</font></div>
</td>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">F3</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="58%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Consolidated Statements of Operations and Comprehensive 
Loss</font></div>
</td>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">F4</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="58%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Consolidated Statement of Shareholders Equity</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Consolidated Statements of Cash Flows</font></div>
</td>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">F5-6</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">F7</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="58%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Notes to Consolidated&#160;&#160;Financial 
Statements</font></div>
</td>
<td align="left" valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">F8-21</font></div>
</td>
</tr><tr>
<td valign="top" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhib
its</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The following documents are filed as part of this Annual Report
on Form 20-F</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">1.1</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Certificate of Continuance - <font style="DISPLAY: inline; 
FONT-WEIGHT: bold">Incorporated herein by reference</font> to Exhibit 3.1 to 
Form 6-K filed on August 1, 2013.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">1.2</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Memorandum and Articles of Association - <font style="DISPLAY: 
inline; FONT-WEIGHT: bold">Incorporated herein by reference</font> to Exhibit 
99.2 to Form 6-K filed on August 1, 2013.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">4(c)1</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Consulting Agreement dated April 1, 2005 with Kam Shah <font 
style="DISPLAY: inline; FONT-WEIGHT: bold">Incorporated herein by reference 
</font>to Exhibit 4 (c) 1 to the Company&#8217;s Annual Report on Form 20-F for 
fiscal 2005 filed on September 28, 2005.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4(c) 
2</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Letter of April 1, 2010 extending consulting Agreement of Mr. 
Kam Shah to March 31, 2015. <font style="DISPLAY: inline; FONT-WEIGHT: 
bold">Incorporated herein by reference </font>to Exhibit 4 (c) 2 to the 
Company&#8217;s registration statement on Form F-1 Amendment No. 2 filed on June
17, 2010.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4(c) 
(iv).1</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">2011 Consultant stock compensation plan - <font style="DISPLAY:
inline; FONT-WEIGHT: bold">Incorporated herein by reference</font> to Form S-8 
filed on April 21, 2011.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4(c) 
(iv).2</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">2013 Stock option plan - <font style="DISPLAY: inline; FONT-
WEIGHT: bold">Incorporated herein by reference</font> to Form S-8 filed on 
December&#160;&#160;19, 2013.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE:
10pt">11.1</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Charter of audit and compensation committee regarding 
compensation matters</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">11.2</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Charter of audit and compensation committee regarding audit 
matters</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">11.3</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Code of conduct</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">12.1</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Certifications of Chief Executive Officer Pursuant to Rule 13a-
14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as 
amended.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">12.2</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Certifications of Chief Financial Officer Pursuant to Rule 13a-
14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as 
amended.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">13.1</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Certification of Chief Executive Officer Pursuant to Section 
906 of the Sarbanes-Oxley Act of 2002.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">13.2</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Certification of Chief Financial&#160;&#160;Officer Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;</font><br>
&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company hereby certifies that it meets all of the 
requirements for filing on Form 20-F and it has duly caused and authorized the
undersigned to sign this Annual Report on its behalf.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">DATED at Toronto, Ontario, Canada, this 25<font style="DISPLAY:
inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> day of July, 
2014</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">PORTAGE BIOTECH&#160;&#160;INC.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: 
underline">Per: /s/ Declan 
Doogan</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Title: Chief Executive Officer</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: 
underline">Per: /s/ Kam 
Shah</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160
;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&
#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Title: Chief Financial Officer</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>portagefinancials.htm
<DESCRIPTION>FINANCIAL STATEMENTS
<TEXT>
<html>
<head>
    <title>portagefinancials.htm</title>
    <!--Licensed to: bontan94-->
    <!--Document Created using EDGARizer 2020 5.4.0.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">
<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 63pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold">&#160;&#160;&#160;&#160;&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 63pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 63pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 63pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 63pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 63pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 63pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold">&#160;&#160;&#160;&#160;&#160; Portage 
Biotech Inc.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 90pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">(Formerly known as Bontan Corporation Inc.)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 90pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Financial 
Statements</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 90pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Years Ended March 31, 2014 and 
2013</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
(US Dollars)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold">Portage Biotech Inc.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">(Formerly known as Bontan Corporation Inc.)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Financial 
Statements</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Years Ended March 31, 2014 and 
2013</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(US Dollars)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 24pt">Index</font></div>
</td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="56%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Independent Auditor&#8217;s Report of Registered Public 
Accounting Firm</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2-3</font></div>
</td>
</tr><tr>
<td valign="top" width="56%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Consolidated Statements of Financial Position</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">4</font></div>
</td>
</tr><tr>
<td valign="top" width="56%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Consolidated Statements of Operations and Comprehensive 
Loss</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">5</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Consolidated Statements of Changes in Shareholders&#8217; 
Equity</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">6</font></div>
</td>
</tr><tr>
<td valign="top" width="56%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Consolidated Statements of Cash Flows</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">7</font></div>
</td>
</tr><tr>
<td valign="top" width="56%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Notes to Consolidated Financial Statements</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8-
25</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-90pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Schwartz Levitsky Feldman llp</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-90pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">CHARTERED ACCOUNTANTS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-90pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">LICENSED PUBLIC ACCOUNTANTS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-90pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">TORONTO <font style="DISPLAY: inline;" face="Symbol, 
serif">&#183;</font><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#160;</font>MONTREAL</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
35.95pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New 
Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1" style="MARGIN-LEFT: 
1.3pt"></font>INDEPENDENT AUDITOR&#8217;S REPORT OF REGISTERED PUBLIC ACCOUNTING
FIRM</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
36pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New 
Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To the Shareholders of Portage 
Biotech Inc. (formerly known as Bontan Corporation Inc.)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We have audited the accompanying consolidated financial 
statements of Portage Biotech Inc. (formerly known as Bontan Corporation Inc.), 
which comprise the consolidated statements of financial position as at March 31,
2014 and March 31, 2013, and the consolidated statements of operations and 
comprehensive loss, changes in shareholders&#8217; equity and cash flows for the
years ended March 31, 2014 and 2013 and a summary of significant accounting 
policies and other explanatory information.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Management's&#160;Responsibility for the 
Consolidated Financial Statements</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Management is responsible for the preparation and fair 
presentation of these consolidated financial statements in accordance with 
International Financial Reporting Standards as issued by the International 
Accounting Standards Board, and for such internal control as management 
determines is necessary to enable the preparation of consolidated financial 
statements that are free from material misstatement, whether due to fraud or 
error.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Auditor&#8217;s Responsibility</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Our responsibility is to express an opinion on these 
consolidated financial statements based on our audits.&#160;&#160;We conducted 
our audits in accordance with Canadian generally accepted auditing standards and
the standards of the Public Company Accounting Oversight Board (United 
States).&#160;&#160;Those standards require that we comply with ethical 
requirements and plan and perform the audit to obtain reasonable assurance about
whether the consolidated financial statements are free from material 
misstatement. We were not engaged to perform an audit of the Company&#8217;s 
internal control over financial reporting. Our audits included consideration of 
internal control over financial reporting as a basis for
designing audit procedures that are appropriate in the circumstances, but not 
for the purpose of expressing an opinion on the effectiveness of the 
Company&#8217;s internal control over financial reporting. Accordingly, we 
express no such opinion.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">An audit involves performing procedures to obtain audit 
evidence about the amounts and disclosures in the consolidated financial 
statements. The procedures selected depend on the auditor&#8217;s judgment, 
including the assessment of the risks of material misstatement of the 
consolidated financial statements, whether due to fraud or error. An audit also 
includes evaluating the appropriateness of accounting policies used and the 
reasonableness of accounting estimates made by management, as well as evaluating
the overall presentation of the consolidated financial statements.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">We believe that the audit evidence we have obtained in our 
audits is sufficient and appropriate to provide a basis for our audit 
opinion.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Opinion</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">In our opinion, the consolidated financial statements present 
fairly, in all material respects, the financia</font><br>
<br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">position of Portage Biotech Inc (formerly known as Bontan 
Corporation Inc.) as at March 31, 2014 and March 31, 2013, and its financial 
performance and its cash flows for the years ended March 31, 2014 and 2013 in 
accordance with International Financial Reporting Standards as issued by the 
International Accounting Standards Board.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Emphasis of Matter</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Without qualifying our opinion, we draw attention to Note 1 to 
the consolidated financial statements which indicates that the Company has 
accumulated losses totaling $6,334,433 and negative cash flows from operating 
activities of $1,935,418. These conditions, along with other matters as set 
forth in Note 1 indicate the existence of a material uncertainty that raises 
substantial doubt about the Company&#8217;s ability to continue as a going 
concern.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 216pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8220;SCHWARTZ LEVITSKY FELDMAN 
LLP&#8221;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0.2pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">July 25,
2014&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Chartered 
Accountants</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0.2pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Toronto, Ontario&#160;Licensed Public Accountants</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2300 Yonge Street, Suite 1500, 
Box 2434</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Toronto, Ontario M4P 1E4</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Tel:&#160;&#160;416 785 5353</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Fax:&#160;&#160;416 785 5663</font></div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold">Portage Biotech Inc.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">(Formerly known as Bontan Corporation Inc.)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Statements of Financial 
Position</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(US Dollars)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">As at March 31,</font></div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-TOP: black 0.5pt 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Note</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; BORDER-
TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-TOP: black 0.5pt 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; BORDER-
TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-TOP: black 0.5pt 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2013*&#160;(Note 2)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; BORDER-
TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Assets</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Current</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Cash</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">2,032,058</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">190,960</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Advances and other 
receivable</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">227,233</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">295,441</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">2,259,291</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY:
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">486,401</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Long-term assets</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;Goodwill and Intangible assets</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2(ii)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: 
times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; 
FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">3,000,000</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT:
bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; 
FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;Office equipment and furniture</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">4,122</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY:
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">5,263,413</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">486,401</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liabilities and Shareholders' 
equity</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Current liabilities</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Accounts payable and accrued 
liabilities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY:
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">(d)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">191,972</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">12,392</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY:
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">191,972</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">12,392</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shareholders' Equity</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY:
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Capital stock</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">7,256,715</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">503,495</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock option reserve</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">(a)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">362,440</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Warrants</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">(i)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">1,108,402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Deficit</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY:
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">(6,334,433</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">(29,486</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Shareholders' equity</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">2,393,124</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">474,009</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Non-controlling interests</font></div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; 
FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2(ii)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: 
left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: 
right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">2,678,317</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: 
left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: 
right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total equity</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE:
10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">5,071,441</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">474,009</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total&#160;&#160;liabilities and 
Shareholders' equity</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY:
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">5,263,413</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">486,401</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Commitments and Contingent Liabilities (Note
10)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Related Party Transactions (Note 
12)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY:
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">&#160;* Comparatives are for Portage Pharma Ltd (accounting 
acquirer), which was incorporated on May 23, 2012.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">On behalf of 
the Board</font>&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: 
underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;&#160;&#8221;Kam 
Shah&#8221;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#1
60;</font> Director&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: 
underline">&#160;&#160;&#160;&#160;&#160;&#160;&#8221;Declan 
Doogan&#8221;&#160;&#160;&#160;&#160;&#160;&#160;</font>Director</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;
(signed)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;(signed)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 18pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">The accompanying notes are an integral part of these consolidated 
financial statements.</font></font></div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold">Portage Biotech Inc.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">(Formerly known as Bontan Corporation Inc.)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Statements of Operations and 
Comprehensive Loss</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(US Dollars)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="42%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid; 
BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note</font></div>
</td>
<td align="left" valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid;
BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended March 31, 2014</font></div>
</td>
<td align="left" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">May 23, 2012 to March 31, 2013 * (Note 2)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Expenses</font></div>
</td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160; &#160;Acquisition related costs</font></div>
</td>
<td valign="bottom" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2(i) &amp; 6</font></div>
</td>
<td align="right" valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,839,398</font></div>
</td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160; &#160;Consulting fees</font></div>
</td>
<td valign="middle" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">10(a) &amp; (b) and 11</font></div>
</td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,162,362</font></div>
</td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160; Research and development</font></div>
</td>
<td valign="bottom" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">7(d) and 10((c) to( h) )</font></div>
</td>
<td align="right" valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,135,779</font></div>
</td>
<td align="right" valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;26,976</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Professional fees</font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;335,692<
/font></div>
</td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Office and general</font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;39,501</font></div>
</td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Payroll</font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;39,348</font></div>
</td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Shareholders' information</font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;29,835</font></div>
</td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Rent</font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;17,009</font></div>
</td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Travel, meals and 
promotions</font></div>
</td>
<td valign="middle" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">12 (i)</font></div>
</td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;14,357</font></div>
</td>
<td align="right" valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;2,470</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Transfer agents fees</font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;11,329</font></div>
</td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Bank charges and interest</font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;3,351</font></div>
</td>
<td align="right" valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;40</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Communication</font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;3,070</font></div>
</td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Amortization</font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT:
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;1,164</font></div>
</td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Exchange gain</font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;(5,565)</font></div>
</td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="42%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$6,626,630</font></div>
</td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;$29,486</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="42%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net loss and comprehensive loss for 
year</font></div>
</td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$(6,626,630)</font></div>
</td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;$(29,486)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net loss&#160;&#160;and comprehensive loss 
attributable to :</font></div>
</td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;&#160;&#160;Owners of the 
Company</font></div>
</td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(6,304,947)</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;(29,486)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;&#160;&#160;&#160;Non-controlling 
interest</font></div>
</td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(321,683)</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;-</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="42%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$(6,626,630)</font></div>
</td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;$(29,486)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Basic and diluted loss per 
share</font></div>
</td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="42%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Net Loss per share</font></div>
</td>
<td valign="middle" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">9</font></div>
</td>
<td align="right" valign="middle" width="11%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$(0.04)</font></div>
</td>
<td align="right" valign="middle" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$(0.00)</font></div>
</td>
</tr><tr>
<td valign="bottom" width="42%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">* Comparatives are for Portage Pharma Ltd (accounting acquirer)
which was incorporated on May 23, 2012</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">The accompanying notes are an integral part of these consolidated 
financial statements.</font></font></div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold">Portage Biotech Inc.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">(Formerly known as Bontan Corporation Inc.)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Statements of Changes in 
Shareholders&#8217; Equity</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Year ended March 31, 
2014&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(US Dollars)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid;
BORDER-TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; 
BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number of Shares</font></div>
</td>
<td align="left" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; 
BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-5.4pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Capital Stock</font></div>
</td>
<td align="left" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid; 
BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-5.35pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock Option Reserve</font></div>
</td>
<td align="left" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; 
BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-5.35pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Warrants</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid;
BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accumulated Deficit</font></div>
</td>
<td align="left" colspan="2" valign="top" width="9%" style="BORDER-BOTTOM: black
2px solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Non-controlling interest</font></div>
</td>
<td align="left" colspan="2" valign="top" width="10%" style="BORDER-BOTTOM: 
black 2px solid; BORDER-TOP: black 1pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Equity</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance, May 23, 2012</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">81,759,076</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">$&#160;&#160;503,495</font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" colspan="3" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;503,495</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Net loss for period</font></div>
</td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
(29,486)</font></div>
</td>
<td colspan="2" valign="middle" width="9%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" colspan="2" valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
(29,486)</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="16%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance, March 31, 2013</font></div>
</td>
<td align="right" valign="middle" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">81,759,076</font></div>
</td>
<td align="right" valign="middle" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$&#160;&#160;503,495</font></div>
</td>
<td align="right" valign="middle" width="8%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-5.35pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;-</font></div>
</td>
<td align="right" valign="middle" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-5.35pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;$&#160;&#160;&#160;&#160;&#160;-</font></div>
</td>
<td align="right" valign="middle" width="13%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$&#160;&#160;&#160;&#160;
(29,486)</font></div>
</td>
<td align="right" colspan="2" valign="middle" width="9%" style="BORDER-BOTTOM: 
black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></div>
</td>
<td align="right" colspan="2" valign="middle" width="10%" style="BORDER-BOTTOM: 
black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$&#160;&#160;474,009</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance, April 1, 2013</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">81,759,076</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$&#160;&#160;503,495</font></div>
</td>
<td align="right" valign="middle" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-5.35pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;$&#160;&#160;&#160;&#160;&#160;-</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-5.35pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;-</font></div>
</td>
<td align="right" valign="middle" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$ (29,486)</font></div>
</td>
<td align="right" colspan="2" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;-
</font></div>
</td>
<td align="right" colspan="2" valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$&#160;&#160;474,009</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Issued on reverse acquisition (Note 2)</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">81,759,076</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,761,413</font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-5.35pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;1,108,402</font></div>
</td>
<td valign="middle" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="middle" width="9%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" colspan="2" valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;2,869,815</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Issued for financial advisory services relating to the 
acquisition transaction</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">9,811,091</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,826,325</font></div>
</td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" colspan="2" valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;3,826,325</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Exercise of warrants</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1,450,000</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;175,000<
/font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="middle" width="9%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" colspan="2" valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;175,000</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Exercise of options</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1,996,547</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;299,482<
/font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="middle" width="9%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" colspan="2" valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;299,482</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Value of shares issued as compensation</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">4,000,000</font></div>
</td>
<td align="right" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;691,000<
/font></div>
</td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="middle" width="9%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" colspan="2" valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;691,000</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Value of options issued</font></div>
</td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-5.35pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;362,440</font></div>
</td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="middle" width="9%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" colspan="2" valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;362,440</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Acquisition of Biohaven (Note 2)</font></div>
</td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" colspan="2" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;3,000,000</font></div>
</td>
<td align="right" colspan="2" valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;3,000,000</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Net loss for year</font></div>
</td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;(6,304,947)</font></div>
</td>
<td align="right" colspan="2" valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;(321,683)</font></div>
</td>
<td align="right" colspan="2" valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;(6,626,630)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance, March 31, 2014</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">180,775,790</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$ 7,256,715</font></div>
</td>
<td align="right" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-5.35pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$ 362,440</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-5.35pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$ 1,108,402</font></div>
</td>
<td align="right" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$ (6,334,433)</font></div>
</td>
<td align="right" colspan="3" valign="bottom" width="9%" style="BORDER-BOTTOM: 
black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$ 2,678,317</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$ 5,071,441</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">The accompanying notes are an integral part 
of these consolidated financial statements.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><br>
</div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold">Portage Biotech Inc.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">(Formerly known as Bontan Corporation Inc.)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Statements of Cash 
Flows</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(US Dollars)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="51%" style="BORDER-BOTTOM: black 2px solid;
BORDER-TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: 
black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="15%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended March 31, 2014</font></div>
</td>
<td align="left" valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid;
BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">May 23, 2012 to March 31, 2013</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash flows from operating 
activities</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;Net loss for period</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$ (6,626,630)</font></div>
</td>
<td align="right" valign="bottom" width="14%">
<div align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;$&#160;&#160;(29,486)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Adjustments for non-cash items:</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;Amortization of office equipment and 
furniture</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;1,164</font></div>
</td>
<td align="left" valign="bottom" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;-</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;Value of shares and options expensed as 
consulting fee</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,
053,440</font></div>
</td>
<td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;Acquisition related costs</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,
826,325</font></div>
</td>
<td align="left" valign="bottom" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;-</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net change in working capital 
components</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;Other receivables</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;(73,270)</font></div>
</td>
<td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;Accounts payable and accrued 
liabilities</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;(116,447)</font></div>
</td>
<td align="right" valign="bottom" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;12,392</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="51%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE:
10pt">&#160; </font></td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;$ (1,935,418)</font></div>
</td>
<td align="right" valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
(17,094)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash flows from financing 
activities</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;Cash received on reverse acquisition (Note 
2)</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">3,006,593</font></div>
</td>
<td align="left" valign="bottom" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;-</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;Options and 
warrants&#160;&#160;excercised</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;474,482</font></div>
</td>
<td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;Capital contribution</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;295,441</font></div>
</td>
<td align="right" valign="bottom" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;208,054</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="51%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,776,516</fo
nt></div>
</td>
<td align="right" valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;208,054</font
></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Increase in cash during year</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,
841,098</font></div>
</td>
<td align="right" valign="bottom" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;190,960<
/font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="51%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash at beginning of year</font></div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">190,960</font></div>
</td>
<td align="left" valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;-</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="51%" style="BORDER-BOTTOM: black 4px 
double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash at end of year</font></div>
</td>
<td valign="middle" width="2%" style="BORDER-BOTTOM: black 4px double"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td align="right" valign="middle" width="15%" style="BORDER-BOTTOM: black 4px 
double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,032,058</fo
nt></div>
</td>
<td align="right" valign="middle" width="14%" style="BORDER-BOTTOM: black 4px 
double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;190,960</font
></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplemental disclosures</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Non-cash investing activities</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="51%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Value of shares and warrants issued on acquisition</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
(2,869,815)</font></div>
</td>
<td align="right" valign="bottom" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;-</font></div>
</td>
</tr><tr>
<td valign="bottom" width="51%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="51%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td align="right" valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td align="right" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT:
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
(2,869,815)</font></div>
</td>
<td align="right" valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;-</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">The accompanying notes are an integral part of these consolidated 
financial statements.</font></font></div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 18pt; FONT-WEIGHT: bold">Portage Biotech Inc.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">(Formerly known as Bontan Corporation Inc.)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial 
Statements</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(US Dollars)</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">March 31, 2014 and 2013</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">1.&#160;&#160;&#160;&#160;&#160;&#160;NATURE
OF OPERATIONS AND GOING CONCERN</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Portage Biotech Inc. (&#8220;the Company&#8221;) was operating 
as an Ontario, Canada incorporated company, Bontan Corporation Inc. 
(&#8220;Bontan&#8221;), until July 5, 2013. On July 5, 2013 Bontan changed its 
name to the current name and was issued a certificate of Continuance by the 
Registrar of Corporate Affairs of the British Virgin Islands 
(&#8220;BVI&#8221;).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company now continues as a BVI incorporated company with 
its registered office located at FH Chambers, P.O. Box 4649, Road Town, Tortola,
BVI. Its Toronto agent is located at 47 Avenue Road, Suite 200, Toronto, 
Ontario, M5R 2G3, Canada.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company continues to be a reporting issuer with Ontario 
Securities Commission and US Securities and Exchange Commission and its shares 
trade on the Quotation Board of the OTC Markets under the trading symbol 
&#8220;PTGEF,&#8221; effective August 23, 2013. Prior to this date, it was 
trading as Bontan Corporation Inc. under the trading symbol 
&#8220;BNTNF&#8221;.&#160;&#160;Effective October 28, 2013, the Company&#8217;s
shares are also listed for trading in US currency on the Canadian Securities 
Exchange (formerly, Canadian National Stock Exchange) under the symbol 
&#8220;PBT.U&#8221;.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Since December 2012, the Company changed the focus of its 
business activities to biotechnology. On June 4, 2013, it acquired Portage 
Pharma Ltd (&#8220;PPL&#8221;), a private limited company incorporated on May 
23, 2012 under BVI laws, through the exchange of shares. The acquisition has 
been accounted for as a reverse acquisition as explained in Note 2.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: 
inline">is engaged in researching and developing pharmaceutical and biotech 
products through to clinical &#8220;proof of concept&#8221; with an initial 
focus on unmet clinical needs. Following proof of concept, the Company will look
to sell or license the products to large pharmaceutical companies for further 
development and commercialization.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">The 
Company is in the pre-clinical stage, and as such no revenue has been generated 
from its operations. The Company has accumulated losses of $6,334,433 and has 
negative cash flows from operating activities of $1,935,418 at March 31, 
2014.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">The 
Company continues to obtain financing, although there are no assurances that the
management&#8217;s plan will be realized. Management believes the Company will 
be able to secure the necessary financing to continue operations in the future. 
These conditions indicate the existence of a material uncertainty that raises 
substantial doubt about the Company&#8217;s ability to continue as a going 
concern. The consolidated financial statements do not include any adjustments 
related to the recoverability and classification of recorded asset amounts, or 
the amounts and classification of liabilities, which might be necessary should 
the Company be unable to
continue its operations.</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: 
inline">2.</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="BACKGROUND-COLOR: #ffffff; 
DISPLAY: inline">ACQUISITIONS</font></font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: 
inline">(i)</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="BACKGROUND-COLOR: #ffffff; 
DISPLAY: inline">Reverse Acquisition Transaction</font></font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">On June 4, 2013, the Company completed an acquisition with PPL 
pursuant to which a wholly owned subsidiary of the Company, Portage Acquisition 
Inc. and PPL amalgamated, resulting in the Company owning all of the issued and 
outstanding shares of the amalgamated entity.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Pursuant to a Share Exchange Agreement, Bontan issued 
81,759,076 common shares and 71,456,420 warrants to PPL shareholders in exchange
for PPL shareholders transferring all their shares in favour of Portage 
Acquisition Inc. Warrants can be exercised within two years at an exercise price
of US$0.29 to acquire an equal number of common shares of the Company. In 
addition, Bontan also issued 9,811,091 shares to a company as compensation for 
financial advisory services rendered in connection with the transaction. The 
fair value of these shares of $ 3,826,325 was expensed.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Although the transaction resulted in PPL becoming a wholly 
owned subsidiary of the Company, the transaction constitutes a reverse 
acquisition in as much as the shareholders of PPL own a substantial majority of 
the outstanding common shares of the Company and three out of four members of 
the Board of Directors of the Company are PPL shareholders. As a result, PPL 
controls the Company.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The transaction has therefore been accounted for as a reverse 
acquisition in accordance with guidance provided in IFRS 2 <font style="FONT-
STYLE: italic; DISPLAY: inline">Share-based payment</font> and IFRS 3 <font 
style="FONT-STYLE: italic; DISPLAY: inline">Business Combinations</font>. As 
Bontan did not meet the definition of a business according to the definition in 
IFRS 3, this reverse acquisition does not constitute a business combination; 
rather it is treated as an issuance of shares by PPL for the fair value of the 
net assets of Bontan followed by a recapitalization of the Company.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">These consolidated financial statements represent a 
continuation of the financial statements of PPL and include:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The assets and liabilities of PPL at their pre-acquisition 
carrying amounts as at&#160;&#160;March 31, 2014 and expenses for the year ended
on that date</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The assets and liabilities of Bontan as at March 31, 2014 and 
expenses from June 4, 2013 to March 31, 2014.</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Share capital representing the total number of shares issued by
the Company.</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Value of the share capital was computed by adding to the value 
of the share capital of PPL on the date of acquisition, June 4, 2013, the fair 
value of Bontan as allocated to shares issued on the date of acquisition, and 
adjusted to any exercise or issuance of shares, warrants and options during the 
year ended March 31, 2014.</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">e.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Comparative figures are those of PPL, before the 
transaction.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The fair value of the consideration is determined based on the
fair value of net assets of Bontan acquired by PPL, which was computed as 
$2,869,815, as follows:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Cash</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,006,593</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Office equipment and furniture</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,286</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Other assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">153,963</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(296,027</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="88%" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY:
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Fair value of net assets</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-
ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">2,869,815</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 
2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">The fair value of the consideration was allocated:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">To shares issued</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,761,413</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">To warrants issued</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,108,402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline;
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">(ii)&#160;&#160;&#160;&#160;&#160;&#160;Acquisition</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">On January 6, 2014, the Company acquired approximately 54% 
equity in Biohaven Pharmaceutical Holding Company Limited, 
(&#8220;Biohaven&#8221;) a private corporation incorporated on September 25, 
2013 under the laws of the British Virgin Islands for $3.5 million, payable in 
cash as $ 1.75 million upfront and the balance in three instalments over the 
next eleven months.<font style="DISPLAY: inline; FONT-FAMILY: Times New 
Roman">&#160;</font>Biohaven is engaged in the identification and development of
clinical stage neuroscience compounds targeting the glutamatergic system. 
Biohaven has a worldwide license from Yale University to use intellectual 
property relating to the use of certain glutamate modulating agents in
the treatment of neuropsychiatric disorders (see Note 10(e)).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company has a majority equity interest and also controls 
the Board of Directors of Biohaven. As a result, these financial statements 
include results of operations for Biohaven from January 6, 2014 to March 31, 
2014 and assets and liabilities as of March 31, 2014.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The non-controlling interests in Biohaven on the date of 
acquisition was valued at $ 3 million based on their 46% equity being valued on 
the basis of the price the Company paid for 54% equity in Biohaven. In absence 
of any net tangible assets in Biohaven on the date of the acquisition, the 
entire amount was treated as goodwill and intangible assets as per <font 
style="FONT-STYLE: italic; DISPLAY: inline">IFRS 3 &#8211; business 
combinations</font>.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The initial accounting for the business combination was 
incomplete by the end of the reporting period in which the combination occurred 
and as a result the Company has reported provisional amounts for the items 
during the measurement period (which cannot exceed one year from January 6, 
2014) and which may result in additional assets or liabilities, including income
taxes, being recognized, to reflect new information obtained about facts and
circumstances that existed at the acquisition date that, if known, would have 
affected the amounts recognized at that date.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The provisional amounts were determined as 
follows:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Goodwill 
and intangible assets</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$3,000,000</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Other net 
assets</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline">$3,500,000</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="64%">
<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;Net assets acquired</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline">$6,500,000</font></font></div>
</td>
</tr><tr>
<td valign="top" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;Cash
consideration paid for company&#8217;s interest (54%)</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$3,500,000</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Non-
controlling interest</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline">$3,000,000</font></font></div>
</td>
</tr><tr>
<td valign="top" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline">$6,500,000</font></font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Non-controlling interest was measured at the present 
ownership&#8217;s proportionate share of the recognized amounts in the net 
identifiable assets of Biohaven.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;</font><br>
&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;BASIS 
OF PRESENTATION</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">(a)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Statement of Compliance and Basis of 
presentation</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">These consolidated financial statements have been prepared in 
accordance with the International Financial Reporting Standards 
(&#8220;IFRS&#8221;) issued by the International Accounting Standards Board 
(&#8220;IASB&#8221;), and interpretations of the International Financial 
Reporting Interpretations Committee.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">These consolidated financial statements have been prepared on a
historical cost basis except for stock based compensation and warrants which are
measured at fair value as detailed in Notes 7 and 8 to these financial 
statements.&#160;&#160;In addition, these consolidated financial statements have
been prepared using the accrual basis of accounting, except for cash flow 
information.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company has no requirement to report on segments as it 
operates as only one segment.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">These consolidated financial statements were approved and 
authorized for issue by the Audit Committee and Board of Directors on July 25, 
2014</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1" style="MARGIN-LEFT: 
36pt"></font>(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;Consolidation</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The consolidated financial statements include the accounts of
the Company and,</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">a.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Portage Services Ltd. (previously 1843343 Ontario Inc.), a 
wholly owned subsidiary incorporated in Ontario on January 31, 2011. 1843343 
Ontario Inc. changed its name to Portage Services Ltd. effective July 11, 
2013.</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">b.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Portage Pharmaceuticals Ltd. (previously Portage Acquisition 
Inc.), a wholly owned subsidiary incorporated on April 5, 2013 under the laws of
the BVI, as a BVI business company. On July 23, 2013, Portage Pharma Limited 
merged with Portage Acquisition Inc. and the merged entity was known as Portage 
Acquisition Inc., which changed its name on August 27, 2013.</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font 
style="DISPLAY: inline; FONT-SIZE: 10pt">c.</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Biohaven Pharmaceutical Holding Company Limited 
(&#8220;Biohaven&#8221;). ( Note 2(ii))</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">All inter-company balances and transactions have been 
eliminated on consolidation.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">(c)&#160;&#160;&#160;&#160;&#160;&#160;Functional and presentation 
currency</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">On June 4, 2013, the Company did an analysis applying the 
primary and secondary indicators in IAS 21 and determined that, as a result of 
the reverse acquisition transaction discussed in Note 2 and change of its 
jurisdiction to BVI; its economic circumstances have changed. The Company incurs
substantially all expenses in US Dollars and expects future revenues in US 
Dollars.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The management therefore concluded that the US Dollar is the 
most appropriate functional currency for all operations. The Company has also 
decided to change its presentation currency to the US Dollar.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The effect of the above change in functional currency has been 
accounted for prospectively as provided under IAS 21 <font style="FONT-STYLE: 
italic; DISPLAY: inline">the effect of changes in foreign exchange rates</font>.
Accordingly, all Non-US dollar items were translated into US dollars using the 
exchange rate as of June 4, 2013. The non-monetary items were translated at the 
historical exchange rates.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(e)&#160;&#160;&#160;&#160;&#160;&#160;Use 
of Estimates and judgments</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The preparation of the consolidated financial statements in 
conformity with IFRS requires management to make judgments, estimates and 
assumptions that affect the application of accounting policies and the reported 
amounts of assets, liabilities, income and expenses. Actual results may differ 
from these estimates.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Estimates and underlying assumptions are reviewed on an ongoing
basis. Revisions to accounting estimates are recognized in the period in which 
the estimates are revised and in any future periods affected. Significant areas 
where estimation uncertainty and critical judgments are applied include 
valuation of financial instruments, research and development costs, fair value 
used for acquisition and measurement of share- based compensation.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div>&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">4.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNIFICANT ACCOUNTING POLICIES</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The accounting policies set out below have been applied 
consistently to all periods presented in these consolidated financial 
statements, and have been applied consistently by the Company and its 
subsidiaries.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financial instruments</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financial 
assets</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">All financial assets are initially recorded at fair value and 
are designated upon inception into one of the following four categories: held-
to-maturity, available-for-sale, loans and receivables or at fair value through 
profit or loss (&#8220;FVTPL&#8221;).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Financial assets classified as FVTPL are measured at fair value
with unrealized gains and losses recognized through earnings. The 
Company&#8217;s cash is classified as FVTPL.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Financial assets classified as loans and receivables are 
measured at amortized cost using the effective interest method. The 
Company&#8217;s advances and other receivables are classified as loans and 
receivables.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Transactions costs associated with FVTPL financial assets are 
expensed as incurred, while transaction costs associated with all other 
financial assets are included in the initial carrying amount of the 
asset.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financial 
liabilities</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">All financial liabilities are initially recorded at fair value 
and designated upon inception as FVTPL or other financial 
liabilities.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Financial liabilities classified as other financial liabilities
are initially recognized at fair value less directly attributable transaction 
costs. After initial recognition, other financial liabilities are subsequently 
measured at amortized cost using the effective interest method. The 
Company&#8217;s trade and other payables are classified as other financial 
liabilities.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The effective interest method is a method of calculating the 
amortized cost of a financial liability and of allocating interest expense over 
the relevant period. The effective interest rate is the rate that exactly 
discounts estimated future cash payments through the expected life of the 
financial liability, or, where appropriate, a shorter period.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Impairment of financial 
assets</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company assesses at each date of the statement of financial
position whether a financial asset is impaired.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Assets carried at amortized
cost</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">If there is objective evidence that an impairment loss on 
assets carried at amortized cost has been incurred, the amount of the loss is 
measured as the difference between the asset&#8217;s carrying amount and the 
present value of estimated future cash flows discounted at the financial 
asset&#8217;s original effective interest rate. The carrying amount of the asset
is then reduced by the amount of the impairment. The amount of the loss is 
recognized in profit or loss.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">If, in a subsequent period, the amount of the impairment loss 
decreases and the decrease can be related objectively to an event occurring 
after the impairment was recognized, the previously recognized impairment loss 
is reversed to the extent that the carrying value of the asset does not exceed 
what the amortized cost would have been had the impairment not been recognized. 
Any subsequent reversal of an impairment loss is reversed through profit or 
loss.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 198pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Foreign currency 
translation</font></font></div>
</td>
<td>&#160;</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The functional and presentation currency of the Company and its
subsidiaries (Note 3) is the US dollar. Monetary assets and liabilities are 
translated at exchange rates in effect at the balance sheet 
date.&#160;&#160;Non-monetary assets are translated at exchange rates in effect 
when they were acquired. Revenue and expenses are translated at the approximate 
average rate of exchange for the period, except that amortization is translated 
at the rates used to translate related assets. Foreign currency differences 
arising on retranslation are recognised in profit or loss.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Share-based payments</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company accounts for share-based payments granted to 
directors, officers, employees and consultants using the Black-Scholes option-
pricing model to determine the fair value of the plan at the grant date. Share-
based payments to employees, officers and directors are recorded<font 
style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>and reflected as an 
expense over the vesting period with a corresponding amount reflected in stock 
option reserve. On exercise, the associated amounts previously recorded in the 
stock option reserve are transferred to the common share capital.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The quoted market price of the Company&#8217;s shares on the 
date of issuance under any share- based plan is considered as fair value of the 
shares issued.</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Share-based payments to non-employees are recognized and 
measured at the date the services are received based on the fair value of the 
services received unless if the fair value of the services cannot be reliably 
measured in which case it is based on the fair value of equity instruments 
issued using the Black-Scholes option pricing model.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accounting for equity units</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">When the Company issues Units under a private placement 
comprising of common shares and warrants, the Company follows the relative fair 
value method of accounting for warrants attached to and issued with common 
shares of the Company. Under this method, the fair value of warrants issued is 
estimated using a Black-Scholes option pricing model which is added to fair 
value of the common shares determined using the stock price at the date of 
issuance and the percentage relative to the fair values determined. The fair 
value of the common shares and the warrants are proportionately adjusted to the 
net proceeds received. The fair value is then related to the total of the net 
proceeds received on issuance of the common
shares.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Loss per Share</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Basic loss per share is calculated by dividing net loss (the 
numerator) by the weighted average number of common shares outstanding (the 
denominator) during the period.&#160;&#160;Diluted loss per share reflects the 
dilution that would occur if outstanding stock options and share purchase 
warrants were exercised or converted into common shares using the treasury stock
method and are calculated by dividing net loss applicable to common shares by 
the sum of the weighted average number of common shares outstanding and all 
additional common shares that would have been outstanding if potentially 
dilutive common shares had been issued.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The inclusion of the Company&#8217;s stock options and share 
purchase warrants in the computation of diluted loss per share would have an 
anti-dilutive effect on loss per share and are therefore excluded from the 
computation.&#160;&#160;Consequently, there is no difference between basic loss 
per share and diluted loss per share.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development 
Expenses</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">(i)</font></div>
</td>
<td>
<div align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and 
development</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Expenditure on research activities, undertaken with the 
prospect of gaining new scientific or technical knowledge and understanding, is 
recognized in profit or loss as incurred.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Development activities involve a plan or design for the 
production of new or substantially improved products and processes. Development 
expenditures are capitalized only if development costs can be measured reliably,
the product or process is technically and commercially feasible, future economic
benefits are probable, and the Company intends to and has sufficient resources 
to complete development and to use or sell the asset. No development costs have 
been capitalized to date.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Research and development expenses include all direct and 
indirect operating expenses supporting the products in development.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">(ii)</font></div>
</td>
<td>
<div align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Subsequent 
expenditure</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Subsequent expenditure is capitalized only when it increases 
the future economic benefits embodied in the specific asset to which it relates.
All other expenditures are recognized in profit or loss as 
incurred.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold">(iii)</font></div>
</td>
<td>
<div align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Clinical trial 
expenses:</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Clinical trial expenses are a component of the Company&#8217;s 
research and development costs. These expenses include fees paid to contract 
research organizations, clinical sites, and other organizations who conduct 
development activities on the Company&#8217;s behalf. The amount of clinical 
trial expenses recognized in a period related to clinical agreements are based 
on estimates of the work performed using an accrual basis of accounting. These 
estimates incorporate factors such as patient enrolment, services provided, 
contractual terms, and prior experience with similar contracts</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Intangible assets</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;</font><br>
&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Intangible assets that are acquired separately and have finite 
useful lives are measured at cost less accumulated amortization and accumulated 
impairment losses. Subsequent expenditures are capitalized only when they 
increase the future economic benefits embodied in the specific asset to which it
relates.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Costs incurred in obtaining a patent are capitalized and 
amortized on a straight-line basis over the legal life of the respective patent,
ranging from five to twenty years, or its economic life, if shorter. Costs 
incurred in obtaining a trademark are capitalized and amortized on a straight-
line basis over the legal life of the respective trademark, being ten years, or 
its economic life, if shorter. Costs incurred in obtaining a customer list are 
capitalized and amortized on a straight-line basis over its estimated economic 
life of approximately ten years.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Costs incurred in successfully obtaining a patent, trademark or
customer list are measured at cost less accumulated amortization and accumulated
impairment losses. The cost of servicing the Company's patents and trademarks 
are expensed as incurred.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">At each year end, the Company reviews the carrying amounts of 
the intangible assets to</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">determine whether there is any indication that those assets 
have suffered an impairment loss. If any such indication exists, the recoverable
amount of the asset is estimated in order to determine the extent of the 
impairment loss (if any).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Goodwill</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Goodwill arising on the acquisition of a subsidiary is included
in intangible assets on a provisional basis. Goodwill is tested annually for 
impairment and carried at cost less accumulated impairment losses which are not 
reversed. Goodwill is allocated to the cash generating unit expected to benefit 
from the business combination in which the goodwill arose, for the purpose of 
impairment testing.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Business Combinations</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company applies the acquisition method to account for all 
acquired businesses, whereby the identifiable assets acquired and the 
liabilities assumed are measured at their acquisition-date fair values (with few
exceptions as required by IFRS 3 <font style="FONT-STYLE: italic; DISPLAY: 
inline">Business Combinations</font>).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The consideration transferred in a business combination is 
measured at fair value, which is calculated as the sum of the acquisition-date 
fair values of the assets transferred, the liabilities incurred and the equity 
interests issued by the Company.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Acquisition-related costs (e.g. finder&#8217;s fees, consulting
fees, administrative costs, etc.) are recognized as expenses in the periods in 
which the costs are incurred and the services are received.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">On acquisition date, goodwill is measured as the excess of the 
aggregate of consideration transferred, any non-controlling interests in the 
acquiree, and acquisition-date fair value of the Company's previously held 
equity interest in the acquiree (if business combination achieved in stages) 
over the net of the acquisition-date amounts of the identifiable assets acquired
and the liabilities assumed.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">If, after appropriate reassessment, the amount as calculated 
above is negative, it is recognized immediately in profit or loss as a bargain 
purchase gain.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">At acquisition date, non-controlling interests in the acquiree 
that are present ownership interests and entitle their holders to a 
proportionate share of the entity's net assets in the event of liquidation are 
measured at either fair value or the present ownership instruments&#8217; 
proportionate share in the recognized amounts of the acquiree's identifiable net
assets. This choice of measurement is made separately for each business 
combination. Other components of non-controlling interests are measured at their
acquisition-date fair values, unless otherwise required by IFRS.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The acquisition-date fair value of any contingent consideration
is recognized as part of the consideration transferred by the Company in 
exchange for the acquiree. Changes in the fair value of contingent consideration
that result from additional information obtained during the measurement period 
(maximum one year from the acquisition date) about facts and circumstances that 
existed at the acquisition date are adjusted retrospectively against 
goodwill.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Provisions</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;</font><br>
&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">A provision is recognized if, as a result of a past event, the 
Company has a present legal or constructive obligation that can be estimated 
reliably, and it is probable that an outflow of economic benefits will be 
required to settle the obligation. Provisions are determined by discounting the 
expected future cash flows at a pre-tax rate that reflects current market 
assessments of the time value of money and the risks specific to the liability. 
The unwinding of the discount is recognized as finance cost.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Contingent liability:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">A contingent liability is a possible obligation that arises 
from past events and of which the existence will be confirmed only by the 
occurrence or non-occurrence of one or more uncertain future events not within 
the control of the Corporation; or a present obligation that arises from past 
events (and therefore exists), but is not recognized because it is not probable 
that a transfer or use of assets, provision of services or any other transfer of
economic benefits will be required to settle the obligation; or the amount of 
the obligation cannot be estimated reliably.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 21.3pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Determination of fair value</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">A number of the Company&#8217;s accounting policies and 
disclosures required the determination of fair value, both for financial and 
non-financial assets and liabilities. Fair values have been determined for 
measurement and/or disclosure purposes based on the following methods. When 
applicable, further information about the assumptions made in determining fair 
values is disclosed in the notes specific to that asset or
liability.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 
10pt">a&#160;&#160;&#160;&#160;&#160;)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;Office equipment and furniture are recognized at fair 
value in a business combination. The fair value of property, plant and equipment
is the estimated amount for which the property, plant and equipment could be 
exchanged on the acquisition date between a willing buyer and a willing seller 
in an arm&#8217;s length transaction after proper marketing wherein the parties 
had each acted knowledgeably, prudently and without compulsion. The fair value 
of oil and natural gas interests (included in property, plant and equipment) is 
estimated with reference to the discounted cash flows expected to be derived 
from oil and gas
production based on externally prepared reserve reports. The risk-adjusted 
discount rate is specific to the asset with reference to general market 
conditions, being 10% for fiscal 2013 (2012 &#8211; 10%).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 
10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;The fair value of advances and receivable and accounts payable
and accruals is estimated as the present value of future cash flows, discounted 
at the market rate of interest at the reporting date.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 
10pt">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;The fair value of stock options is measured using a Black 
Scholes option pricing model. Measurement inputs include share price on 
measurement date, exercise price of the instrument, expected volatility (based 
on weighted average historic volatility adjusted for changes expected due to 
publicly available information), weighted average expected life of the 
instruments (based on historical experience and general option holder behavior),
expected dividends, and the risk-free interest rate (based on government 
bonds).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income Tax</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company is a British Virgin Island corporation. The 
Government of British Virgin Islands does not, under existing legislation, 
impose any income, corporate or capital gains tax, estate duty, inheritance tax,
gift tax or withholding tax upon the Company or its security holders. The 
British Virgin Islands is not party to any double taxation 
treaties.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Notwithstanding the above, the Company complies with IAS 12 
which provides for the following</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Income tax expense comprises current and deferred tax. Income 
tax expense is recognized in profit or loss except to the extent that it relates
to items recognized directly in equity, in which case it is recognized in 
equity.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Current tax is the expected tax payable on the taxable income 
for the year, using tax rates enacted or substantively enacted at the reporting 
date, and any adjustments to tax payable in respect of previous 
years.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Deferred tax is recognized using the balance sheet method, 
providing for temporary differences between the carrying amounts of assets and 
liabilities for financial reporting purposes and the amounts used for taxation 
purposes. Deferred tax is not recognized on the initial recognition of assets or
liabilities in a transaction that is not a business combination. In addition, 
deferred tax is not recognized for taxable temporary differences arising on the 
initial recognition of goodwill. Deferred tax is measured at the tax rates that 
are expected to be applied to temporary differences when they reverse, based on 
the laws that have been enacted or substantively enacted by the reporting date. 
Deferred tax assets and
liabilities are offset if there is a legally enforceable right to offset, and 
they relate to income taxes levied by the same tax authority on the same taxable
entity, or on different tax entities, but they intend to settle current tax 
liabilities and assets on a net basis or their tax assets and liabilities will 
be realized simultaneously.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 21.3pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">A deferred tax asset is recognized to the extent that it is 
probable that future taxable profits will be available against which the 
temporary difference can be utilized. Deferred tax assets are reviewed at each 
reporting date and are reduced to the extent that it is no longer probable that 
the related tax benefit will be realized.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 21.3pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">No deferred tax asset has been recognized for losses incurred 
as the entities in which the losses arose are in the British Virgin 
Islands.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">There were no significant tax liabilities or assets nor any 
interest and penalties at March 31, 2014 and 2013. The Company is currently not 
aware of any issues under review that could result in significant payments, 
accruals or material deviation from its position</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accounting Standards and 
Interpretations Adopted in fiscal 2014</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">On April 1, 2013 the Company adopted the following standards 
and amendments to existing standards:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">IFRS 10, <font style="FONT-STYLE: italic; DISPLAY: 
inline">Consolidated Financial Statements </font>(&#8220;IFRS 10&#8221;) 
replaces consolidation requirements in IAS 27 &#8220;Consolidated and Separate 
Financial Statements&#8221; and Standing Interpretation Committee Interpretation
12, <font style="FONT-STYLE: italic; DISPLAY: inline">Consolidation &#8211; 
Special Purpose Entities </font>(&#8220;SIC-12&#8221;). IFRS 10 provides a 
revised definition of control so that a single control model can be applied to 
all entities for consolidation purposes.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">IFRS 11, <font style="FONT-STYLE: italic; DISPLAY: 
inline">Joint Arrangements </font>(&#8220;IFRS 11&#8221;) replaces IAS 31, <font
style="FONT-STYLE: italic; DISPLAY: inline">Interests in Joint Ventures 
</font>and SIC-13, <font style="FONT-STYLE: italic; DISPLAY: inline">Jointly 
Controlled Entities &#8211; Non-Monetary Contributions by Ventures, </font>and 
requires a single method to account for interests in jointly controlled 
entities.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">IFRS 12, <font style="FONT-STYLE: italic; DISPLAY: 
inline">Disclosure of Interests in Other Entities </font>(&#8220;IFRS 12&#8221;)
establishes enhanced disclosure requirements about an entity&#8217;s interests 
in consolidated and unconsolidated entities, such as subsidiaries, joint 
arrangements, associates, and unconsolidated structured entities (special 
purpose entities).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">IFRS 13, <font style="FONT-STYLE: italic; DISPLAY: inline">Fair
Value Measurements </font>(&#8220;IFRS 13&#8221;) establishes a single source of
guidance for all fair value measurements required by other IFRS; clarifies the 
definition of fair value; and enhances disclosure about fair value measurements.
IFRS 13 applies when other IFRS require or permit fair value disclosure. IFRS 13
specifies how we should measure fair value and disclose fair value information. 
It does not specify when an entity should measure an asset, a liability or its 
own equity instrument at fair value.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Amendments to IAS 1, <font style="FONT-STYLE: italic; DISPLAY: 
inline">Presentation of Financial Statements, </font>require entities to group 
items within other comprehensive income that may be reclassified to net 
income.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The standards and amendments listed above did not have a 
significant impact on the Company&#8217;s financial statements.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">New standards and interpretations not yet 
adopted</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Standards issued but not yet effective up to the date of 
issuance of the Company&#8216;s interim&#160;&#160;consolidated financial 
statements are listed below. This listing is of standards and interpretations 
issued which the Company reasonably expects to be applicable at a future date. 
The Company intends to adopt those standards when they become 
effective.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">IFRS 9 <font style="DISPLAY: inline; FONT-FAMILY: Times New 
Roman">&#8208;</font> <font style="FONT-STYLE: italic; DISPLAY: 
inline">Financial Instruments</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The IASB intends to replace IAS 39, Financial Instruments: 
Recognition and Measurements, with IFRS 9, Financial Instruments. IFRS 9 will be
published in six phases, of which the first phase has been 
published.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">For financial assets, IFRS 9 uses a single approach to 
determine whether a financial asset is measured at amortized cost or fair value,
and replaces the multiple rules in IAS 39. The approach in IFRS 9 is based on 
how an entity manages its financial instruments in the context of its business 
model and the contractual cash flow characteristics of the financial assets. The
new standard also requires a single impairment method to be used. For financial 
liabilities, the approach to the fair value option may require different 
accounting for changes to the fair value of a financial liability as a result of
changes to an entity&#8217;s own credit risk.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">IFRS 9 (2014) is effective for the Company for annual periods 
beginning on April 1, 2018, but is available for early adoption. The Company has
yet to assess the full impact of IFRS 9.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">IAS 32 (Amendment) &#8211; <font style="FONT-STYLE: italic; 
DISPLAY: inline">Financial Instruments</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The amendment relates to offsetting financial assets and 
financial liabilities and is effective for the Company for periods beginning on 
or after April 1, 2014. The Company has yet to assess the full impact of IFRS 32
amendment.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">5.&#160;&#160;&#160;&#160;&#160;&#160;CASH</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Cash includes $ 899,064 (2013: Nil) held in trust by a US 
lawyer, pending opening of a bank account by Biohaven. There are no restrictions
on use of cash.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">6.&#160;&#160;&#160;&#160;&#160;&#160;CAPITAL STOCK</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;Authorized<font 
style="DISPLAY: inline; FONT-WEIGHT: bold">:&#160;&#160;</font>Unlimited number 
of common shares</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Issued</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="54%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common</font></div>
</td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="54%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shares</font></div>
</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Amount</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="54%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Balance at May 23, 2012</font></div>
</td>
<td align="left" valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;81,759,076</font></div>
</td>
<td align="left" valign="bottom" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;503,495</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="54%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Balance at&#160;&#160;March 31, 2013</font></div>
</td>
<td align="left" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;81,759,076</font></div>
</td>
<td align="left" valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;503,495</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="54%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Issued on acquisition of PPL&#160;&#160;
(Note 2)</font></div>
</td>
<td align="left" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;81,759,076</font></div>
</td>
<td align="left" valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT:
bold">&#160;&#160;&#160;&#160;&#160;&#160;1,761,413</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="54%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Issued for financial advisory services in 
connection with the acquisition of PPL (Note 2)</font></div>
</td>
<td align="left" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9,811,091</font></div>
</td>
<td align="left" valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;3,826,325</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="54%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exercise of warrants</font></div>
</td>
<td align="left" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,450,000</font></div>
</td>
<td align="left" valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;175,000</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="54%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exercise of options</font></div>
</td>
<td align="left" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,996,547</font></div>
</td>
<td align="left" valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;299,482</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="54%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shares issued as compensation 
( c)</font></div>
</td>
<td align="left" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,000,000</font></div>
</td>
<td align="left" valign="middle" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;691,000</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="54%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance at March 31, 2014</font></div>
</td>
<td align="left" valign="middle" width="11%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;&#160;&#160;180,775,790</font></div>
</td>
<td align="left" valign="middle" width="12%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;$&#160;&#160;&#160;7,256,715</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(c)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">On December 12, 2013, the Chairman and CEO were issued one and 
a half million shares each, as restricted shares and on December 16, 2013, the 
CFO was issued one million shares under the 2011 Consultants Compensation Plan 
in lieu of cash fee for services provided and to be provided. The shares were 
valued at $691,000 based on the market price of the Company&#8217;s common 
shares prevailing on the dates of their issuance. Since the shares were issued 
without any conditions of forfeiture or cancellation, entire value was expensed 
during the year ended March 31, 2014 as consulting fee (note 11).</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;
(e)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">As at March 31, 2014, the Company had the following active 
Consultant Stock Compensation Plan:</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>&#160;</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY:
times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="middle" width="11%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Date of registration*</font></div>
</td>
<td align="left" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Registered shares under Plan</font></div>
</td>
<td align="left" valign="middle" width="8%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Issued to March 31, 2012</font></div>
</td>
<td align="left" valign="middle" width="9%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">As at April 1, 2013</font></div>
</td>
<td align="left" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">( see (c ) above)</font></div>
</td>
<td align="left" valign="middle" width="9%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cancelled (i)</font></div>
</td>
<td align="left" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance at March 31, 2014</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2011 Plan</font></div>
</td>
<td align="right" valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">11-Apr-11</font></div>
</td>
<td align="right" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">6,000,000</font></div>
</td>
<td align="left" valign="bottom" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;(938,333)</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">5,061,667</font></div>
</td>
<td align="left" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;(1,000,000)</font></div>
</td>
<td align="left" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;-</font></div>
</td>
<td align="right" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">4,061,667</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 31.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">*</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Registered with the Securities and Exchange Commission of the 
United States of America (SEC) as required under the Securities Act of 
1933.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 28.35pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(f)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">As required under listing requirements by Canadian Securities 
Exchange, the Company signed, on October 25, 2013, an escrow agreement with TMX 
Equity Transfer Services to have 89,941,793 of its common shares and 69,524,447 
of its warrants issued to four insiders under an escrow arrangement. The 
escrowed shares and warrants will be released in agreed tranches over the period
of three years.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">7.&#160;&#160;&#160;&#160;&#160;&#160;STOCK 
OPTION PLANS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 45pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(a)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Stock option reserve:</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 58.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">On December 17, 2013, the Company issued total of 4,450,000 
options to 10 consultants including 2.9 million options to the four directors 
under 2013 Option Plan. These options are valid for five years and are 
convertible into equal number of common shares of the Company at an exercise 
price of $0.20 per common share. The Options were registered with the US 
Securities and Exchange Commission on December 19, 2013 and will vest as 
follows:</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 63pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">-&#160;&#160;&#160;&#160;&#160;3,850,000 options will vest in 
equal monthly instalments over the year ending December<font id="TAB1" 
style="MARGIN-LEFT: 12pt"></font>31, 2014</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 63pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">-&#160;&#160;&#160;&#160;&#160;300,000 options were vested on 
the date of their issuance and</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 63pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">-&#160;&#160;&#160;&#160;&#160;300,000 options will vest on 
October 17, 2014</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The fair value of these options has been estimated using a 
Black-Scholes option pricingmodel with the following assumptions:</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Risk free interest rate</font></div>
</td>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">1%</font></div>
</td>
</tr><tr>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Expected dividend</font></div>
</td>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Nil</font></div>
</td>
</tr><tr>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Expected volatility</font></div>
</td>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">105.27%</font></div>
</td>
</tr><tr>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Expected life</font></div>
</td>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">1826 days</font></div>
</td>
</tr><tr>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Market price</font></div>
</td>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">US$0.18</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE:
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 58.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The fair value of the options as per the Black-Scholes option 
pricing model amounted to $604,055, of which options valued at $362,440 vested 
as at March 31, 2014 were accounted for as option reserve and expensed as 
consulting fee (note 11). The value of options not vested as at March 31, 2014 
will be accounted upon vesting of the related options as per the accounting 
policy.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(b)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The following is a summary of all active Stock Option Plans as 
at March 31, 2014:</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Stock Option Plan</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1999</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2003</font></div>
</td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">The Robinson</font></div>
</td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2005</font></div>
</td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Total</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Plan</font></div>
</td>
<td valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1999 Stock Option Plan</font></div>
</td>
<td valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2003 Stock Option Plan</font></div>
</td>
<td valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Robinson Plan</font></div>
</td>
<td valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2005 Stock Option Plan</font></div>
</td>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2013 Option Plan</font></div>
</td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Date of Registration</font></div>
</td>
<td valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">April 30, 2003</font></div>
</td>
<td valign="middle" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">July 22, 2004</font></div>
</td>
<td valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Dec. 5, 2005</font></div>
</td>
<td valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Dec. 5, 2005</font></div>
</td>
<td valign="middle" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Dec 19, 2013</font></div>
</td>
<td valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Total</font></div>
</td>
</tr><tr>
<td valign="middle" width="17%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="middle" width="57%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">number of options</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Registered *</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;3,000,000</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;2,500,000</font></div>
</td>
<td align="right" valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,100,000</fon
t></div>
</td>
<td align="right" valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,000,000</font></di
v>
</td>
<td align="right" valign="bottom" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;4,450,000</font></div>
</td>
<td align="right" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;12,050,000</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Issued</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;3,000,000</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;2,500,000</font></div>
</td>
<td align="right" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,100,000</fon
t></div>
</td>
<td align="right" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,000,000</font></di
v>
</td>
<td align="right" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;4,450,000</font></div>
</td>
<td align="right" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;12,050,000</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Outstanding, April 1, 2013</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;1,730,000</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;1,945,000</font></div>
</td>
<td align="right" valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,100,000</fon
t></div>
</td>
<td align="right" valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;61
0,000</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;-</font></div>
</td>
<td align="right" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,385,000</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Issued</font></div>
</td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;4,450,000</font></div>
</td>
<td align="right" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,450,000</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Exercised</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;(482,100)</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;(1,514,447)</font></div>
</td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;(1,996,547)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Expired</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;(1,247,900)</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;(430,553)</font></div>
</td>
<td align="right" valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
(1,100,000)</font></div>
</td>
<td align="right" valign="bottom" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;(50,000)</font></div>
</td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;(2,828,453)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Outstanding, March 31, 2014</font></div>
</td>
<td align="right" valign="middle" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;-</font></div>
</td>
<td align="right" valign="middle" width="9%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;-</font></div>
</td>
<td align="right" valign="middle" width="11%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></div>
</td>
<td align="right" valign="middle" width="11%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;56
0,000</font></div>
</td>
<td align="right" valign="middle" width="8%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;4,450,000</font></div>
</td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,010,000</font></div>
</td>
</tr><tr>
<td valign="bottom" width="17%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Options fully vested - March 31, 2014</font></div>
</td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;56
0,000</font></div>
</td>
<td align="right" valign="middle" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;1,262,490</font></div>
</td>
<td align="right" valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,822,490</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Options not yet vested as at March 31, 2014</font></div>
</td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="11%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></div>
</td>
<td align="right" valign="middle" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;3,187,510</font></div>
</td>
<td align="right" valign="middle" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,187,510</font></div>
</td>
</tr><tr>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td align="right" valign="middle" width="9%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td align="right" valign="middle" width="9%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%" style="BORDER-BOTTOM: black 2px 
solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160; </font></td>
<td align="right" valign="middle" width="11%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;56
0,000</font></div>
</td>
<td align="right" valign="middle" width="8%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;4,450,000</font></div>
</td>
<td align="right" valign="middle" width="10%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,010,000</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 49.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">*&#160;&#160;&#160;Registered with the Securities and Exchange 
Commission of the United States of America (SEC) as required under the 
Securities Act of 1933.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(c)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The weighted average exercise price of the outstanding stock 
options was US$0.22 as at March 31, 2014 and weighted average remaining 
contractual life was approximately 4.33 years.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 
0pt" align="justify"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The options can be exercised at any time after vesting within 
the exercise period in accordance with the applicable option agreement. The 
exercise price was more than the market price on the date of the grants for all 
options outstanding as at March 31, 2014.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(d)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company&#8217;s wholly owned subsidiary, PPL granted 33,542
options to its two consultants to acquire equal number of shares in PPL at an 
exercise price of $1.10 per PPL share. The options are to be vested over two 
years by March 31, 2016 and are valid for five years from the date of grant. 
None of the options have so far been exercised. The options were valued at their
intrinsic value of $173,412, based on the value offered to PPL for its shares 
under the reverse take-over transaction explained in Note 2(i). This is treated 
as cash-settled share-based payment transaction as per IFRS 2. $ 57,226 of the 
total representing the value of options vested as at March 31, 2014 was 
therefore expensed as consulting fee and included as part of&#160;&#160;research
and development
expenses&#160;&#160;and related liability included in accounts payable and 
accrued liabilities.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">8.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">WARRANTS</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(i)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The movements during the year ended March 31, 2014 were as 
follows:</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="32%" style="BORDER-BOTTOM: black 2px 
solid; BORDER-TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY:
times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="12%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;# of warrants</font></div>
</td>
<td valign="middle" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;Weighted average exercise price</font></div>
</td>
<td valign="middle" width="13%" style="BORDER-BOTTOM: black 2px solid; BORDER-
TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Fair value</font></div>
</td>
</tr><tr>
<td valign="top" width="32%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Issued and outstanding, April 1, 2012</font></div>
</td>
<td valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">68,071,420</font></div>
</td>
<td valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-1.1pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">$&#160;&#160;&#160;0.30</font></div>
</td>
<td valign="top" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="32%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Cancelled</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">(2,000,000)</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-1.1pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">$&#160;&#160;0.35</font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="32%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Issued and outstanding, March 31, 2013</font></div>
</td>
<td valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">66,071,420</font></div>
</td>
<td valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-1.1pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">$&#160;&#160;&#160;&#160;0.29</font></div>
</td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="32%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Issued on acquisition ( Note 2 and 8(ii))</font></div>
</td>
<td valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">71,456,420</font></div>
</td>
<td valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-1.1pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">$&#160;&#160;0.29</font></div>
</td>
<td valign="top" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$&#160;&#160;1,108,402</font></div>
</td>
</tr><tr>
<td valign="top" width="32%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Exercised</font></div>
</td>
<td valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">(1,450,000)</font></div>
</td>
<td valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-1.1pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">$&#160;&#160;(0.12)</font></div>
</td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="32%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Expired</font></div>
</td>
<td valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">(21,796,420)</font></div>
</td>
<td valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-1.1pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">$&#160;&#160;&#160;(0.19)</font></div>
</td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="32%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Issued and outstanding, March 31, 2014</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">114,281,420</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
-1.1pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">$&#160;&#160;&#160;0.31</font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">$ 1,108,402</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(ii)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The Company issued 71.4 million warrants to nine shareholders 
of PPL as per the terms of the Share Exchange Agreement as explained in Note 
2(i). These warrants are convertible into equal number of common shares at an 
exercise price of $0.29 per warrant and expire within two years of their 
issuance.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The fair value of these warrants has been estimated using a 
Black-Scholes option pricingmodel with the following assumptions:</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Risk free interest rate</font></div>
</td>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">1%</font></div>
</td>
</tr><tr>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Expected dividend</font></div>
</td>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Nil</font></div>
</td>
</tr><tr>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Expected volatility</font></div>
</td>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">137.71%</font></div>
</td>
</tr><tr>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Expected life</font></div>
</td>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">730 days</font></div>
</td>
</tr><tr>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Market price</font></div>
</td>
<td valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">US$0.39</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Using the relative fair value method, an amount of $1,108,402 
for warrants issued hasbeen accounted for as the value of warrants.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(iii)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Details of weighted average remaining life of the warrants 
granted and outstanding are as follows:</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">March 31,</font></div>
</td>
<td colspan="2" valign="top" width="27%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td colspan="2" valign="top" width="27%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">2013</font></div>
</td>
</tr><tr>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="27%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Warrants outstanding &amp; 
exercisable</font></div>
</td>
<td colspan="2" valign="top" width="27%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Warrants outstanding &amp; exercisable</font></div>
</td>
</tr><tr>
<td valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Exercise price in US$</font></div>
</td>
<td valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number</font></div>
</td>
<td valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted average remaining contractual life 
(years)</font></div>
</td>
<td valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Number</font></div>
</td>
<td valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Weighted average remaining contractual life 
(years)</font></div>
</td>
</tr><tr>
<td valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.10</font></div>
</td>
<td valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">-</font></div>
</td>
<td valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">-</font></div>
</td>
<td valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">10,400,000</font></div>
</td>
<td valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1.00</font></div>
</td>
</tr><tr>
<td valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.25</font></div>
</td>
<td valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">-</font></div>
</td>
<td valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">-</font></div>
</td>
<td valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">12,846,420</font></div>
</td>
<td valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1.00</font></div>
</td>
</tr><tr>
<td valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.29</font></div>
</td>
<td valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">71,456,420</font></div>
</td>
<td valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">1.18</font></div>
</td>
<td valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">0.35</font></div>
</td>
<td valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">42,825,000</font></div>
</td>
<td valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">0.92</font></div>
</td>
<td valign="top" width="11%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">42,825,000</font></div>
</td>
<td valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1.90</font></div>
</td>
</tr><tr>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid"><font 
style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; 
</font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">114,281,420</font></div>
</td>
<td valign="top" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">1.08</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">66,071,420</font></div>
</td>
<td valign="top" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">1.59</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">9.&#160;&#160;&#160;&#160;&#160;&#160;LOSS 
PER SHARE</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Loss per share is calculated on the weighted average number of 
common shares outstanding during the year, which was 161,977,171 (2013: 
81,759,076).</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Weighted average number of shares to be considered for the 
prior year would be the number of shares issued in the reverse 
acquisition.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT:
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company had approximately 114 million warrants (2013: 66 
million) and 5 million options (2013: 5.4 million) which were not exercised as 
at March 31, 2014. Inclusion of these warrants and options in the computation of
diluted loss per share would have an anti-dilutive effect on the loss per share 
and are therefore excluded from the computation. Consequently, there is no 
difference between loss per share and diluted loss per share.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;COMMI
TMENTS AND CONTINGENT LIABILITIES</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(a)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company entered into a consulting contract with Mr. Kam 
Shah, the Chief Financial Officer on April 1, 2005 for a five-year term. This 
term was extended by another five years to March 31, 2015 by the audit committee
on April 1, 2010. Mr Shah&#8217;s monthly fee is $15,000 plus taxes. Further, 
the contract provides for a lump sum compensation of US$250,000 for early 
termination of the contract without cause. The contract also provides for 
entitlement to stock compensation and stock options under appropriate plans as 
may be decided by the board of directors from time to time. For the year ending 
December 31, 2014, Mr. Shah accepted one million common shares in lieu of his 
compensation for that year (Note 6(c)).</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">PPL has signed a contract with an independent contract research
and manufacturing organization to manufacture certain proprietary peptides for a
total costs currently estimated at between $ 169,000 and $272,000 of which $ 
107,711 has already been incurred and paid for as at March 31, 
2014.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(c)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Under the terms of the License Agreement dated January 25, 
2013, PPL is required to reimburse to the Licensor, Trojan Technologies Limited,
50% of all maintenance costs of the US Patent # 7,968,512 and to pay royalties 
of 3% on Net Receipts from sales of the Licensed Product and 5% on Net Receipts 
from third parties in respect of development or other exploitation of Licensed 
Intellectual Property and/or Licensed Products up to a maximum of $ 30 million. 
Total amount that may be payable in future under the terms of the Agreement 
cannot be reasonably estimated at this time.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE:
10pt">(d)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">PPL has signed consulting contracts with its Chief Executive 
Officer and Chief Scientific Officer expiring in or around March 2015 and 
carrying a total monthly commitment of $21,250.Early termination without cause 
would require a lump sum compensation of $ 75,000 to be paid to the two 
consultants.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(e)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Under a Securities Purchase Agreement signed on January 6, 2014
with Biohaven, the Company agreed to pay $ 3.5 million for 54% equity in 
Biohaven of which $ 1,750,000 was paid on January 6, 2014. Of the balance, $ 
750,000 will be payable on August 1, 2014, $ 500,000 will be payable on December
3, 2014 and the balance $ 500,000 will be payable on February 4, 2014. Failure 
to pay will result in the Company forfeiting its equity in Biohaven 
proportionate to the unpaid amount.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE:
10pt">(f)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Biohaven has signed a Master Service Agreement on January 31, 
2014, as subsequently amended in April 2014, with Biohaven Pharmaceuticals Inc, 
a private Delaware incorporated research and development company 
(&#8220;BPI&#8221;). BPI is owned by non-controlling shareholders of Biohaven 
and is engaged by Biohaven to conduct, on behalf of Biohaven, research and 
development services relating to identification and development of clinical 
stage neuroscience compounds targeting the glutamatergic system. The agreement 
expires on December 31, 2018 and will automatically renew on a year to year 
basis. Either party can terminate the agreement upon ninety days prior notice. 
Agreed fee for the period up to June 30, 2015 is $ 3 million payable in 
quarterly instalment commencing from March 1,
2014.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(g)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">On March 3, 2014, Biohaven signed a contract with an 
independent contract research and manufacturing organization to investigate 
technical feasibility of developing a new formulation for Bio haven using 
nanosuspension and emulsion formulation approaches. The contract is 
approximately for fifty five weeks involving several agreed milestones for a 
total price of approximately $ 345,000.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(h)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Under the terms of the License Agreement dated September 16, 
2013 signed with Yale University, Biohaven is required to pay to the Licensor a 
milestone royalty of $ 2 million within six months of receiving approval of an 
NDA ( New Drug Application) and pay earned royalty at 3% on worldwide annual net
sales of the licensed products, subject to minimum royalty payment of $ 300,000 
in the year one, $ 600,000 in year two, $ 750,000 in year three and $ 1 million 
from year four onwards subject to reduction ranging from 33% to 95% depending on
sales of generic exceeding an agreed market share on a country by country basis 
and further reduction by 50% is licensee is required to pay third party 
royalties. Total amount that may be payable in future under the terms of the 
Agreement cannot be reasonably
estimated at this time. Licensor also has right to purchase in cash up to 10% of
any securities offered in future financing.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">11.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSULTING FEE</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="29%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: 
black 0.5pt solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP:
black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Notes</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: 
black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended March 31, 2014</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: 
black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">May 23, 2012to March 31, 2013</font></div>
</td>
</tr><tr>
<td valign="top" width="29%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Cash fee</font></div>
</td>
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1
08,921</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="29%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Shares issued to key management</font></div>
</td>
<td valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">6 ( c)</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">691,000</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="29%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Options issued to key management</font></div>
</td>
<td valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">7 (a)</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">231,838</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="29%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Options issued to others</font></div>
</td>
<td valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">7 (a)</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">130,603</font></div>
</td>
<td align="right" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="29%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="14%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,162,362</font></div>
</td>
<td align="right" valign="top" width="14%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-
</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;RELAT
ED PARTY TRANSACTIONS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Transactions with related parties are incurred in the normal 
course of business and are measured at the exchange amount, which is the amount 
of consideration established and agreed to between the related parties. Related 
party transactions and balances have been listed below, unless they have been 
disclosed elsewhere in the consolidated financial statements.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(i)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Business expenses of $12,786 were reimbursed to directors of 
the Company.</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(ii)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Consulting fees include cash fee paid to key management for 
services of $102,458.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;FINAN
CIAL INSTRUMENTS AND RISK MANAGEMENT</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company&#8217;s financial instruments recognized in the 
balance sheet consist of the following:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="31%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="19%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">March 31, 2014</font></div>
</td>
<td colspan="2" valign="top" width="19%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">March 31, 2013</font></div>
</td>
</tr><tr>
<td valign="top" width="31%"><font style="DISPLAY: inline; FONT-FAMILY: times
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Carrying value</font></div>
</td>
<td valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair value</font></div>
</td>
<td valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Carrying value</font></div>
</td>
<td valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Fair value</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="31%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Financial 
assets</font></font></div>
</td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="31%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Cash</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2,032,058</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">2,032,058</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">190,960</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">190,960</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="31%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Advances and other receivable</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">227,233</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">227,233</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">295,441</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">295,441</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="31%" style="BORDER-BOTTOM: black 2px 
solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Financial 
liabilities</font></font></div>
</td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new
roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="31%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">Accounts payable and accrued liabilities</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">191,972</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">191,972</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">12,392</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">12,392</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Fair value estimates are made at a specific point in time, 
based on relevant market information and information about financial 
instruments. These estimates are subject to and involve uncertainties and 
matters of significant judgment, therefore cannot be determined with precision. 
Changes in assumptions could significantly affect the estimates.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">A summary of the Company&#8217;s risk exposures as it relates 
to financial instruments are reflected below:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-
SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 
10pt">a)</font></font></div>
</td>
<td>
<div align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair value of financial 
instruments</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company&#8217;s financial assets and liabilities are 
comprised of cash, advances and receivable and, accounts payable and accrued 
liabilities.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company classifies the fair value of these transactions 
according to the following fair value hierarchy based on the amount of 
observable inputs used to value the instrument:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Level 1 &#8211; Values are based on unadjusted quoted prices 
available in active markets for identical assets or liabilities as of the 
reporting date.</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Level 2 &#8211; Values are based on inputs, including quoted 
forward prices for commodities, time value and volatility factors, which can be 
substantially observed or corroborated in the marketplace. Prices in Level 2 are
either directly or indirectly observable as of the reporting date.</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Level 3 &#8211; Values are based on prices or valuation 
techniques that are not based on observable market data.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Assessment of the significance of a particular input to the 
fair value measurement requires judgment and may affect the placement within the
fair value hierarchy.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company&#8217;s financial instruments are exposed to 
certain financial risks: credit risk, liquidity risk, other price risk and 
market risk.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Credit risk</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Credit risk is the risk of loss associated with a counter-
party&#8217;s inability to fulfill its payment obligations. The credit risk is 
attributable to various financial instruments, as noted below. The credit risk 
is limited to the carrying value amount carried on the statement of financial 
position.</font></div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">a.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Cash&#8211; Cash is held with a major international financial 
institution in Canada and a major law firm in the USA and therefore the risk of 
loss is minimal.</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">b.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Other receivable &#8211; The Company is not exposed to major 
credit risk attributable to customers. A significant portion of this amount is 
prepaid to BPI under a master service agreement.</font></div>
</td>
</tr></table>
</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">c)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liquidity risk</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Liquidity risk is the risk that the Company will encounter 
difficulty in satisfying financial obligations as they become due.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company&#8217;s approach to managing liquidity is to 
ensure, as far as possible, that it will have sufficient liquidity to meet its 
liabilities when due, under both normal and stressed conditions without 
incurring unacceptable losses or risking harm to the Company&#8217;s reputation.
The Company holds sufficient cash to satisfy obligations under accounts payable 
and accruals.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company monitors its liquidity position regularly to assess
whether it has the funds necessary to take care of its operating needs and needs
for investing in new projects. The company has changed its business focus to 
biotechnology as explained in Note 1. The Company believes that its existing 
cash will allow it to finance the drug development work apart from meeting its 
operational needs for at least another year. However, the exact need for 
additional cash cannot be reasonably ascertained at this stage&#160;&#160;Should
the Company require further funding, it intends to secure it through further 
rounds of&#160;&#160;equity financing.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;</font><br>
&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">However, as a biotech company at an early stage of development 
and without significant internally generated cash flows, there are inherent 
liquidity risks, including the possibility that additional financing may not be 
available to the Company, or that actual drug development expenditures may 
exceed those planned. The current uncertainty in global markets could have an 
impact on the Company&#8217;s future ability to access capital on terms that are
acceptable to the Company. There can be no assurance that required financing 
will be available to the Company.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CAPIT
AL DISCLOSURES</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company considers the items included in Shareholders&#8217;
Equity as capital. The Company had payables of approximately $ 192,000 as at 
March 31, 2014 and current assets, mostly in cash, of approximately $2.2 
million. The Company&#8217;s objectives when managing capital are to safeguard 
the Company&#8217;s ability to continue as a going concern in order to pursue 
new business opportunities and to maintain a flexible capital structure which 
optimizes the costs of capital at an acceptable risk.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company manages the capital structure and makes adjustments
to it in light of changes in economic conditions and the risk characteristics of
the underlying assets. To maintain or adjust the capital structure, the Company 
may attempt to issue new shares, issue new debt, acquire or dispose of assets or
adjust the amount of cash.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">As at March 31, 2014, the shareholders&#8217; equity was 
approximately $ 2.1 million, $2 million of it was held in the form of 
cash.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Company is not subject to any externally imposed capital 
requirements and does not presently utilize any quantitative measures to monitor
its capital. There have been no changes to the Company&#8217;s approach to 
capital management during the year ended March 31, 2014.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SUBSE
QUENT EVENT</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">On July 25, 2014, the Company secured bridge loans of $ 
300,000. The loans, covered by promissory notes are for one-year term, with 
coupon at 5% payable in shares to be valued at 10% discount over the next 
financing price. The loans are convertible into shares or units&#160;&#160;of 
the Company at the time of the next financing round, to be priced at the price 
set for the next financing discounted by 10% or repayable fully in 
cash.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">$ 200,000 of the loans was advanced by two of the directors of 
the Company.</font></div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11.1
<SEQUENCE>3
<FILENAME>compensationmatters.htm
<DESCRIPTION>COMPONSATION MATTERS
<TEXT>
<html>
<head>
    <title>compensationmatters.htm</title>
    <!--Licensed to: bontan94-->
    <!--Document Created using EDGARizer 2020 5.4.0.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">
<br>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">PORTAGE BIOTECH INC.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHARTER OF THE AUDIT AND COMPENSATION 
COMMITTEE</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">RELATING TO COMPENSATION 
MATTERS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Amended and restated as of June 27, 
2013)</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">I.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Genera
l Focus</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Audit and Compensation Committee (the 
&#8220;Committee&#8221;) shall discharge the responsibilities of the Board of 
Directors (the &#8220;Board&#8221;) with respect to the Corporation&#8217;s 
compensation programs and compensation of the Corporation&#8217;s 
executives.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">II.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Struc
ture and Operations</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee shall be comprised of three members of the Board,
two of whom is determined by the Board to be "independent" under the rules of 
the regulatory bodies to which the Corporation is subject to and under the 
corporate laws of the British Virgin Islands. At least two members must satisfy 
the requirements of a &#8220;non-employee director&#8221; for purposes of Rule 
16b-3 under the Securities Exchange Act of 1934, as amended, The Board shall 
select members based upon their knowledge and experience in compensation matters
and with care to avoid any conflicts of interest.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Each member of the Committee shall be appointed by the Board 
and shall serve until such member&#8217;s successor is duly elected and 
qualified or until such member&#8217;s earlier resignation or removal.&#160; The
members of the Committee may be removed, with or without cause, by majority vote
of the Board.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Board shall elect the Chair of the Committee.&#160; The 
Chair will approve the agendas for Committee meetings.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">In fulfilling its responsibilities, the Committee shall be 
entitled to delegate any or all of its responsibilities to a subcommittee of the
Committee, including to a subcommittee comprised solely of one director.&#160; 
The Committee also shall be entitled to delegate its authority to one or more 
directors (whether or not such directors serve on the Committee) as the 
Committee deems appropriate, provided, however, that the Committee shall not 
delegate any power or authority required by law, regulation or listing standard 
to be exercised by the Committee as a whole.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">III.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Meet
ings</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee shall meet as frequently as circumstances 
dictate.&#160; The Chair of the Committee or a majority of the members of the 
Committee may call a special meeting of the Committee.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">All non-management directors who are not members of the 
Committee may attend meetings of the Committee, but may not vote.&#160; 
Additionally, the Committee may invite to its meetings any director, member(s) 
of management of the Corporation and such other persons as it deems appropriate 
in order to carry out its responsibilities.&#160; The Committee may also exclude
from its meetings any person it deems appropriate in order to carry out its 
responsibilities.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">A majority of the Committee members, but not less than two, 
will constitute a quorum.&#160; A majority of the Committee members present at 
any Committee meeting at which a quorum is present may act on behalf of the 
Committee.&#160; The Committee may meet by telephone or videoconference and may 
take action by unanimous written consent.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee shall appoint a person, who need not be a member,
to act as secretary, and minutes of the Committee&#8217;s proceedings shall be 
kept in minute books provided for that purpose.&#160; The agenda of each 
Committee meeting will be prepared by the secretary and, whenever reasonably 
practicable, circulated to each Committee member prior to each 
meeting.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">IV.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Respo
nsibilities and Duties</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The following functions shall be the common recurring 
activities of the Committee in carrying out its responsibilities outlined in 
Section I of this Charter.&#160; These functions should serve as a guide with 
the understanding that the Committee may carry out additional functions and 
adopt additional policies and procedures as may be appropriate in light of 
changing business, legislative, regulatory, legal or other conditions.&#160; The
Committee shall also carry out any other responsibilities and duties delegated 
to it by the Board from time to time related to the purposes of the Committee 
outlined in Section I of this Charter.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee, in discharging its oversight role, is empowered 
to study or investigate any matter of interest or concern that the Committee 
deems appropriate and shall have the sole authority to retain or terminate 
outside counsel or other experts for this purpose, including the sole authority 
to approve the fees payable to such counsel or experts and any other terms of 
retention.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: 
underline">Setting Compensation for Executive Officers and 
Directors</font></font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">1.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Establish and review the overall compensation philosophy of the
Corporation.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">2.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Based upon input from the other directors regarding the 
performance of the Chief Executive Officer, Chief Financial 
Officer&#160;&#160;and other executive officers,(&#8220;the executive 
officers&#8221;) review and approve the annual fee, salary, bonus, stock options
and other benefits, direct and indirect, of the executive officers.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">3.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">In connection with executive compensation 
programs:</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE:
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(i)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review and recommend to the full Board, or approve, new 
executive compensation programs;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(ii)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review on a periodic basis the operations of the 
Corporation&#8217;s executive compensation programs to determine whether they 
are properly coordinated and achieving their intended purpose(s), including 
whether the Corporation&#8217;s compensation programs encourage excessive risk-
taking and discuss, at least annually, the relationship between risk management 
policies and practices and compensation, and evaluate compensation policies and 
practices that could mitigate any such risk;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(iii)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review on a periodic basis the aggregate amount of compensation
paid or potentially payable to the executive officers through the use of tally 
sheets or such other method as the Committee may determine; and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(iv)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Take steps to modify any executive compensation program that 
yields payments and benefits that are not reasonably related to executive and 
corporate performance.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(v)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee shall consider the results of shareholder 
advisory votes regarding named executive officer compensation when evaluating 
and determining executive compensation (and shall recommend the frequency with 
which the Corporation shall conduct future shareholder advisory votes regarding 
executive compensation).</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">4.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review and recommend to the full Board compensation of 
directors.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">5.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review and make recommendations to the full Board, or approve, 
any contracts or other transactions with executive officers of the Corporation, 
including consulting arrangements, employment contracts and severance or 
termination arrangements, or any revisions thereto.&#160; Notwithstanding any 
other provision of this Charter, the Committee shall review and make 
recommendations to the Board for approval of any consulting arrangement, 
employment contract, severance or termination arrangement with the Chief 
Executive Officer and Chief Financial Officer, or any revision 
thereto.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">6.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review and approve annual performance goals for performance-
based compensation and determine whether the performance goals and objectives 
are attained.</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: 
underline">Monitoring Incentive and Equity-Based Compensation 
Plans</font></font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">7.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review the Corporation&#8217;s executive compensation plans, 
including incentive-compensation and equity-based plans, in light of the goals 
and objectives of these plans, and amend, or recommend that the Board amend, 
these plans if the Committee deems it appropriate.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE:
10pt">8.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Administer any short-term incentive plan covering executive 
officers of the Corporation; determine whether performance targets have been met
and determine the amounts and terms of any awards.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">9.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review and recommend for Board approval all equity compensation
plans to be submitted for shareholder approval under the relevant regulatory 
standards and BVI Corporate laws provided, however, that any equity compensation
plan that satisfies an exception to this requirement shall not be required to be
approved by the Corporation&#8217;s shareholders.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">10.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review and make recommendations to the Board, or approve, all 
awards of shares, share options or other awards pursuant to the 
Corporation&#8217;s equity-based plans; provided that the authority to issue 
such awards to employees who are not executive officers may be delegated as 
above described</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: 
underline">Reports</font></font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">11.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review and discuss with management the Corporation&#8217;s 
compensation discussion and analysis (&#8220;CD&amp;A&#8221;), and based on that
review and discussion, recommend to the Board that the CD&amp;A be included in 
the Corporation&#8217;s annual proxy statement or annual report on Form F-
20.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">12.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Report regularly to the Board (i) following meetings of the 
Committee, (ii) with respect to such other matters as are relevant to the 
Committee&#8217;s discharge of its responsibilities and (iii) with respect to 
such recommendations as the Committee may deem appropriate. The report to the 
Board may take the form of an oral report by the Chair or any other member of 
the Committee designated by the Committee to make such report.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">13.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Maintain minutes or other records of meetings and activities of
the Committee.</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: 
underline">Advisors</font></font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">14.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee has the sole authority to select, oversee and 
terminate compensation consultants, legal counsel or other advisors to advise 
the Committee, and to approve the terms of any such engagement and the fees of 
any such compensation consultant, legal counsel or other advisor.&#160; In 
selecting a compensation consultant, legal counsel or other advisor, the 
Committee shall take into account factors (including factors related to the 
independence of such compensation consultant, legal counsel or other advisor) it
considers appropriate or as may be required by applicable law or listing 
standards. The Committee shall receive appropriate funding from the Corporation 
for the payment of compensation to the compensation consultants,
legal counsel or other advisors retained by the Committee pursuant to the 
provisions of this Charter.</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">V.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Annual
Performance Evaluation</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee shall perform a review and evaluation, at least 
annually, of the performance of the Committee and its members, including a 
review of the compliance of the Committee with this Charter.&#160; In addition, 
the Committee shall review and reassess, at least annually, the adequacy of this
Charter and recommend to the Board any modifications to this Charter that the 
Committee considers necessary or valuable.&#160; The Committee shall conduct 
such evaluations and reviews in such manner as it deems 
appropriate.</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11.2
<SEQUENCE>4
<FILENAME>auditmatters.htm
<DESCRIPTION>AUDIT MATTERS
<TEXT>
<html>
<head>
    <title>auditmatters.htm</title>
    <!--Licensed to: bontan94-->
    <!--Document Created using EDGARizer 2020 5.4.0.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">
<br>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">PORTAGE BIOTECH INC.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHARTER OF THE AUDIT AND COMPENSATION 
COMMITTEE</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">RELATING TO AUDIT MATTERS</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">(amended and restated as of June 27, 
2013)</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">I.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Genera
l Focus</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Audit and Compensation Committee (the "Committee") shall 
provide assistance to the Portage Biotech Inc.&#8217;s&#160;&#160;(the 
"Corporation") Board of Directors ("Board") in fulfilling its responsibilities 
with respect to its oversight of:</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(i)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The quality and integrity of the Corporation's financial 
statements;</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(ii)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Corporation's compliance with legal and regulatory 
requirements;</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(iii)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The independent auditor's qualifications and 
independence;</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(iv)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The performance of the Corporation's independent auditors; 
and</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(v)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The implementation and effectiveness of the Corporation's 
ethics and compliance program.</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">II.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Struc
ture and Operations</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee shall be comprised of three members of the Board,
two of whom is determined by the Board to be "independent" under the rules of 
the regulatory bodies to which the Corporation is subject to and under the 
corporate laws of the British Virgin Islands.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Each member of the Committee shall have a working familiarity 
with basic finance and accounting practices (or acquire such familiarity within 
a reasonable period after his or her appointment) and at least one member shall
in the judgment of the Board of Directors have accounting or related financial 
management expertise as required by the rules of the OSC.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Each member of the Committee shall be appointed by the Board 
and shall serve until such member's successor is duly elected and qualified or 
until such member's earlier resignation or removal.&#160; The members of the 
Committee may be removed, with or without cause, by majority vote of the 
Board.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Board shall elect the Chair of the Committee.&#160; The 
Chair will approve the agendas for Committee meetings.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">III.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Meet
ings</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee shall meet as frequently as circumstances 
dictate.&#160; Each regularly scheduled meeting will conclude with an executive 
session of the Committee absent the members of management.&#160; The Chair of
the Committee or a majority of the members of the Committee may call a special 
meeting of the Committee.&#160; As part of its goal to foster open 
communication, the Committee shall periodically meet separately with each of 
management, and the independent auditors to discuss any matters that the 
Committee or each of these groups believe should be discussed 
privately.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">All non-management directors who are not members of the 
Committee may attend meetings of the Committee, but may not vote.&#160; 
Additionally, the Committee may invite to its meetings any director, member(s) 
of management of the Corporation and such other persons as it deems appropriate 
in order to carry out its responsibilities.&#160; The Committee may also exclude
from its meetings any person it deems appropriate in order to carry out its 
responsibilities.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">A majority of the members, but not less than two, will 
constitute a quorum.&#160; A majority of the members present at any meeting at 
which a quorum is present may act on behalf of the Committee.&#160; The 
Committee may meet by telephone or videoconference and may take action by 
unanimous written consent.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee shall appoint a person who need not be a member 
thereof to act as secretary and minutes of its proceedings shall be kept in 
minute books provided for that purpose.&#160; The agenda of each meeting will be
prepared by the secretary and, whenever reasonably practicable, circulated to 
each member prior to each meeting.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">IV.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Respo
nsibilities and Duties</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The following functions shall be the common recurring 
activities of the Committee in carrying out its responsibilities outlined in 
Section I of this Charter.&#160; These functions should serve as a guide with 
the understanding that the Committee may carry out additional functions and 
adopt additional policies and procedures as may be appropriate in light of 
changing business, legislative, regulatory, legal or other conditions.&#160; The
Committee shall also carry out any other responsibilities and duties delegated 
to it by the Board of Directors from time to time related to the purposes of the
Committee outlined in Section I of this Charter.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee, in discharging its oversight role, is empowered 
to study or investigate any matter of interest or concern that the Committee 
deems appropriate.&#160; In this regard, the Committee shall have the authority 
to retain outside legal, accounting or other advisors for this purpose, 
including the authority to approve the fees payable to such advisors and any 
other terms of retention.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee shall be given full access to the Corporation's 
Board, corporate executives and independent accountants, as necessary, to carry 
out these responsibilities.&#160; While acting within the scope of its stated 
purpose, the Committee shall have all the authority of the Board.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Notwithstanding the foregoing, the Committee is not responsible
for certifying the Corporation's financial statements or guaranteeing the 
independent auditor's report.&#160; The fundamental responsibility for the 
Corporation's financial statements and disclosures rests with management and the
independent auditors.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: 
underline">Documents/Reports Review</font></font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">1.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Meet with management and the independent auditors to review and
discuss, prior to public dissemination, the Corporation's annual audited 
financial statements and quarterly financial statements, including the 
Corporation's specific disclosures under "Management's Discussion and Analysis 
of Financial Condition and Results of Operations"</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">2.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Report to the Board whether, based on its discussions with 
management and the independent auditor, it recommends to the Board that the most
recent year's audited financial statements be included in the Corporation's 
annual report on Form 20-F&#160;&#160;to be filed with the SEC.</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">3.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review and discuss with management and the independent auditors
the Corporation's earnings press releases (paying particular attention to the 
use of any "pro forma" or "adjusted" non-GAAP information).</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">4.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review and discuss with management and the independent auditors
financial information and earnings guidance provided to analysts and rating 
agencies.&#160; The Committee's discussion in this regard may be general in 
nature (i.e., discussion of the types of information to be disclosed and the 
type of presentation to be made) and need not take place in advance of each 
instance in which the Corporation may provide earnings guidance.</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: 
underline">Independent Auditors</font></font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">5.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee shall have the direct responsibility and 
authority to appoint, retain, compensate, evaluate, oversee and, where 
appropriate, replace the independent auditors.&#160; The Committee shall inform 
the independent auditors that such firm shall report directly to the Committee. 
The Committee shall resolve disagreements between management and the independent
auditor regarding financial reporting.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">6.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review the independent auditors' audit plan and areas of audit 
focus.&#160; Review the fees and other significant compensation to be paid to 
the independent auditors.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">7.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Approve in advance any audit or non-audit engagement or 
relationship between the Corporation and any independent auditor engaged to 
prepare or issue an audit report or perform other audit, review or attest 
services, other than prohibited non-auditing services, as specified in the rules
and regulations of the SEC/OSC or any rules of the Public Company Accounting 
Oversight Board promulgated thereunder.&#160; The Committee shall not approve 
any "prohibited non-auditing services" without obtaining a prior exemption from 
the Public Company Accounting Oversight Board.&#160; Audit and non-audit 
engagements must be approved either (a) explicitly in advance or (b) pursuant to
a pre-approval policy established by the Committee.&#160;
&#160;The Committee may delegate to one or more members of the Committee the 
authority to grant such pre-approvals.&#160; The delegatee's decisions regarding
approval of services shall be reported by such delegatee to the full Committee 
at each regular Committee meeting.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">8.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review and assess, at least annually, the qualifications, 
performance and independence of the independent auditors, including a review and
evaluation of the lead partner.&#160; In conducting its review and evaluation, 
the Committee should:</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(a)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review the written report of the independent auditor that 
delineates all relationships between the independent auditor and the Corporation
that the auditors believe may impact their independence and objectivity, which
report should be submitted to the Committee at least annually, and discuss with 
the independent auditor and management the scope of any such disclosed 
relationship and their actual or potential impact on the independent auditor's 
independence and objectivity;</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(b)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Obtain and review a report by the Corporation's independent 
auditor describing:&#160; (i) the auditor's internal quality-control procedures;
and (ii) any material issues raised by the most recent internal quality-control 
review, or peer review, of the auditor or by any inquiry or investigation by 
governmental or professional authorities within the preceding five years, 
respecting one or more independent audits carried out by the auditor, and any 
steps taken to deal with any such issues; and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(c)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Take into account the opinions of management.</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: 
underline">Financial Reporting Process</font></font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">9.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">In consultation with the independent auditors 
and&#160;&#160;management,&#160;&#160;review the integrity of the 
Corporation&#8217;s financial reporting processes, both internal and 
external.&#160; In connection therewith, the Committee should obtain and discuss
with management and the independent auditor reports from management and the 
independent auditor regarding: (i) all critical accounting policies and 
practices to be used by the Corporation; (ii) analyses prepared by management
and/or the independent auditor setting forth significant financial reporting 
issues and judgments made in connection with the preparation of the financial 
statements, including all alternative treatments of financial information within
generally
accepted accounting principles that have been discussed with the 
Corporation&#8217;s management, the ramifications of the use of the alternative 
disclosures and treatments and the treatment preferred by the independent 
auditor; (iii) effects of changes in accounting standards that may materially 
affect the Corporation&#8217;s financial reporting practices; (iv) major issues 
regarding accounting principles and financial statement presentations, including
any significant changes in the Corporation&#8217;s selection or application of 
accounting principles; (v) the integrity of the Corporation&#8217;s financial 
reporting practices and the adequacy and effectiveness of internal controls, 
including a review of significant findings identified by the independent 
auditors and internal audit, management&#8217;s responsiveness to such 
recommendations and any specific audit steps adopted in light
of material control deficiencies and (vi) any other material written 
communications between the independent auditor and the Corporation&#8217;s 
management.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">10.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee will receive and review any disclosure from the 
Corporation's Chief Executive Officer and Chief Financial Officer made in 
connection with the certification of the Corporation's quarterly and annual 
reports filed with the SEC/OSC of: (i) significant deficiencies and material 
weaknesses in the design or operation of internal control over financial 
reporting which are reasonably likely to adversely affect the 
Corporation&#8217;s ability to record, process, summarize, and report financial 
data; and (ii) any fraud, whether or not material, that involves management or 
other employees who have a significant role in the Corporation&#8217;s internal 
controls.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">11.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review periodically the effect of regulatory and accounting 
initiatives, as well as off-balance sheet structures, on the financial 
statements of the Corporation.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">12.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review with the independent auditor (i) any audit problems or 
other difficulties encountered by the auditor in the course of the audit 
process, including any restrictions on the scope of the independent auditor's 
activities or on access to requested information and any significant 
disagreements with management and (ii) management's responses to such 
matters.&#160; Without excluding other possibilities, the Committee may wish to 
review with the independent auditor (i) any accounting adjustments that were 
noted or proposed by the auditor but were "passed" (as immaterial or otherwise),
(ii) any communications between the audit team and the audit firm's national 
office respecting auditing or accounting issues presented by the
engagement and (iii) any "management" or "internal control" letter issued or 
proposed to be issued by the independent auditor to the Corporation.&#160; The 
review should also include discussion of the responsibilities, budget and 
staffing of the corporation's internal audit function.</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Legal
Compliance/General</font></font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">13.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review periodically, with the Corporation's chief financial 
officer, any legal matter that could have a significant impact on the 
Corporation's financial statements and any material inquiries or reports 
received from regulatory or governmental agencies.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">14.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review periodically the content and operation of the 
Corporation's ethics and compliance program and the Code of Business 
Ethics.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">15.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Discuss with management and the independent auditors at least 
annually the Corporation's guidelines and policies with respect to risk 
assessment and risk management.&#160; The Committee should discuss the 
Corporation's major financial risk exposures and the overall steps management 
has taken to monitor and control such exposures; however, the Committee is not 
responsible for detailed review of financial risk exposure and management, which
responsibility has been delegated to another committee of the 
Board.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">16.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Establish, and review periodically, procedures for:&#160; (i) 
the receipt, retention and treatment of complaints received by the Corporation 
regarding accounting, internal accounting controls or auditing matters and (ii) 
the confidential, anonymous submission by employees of the Corporation of 
concerns regarding questionable accounting or auditing matters.</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: 
underline">Reports</font></font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">17.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Review and approve the Committee's report required to be 
included in the Corporation's annual proxy statement, pursuant to and in 
accordance with applicable rules and regulations of the SEC/OSC.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">18.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Report regularly to the full Board including:</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(i)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">with respect to any issues that arise with respect to the 
quality or integrity of the Corporation's financial statements, the 
Corporation's compliance with legal or regulatory requirements, the performance 
and independence of the Corporation's independent auditors or the performance of
the internal audit function;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(ii)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">following all meetings of the Committee; and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">(iii)&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">with respect to such other matters as are relevant to the 
Committee's discharge of its responsibilities.</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The report to the Board may take the form of an oral report by 
the Chair of the Committee or any other member of the Committee designated by 
the Committee to make such report.</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">19.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Maintain minutes or other records of meetings and activities of
the Committee.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 
10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">20.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee shall receive appropriate funding from the 
Corporation for the payment of compensation to the independent auditors and to 
other advisors retained by the Committee pursuant to the provisions of this 
Charter.</font></div>
</td>
</tr></table>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT:
bold">V.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Annual
Performance Evaluation</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">The Committee shall perform a review and evaluation, at least 
annually, of the performance of the Committee and its members, including a 
review of the compliance of the Committee with this Charter.&#160; In addition, 
the Committee shall review and reassess, at least annually, the adequacy of this
Charter and recommend to the Board any improvements to this Charter that the 
Committee considers necessary or valuable.&#160; The Committee shall conduct 
such evaluations and reviews in such manner as it deems 
appropriate.</font></div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11.3
<SEQUENCE>5
<FILENAME>codeconduct.htm
<DESCRIPTION>CODE OF CONDUCT
<TEXT>
<html>
<head>
    <title>codeconduct.htm</title>
    <!--Licensed to: bontan94-->
    <!--Document Created using EDGARizer 2020 5.4.0.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">PORTAGE BIOTECH INC. AND ALL 
SUBSIDIARIES</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY:
Times New Roman; FONT-SIZE: 10pt">Code of Conduct</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Our Company's Board of Directors adopted a Code of Business 
Conduct and Ethics that applies to, among other persons, our Company's Chief 
Executive Officer&#160;&#160;and Chief Financial Officer (being our principal 
executive officers) and members of our audit committee and any future committees
that may be established from time to time, all our key consultants, as well as 
persons performing similar functions. As adopted, our Code of Business Conduct 
and Ethics sets forth written standards that are designed to deter wrongdoing 
and to promote:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><a name="page_95"><!--EFPlaceholder--></a>&#160;(1) honest and 
ethical conduct, including the ethical handling of actual or apparent conflicts 
of interest between personal and professional relationships;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">(2) Full, fair, accurate, timely, and understandable disclosure
in reports and documents that we file with, or submit to, the Securities and 
Exchange Commission and in other public communications made by us;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">(3) Compliance with applicable governmental laws, rules and 
regulations;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">(4) the prompt internal reporting of violations of the Code of 
Business Conduct and Ethics to an appropriate person or persons identified in 
the Code of Business Conduct and Ethics; and</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">(5) Accountability for adherence to the Code of Business 
Conduct and Ethics.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Our Code of Business Conduct and Ethics requires, among other 
things, that all of our Company's personnel and consultants shall be accorded 
full access to our CEO/CFO and members of our audit committee with respect to 
any matter which may arise relating to the Code of Business Conduct and Ethics. 
Further, all of our Company's personnel and consultants are to be accorded full 
access to our Company's board of directors if any such matter involves an 
alleged breach of the Code of Business Conduct and Ethics by our CEO or 
CFO.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">In addition, our Code of Business Conduct and Ethics emphasizes
that all employees, and particularly managers and/or supervisors and our key
consultants have a responsibility for maintaining financial integrity within our
Company, consistent with generally accepted accounting principles, and federal, 
provincial and state securities laws. Any employee who becomes aware of any 
incidents involving financial or accounting manipulation or other 
irregularities, whether by witnessing the incident or being told of it, must 
report it to his or her immediate supervisor or to our Company's CEO. If the 
incident involves an alleged breach of the Code of Business Conduct and Ethics 
by the CEO, the incident must be reported to any
member of our Board of Directors. Any failure to report such inappropriate or 
irregular conduct of others is to be treated as a severe disciplinary matter. It
is against our Company policy to retaliate against any individual who reports in
good faith the violation or potential violation of our Company's Code of 
Business Conduct and Ethics by another.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>6
<FILENAME>ceo.htm
<DESCRIPTION>EXHIBIT 12.1 CEO
<TEXT>
<html>
<head>
    <title>ceo.htm</title>
    <!--Licensed to: bontan94-->
    <!--Document Created using EDGARizer 2020 5.4.0.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
<br>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 12.1</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;CERTIFICATION</font></div>
<br>
<br>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 
10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160; I, Declan Doogan, certify that:</font></div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left">
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="TEXT-ALIGN:
left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left;">
<td align="right" style="WIDTH: 45pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">1.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">I have reviewed this annual report on Form 20-F of Portage 
Biotech Inc.;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" 
width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left;">
<td style="TEXT-ALIGN: left; WIDTH: 44px">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 10px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">2.</font></div>
</td>
<td width="1591" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain 
any untrue statement of a material fact or omit to state a material fact 
necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by 
this report;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" 
width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left;">
<td style="TEXT-ALIGN: left; WIDTH: 42px">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 12px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">3.</font></div>
</td>
<td width="1591" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and
other financial information included in this report, fairly present in all 
material respects the financial condition, results of operations and cash flows 
of the company as of, and for, the periods presented in this 
report;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" 
width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left;">
<td style="TEXT-ALIGN: left; WIDTH: 41px">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 13px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">4.</font></div>
</td>
<td width="1591" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">The issuer&#8217;s other certifying officer(s) and I
are&#160;&#160;responsible for establishing and maintaining disclosure controls 
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 
internal control over financial reporting (as defined in Exchange Act Rules 13a-
15(f) and 15d-15(f)) for the issuer and have:</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left">
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="TEXT-ALIGN:
left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left;">
<td align="right" style="WIDTH: 96px">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">a.&#160;&#160;</font></div>
</td>
<td width="1549">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused 
such disclosure controls and procedures to be designed under my supervision, to 
ensure that material information relating to the company, including its
consolidated subsidiaries, is made known to me by others within those entities, 
particularly during the period in which this report is being 
prepared;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" 
width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left;">
<td style="TEXT-ALIGN: left; WIDTH: 82px">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 14px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">b.</font></div>
</td>
<td width="1549" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">Designed such internal control over financial 
reporting, or caused such internal control over financial reporting to be 
designed under my supervision, to provide reasonable assurance regarding the 
reliability of financial reporting and the preparation of financial statements 
for external purposes in accordance with generally accepted accounting 
principles;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" 
width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left;">
<td style="TEXT-ALIGN: left; WIDTH: 82px">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 14px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">c.</font></div>
</td>
<td width="1549" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">Evaluated the effectiveness of the company's 
disclosure controls and procedures and presented in this report my conclusions 
about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" 
width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left;">
<td style="TEXT-ALIGN: left; WIDTH: 82px">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 14px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">d.</font></div>
</td>
<td width="1549" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">Disclosed in this report any change in the company's
internal control over financial reporting that occurred during the period 
covered by the annual report that has materially affected, or is reasonably 
likely to materially affect, the company's internal control over financial 
reporting; and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" 
width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left;">
<td style="TEXT-ALIGN: left; WIDTH: 40px">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 14px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">5.</font></div>
</td>
<td width="1591" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">The issuer&#8217;s other certifying officer(s) and I
have disclosed, based on our most recent evaluation of internal control over 
financial reporting, to the company's auditors and the audit committee of the
company's board of directors (or persons performing the equivalent 
functions):</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" 
width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left;">
<td style="TEXT-ALIGN: left; WIDTH: 82px">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 14px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">a.</font></div>
</td>
<td width="1549" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses
in the design or operation of internal control over financial reporting which 
are reasonably likely to adversely affect the company's ability to record, 
process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" 
width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left;">
<td style="TEXT-ALIGN: left; WIDTH: 82px">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 14px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">b.</font></div>
</td>
<td width="1549" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times 
New Roman; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves 
management or other employees who have a significant role in the company's 
internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 
0pt; MARGIN-RIGHT: 0pt">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; 
FONT-WEIGHT: bold">Date: </font>July 24, 2014&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">/s/ Declan Doogan</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="32%" style="BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Declan Doogan</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Chief Executive Officer</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>7
<FILENAME>cfo.htm
<DESCRIPTION>EXHIBIT 12.2 CFO
<TEXT>
<html>
<head>
    <title>cfo.htm</title>
    <!--Licensed to: bontan94-->
    <!--Document Created using EDGARizer 2020 5.4.0.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">
<br>
<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 12.2</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">I, Kam Shah, certify that:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 45pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">1.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">I have reviewed this annual report on Form 20-F of Portage 
Biotech&#160;&#160;Inc.;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">2.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue 
statement of a material fact or omit to state a material fact necessary to make 
the statements made, in light of the circumstances under which such statements 
were made, not misleading with respect to the period covered by this 
report;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE:
10pt">3.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other 
financial information included in this report, fairly present in all material 
respects the financial condition, results of operations and cash flows of the 
company as of, and for, the periods presented in this report;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">4</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The issuer&#8217;s other certifying officer(s) and I 
are&#160;&#160;responsible for establishing and maintaining disclosure controls 
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 
internal control over financial reporting (as defined in Exchange Act Rules 13a-
15(f) and 15d-15(f)) for the issuer and have:</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-
FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman">
<tr valign="top">
<td align="right" style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">a.&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused 
such disclosure controls and procedures to be designed under my supervision, to 
ensure that material information relating to the company, including its
consolidated subsidiaries, is made known to me by others within those entities, 
particularly during the period in which this report is being 
prepared;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Designed such internal control over financial reporting, or 
caused such internal control over financial reporting to be designed under my 
supervision, to provide reasonable assurance regarding the reliability of 
financial reporting and the preparation of financial statements for external 
purposes in accordance with generally accepted accounting 
principles;</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Evaluated the effectiveness of the company's disclosure 
controls and procedures and presented in this report my conclusions about the 
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Disclosed in this report any change in the company's internal 
control over financial reporting that occurred during the period covered by the 
annual report that has materially affected, or is reasonably likely to 
materially affect, the company's internal control over financial reporting; 
and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22.5pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">5.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">The issuer&#8217;s other certifying officer(s) and I have 
disclosed, based on our most recent evaluation of internal control over 
financial reporting, to the company's auditors and the audit committee of the
company's board of directors (or persons performing the equivalent 
functions):</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the 
design or operation of internal control over financial reporting which are 
reasonably likely to adversely affect the company's ability to record, process, 
summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" 
id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 
10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 
10pt">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or
other employees who have a significant role in the company's internal control 
over financial reporting.</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; 
FONT-WEIGHT: bold">Date: </font>July 24, 2014&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman;
FONT-SIZE: 10pt">/s/ Kam Shah</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify">&#160;</div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="32%" style="BORDER-TOP: black 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Kam Shah</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
FONT-SIZE: 10pt">Chief Financial Officer</font></div>
</td>
</tr></table>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>8
<FILENAME>ceoexhibit.htm
<DESCRIPTION>EXHIBIT 13.1 CEO
<TEXT>
<html>
<head>
    <title>ceoexhibit.htm</title>
    <!--Licensed to: bontan94-->
    <!--Document Created using EDGARizer 2020 5.4.0.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: 
bold">&#160;</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;Exhibit 
13.1</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Certification by the Principal Executive Officer pursuant 
to</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">section 906 of the sarbanes-oxley act of 2002</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">In connection with the annual report on Form 20-F of Portage 
Biotech Inc.. for the year ended March 31, 2014, as filed with the Securities 
and Exchange Commission, I, Declan Doogan as Chief Executive Officer of the 
Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to 
Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge 
that:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">1. &#160;The annual report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; 
and</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">2. &#160;The information contained in the annual report fairly 
presents, in all material respects, the financial condition and results of 
operations of the Registrant.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Date: &#160;July 24, 2014</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ 
Declan Doogan</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Declan Doogan</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Chief Executive Officer</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">A signed original of this written statement required by Section
906, or other document authenticating, acknowledging, or otherwise adopting the 
signature that appears in typed form within the electronic version of this 
written statement required by Section 906, has been provided to the Company and 
will be retained by the Company and furnished to the Securities and Exchange 
Commission or its staff upon request.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>9
<FILENAME>cfoexhibit.htm
<DESCRIPTION>EXHIBIT 13.2 CFO
<TEXT>
<html>
<head>
    <title>cfoexhibit.htm</title>
    <!--Licensed to: bontan94-->
    <!--Document Created using EDGARizer 2020 5.4.0.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">
<br>
<br>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block"><font 
style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-
WEIGHT: bold">&#160;Exhibit 13.1</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Certification by the Principal Financial Officer pursuant 
to</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">section 906 of the sarbanes-oxley act of 2002</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">In connection with the annual report on Form 20-F of Portage
Biotech Inc.. for the year ended March 31, 2014, as filed with the Securities 
and Exchange Commission, I, Kam Shah as Chief Financial Officer of the 
Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to 
Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge 
that:</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">1. &#160;The annual report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; 
and</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">2. &#160;The information contained in the annual report fairly 
presents, in all material respects, the financial condition and results of 
operations of the Registrant.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Date: &#160;July 24, 2014</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ 
Kam Shah</font></font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Kam Shah</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">Chief Financial Officer</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 
0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; 
FONT-SIZE: 10pt">A signed original of this written statement required by Section
906, or other document authenticating, acknowledging, or otherwise adopting the 
signature that appears in typed form within the electronic version of this 
written statement required by Section 906, has been provided to the Company and 
will be retained by the Company and furnished to the Securities and Exchange 
Commission or its staff upon request.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-
FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; 
FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
<br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>flowchart2014.jpg
<TEXT>
begin 644 flowchart2014.jpg
M_]C_X``02D9)1@`!`0$`E@"6``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````"6`````0```)8````!4&%I;G0N3D54('8U+C`P`/_B#%A)0T-?4%)/
M1DE,10`!`0``#$A,:6YO`A```&UN=')21T(@6%E:(`?.``(`"0`&`#$``&%C
M<W!-4T94`````$E%0R!S4D="``````````````````#VU@`!`````-,M2%`@
M(```````````````````````````````````````````````````````````
M````$6-P<G0```%0````,V1E<V,```&$````;'=T<'0```'P````%&)K<'0`
M``($````%')865H```(8````%&=865H```(L````%&)865H```)`````%&1M
M;F0```)4````<&1M9&0```+$````B'9U960```-,````AG9I97<```/4````
M)&QU;6D```/X````%&UE87,```0,````)'1E8V@```0P````#')44D,```0\
M```(#&=44D,```0\```(#&)44D,```0\```(#'1E>'0`````0V]P>7)I9VAT
M("AC*2`Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY``!D97-C````````
M`!)S4D="($E%0S8Q.38V+3(N,0``````````````$G-21T(@245#-C$Y-C8M
M,BXQ````````````````````````````````````````````````````````
M``````````!865H@````````\U$``0````$6S%A96B``````````````````
M````6%E:(````````&^B```X]0```Y!865H@````````8ID``+>%```8VEA9
M6B`````````DH```#X0``+;/9&5S8P`````````6245#(&AT='`Z+R]W=W<N
M:65C+F-H```````````````6245#(&AT='`Z+R]W=W<N:65C+F-H````````
M`````````````````````````````````````````````````````&1E<V,`
M````````+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E
M("T@<U)'0@``````````````+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@
M8V]L;W5R('-P86-E("T@<U)'0@````````````````````````````!D97-C
M`````````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y
M-C8M,BXQ```````````````L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N
M(&EN($E%0S8Q.38V+3(N,0``````````````````````````````````=FEE
M=P``````$Z3^`!1?+@`0SQ0``^W,``03"P`#7)X````!6%E:(```````3`E6
M`%````!7'^=M96%S``````````$````````````````````````"CP````)S
M:6<@`````$-25"!C=7)V````````!``````%``H`#P`4`!D`'@`C`"@`+0`R
M`#<`.P!``$4`2@!/`%0`60!>`&,`:`!M`'(`=P!\`($`A@"+`)``E0":`)\`
MI`"I`*X`L@"W`+P`P0#&`,L`T`#5`-L`X`#E`.L`\`#V`/L!`0$'`0T!$P$9
M`1\!)0$K`3(!.`$^`44!3`%2`5D!8`%G`6X!=0%\`8,!BP&2`9H!H0&I`;$!
MN0'!`<D!T0'9`>$!Z0'R`?H"`P(,`A0"'0(F`B\".`)!`DL"5`)=`F<"<0)Z
M`H0"C@*8`J("K`*V`L$"RP+5`N`"ZP+U`P`#"P,6`R$#+0,X`T,#3P-:`V8#
M<@-^`XH#E@.B`ZX#N@/'`],#X`/L`_D$!@03!"`$+00[!$@$501C!'$$?@2,
M!)H$J`2V!,0$TP3A!/`$_@4-!1P%*P4Z!4D%6`5G!7<%A@66!:8%M07%!=4%
MY07V!@8&%@8G!C<&2`99!FH&>P:,!IT&KP;`!M$&XP;U!P<'&0<K!ST'3P=A
M!W0'A@>9!ZP'OP?2!^4'^`@+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC["1`)
M)0DZ"4\)9`EY"8\)I`FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*\PL+
M"R(+.0M1"VD+@`N8"[`+R`OA"_D,$@PJ#$,,7`QU#(X,IPS`#-D,\PT-#28-
M0`U:#70-C@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/>@^6
M#[,/SP_L$`D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$<D1Z!('$B82
M11)D$H02HQ+#$N,3`Q,C$T,38Q.#$Z03Q1/E%`84)Q1)%&H4BQ2M%,X4\!42
M%3055A5X%9L5O17@%@,6)A9)%FP6CQ:R%M86^A<=%T$791>)%ZX7TA?W&!L8
M0!AE&(H8KQC5&/H9(!E%&6L9D1FW&=T:!!HJ&E$:=QJ>&L4:[!L4&SL;8QN*
M&[(;VAP"'"H<4AQ['*,<S!SU'1X=1QUP'9D=PQWL'A8>0!YJ'I0>OA[I'Q,?
M/A]I'Y0?OQ_J(!4@02!L()@@Q"#P(1PA2"%U(:$ASB'[(B<B52*"(J\BW2,*
M(S@C9B.4(\(C\"0?)$TD?"2K)-HE"24X)6@EER7')?<F)R97)H<FMR;H)Q@G
M22=Z)ZLGW"@-*#\H<2BB*-0I!BDX*6LIG2G0*@(J-2IH*ILJSRL"*S8K:2N=
M*]$L!2PY+&XLHBS7+0PM02UV+:LMX2X6+DPN@BZW+NXO)"]:+Y$OQR_^,#4P
M;#"D,-LQ$C%*,8(QNC'R,BHR8S*;,M0S#3-&,W\SN#/Q-"LT932>--@U$S5-
M-8<UPC7]-C<V<C:N-NDW)#=@-YPWUS@4.%`XC#C(.04Y0CE_.;PY^3HV.G0Z
MLCKO.RT[:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B`^8#Z@/N`_(3]A/Z(_XD`C
M0&1`ID#G02E!:D&L0>Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:1=Y&
M(D9G1JM&\$<U1WM'P$@%2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+XDPJ
M3'),NDT"34I-DTW<3B5.;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q4GQ2
MQU,34U]3JE/V5$)4CU3;52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9&EEI
M6;A:!UI66J9:]5M%6Y5;Y5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV`%8%=@
MJF#\84]AHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUGDV?I
M:#]HEFCL:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>;WAO
MT7`K<(9PX'$Z<95Q\')+<J9S`7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW5G>S
M>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^`7YB?L)_(W^$?^6`
M1X"H@0J!:X'-@C""DH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B`2(:8C.
MB3.)F8G^BF2*RHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI`&D&Z0UI$_D:B2
M$9)ZDN.339.VE""4BI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:U9M"
MFZ^<')R)G/>=9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16I,>E
M.*6IIAJFBZ;]IVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:Q<K-"M1*VXKBVNH:\6
MKXNP`+!UL.JQ8+'6LDNRPK,XLZZT);2<M1.UBK8!MGFV\+=HM^"X6;C1N4JY
MPKH[NK6[+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'#`[,%GP>/"7\+;PUC#U,11
MQ,[%2\7(QD;&P\=!Q[_(/<B\R3K)N<HXRK?+-LNVS#7,M<TUS;7.-LZVSS?/
MN-`YT+K1/-&^TC_2P=-$T\;42=3+U4[5T=95UMC77-?@V&38Z-ELV?':=MK[
MVX#<!=R*W1#=EMX<WJ+?*=^OX#;@O>%$X<SB4^+;XV/CZ^1SY/SEA.8-YI;G
M'^>IZ#+HO.E&Z=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_RC/,9
M\Z?T-/3"]5#UWO9M]OOWBO@9^*CY./G'^E?ZY_MW_`?\F/TI_;K^2_[<_VW_
M___;`$,``@$!`@$!`@("`@("`@(#!0,#`P,#!@0$`P4'!@<'!P8'!P@)"PD(
M"`H(!P<*#0H*"PP,#`P'"0X/#0P."PP,#/_;`$,!`@("`P,#!@,#!@P(!P@,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#/_``!$(`:H"+`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0``````````
M`0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q0083
M46$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#
M1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7
MF)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7F
MY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)
M"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@4
M0I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I3
M5%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2E
MIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U
M]O?X^?K_V@`,`P$``A$#$0`_`/W\HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`$<
M;EKY`\':GJNL^%-+O+CQ%XM>XO+2*:5EU^]0,[("2%64`<GH``*^P#TKX[^'
M?_(@:'_V#X/_`$6M`&H)KYNGB+Q<?IXBOO\`X[2275Y#MW^(_%B>8VU=WB.^
M&X^G^MZ^U>7?&KX<76J?$;2=0TNP:8>);*?PMK5Q"NV6VM)<2B<OU&P12HO/
MWKA?2N'M?AKKE[IWA'4-8TR^7Q%I.OV6BM?Q6?VB?[%9+<1?:SA6VK*[L^2-
MN#'QQB@#Z+,E\%S_`,)!XNQC/_(Q7W_QVHH-3N+F39'XF\52-@G"^)+T]&VG
M_EKV8$'T->.>&?B'\1-6TO3Y+K3;Z&^V:>JP-I;1Q7Q:X9+UIF9<P[(EW@?)
MV(#@[1PW@[3?$'P[BGUNPT[4M);0M%NKFX6;36C6Y@CUB>=[8-*@56>V)*<@
M@LIZ9R`?46^__P"A@\7?^%%??_':-]__`-#!XN_\**^_^.UY[K&O>.])\%-<
M0Z=97DC11S-/YYDO8/,F4R(MJD(1S#"S;3YA9VC`V'.*YK7/$_Q.@$UQHT$F
MH6LDU[86`N[)87?$,<L%U.NU64!EN8L87<3`=N"20#V???\`_0P>+O\`PHK[
M_P".T;K_`/Z&#Q=_X45]_P#':\5\4^/?'UDEU=V<.L;?[$.KV]F-(\YDN6N0
M$LW9$.XB(X95.\')W8&:L-X[^(3W.I3-9R6\,6I&W:WCT^2>2WM#>HB7,)\H
M+(WV4LY3=(2Q'RC:R$`]?AN;RX4M'XC\6.H)4E?$=\<$'!'^M[$$5I_#_4]2
ML?BYX1C77/$DT-YJ$D,\5SK%U<Q2I]DN&P4DD93\RJ>G!`KS#]F?1[C0?AU>
M6]Q;WEJW]NZM,@N;8V\DD<E_/)&^S:H`965N`!SVY%>E^"_^2P>"/^PK)_Z1
M75`'U%03@44'I0!^7OQN_;0^*'AGXT>,--L?&.J6]C8ZW>VUO"HCVQ1I.ZJH
M^7H%`%<O_P`-V?%L?\SOJWY1_P#Q-<O^T6?^,@_'?_8Q:AV_Z>I*XS/^<4`>
MM_\`#=GQ<_Z'?5?RC_\`B:7_`(;I^+A'_([:M^4?_P`37D>?\XKZ&^'/C*Q^
M'G[.7@[7M2M[B\M[/Q)>I+;1Q*RW\?V=<02%C@1DD]0W<A<YH`Y3_ANOXN8_
MY';5ORC_`/B:/^&[/BY_T.^J_E'_`/$UH0_L]:5KNF0WS7TEJVK>'+KQ0DL)
M465F4E(%H01G/1=VX89E&T]]KPC\`/"-I\3=*T>:#6=2N+SPV=;\F69/++/8
M/,J`*@9F5\8]<#/H0#E?^&[/BY_T.^J_E'_\31_PW9\7/^AWU7\H_P#XFIM"
M_9K6_P#A7JVM:A!J6FW<&E3ZS8@SB:.6*.98O+D40KL;EN3)NR,E`*V-2_9=
M\-P:EI.CQZ[>0ZEJVJV>GPW,S((3%+;K)+,8]@:-E=O+5)'!)^AH`P?^&[/B
MY_T.^J_E'_\`$T#]NWXMG_F>-4_*/_XFL/XL?#K2_`.N:=:Z<-7FO?M$T-Y9
M7]NT81DEPBK(R)OWIU`7@]R"*]B\1_"32_CSK>FRZ=J,_A[2]2U:>SN-"N[9
M%GTZYMK4LT-JR_*T9VA.!PQ!()XH`\Y_X;L^+G_0[ZK^4?\`\30?V[?BV/\`
MF=]5_*/_`.)JQH_P.\,:A<Z],UQXC^S^']`35KJW:(6\R3"9(I(0TD0WK\Q8
M.%7T([U1U_X7>$['X6:9XPT^ZU::SNY);%K:2YB%Q%>K*N%.$QL,!:3.#S@9
M&10!-_PW9\7/^AWU7\H__B:/^&[/BY_T.^J_E'_\374?%?\`9_M8O%?C76=2
MNM7UQ='UJTL)X=/@ABN@DL*R-<NB)L"_PJ%503U85@ZM^SIH>@>&]$EN]4UA
MKO7K"SOK6>TL7N;=C--MEAPJ?>C4C!WY9UV[5R#0!5_X;L^+G_0[ZK^4?_Q-
M'_#=OQ;Q_P`CQJGY1_\`Q-8/QO\`A79_#>[TN;3;K^T-*UB*66TNUG$BW")(
M4SC8C(1MP59>H.":Z;5=(N=<_91\%VMI"TUY?>(KRVC51AI0$CVKD]@6;J<#
M<:`*_P#PW9\7/^AWU7\H_P#XF@?MV_%L_P#,[ZKZ=(__`(FNB\2?LY:3J6N6
MZ:=:ZE:V^G^"H=?,<+[Y-6F\M6:.-BF-VY\L1NP%X45D?M9>'+[4_%VFWEO8
MWTEOI_A;2I+R0QLWV4-&J@RM@8)8XR0,G-`%3_ANSXN?]#OJOY1__$T?\-V?
M%S_H=]5_*/\`^)KR3/\`G%&?\XH`]W^&/[=/Q0D^(NAKJ'BS4KZQ-]#Y]NX3
M;,F\94_+T(K]./!NN-X@\,V=XPVM<1AR/3-?C3\/#_Q76D?]?<?;_:%?L1\*
MO^2>Z3_UP6@#I****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`/2OCOX=_\B!H?_8/
M@_\`1:U]B'I7QW\._P#D0-#_`.P?!_Z+6@#8HHKD?C5\.9?BCX-&FPR1PS+.
MLZ2.W",%8`X*NC8+`[71E8#!`R&`!O>*?$4/A/POJ&K3QS36NFV\EU*L6"[)
M&I9MN2`3@'O4<UIIOQ`\,0K=6J7FGW\23F"9<AU.&`9>G7''(R*\GNOV6]2=
MIH4U+2S#-=7=RTZVQADS<Z6+%P$7Y0`X\S`."#MXQDLU#]E.\O;1F@NM+TRX
MD-OMA@B$MK;M%`8C.8I$,<SR`G<&13M"!74KN(!Z=XH^)5CX/\":GX@O+?4!
M9Z49/.3R#',0DA0LJOMRI(R#GE<$<$5KZ7JBZL+AHX;J(6\[P$30-&7*G&Y<
M_>4XX8<&O$M6_91U;5-`UNS:]T:1=4&H"WCEC=H]-:XOGNTDCX^]A_*;@<1H
MP/!4SZ[^S9XCU5+V.'5-'M8;K6I=9C18@7AD-S;SKB0Q[EXB="$V??#9;`6@
M#W"CO^.*\%UO]G"/0[*SFAT^QC\37WB:>=;ZPLC,4LKJ:X,T<K[1M5;>XF5<
M\;UC/)PH]TT_3X=)T^"UM8HX+:UC6&*.-=J1HH`55'8```>U`$U6O!?_`"6#
MP1_V%9/_`$BNJJU:\%_\E@\$?]A63_TBNJ`/J*@]**#TH`_&W]HO_DX/QW_V
M,6H=_P#IZDKC,?YS79_M%G_C(/QW_P!C%J';_IZDKC,_YQ0`8_SFK3:U>R6"
MVC75R]JARL#3,8U.<\+G'7VJKG_.*.O_`.J@"RNH7@TUH%FN/L?F!FC$C"(O
MSC('&[@^_!]*FF\2:C->PW$E]>/<0?ZJ1KAR\?KM.<C//2N]\6ZI/X'\`>!X
M='D\M=:TJ>YNI8Q\\D[W<D;`'J&"0QJ,=L_WCGT7XZ^#%\??M`^/M)N+AK;2
M_"^GR:Y;V4*!))W6V@S%&2,*#G<<`\;C@GF@#YZ@\07]NFQ;R[6/+'8)V"_-
M][H>_?U[UV/CC]HCQ!XYTK5+&XFECL]8DCDN+<W4TL,>PAE6)'8K&NX9PO/;
M..*[*Y_9T\-^']-UC4K[4-8GL]-T72];:W@:(7%NMW*B/#(2A7>BDL#A=P*\
M+5:\_9OTFT\/3SG4[H20^$8_%2W1*_99BTFS[*!@D.?NAMQ^<$;:`/(M1U>Z
MU>59+JXN+B2-=JM)*S$#K@9/2BZUF\OKB.::ZN9I8<;'DF9F3!SP2<CGFO;?
M%W[,_AW0X_$BV]UK7G>%Y-&>5II(S'=17RH6`P@\MD).&)8$=1WJ?XD_L]:'
M8^-O'5Q#;ZE:Z=X=U>TT^WTZVD`EF2>0IYJLZG$8P`.&W,P^84`>)MXLU1I9
MI/[1OM]P`LK"X?,@`P`3G)&..35.*[N(T58YI46.3S%".5"/P-P]#P!^5==\
M7O@_=?#'Q3JUO#-_:6CZ;J3Z:FH*H"2R*H?80"<.%/(]0V.E=[XDTG4/"/PC
M^&^K^";-KB"1'FU2XMH#,TNH+)S%/C)VA<;48[2"2!S0!XY)XCU*6[DF:_OF
MFF3RG<W#[F3^Z3G)'UJ--9O$L%M?M-Q]E1MXB$K!`WKCIGWKU?5/V<H=!^#5
MUX@U)+ZSU2QBT^[:%;A98;F"[=PN,1`1L%`.`\G7!`X`V_'?[)FGZ??Z[INA
MRZK=:IHGB"RT54N)X_+OA<QEE8$(OED,,<EAS^%`'A5]J%QJ=QYMS/-<2,`N
M^64NV/J>:LV_BC5+2R^SPZC?0VZC`C2X=5`/MG'K7MUS^R7ILVI:,(;K4X5O
M-,U2]GLBPEN));*1D,,+>7&27QD9CX`)`88SJ?$;X1O\0]9\'S75CJ']FZ5X
M,TY[[;=".YA\R>2,'_5.7;<>0(\=R5&30!\]QZWJ$(M9([JZC^RADMV$K#R1
MW"G^'KV]:;/KE[<P^7+=7,D>W9M:5B"H.0/H#@X]17JGB'X<V_@BP^*WAN:9
M[RU\*7,$MA<2#:_G_:DAX'8O$\A('7R@>=HQY"3S_P#6H`3'^<T8_P`YHS_G
M%&?\XH`V?AX/^*ZTC_K[C[_[0K]B/A5_R3W2?^N"U^._P\/_`!76D?\`7W'V
M_P!H5^Q'PJ_Y)[I/_7!:`.DHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`$;[M?-V
M@?LT>/=`T*RL5A\)3+90)`)#JUPAD"J%SM^RG&<=,FOI*B@#YY_X9^\??\^O
MA'_P<7'_`,BT?\,_>/O^?7PC_P"#BX_^1:^AJ*`/GG_AG[Q]_P`^OA'_`,'%
MQ_\`(M'_``S]X^_Y]?"/_@XN/_D6OH:B@#YY_P"&?O'W_/KX1_\`!Q<?_(M-
M?X"^.XA\UOX/7ZZS<?\`R)7T17Q?_P`%/M-^)%OKMKK?AFZUZT\+Z7IR?;WL
MKLQHDIEDRY16R<*$RV.`5[9P`>DI\`?'DBY6V\(,/;6+C_Y%I?\`AG[Q]_SZ
M^$?_``<7'_R+7+_\$]OVO[7XB^&8?#FMW3+KUHHPTTF6N!V.3UKZN!R*`/GG
M_AG[Q]_SZ^$?_!Q<?_(M7_!?P"\8:?\`$3P]J>I)X;@L='O'N9?LVH33RN#!
M+$`JM`@ZR`Y+=!WKW>B@`H/2BB@#\[?V@_\`@G;XPU3XM>(-6L+BWO+?6M2N
M;]-L;#RA+*\@4^XW8KB/^'=7C[_GC'^7_P!>OU(**W50?PI/*7^ZOY4`?EQ_
MP[J\??\`/&/\O_KT?\.ZO'O_`#QC_P"^?_KU^H_E+_=7\J/*7^ZOY4`?F2/V
M%?B6-%MM/^7[/93M<VQ`.^W=@`Q5@<C.U<CU4'US%/\`L%?$RYOX[J2>XDNH
MAA)FE<R*.V&W9'X5^G?E+_=7\J/*7^ZOY4`?F+'^P;\38DN%6XN%%US/B5QY
MQQ@[OF^;\:B'_!/_`.)"VBVX=Q;QMO2+<WEJW]X+G&>>O6OT_P#*7^ZOY4>4
MO]U?RH`_,B?]A7XHW4<D<EY=R1S+LD5YG8..P.6Y')Z^M-3]@_XFQW?VA9IQ
M<;/+\WS7W[<8VYW=.!^0K].?*7^ZOY4>4O\`=7\J`/S#F_8'^(\^CQZ>VW['
M%*TXB"8!D(`+'').!@9/'..IS':_\$_OB/80RQV[26\=P-LJQL560<\$9P1R
M?S/K7Z@>4O\`=7\J/*7^ZOY4`?F+!^P9\3K:!8H[BX2.-=BJLK@!<YQC=TSS
MCIGGK4D_["WQ2NHY%EO+N19B"X>9VWD=,_-7Z;>4O]U?RH\I?[J_E0!^8[_L
M(_%"61':ZN6DCD\U6,KY5^A8'=P>V>M-;]@SXG.VYKFY.59/]:W"M]Y>O0]2
M._?-?IUY2_W5_*CRE_NK^5`'YE77[#7Q.OM*DL9G\ZWN)Q<S%QN>9U7:A9LY
M.T;@!G`W-@<UF_\`#NKQ[_SQC_+_`.O7ZC^4O]U?RH\I?[J_E0!^7'_#NKQ]
M_P`\8_R_^O1_P[J\??\`/&/\O_KU^H_E+_=7\J/*7^ZOY4`?F/X5_P""?GCS
M1O$MC=M;QLMO.DA`'4`Y]:_1[X?:;+I'@W3[:9=LL,(5AZ&MKRE_NK^5.H`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`,XKS?Q7^U[\-?`_B&[TG5?%VEV6I6$ABN+>0ONB8=C\M>D-TK\B_VUC_Q
ME;XZ_P"PH_;V%`'Z-?\`#='PE_Z'C1_S?_XFC_ANCX2_]#QH_P";_P#Q-?DI
MG_.*,_YQ0!^M?_#='PE_Z'C1_P`W_P#B:/\`ANCX2_\`0\:/^;__`!-?DIG_
M`#BC/^<4`?K7_P`-T?"7_H>-'_-__B:/^&Z/A+_T/&C_`)O_`/$U^2F?\XHS
M_G%`'ZU_\-T?"7_H>-'_`#?_`.)H_P"&Z/A+_P!#QH_YO_\`$U^2F?\`.*,_
MYQ0!^M?_``W1\)?^AXT?\W_^)H_X;H^$O_0\:/\`F_\`\37Y*9_SBC/^<4`?
MK7_PW1\)?^AXT?\`-_\`XFC_`(;H^$O_`$/&C_F__P`37Y*9_P`XHS_G%`'Z
MU_\`#='PE_Z'C1_S?_XFC_ANCX2_]#QH_P";_P#Q-?DIG_.*,_YQ0!^M?_#=
M'PE_Z'C1_P`W_P#B:CO?VV_A!J-K)#/XTT.6&92CHX9E=2,$$%>0?2OR8S_G
M%&?\XH`^V_"O@?\`9]\$?&V3Q;I?Q&L[:W\_SH-.7>L-IG[RJ=N2N>@/0<<U
M]'Q?MR_"6.-5_P"$XT?Y1CJ__P`37Y*Y_P`XHS_G%`'ZU_\`#='PE_Z'C1_S
M?_XFC_ANCX2_]#QH_P";_P#Q-?DIG_.*,_YQ0!^S'PS^.OA+XQK=-X9URRUA
M;-E6<P$_NRV2N<@=<'\JZVOSC_X)9WTT/Q/O85D98I=A=0<!L9_QK]'!TH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HK
MY5^!>E^.?B]\)=#\27GQ2\76MUJ\!GDA@AM!%&=[#"YA)QQWKK/^%1^,/^BM
M>-O^_5G_`/&:`/?J*\!_X5'XP_Z*UXV_[]6?_P`9H_X5'XP_Z*UXV_[]6?\`
M\9H`]^HKP'_A4?C#_HK7C;_OU9__`!FC_A4?C#_HK7C;_OU9_P#QF@#WZBO`
M?^%1^,/^BM>-O^_5G_\`&:/^%1^,/^BM>-O^_5G_`/&:`/?J*\!_X5'XP_Z*
MUXV_[]6?_P`9H_X5'XP_Z*UXV_[]6?\`\9H`]^HKP'_A4?C#_HK7C;_OU9__
M`!FC_A4?C#_HK7C;_OU9_P#QF@#WZBO`?^%1^,/^BM>-O^_5G_\`&:/^%1^,
M/^BM>-O^_5G_`/&:`/?J*\!_X5'XP_Z*UXV_[]6?_P`9H_X5'XP_Z*UXV_[]
M6?\`\9H`]^HKP'_A4?C#_HK7C;_OU9__`!FC_A4?C#_HK7C;_OU9_P#QF@#W
MZBO`?^%1^,/^BM>-O^_5G_\`&:/^%1^,/^BM>-O^_5G_`/&:`/?J*\!_X5'X
MP_Z*UXV_[]6?_P`9K/\`%?P[\9^'_#&I7T?Q8\:/)9VLLZ*T5GM8HA8`_N>G
M%`'T=17'_L^>);[QE\"O!VK:E.UUJ&IZ+9W5S*5"F21X49FP`!R23P`*["@`
M/2OR+_;6'_&5OCK_`+"C]_85^NAZ5^1?[:Q_XRM\=?\`84?M["@#R['^<T8_
MSFC/^<49_P`XH`,?YS1C_.:LZ/IK:SJUK9K)'"]U*L2O(#M4L<`G`)QSV!KL
MO'W[/.O?#W2]6O+F73;N'0=0&F:A]EE9FM9F7<N0RKN5NS+D9':@#A,?YS1C
M_.:,_P"<5;?0;V/08]4:WD73YKAK5)ROR-*JJS(/<*RG_@0H`J8_SFC'^<T9
M_P`XHS_G%`!C_.:,?YS74_"/X1ZI\:?$TFDZ1-91WD=O)<XN79%9$&6P0IY`
M['K4^L_!;4M`ALYKJ^T>&UU/26UBRN)+GRTO(E)&Q`P#>:6!`0@$GIQ0!Q^/
M\YHQ_G-!/'_UJN:]H-[X7U::QU"WDM+RW($L4BX9"1G!'T(/XT`4\?YS1C_.
M:6-=\BJ650Q`W$'`_+FN@^*/PXO?A/XPET74)K6XNH889R]N6:,B6)9%QN`/
M`<`\=:`.>Q_G-&/\YKI#\,+Y?A4/&'VBQ_LLZC_9?E[G\_SPGF8V[<8V<YSC
MMUXKF\_YQ0`8_P`YHQ_G-&?\XHS_`)Q0`8_SFC'^<T9_SBC/^<4`?4?_``2W
M_P"2L77T3^M?I$.E?F[_`,$M_P#DK%U]$_K7Z1#I0`4444`>1_$#]IC5/#?Q
M-U#POH7@?5/%%UI-K;W-W+!?6ULD8FW[!^]89^X>E4/^&F?'/_1'=>_\'EA_
M\<JII/\`R=W\1/\`L$Z/_*YK@/$7[9DW@KX]^)/#^KZ6EOX8\/RRP2ZFD%UO
MW1Z5#J)PQB^SR.5>1?)20RX3?MV\@`]*_P"&F?''_1'=>_\`!W8?_'*/^&F?
M''_1'=>_\'=A_P#'*Y&]_;5\+Z)J^CZ;JVGZWH^K:KK"Z%)8WGV5+BQN6^S[
M`ZB<[U87=N<P>;@29;:`V*6H?MFVNJ:/HLVB^&_$4CZO=::=]U;Q+#:V=W?1
M6J7,NV8LJR;IA'@$YA)953!(!W?_``TSXX_Z([KW_@[L/_CE'_#3/CC_`*([
MKW_@[L/_`(Y7*?&;]KC3_A='XDM[?0]=U6\T.WN$6:*.-;.6^CL&OQ9[VD#!
MS;@2;MNS!QNWX4Q^/_VD]2^&OP_T+[;HEY?>*M1T^.]NX;>U1+?3U,D,;O,O
MGOM7?,%`CDE;@G)568`'7_\`#3/CC_HCNO?^#NP_^.4?\-,^./\`HCNO?^#N
MP_\`CE<-JO[</ASPKHNH7>I6.K&+2UC\^XC6"*V,DUS);P0J\TR#>YC<Y;"*
MJ$LR\976/VU-.N/!%YKOAOPKXH\3V=E%9N\D"V]O#YMQ]F=;<M+*")5BNHY#
M\NS!QOSP`#N/^&F?''_1'=>_\'=A_P#'*/\`AIGQQ_T1W7O_``=V'_QRN6U?
M]L;0=#N;N.XT7Q0%A=X+:1+6%TU&XCN8;6:"$B7EXIYD1MVU20Y1G"DC>\$?
M'^S\=>(]0TNWT/Q!;W6EWL=C=K/'!NMV>.1]SJLK,J`QE-S`!BR,F]&#D`M_
M\-,^./\`HCNO?^#NP_\`CE'_``TSXX_Z([KW_@[L/_CE>81?MJ7&B_%[Q9I&
MMZ1';^'_``\M]Y5ZHFA:9[98'\L2SI':R,ZRR'"3$QB(E]H.1-<_MW^'YM/T
MS7+<^7X9F@^VWTTRAIK:%;?59),&-FC9A)IK+\K,I!."<@T`>D_\-,^./^B.
MZ]_X.[#_`..4?\-,^./^B.Z]_P"#NP_^.5RWP^_;0\)?$@:>MC%JD=UJDT5O
M:V[K"[3NTTL3A&CE>-Q$(FD<HS`(5(+$XKUL'(_^M0!QO_#3/CC_`*([KW_@
M[L/_`(Y1_P`-,^./^B.Z]_X.[#_XY799_P`XHS_G%`'&_P##3/CC_HCNO?\`
M@[L/_CE/T7]JK6CXX\/Z/KWP[UCP[%XBO/L-O=RZE:W""7RWD`*QL6Z(>?\`
M]5=?G_.*\\^,I_XN=\)_^QJ7_P!)+B@#WRBBB@#YC_9D&K']BW0_[!6R;7/[
M&G_LX7C,+<W.9/*\PK\VS?MW8YQG'-:7['$OQ4F_9\T-OC1#H,/Q#/G'4ET@
MC[,!YS^5C!*[O*V;MIQG./9W[%__`":]X._Z\CV_Z:/7I^?\XH`,?YS7FG[5
MUEXJO_ACI\?@V:2UUP^)-%*S""6XCBA&I6WGM+'$\;M"(MYD`=04W9(&:]+S
M_G%9/C?QQHOPY\-7&L>(=4T_1=)L]OG7E].L$$6Y@JY=B`,L0!ZD@4`?,'AC
MQU\:/"&N:7I%Y'JEW<2Z[=,)8?#=U-8ZNLGB&]2X$DSO(;""#3OL\T'F2`.'
M4*90H0\+'JWQ?E\,^'=+?2_&B3>&=`/V:P70;M4FSX9)6:2]7&Z<W\DL)@W!
MP8XCA20S_7%O^TE\/;_7K#3HO&WA.;4=2MOMMG`FJ0M)<P>4TWFH`V63RU9]
MPXVJ3T!JM#^U/\-+VTT^6/QYX0EAU-+B6S==7@87"VXS.RG?R(ARY'"C!.`1
M0!\Y?&[]ISXM?`_PAJVM:M_:7V75M4N+/3X;3PUYEYIR1ZQ+;QK"I)\^2:R0
M3#?D87>!MKTJ;XN>,-2^%7P?U&UU:ZOK7Q)80W.LZ[HWAR;5!<7!@B>-!;HF
MZ&WF9I=TK(OEB-03&6R.D\2?M3_";QC+!H$VM^&?%`U:P&J068GMKBWO;=;G
MR#(#(XB;9*IR,Y!C;`R,5MI^U'\+=.\.ZE>+X\\$V^E>'72UOY1JUNL.G.VX
M)'(=^$)V.`#C[C#^$X`/$O"WQ0^-WCC64TU1JFB_;KV&'4KNZ\(O&GA^4I?&
M6"W:3"W<*^5:XN`63=(/F;S/+7F-<_:.^-WA7PSHEIK']HP:]K]K]N@^P^"Y
MKB9K@Z3#=?8EMU+$(EV6A>1ON*2'9"#(OU7K'QU\%Z`NEF^\5>'[/^WK22_T
MX37\4?VZWCC\QY8\L-R+'\Q8<`<DUSWCO]J#X>^`OB7HFBZYK6B6=]J"7)MK
MVYNX(X;>6,6A,!=W!661+V%U4#YD)/3&0#Q2P^-?QX\5_%'Q-HL>B7F@:>VI
M6%G:W;Z#-<#3XVOU@N71FA2&5?L[&9766=0`K/Y9#0KT'PT^._Q('Q#TK0_%
M6G7CPQ:!!XFU1[/1W^T!&C-F;(0+EUD:[1K@'!(CW*.`:]<N?VD?`J7-XH\3
M:#-!I;W,6I7*ZE;^5I;VZAI5FS(&5E!YP#MQ\VWBN?\`"?[7_P`-?$.BW_B4
MZUH>EZ3"[VIU>[OK2."Z6*]N[5=KB4ED,EO,Z$@*0QP=P<*`<[\9)OB1#^T7
M=6OA6XU33]'UBRT*R:_.G&^M+$!M>>ZDC1CY:R_+8JS'IOAW!AM!\_\`%?QS
M_:"A\$NUCX5D74H-'T[5YKAM)F5/]+^P1RVZ(D<TAGMF.J2O&L4L@"6P*.7V
MM]"WW[2G@>S\1S:7_P`)1H,EY8NRZ@J:G;@Z6!;27.Z<-(&4&*)F&`3M^;`0
M%A;\,_'WP1XPU/2K/2?%OAO4;S7(I+G3X;74(I)+V.,L)'C"ME@I1P2.A1AV
M(`!\P^)?B9\;O$OAV2SN)_$6FW$>BZ;JDUUX?\*7O^CLE[9M<`?:+9'FF>W>
M8^3&ID(1T:",@>9U5GX\^+FD>*YYH8]0B\.:;JB2R1WFBRF34X+C7;BWD<R.
M0T2QV6R?"\*-C86/*GVK5?VCOAWX>N-:COO&GA2RD\.RQPZHL^J01G3G=BB+
M+EOW99LJ`V"2,#FJ=U^U+X%C\;>$_#MGXATG5=8\:,KZ=;65]#-*\#6L]RMT
M5#[C"R6[@.H.25[9(`/`OV4OVF_&?[2G[,_BGQ!/>7VHZ]'J>FFVTQ=,>RN+
M&"3[(\I"H`SQ%FN&1][YA5-Q)WBO0O@WXA^+_B7PUXKCUF1(=7NM`BO]#DN=
M%^R0V%^\U_%]G89_>*J06CL#AOWK'Y5=%7N])^+OPY^'5Q'I/]H>%O"<VI:K
M/86MD]S:6K:A=)(D;[$1_F<NT:X(#Y900"0*CNOVN_AUI5E(^H>+O#]A>0:=
M+JLNGRZG;R7B6\<;2N_EQR-N`C1FRI(P"<\&@#PE_P!HWXX:IX^\(SVO@W7-
M-T7Q%YUY/876B3E]-MF:YBBAE=('59XQ##*ZRRPD?:0`)L,(YM5\??&3PEIF
MES7K>(VDU31]+N=5U6P\)37\MI=R0:A*]O'8Q[MH$RVT3D`LBL/,8%A(OU%X
M#\<Z3\3/"&G>(-#O(=0TG58%N+6YA;<DJ,,@@@_Y-:Q0-C(SCU%`'RGJW[0'
MQ>-IJ&GW&@ZKHNMV=A/=7,\?AF]OK")FCT\Q)!+#%+Y[;I;Y<1K,R&/+QL%"
MO[AIVM:AXD_9JM]0U:UO+'5+[PYY]Y;W<`@N(9FMLNLD8)".&)!4=#D5WA4$
M]!^58?Q-.WX=Z\W]W3K@]/\`IDU`&Q^RM_R;/\/_`/L7;#_TFCKOJ\(_9T_:
M6\!^&OV?_`]C>^*M$M[JUT"QCEB>\0-$PMT!5AG@@@@@UV?_``UG\.?^APT'
M_P`#(_\`&@#T0]*_(O\`;6'_`!E;XZ_["C]_85^FWP__`&F?!?Q1UNXT_0]<
ML]0NK=VC=8FSRIP<>H]QP:_,G]M8_P#&5OCK_L*2=O84`>78_P`YHQ_G-&?\
MXHS_`)Q0!?\`"UU#8>)M/N+AFCMX+F.21@-Q"A@3@=^!7K_B+]I>QU#]HQM:
MD6XU+P4VL_VJVFM;I$7<IL$CITDD3@C>2#MQD9->(Y_SBC/^<4`>^>%/VA_#
MND7N@B\N-0NI]*L]6AN-4:`F>Y^U!Q!'C=N*Q;@V6/!+!1T)R[7XZZ+XL\">
M'=-\5:EXDEN--UZ6^U#[(`IOK=Q%@J^\;64H3C'T(/->+Y_SBC/^<4`?3V@_
M$[0?B-K$<UM<7DDFB^&-1LKV^FM)9+I%EN`L4D3;Y9=RI+C<2Y`##&"2K/%_
MQQTWPYXMUR:]OH5UK5'T_5-.U.UM)91!%$N!9S1.\<BYP'(.5<G++@C'S*LC
M(?E8CMQ0S%FW$Y8]21UH`]6_9M^,ND_#/XT:AXDUCS8[6Y@NT5+2U'WYNF$W
M851D\9X&`*Z+3_V@_#?V2WANVO&O+?P9>>'9[];?`NIY05A(C!PJ1*Q&[ACD
M\5X[X!\(3?$#QII>AV]Q;VUQJUU':0R3Y$:N[!5W8!.,D<@&NX'[+>K/=PPK
MK&B&2[M;^YM5W2A[DV;,LL:KLSN.QBI.%;!YR"*`.COOVBO#HT&ZCMK&Z\NX
MT2QTZVTTQ*L6FW<#AGN4;/!X)#*-Q,C9P.NMJ7[2?A>^\?>-]4AGU2*X\02V
MMWI6H2V>Z333$^]K8JLP/EL0#\K8..5(Z^66GP3O+SPMJFJ+J6G*NCZ7;ZK=
M0$2>:B3,JQH/EVECN1NN-K`Y[5Q9X/\`]:@#U[7?C5I.O?#5K.WNKK0]<:^O
MYKTV=@B6NM1W65^<!_W9125"X8*.5.:Z#XR?M%^'_B%X-\7Z;'<:A<?VDVF2
M:3'/!\MJ]O$(YCRQ";\<8SD=:\`S_G%&?\XH`]=\`?%W0_#_`,&=#T&ZN+J.
M^L?&,>OSA("T9MUA6-D#9Y8X/&,$'D]JZZ?]IGPG?ZQ;W>K0W^O0V?C.\UN"
MWN80WE6$R$)$NYB`R2'?LX4D=>:^=,_YQ1G_`#B@#M?'FL:5XFFU":;Q%K&K
MW%K&D>F//8B/SE:5W=9&,A9=H<D'YLDD<``UQ9'/_P!>DS_G%&?\XH`,?YS1
MC_.:,_YQ1G_.*`/J/_@EO_R5BZ^B?UK](ATK\W?^"6__`"5BZ^B?UK](ATH`
M****`/"=)_Y.[^(G_8)T?^5S4FL?LZ>"_$/B_4M:O]&2]U#6%=;M;BYFEMYB
M]L+5G%NS&$2&W`B,BH'V97."<QZ3_P`G=_$3_L$Z/_*YKQ_QM\(/%!^.'B[6
M?#/@]-/\57&MC4=-\7S-:+#+:+H]O"+-R)#<.KW",IB>,(/]8#E5R`>L1_LH
M^`XI--D_L-FFTFY^UP3R7]S),\HDCE5IG:0M/M>&)AYI?!B3&-HJY=_LW>"[
MZXT*231(MWAM(8M/"SRHL20R++$K*K`2!)%#*)-VTY(P22?$-0L/C@_A_;8_
M\)Y'`YN?L*W-SHYU.WN_(M1!)=L"8FLO.^UEEC+28*#:5PHXS1_BQ\6_B?K7
MQ/L-!O?$DFK6&J?9+.&UGLY5L[=+N[7SEC<PB)BJVT?DRRJ[*&E#."R$`^J/
M$/[/7@_Q5XFO=8O]&CN+[4;=[:Y9II!','A,#.8PVSS3"3'YNWS-A*[MO%2^
M.?@=X6^).H:?<:UIBWL^EJ8[8^=)'L1F1]C!"`Z[DC8*^X!D5@,@&O+O!U[\
M4/!FO?\`"3>)FU_5+4H(+C1+?[))&<V%EM,**`WF-?&Y3)<K@\X3#4OQU^&7
MC63X[S>,?!MKNO6T2S\/K,T\:(L4\UZ)Y-K'DP.]G<$$998F5<L<4`>DZG\!
M?!]SH6HV<VE10V=X8Y+EDGDAD5HI&ECD616#QLCNS!D*D9ZU6?\`9W\$ZW_:
M##3VF74+-=-N_+U&?;,B*B*6P^#,JQHOG?ZT!`-_`KY]MO@A\6O!T-GX3T)K
MZR\"VNEZI:1V$<%K/'<&6XU$JLTKW*2(6B>SV,L<F"3NV_/GH]!\$?%;P?K]
ME:Z?;ZW9Z>VJ"XB^QSV)LXR]^6N3?"0F1HVM=HC$.6#;\@'80`>R6_[-G@NV
MURZU%=%1[N\9'=I+F:10ZRQ3;U5G*H[2PQ.[*`9&C4N6(%6[?X/^%]#\576N
MBU:/4[R[2YEN)+V9LR`2HBJ&<JJ?OYL1J`FZ1CMW'-<)\"9_'G@:^TZR\8R^
M(-<D\06=D3+,+:1=+O!'=O=AC$%VPJ(K=!PQ+R+@DEB.!\4_`7Q'K/Q,\3+H
MOA_5=)L-9URPU&ZUV==.34R\6J6LI-O.CR/+;+`L[JMQ&'AVJB9!V(`>RZ]^
MS+X$U+5-9U34-)\R75A))>23:A<>7&S!=\L:F39!(=BDR1A&^4'-26O[,7@6
MWTK[&-`MY;7RWA9)99)MZN+H-N+$EL_;;K).<^<V<\8\"^(WA'XZ^,(;C0Y(
MM8NM'NO"=]I=V9);!HKZ9[.Z6*1F$BLLQF^S@@1E3DG>JY2OHCX+Z-X@\.:3
MJUCKVH:AJ@MM2D73[N^>%KBXMC'&P+F)57B1I%'RJ<!>,8)`,W4?V8?#M[>Z
M)-&^I0MX?L=2LK.0W;W%S$;X1K++Y\Q>0N%0A<L1\_(.!CO].T^+2M/@M;==
MD%M&L4:EBVU5&`,GD\#J:FS_`)Q1G_.*`#'^<T8_SFC/^<49_P`XH`,?YS7G
MGQE_Y*=\)_\`L:E_])+BO0\_YQ7GGQE/_%SOA/\`]C4O_I)<4`>^4444`?._
M[%__`":]X-_Z\CW_`.FCUZ?C_.:\P_8O_P"37O!W_7D>W_31Z]/S_G%`!C_.
M:Y3XQ?"M?BUX9M;-=4O=%O=-O[?4[&^M5CD>VGA?<IV2*R,I&5(8=&."#@CJ
M\_YQ7"_M$?&J']GOX=-XMU"!9="TN[A&L29.^TM9'$;3J`#NV.Z,PX^0.>V"
M`>-0_P#!-NSU35=:TW6/$VK7'@O4K6*)["+R$FU"?[-=0RW$[B$%&+7<KA8B
M$SM^50"K=)X3_8%T7PEX7U"QMO$&L6M[J6CZAI$NH6,-O8S+]K-L6G7RHP!(
MHM8@"<YYSQM"^>V7_!1+QQ>>+-:T&;X>Z3INK:0FG6[P7GB&!9(+VYN=.MRD
ML*[KA80U\Y$OE%2(!U\P!;]A^W3XDTCQCJ$WB*+P?I>AV&EZ?)-;-J+K-'*=
M=NM+OKI'=%WV\2Q+*Q(`13'NQO)`!U_@[]@#2?!?A:QTFV\4:VUM##>PW0\B
MV078N-1_M#HL8$?ES%@H3&5;#9(S7(?M%_\`!/75/$G@'3;/P)K/DZE:RP13
M_:]2DTOSK:/^U6(6X@AD=&9M4<,-A#QJ4.-Q)/$G_!0W7+?PAXF\1:/X;T'5
MM"\/V=I.)TUD1FY:[UJ\TV&0,RB);=$M//>1I`-K8&`"U=#\$OV[&\?>/['2
M?$UOX5\+PWV@V^J($\0P7\AFDF@A"YA+1HCO/$L9=P9#(FS>=P0`ZOQK^R>O
MQ7MO"KZ]KEUI\VC:-)I.H0:)#':07ZRVYAEC#D-*L!+%A$SLN4C.-RY/,:M_
MP3YA\1VMU_:7C_Q1=W6K07MEJMR+2QC>_M+NUL+6:#"P;8_W6GQ`.@#@LQR:
M^B<_YQ1G_.*`/!-5_8)TW6I=4DF\6>(EDO-0FU*R2*.VC@TN9Y8YE:*$1^7D
M2Q*[97$C9+`EF)S_`!9_P3LTWQEX2NM-O/&OB@W&H2O+>W:);+]M9[K4+EQ)
M$(A$R[]1D(4KA6AA;!*G/T7G_.*,_P"<4`>%:]^P-X9\2?#>X\,76J:Q]ANK
MN:\>1?*\S?)I/]F=T*D"/#@$$%A@@K\M6_A5^Q7IOPF\8>&]7T_7K^,^'XKA
M)K:UL[6SAU5I3<$_:/*C5G13<,PC)(#HC_>WEO:L_P"<49_SB@#PBQ_8-T>W
M^,.J^,KCQ+X@U"\U/58-4$-P(66`PWHO$B#[-[('`C4,3LC5%7&,FUX!_8ET
M_P"'/C/0=2T_Q-KW]GZ'<0WYTMX[8P75U%82Z>LK/Y?F+_H\F-BL$W(#CD@^
MVY_SBC/^<4`?/EE^Q1/XHU#4M2U[7+C2KC6]4O)=2L=+:.XMKZR>^%U#"TDT
M(D1@5&YHPA_>,H)*HXUM'_88\.:3:+"VIZM,GVA)V+>6&;;IUU88R%X_=W<C
M?[P';(/MN?\`.*,_YQ0!B?#GPE-X#\":3HL^I7&KR:7:QVOVR:-(Y)PBA065
M`%!P!T`%;>/\YHS_`)Q1G_.*`#'^<UA_$P9^'>O+_>TZX_\`135N9_SBL/XE
MG_BWVN?]@^X_]%-0!X+\&/\`@F/X&^(/P?\`"NNW-WK"7>L:1:WDX2<;?,DA
M5VQ\O`RW`[5TO_#I?P"/^7[6_P#O^O\`\37MG[*O_)L_P_\`^Q=L/_2:.N^H
M`^=/@#_P3RT#X#_$&37K74+Z\ERP@60[?)3.0O'WL>IKX6_;5&/VK/'7_84?
MO["OUT/2OR+_`&UC_P`96^.O^PH_;V%`'EV/\YHQ_G-&?\XHS_G%`!C_`#FC
M'^<T9_SBC/\`G%`!C_.:,?YS1G_.*,_YQ0`8_P`YHQ_G-&?\XHS_`)Q0!M_#
M;QA_PKSQ_H^O?9?MC:/>17J0^;Y8D:-@Z@G!XR!GCIZ5VFH_M/:A<>*O#.J6
M]BL4OAF_FOXFFG,\TXFF\QX6?:/W0&Y0@'`9NYKS#/\`G%&?\XH`[FR^-4EO
M:>-8Y]/CF;QE$L3F.7RDLE6995"+M.5&U5`X`48]ZX;'/_UZ,_YQ1G_.*`#'
M^<T8_P`YHS_G%&?\XH`,?YS1C_.:,_YQ1G_.*`#'^<T8_P`YHS_G%&?\XH`,
M?YS1C_.:,_YQ1G_.*`/I_P#X)C7T&E?$O4+JZFCM[>WC$DLLC!4C4`DDD\``
M#.37W1/^U%\/[64QOXNT$,O!_P!-C_QKX&_X)Y^#[7XA^(?$.@WS31V>M63V
M4[1$+(J2(R$J2",X8XX->]W'_!(;P:TK>3KOB%(\_*"\1P/^^*`/>A^U5\/#
M_P`S?H/_`(&Q_P"-7OA;\?\`PK\9(3)X?U:VU!5Z[&^8?4'D?0U\Z_\`#H7P
MC_T'M>/MNB'_`+)7>?LD_L,6O[-&IW%^VJ3:E?7"A7?&Q3]![=/6@"YI/_)W
M?Q$_[!.C_P`KFN]Q_G-<%I/_`"=W\1/^P3H_\KFJNO?M3>%_#>H^/;2Z_M);
MGX=QP2:A&+<%KGSXEEB6W&[]XS;T0#CYV4=P2`>CX_SFC&?_`-=</9?M)>![
MFTDDF\4:#8R6UC!J-W!=W\,,UC!,(S&\REOD!\V,9/&77GD9MV/Q[\%:G>:;
M;V_BSP[--K-NUW8(NH1$WD*[BTD?S?,JA'R1P-C?W3@`ZW'^<T8_SFN(T3]I
M?X?>)(;&33_&WA2\34[MK"S:'58'%W<+MW11D/\`,XWI\HY^=>.11H'[2GP_
M\4ZTFFZ;XV\*7VH2%@MM!JL$DS;4\QOE5R>$!8^P)Z"@#M\?YS1C_.:XFV_:
M2\`7B:6T7C3PM(FM3M:Z>RZI`1>RJRJ8XOF^=@SH"%R077U&9_!7Q\\(_$'P
MG+KFE:_IMQI4.I-I#W'G*J+=B<0"')/WFD90HZMO3&=PR`=?C_.:,?YS7G^I
M_M&:3HWQ*F\.W.FZY'';7EMITVK^1&=/BNKA$>&%F$GF*7$B`,8PFYU7=N(%
M3M^TU\/%\/MJQ\<>$QI:W7V%KO\`M6#R%GV[_*+[L;]OS8ZX&:`.YQ_G-&/\
MYKB]3_:.\`Z-J^J:?>>,_#%M?:'$LVH02:E"LEBC,J!I%W90%G0#=C)8#J<5
M=T?XU>$?$/BB/1+'Q-H-YK$\"W45E#?1//+"R+(LBH&R4*,K!L8*L".*`.GQ
M_G-&/\YKRWQ+^UAH_AS3-6U#^PO$UYI>EWJZ:E_#!`EO?W1O$LVAB:29.5G<
M*6D"(=K%68"IV_:ATF#6(;6;1?$<,(FL[2_O?(ADM=)N;L1F""9TE;+MYT.6
MB$B+YJ%G`.:`/2\?YS1C_.:X#Q5^T1I?A/XW:/X%FT_4YK[5K87?VN/R1;V\
M9$^"P:02L`;=@S(C*A>,,1O%=\&R*`%Q_G->>?&7_DIWPG_[&I?_`$DN*]#S
M_G%>>?&4_P#%SOA/_P!C4O\`Z27%`'OE%%%`'SO^QA_R:]X._P"O(_\`HQZ]
M.!5N_;(YZUX[^S)X<;QA^Q;HFDI?7VEOJFC3VBWMF_EW-H9#(GFQ-_"ZYW*>
MQ`K3_8X_9RN/V4/V>M#\"W7B[7?'$^C^<6U?5VW7-QYDSRA3R2%7?M4%C@`#
M/3`!ZCBL7Q_X]\/_``S\+3ZQXFU?2]#T:!DCFO-1N$@MT9W"(&=R%!9V50#U
M+`=36QC_`#BN$_:,^$U[\:?AW;Z)I^J3:+<)K.F:@;V!_+F@2VO8;AS&Q1P)
M-L;!=RD9(S@<@`Z6#Q7H-[X67Q%%J&ES:+/:K>+J23HUO)!@.LOF`[2F,$-G
M&.:M75YIT-_;VLTEJMS=JXAB?`>4#!?`/4#()^M?'X_8-^*=MJFGPV?B;0K'
M3=+\)3^&X3;:I<1^<39301R21&V9]QF:.=F6X"@Y`B9E\U^@U7]B[X@:M+XH
MBCUS3]+L=8U2]NX#'KM[-=NEPRDL\RPQE#A2%10S1C`\V3"E0#ZH^SP;2GEQ
M[7&TKMX(YX_4_G63IOB[0=4\8:AH-K<6TVKZ3#%)>0(A)MD?F,,V-H)&"%SD
M`@XP03\@:I^S_P"/?`O[6_P^L8]%O-=\!:/?27MM+#?W.W2UDU+49D5&8&-5
MA@FM/-24J76")(BY3%>H>._V4O$MC\2?%'C#P9_PCL>K^(M=COI$O+ZYM%N+
M7^Q7T\B1XXI"'CFD,RJ%(;8`60G*@'T26453T#Q)8>*+26XT^ZCNX8;F:S=X
MR2%FAD:*5/JLB,I]Q7R[<_L->-XK'4KNW\26LFMZA;M:W!DUB^2&]MQ;Z8HM
M6(4^5&\EI=!G1=RBZ+@,S,M:WP'_`&1?%_PL^)OA'5IO[!L]+TQ]6DO[6WUV
M\O8[>.[NKZXC@MXY;="S*;B`-.TB;EB*F%BL3Q@'T%;^/-%N]=MM,AU*TFOK
MQ+F2&&.3>9%MY$BGQCC,<DB*PZ@MCUK6WK_>QQGDXXKY+N_^">NJ/?7S6:Z#
MI+6=WXGO](NK35;R.9KK4KVUN[2XE58U"-#Y3QLH:0'9&XR6*I:\=?L0>,-2
MTE%TG5--;4+Z^U^YN[J?7+^W:PGO;X2V&HP[$;S9[.W7RTA;RTR[`2!<[@#Z
MJ#J1]X?G5'2?%.FZ[J6I6=G>0W%UH]PMK>Q*WS6\K11S!&]S'+&WT<5\:_M1
M_`KXRZ3X(U7^RH=(UZU749H[2"&_O[A[RUN-5DO=UW!'$KJL<;+"4A,I.T'A
M"P3O/V8/V1-6\`>)?#_C"1)]%NKC[*;VPNM4EN+J.R70+:R^S3;5$,DHNX1(
MS``$*ISD;0`?3AD4'[WX57U36+30[(W-Y<PVMNK*AEE?8@+,%49/'+$`>I(]
M:^,I/V$OBAX;\"ZUYWB+_A++Z6_DO'M+WQ1<0P:CBUO(TNE^SV,3PW`DGAD\
MIVGW-!'^_4HCCK]"_9F^*6JBT6XU72;72?L\=U&\NJ70OS+)'I?F0RPB+8H0
MV=QAA(Q;SAE5^8D`^H-/U2UU:U$]K<0W4+,RB2*0.A*DAAD<9!!!'8@U+YJ?
MWO?K7RCX`_9#\2_"[QWX+T;3X[73?#;:QJ5YK_\`9EW-)#>6D5Z+_3V?>B"*
M8S$1/$N\-&TOSL!Q;^+?['OQ&^(O[0_BWQ!;>)K.Q\,ZYIJZ?:V\.JSV\RKO
ML&^9([?>C*;>YQ(MP1B9<1QMO=@#Z7U[Q+I_A>SCN-0NH[6&:XAM$=R<-+-*
ML42?5I'51[L*O#D5\J7/[$'BR#QUH+Q7>BWWA_1=8@O;%;K6KY)="MX->N-0
M"00B-HYC+:R6\!61E$9M(PI<8*_52C"__6H`=BL/XEC'P]US_L'W'_HIJVL?
MYQ6'\2_^2?:Y_P!@^X[?],FH`V/V5O\`DV?X?_\`8NV'_I-'7?5P/[*O_)L_
MP_\`^Q=L/_2:.N^H`#TK\F_VV?">J1_M1>-)VTS45AN-2=XI#;OME7`Y4XP1
M[BOUDK`\4?#/1?&-PLNHV,-RZC`+C.*`/QF_X1S4/^?"^_[\/_A1_P`(YJ'_
M`#X7W_?A_P#"OV$_X4!X4_Z`]K_WS1_PH#PI_P!`>U_[YH`_'O\`X1S4/^?"
M^_[\/_A3(M$O)R_EV=U)Y;;'VQ,=I]#QUK]?]5^"7@_1M+N+RXTJT2"TB::1
MBHPJJ,D_D*\Y_9#^!.AZU\#]/US5-*A:^\333ZP^Y>BSRL\8'L(]F*`/S)_X
M1S4/^?"^_P"_#_X4?\(YJ'_/A??]^'_PK]A/^%`>%/\`H#VO_?-'_"@/"G_0
M'M?^^:`/Q[_X1S4/^?"^_P"_#_X4?\(YJ'_/A??]^'_PK]A/^%`>%/\`H#VO
M_?-'_"@/"G_0'M?^^:`/Q[_X1S4/^?"^_P"_#_X4?\(YJ'_/A??]^'_PK]A/
M^%`>%/\`H#VO_?-'_"@/"G_0'M?^^:`/Q[_X1S4/^?"^_P"_#_X4?\(YJ'_/
MA??]^'_PK]A/^%`>%/\`H#VO_?-'_"@/"G_0'M?^^:`/QXFT2\MU#26EU&K$
M*"\;+DGH.>]//AO4!_RX7W_?A_\`"OUC^+/[*7AGQW\-]8TFWT^WL[N\MF6V
MN%&&@F',;Y]F`-9'[.G@[PO\6?A)I>J7>BV\.K1J;/5(2N#!>0DQS*1V^=2<
M>A%`'Y9_\(YJ'_/A??\`?A_\*/\`A'-0_P"?"^_[\/\`X5^PG_"@/"G_`$![
M7_OFC_A0'A3_`*`]K_WS0!^/?_".:A_SX7W_`'X?_"C_`(1S4/\`GPOO^_#_
M`.%?L)_PH#PI_P!`>U_[YH_X4!X4_P"@/:_]\T`?CW_PCFH?\^%]_P!^'_PH
M_P"$<U#_`)\+[_OP_P#A7["?\*`\*?\`0'M?^^:/^%`>%/\`H#VO_?-`'PS_
M`,$P=,N+'XL7'G6\\.0N/,C*YZ^M?HT.E<WX=^$^@^%;[[38Z?!;S`8#*N#7
M2"@`HHHH`\)TC_D[SXB?]@G1_P"5S63XP_9/T/QC\0)O$5SJ&IQW-Q?R7TT,
M;JL,^ZSM;=8W&/F5'L[>=<\K(G'!(.KI;;?VN?B*?32=(_E<UXQ\8?BWXFT;
MXM>+M'T?Q--JEY++8G3[6TN%\C0U%YIZ/'>0+$)H_,\R0K)YK"1))!M7:M`'
M76G[!VCVOC1]:F\2:]>8L[6RB@G6%UA2"6QE`#;-VTM81_+G:/-D.,D$4_B;
M^P?;>++R34M/\1:DM];PZFUC9W*1-9K<7AOV+'Y-RKNOV#;,%A#%G.TYY?QU
M^V/XMT[7].\+OI]E'J&H6&JPWEQ9V[1%);?^T8H[BW+3^8%+62,5$<NWSU!D
M!*[^KM_BUXUA_9Y\03:E-;VFM:'>:;9SZEIUL\A@LIX[&6XN@DH?=)!#<SDD
M@JS0;M@!*``Q/A-^P1<KI_AV]\;:E#/KGAV_FE3R)SJJWD#R03#SY[F)7>82
M0Y$BHFU"JX)0/7<7/[%'AN^T"WTV:^U(VL6G6FER"/RXVEBM[>]@ZA>"RWLA
M)]57'?/#P^+/%VI>/KJX\"^)KSQUX;T'PJ=1MIIM4B']HWCS:BJ(%BM2MWEH
M8DQYL.T*#ER376?LP>/)_%?C;4H+'QEJGCK05TBUN;F\O885^PZ@[R!X%,<4
M85BJAG@(+183(7?R`2>#_P!A[0?"6ABS74[R:1K:YMI)DM;>`R>=+9.7*QH!
MN`L85R>Q/;:!W?A3X43>#_#=YIMIKU_Y=QK4NK12/!"SP)+=_:9+<?)@JS-(
MNXC>H?((90:Z_'^<48_SB@#S#Q5^S!:^,_'.J:A?:_JS:'K-Y:ZC>:+''"L%
MQ<6T<:0LTFWS=JF*-]JLN70$DC*GFQ^P[;I9(P\:>(O[5CLQI*W_`-FL]W]G
M"`P?9O+\GR\[23YFW=N/]WY*]SQ_G%&/\XH`^6_"/["'B*/Q/XRM-2U^.Q\+
MZS*7TUK.^EN;J&,7GVB.'R98Q%#$5W+*BF3SF*L2NT@^I_"_]E+1_A6NA_9-
M2U&Y;0Y[:>)IA&&E,&DC3%#;5'6,;SC'S=,#BO4<?YQ1C_.*`/'_`!7^R.OB
M7PSJN@CQ9JT?A^^U)=6MM.FL;2YBL[@:@E^W+Q%I$,RL`CD@+(PYPI6Q!^RK
M&NIJTGBC5O[+NKFQU#5-+BM;:&UU"ZLT@2*0;8]T*$6MN&CC(4^4,8RV[UC'
M^<48_P`XH`\;^+W[&NG_`!:^)P\4-XEUS2;K;`3':Q6[9,.2J;Y(V?R&)!D@
M)V.44X#9)]D1-J@48_SBC'^<4`.Q7G?QE&/B=\)_^QJ'_I)<5Z%C_.*\]^,G
M_)3OA/\`]C4O;_ITN*`/?****`/G?]B\9_9>\'?]>1_]&/7J&*\N_8P_Y->\
M&_\`7D>W_31Z]/Q_G%`#L5RGQ@^*</PC\,6]\VEZEKEW?7T&G66G6!B6XO)Y
MGVJJM-)'&N!EB7=0`IZG`/4X_P`XK'\??#S0_BEX8FT7Q%I=GK&ESO'(]M<Q
M[D+QN'1AZ,K*K`CD$`B@#Y=N_P#@ILW_``JO44A\-:PWC:S\+76M22#3PVE6
M5W'92W:6TQ$VX$QQKD@[,NJB3<P%>I>!OVN+KQS\==-\%Q^!?$&ELUOJ7]KS
M7MU9;M&GM!8NJ,L4[B19(K^!MT1?;YT8(R)?+Z:7]ECX9VD)=O!7AF&&'3&T
MDK]B1(ELMC(82O"[!&[ITX5F7H2*N>%?@1X#\%WVBOH_AO1=,NM#-S-IK6\"
MQO;?:`HG*D==_P`@;J#M3T6@#QGP=^W+KEG-J4WB3PKJ4ANM=U'2]$TG3[:T
M6ZG6#6(M*BS.U\8V+3.2Q<1`9;'RHK2:6J?\%*?!^C-#Y^A^*-LGAV;Q#(8U
MM9#;B*U>Z>TD59RRW'E1N0"`C8&'((->R/\`!CPI)<V\S:!IAEM+F2\A;R.8
MII+H7CR#_::Y`E)_OC/6L6Y_92^&]YJ;7DO@OP^]TUF^GF0V@W&!XVB:,^QC
M8H>^WCH`*`.6T?\`;*A\2:M_9-KX*\70ZW;?:O[4M)C8DZ$L+*GFSD76R1&+
MJRB!I&VYR%(Q7.67_!1G0;?1;R\U#PWXFAM-/T\7+:DR6=O9WDXALI7ACWW6
MZ,A;Z`EYML2C?F3"DUZYK?[/W@GQ)XCM]7O_``QH]UJEK<27<5S);@R)+)LW
MMGOGRHS@\9C4]0#6!\3_`-D+P3\3/AQ>>&O[+CT6WO-I%SIL4<=Q;D>0,IO1
MT.5M8%(=&4K&`010!T?P*^+4/QU^%6D^++;3-0TBVUA9'BMKUX7E"+*\8?=#
M))&ROMWJR.P*LISS778KE?@O\*+/X(?#32_"^GWVJ:E9Z4KK'<:C(LEQ)OD:
M0[BBH@`+D*B*J(H554*H`Z:.>.62159&:(A7`YVG`.#Z'!!_$4`2;:,4W'^<
M5&UU&LZQEE\Q@6"GJ0,9(]<9'3UH`FQ1BFX_SBC'^<4`.Q1BFX_SBC'^<4`.
MQ1BFX_SBC'^<4`.Q6'\2QCX>ZY_V#[C_`-%-6UC_`#BL/XE_\D^US_L'W';_
M`*9-0!L?LK?\FS_#_P#[%VP_])HZ[ZN!_95_Y-G^'_\`V+MA_P"DT==]0`44
M44`%%%%`'E_[8OB&?1?V?==M+/=_:'B`1:):@?>:2ZD6#CWVNQ_"O0?"N@0>
M$_#&FZ7:J%MM-M8K6(`=$10H_05RWQ;^%=U\3?$O@N;[5##IGAO6%U>Z@<'?
M<O'&XA"]OED8,<^E=NHVJ!0`M%%%`!1110`4444`%%%%``PW#%>,^$7_`.%/
M_M5ZYH9_=Z/\0K8ZWI^?N+?P@)=1CW=/+D_!J]FKA?CE\)KCXEV>@W6EW4&G
MZ[X;U>WU2RN90=H"MMFC;`)VO$SJ0.IQ0!W5%%%`!1110`4444`%%%%`!111
M0!X1I+*/VO?B(,\_V3H_'X7-=[E:I_$/]E7P9\4/%TVN:M9:@VIW$*022VVJ
M75IO1,[05BD4'&3SC/-8O_##'P]_Y]?$'_A1ZA_\>H`Z;*T96N9_X88^'O\`
MSZ^(/_"CU#_X]1_PPQ\/?^?7Q!_X4>H?_'J`.FRIHW"N9_X88^'O_/KX@_\`
M"CU#_P"/4?\`##'P]_Y]?$'_`(4>H?\`QZ@#IMPHW"N9_P"&&/A[_P`^OB#_
M`,*/4/\`X]1_PPQ\/?\`GU\0?^%'J'_QZ@#IMPHW"N9_X88^'O\`SZ^(/_"C
MU#_X]1_PPQ\/?^?7Q!_X4>H?_'J`.FW"C<*YG_AACX>_\^OB#_PH]0_^/4?\
M,,?#W_GU\0?^%'J'_P`>H`Z;<*-PKF?^&&/A[_SZ^(/_``H]0_\`CU'_``PQ
M\/?^?7Q!_P"%'J'_`,>H`Z;<*-PKF?\`AACX>_\`/KX@_P#"CU#_`./4?\,,
M?#W_`)]?$'_A1ZA_\>H`Z;<*\\^,K#_A9WPG_P"QJ7_TDN*W?^&&/A[_`,^O
MB#_PH]0_^/5>\+?L<>!?!WBK3M:LK'5&U#2I?/M7N=8O+E(GVE=VR25E)PQ'
M([T`>I4444`?,?[,EEJ>I?L6:);Z+>0Z?K%QHT\=A=31>=';3DR".1D_B56(
M)7N!BM/]C?P/\2OAU^SQH&D?%WQ1IOC+Q]:>=_:.K6$7EPW`:5FB`^2/<5C*
MJ6\M,D=#]YC]C#_DU[P;_P!>1[?]-'KT_'^<4`.Q7EG[8_PJU+XT_!%O#NEV
M>EWUQ>:WH\LL.IV2WUGY$.IVLTS30,Z":-8HW9H]X+`$#)(!]1Q_G%<K\9/B
M>OPH\)17T>G7.L7]]>V^FZ?86[*CW=Q/($1=SD*JC)9F)^558@,0`0#YT\8?
M"/XH>`_!LWPS\/V.O>(/#,FE2V\>IB6RCM!"VE:C&]J4>42IF\:UV(JE50H-
MP56K.\*_"7XMZCJN@W6I:7KMU;Z'<);V1\0/IDU[;VYO/#\DV\6Y\G;NM=0D
MC(RZJ@QAM@KU"+]L'6[GQ;HNBQ_#ZZ_M"^UJ;P]?I-K-NG]G7D5J]ZPRJL)(
MS:*DJNI!82JI5&W!9M,_:\U+Q!X>T/4=/\!ZM,GC:2+_`(19'U*UC_M2!H)K
MC[1+EC]G40Q;\-N8^8@`W;E0`Q?#4'Q8'[*U\MU'XZ_X3YKRR_M#[1+I/VIT
M\VV_M#^S"A\E8S%]H\CSR&#8S@8KE_$VF?'F;6-5_L'_`(3BW']F2KI[ZG+H
M[P"#^QL1"01DL=2&J$%B!Y'EAN2#BNFL?^"BNAWGQ5\+^%6T.ZM;SQ`+>*6*
MYO[:.\M+B2^O;!XU@W9G6&>QE\QXV*JA##=D"NF@_:HO]?\`']SH6@>$;SQ!
M+'>W8C>&\AMU^Q6DL=M-.QD(^<W?VF*.,<.+=G+*",@'DOQ2L?C3\']&U*Z3
MQ+XXUO2[C4#80MC2WNXXGUG2XK4PCRD3SI+:>_!:4%1M7=MVJ:IWL7[2XU_0
M8[*W\2K81Z/JJRO<RZ7,TA>/5#8?:&5UVW:$:8&\M9(V9F.Y%#[O=-5_;;^&
MNCP:@UUK&I1R:9?G3)[8:#?O=&812S?)"L)DDC\NWF<2HK1E8G.["G%W5?VO
M?A]HFK7]C/K5Q]JT^TAO2B:5=R?:XYGA2/[,5B(NF9[B!=D!=]TJ+C+`$`\@
MO8?C!X&\8>'=!D\0:UJ5OXFU_P#LE+B^%H\]O:FTLKZ>[/E1JH"&VU2W4;1\
MUQ#P0$-2?&#X:_$S3/B3XYUCPI8ZO;#5)YIK6\TZ*QFO9<P>'XPB&>1=@=;6
M]1CN&`F[#,L8/;>&OV\?!MSX(N_$6MR7FBZ79MEW%C=W4D49NKV!))8XX-\*
M$64CDN`$!(8KMR>\\$_M"^$?B)X\U+PUI.I27&L:7Y_GQM8SQ1L8)5AG$<KH
M(Y3'(\:N(V;;YB$X#*2`?,/BSX?_`+0.E6/B*3P[=>-M-U#7M?L-0N9&DTS5
M?L\!T:-&2V5Y;=/W=[&5ESL!"Q%%96DSZ3\$_!WQ(G_:EFUSQC;^()+6PT_6
MK&.XG>P72`DU]9O9BSCB8W`+6T`,OG<"16VDC!.KX=_;T\(KX/U#7/$RR>%[
M&UU-M,BBD?[=?%U5W99[:W#RV\BI&TCK(N$3YBV,X[C1/VF/!?B/Q$VEV.J7
M%Q<?;O[-CF&G7(M+FX"RLT<-P8_)F*""4/Y;ML9"K;6(4@'A?A3PI\>O$NJ0
M66I:EXRT.SNKZV&LW9FTK,3B._,[:>45R+0M]C5?.4R@%>`PD-?1WP<&O'X2
M>%_^$IW?\)-_95K_`&MG8#]K\I?.^Y\GW]WW>/3BO/\`7/VY/`=C92W5A=ZE
MK$%K$EQ.;32;MAL?3WU"-8V\K;),]NJN(@P?:V2!C!;%^W5\/K+2(-2UC4KS
M0K2^%N]NE]IEU'<JDL"3&2:'RM\$<:N-\C_NU!4LZAER`>S8HQ7E?C?]K/PS
MX>^#'C+QEIC3ZM8^"Y)8+OS(9+&%Y8Y/+?9-.BQO&K9!E0M&"C#=E2!6\-_M
ME^"[G0K>XUK6M(TR^FTYM7:WM;K^T(5M`LS>>D\2[)(ML#Y=?E#XCSO95(!Z
M[BC%>.Z!^VIX2UGXLKX5D76+!KJPM+NQN+S1[VW\]YI+U##*DD"FVD!LGVK.
M5:0MA`2.94_;G^&+V5G/_;UXBWMQ-;!)-$OXY;=H?(\UIXVA#P1I]IMR9)0B
M!95;=M.:`/7<5A_$L8^'NN?]@^X_]%-7GNK_`+<_PQT*YU>&ZUS4$DT2=+:X
M":#J$@F=WN$46Y6`BY!-K<\P%P!;RDD!&([?QAK-KXC^$NI:A8W$-U8WVDS7
M%O/$P:.:-X6974C@@@@@CJ#0!T/[*W_)L_P__P"Q=L/_`$FCKOJX']E7_DV?
MX?\`_8NV'_I-'7?4`<5\6OC9:_"6\TRWFTK5=6N-469XX[+R056+RPQ8RR(.
MLB]"3U]*Y3_AKVW_`.A,\6?]]V/_`,DU2_:J_P"1Z\(?]>6I?^A6=>6>+?&N
ME^!;"*ZU6Z^RPS2B",^6\A=R"P4!03T5CT[&@#V#_AKVW_Z$SQ9_WW8__)-'
M_#7MO_T)GBS_`+[L?_DFO#?'/Q.L?"6DS&*2"YU,V37\%D9-LCPAT1IB/O"-
M#(I8XX&:S_A_\9+?QG?P6<WV&TO&20&,W0S.ZNP0PJ<,ZM'&9<]E=.O.`#Z"
M_P"&O;?_`*$SQ9_WW8__`"31_P`->V__`$)GBS_ONQ_^2:^=M/\`C/+J'Q/U
MGP[]CTJ'^Q;N*!Y)-4VSRQO:K<&583'T4-@_/C@G/:M>P^,GAC4+N*WCUFU\
MZ?RO)#Y3[0)1(T31[@/,5UBD*LN00C$'`H`]R_X:]M_^A,\6?]]V/_R31_PU
M[;_]"9XL_P"^['_Y)KYYO?V@_#]G<+(EY;WVGS)8&"6Q9KJ:5KNX>"/]TBDK
M&648?)#98`?*-V]H'Q'T?Q1<QPV-TT\LC7"!?(D4JT#B.93N4;2CL%(..3CU
MH`]Z\%_M.V?C'QGIFBMX=\0:9+JLCQ0S71M6BW)%)*0?+F=N5C;^'&:].KYD
M^'/_`"6SP3_V$;C_`--UY7TW0`5Y/K?[6%GI'B+4M/C\+^)+[^S;J2T>>`VB
MQR.C;6V[YU;&0>JBO6*^5=1_Y'/Q-_V';W_T<U`'I7_#7MO_`-"9XL_[[L?_
M`))H_P"&O;?_`*$SQ9_WW8__`"37A?CSXB/X&\2>&[::TA;3==NY+*:]>Y,?
MV*00R2Q_)L(8-Y;+DLN"5'.:X'5?VKY&^'9U[3=#\W[-#>S7T%W=^1+9"WG2
M'!"QL"7WA@#CY><D4`?67_#7MO\`]"9XL_[[L?\`Y)H_X:]M_P#H3/%G_?=C
M_P#)->'O\7O#*637#:Q;K'&\RR@JWF6_DE1,9$QN18]REF8`*&7)&X9XVY_:
M8CTKQA/9ZA9VEKI=GJ]WIT]^+EI`D,.FQWPFVA.XD*D`X4+GGD@`^HO^&O;?
M_H3/%G_?=C_\DT?\->V__0F>+/\`ONQ_^2:\CTSQ58:O!>20W'[O3R!<,Z-&
M(LQK)R6`_@93^-9$'QD\,W-U:PIJT)EO)$BA4JP,A=&DC89'W'1)&5_NLL;D
M$A3@`]S_`.&O;?\`Z$SQ9_WW8_\`R31_PU[;_P#0F>+/^^['_P"2:\+G^-/A
M>`6G_$X@D_M!%EM/*1Y/M:-%YP:+:I\P>5\Y*YPO)Q4Q^+/AH21?\3K3_+FA
M%PDQE`A*&(S#]Y]P$Q*T@!.2BEN@S0![=_PU[;_]"9XL_P"^['_Y)J2P_:XL
MKK5M/M9O"OB>S74+VWL5GE-FT<3S2K$A8).6V[G7.`3CM7@/PY^*2_$'Q)XG
MLX[4PPZ#=PV\4IW@W*R6T4P?:R*5_P!9CC((`()!KJ)_^0QX?_[&'2?_`$O@
MH`^LJ***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`^=_V+QG]E[P=_P!>1_\`1CUZABO&_P!F6[U2P_8LT2XT.UM[[6H=
M&GDT^VN)/*BN+@&0Q([_`,*L^T$]@<UI?L;^+_B=X[_9ZT+5/C%X;TGPG\0+
MCSO[1TS39/,MX`)I%B*_O),;HPC$>8^">O4``]2Q7-?%7X7Z9\6_"G]E:G)>
MVZQW,-[:W5G.8;JRN(7$D4T3CHRLHZ@JPRK!E)!Z/'^<5Y7^V/%XBN?@L+?P
MNMY)JUYK>DVX2UU.?2WDA?4+=9E-S"DDD*&(N&=48A23C&:`-;PK^S?X?\+-
MHLT<VK7E]HNJ7&M&]O+HRW%_>3V\EL\LS$?-^ZD*A0%50J!0%4+7/V7[%_A_
M2=$LM/LO$'C2R@T2>.;03%JN6\.JD<L0BM=R$>68II(RLHD!3:/X$V^&_#S]
MJ'XVVUWHOAV#0;?4VT_PLES=2:QIEU_:.IWD5E))+B5&$.?M,?V4@@?-^\W?
M,J/<U3]M3XPW/C"!]/\`!NF0^']0T.\UW3X[O2+Y;R[AVWSVHR&VK*L<%JTL
M3J&S<%<H=A8`].\/_L!^'_#KQM'XD\578@\C;#=W,;0W1MKVXO[4W.Q%>9HK
MJZFDW;U:3($A?DGI+#]DW1K#1?"45OK'B+3=2\*Z<-,_M'3KO[-/J<+&-Y5N
M!A@WF21^86`#JS/M==S9\KUS]K/XD?#C2M3BU[1[&_OH;>^CL;G3O#E_Y%Y>
M"RTRZM(O+625E!-U=HQ+X;[*3F/#*.R_9<^/7C[XK?$CQ_8^*M"TW2=+T&[>
M'3(XK.Y@NE"W$\:B5I"8Y=\<<<BO'M&&SM*LK$`L^`/V`O`/PVUB:^TU=7\Z
M:Z:ZQ)=`JK&VO+7'"@L/+OI^7+.QVEF)!)IP?\$Z/A[9^([[5K>3Q!:ZA>6\
M$*3PWP62T:"2SEBEC;9DNLEC;L-Y91M("A6*GR[X;?MJ_&;Q'X2TG4-6\)Z'
M;W6H:Q%:7MK%H]^DFAVC+&9YI@S?.UJ[A'"D&3S00(_+8-EW7[>GQ8N_!]YJ
M&CZ1H.J(UY!;O>MX9U&&UT'=)?(RS;ILW6[[-;X>(HJ?:5)RK(6`/8/&G_!-
M[X=^/O"9T?4I/$-Q;N,22/?"26;+7K,6+*068ZA<Y;&X;E*E2,UZ1X,^`7A_
MP'XEAU:P6\%Y#_:14O-N7-_<0W%QQC_GI!'M_N@$=Z^??&/[2/Q2UKP[JTD>
MH:5X/U+1]3T8W&FGP9J-_);6;W5B+F<W!EC2:%DFF)5(TD5(W&0RNR4X?VQ_
MBW>:IXDBOM#T7P_IMKX@&EPWS^&]2OY-'M\WP62>"*13<><;>V1'B9`#=*VU
ME*E@#U#Q9^P!X&\>W4UYKE]XDUC5I)X)%U*^O8Y[F*.%+A(X!NC*&,+=3X+(
MSY?=OW*C+LW/['/AV:WNH;?6O%NGVLFJMK5G!9ZGY<>E74CRO.]O\I*^<T\Q
M<$L/WC;=E>2>-M6^(UI\`O@?K&F:AJ']H:3H$FLZU:75M?//JEY!HSS11W!B
MGBDPTZD/'*'#NRY!*X,_B[]J#XN>"-<FTUK#0M7U&STUI_LEMX6U",7X_LV:
MZ^V1S_:'BCBCG5+9H6W.[`D,IDC2@#UW0/V/O!GASPU!I,$.H-8P7,-R$DNB
M2S1:6NEJ"W7'V90#SG=\V:P-9_X)^^`_$<6E-J$FN:A>:3Y2Q7ES/%--)&D"
M0&-MT97#1Q1@D*&!0%64YS0^"WQ=^*6H_&IM!\7P^';C1C+=VB7&F:'=6;K)
M%:V%RDI>2XE4H?M<L.W`RUN6##)C7C=:_;7\=>%+;Q=->:(MXNEW.KVFG-9^
M%M0:&2>*W,EA!N#M)*SE2LK&.(!_E4`;78`]@'[)7AI_"WC;26O=<9?'MU]K
MU*?[4HF20$%#&=F`5P,,P9C@!F;`Q1\0?L8^%?&%VUYX@U7Q+KFK-IDNC-J%
MUJ`2Z-I()"\.8E10I=UDR%!WP0')\M:\/M_VF/BAX!N?'5K:M;ZA#9ZAJM["
MVI^'-3F?24&K01PIYOFK'<I+!-/Y$<9B53;@-(%#LKO&O[1GQ&URYL]-AM=2
MT&UU;6+&=9'\/:G)>7Z&ZTXRVR,DQ6RV1R3%P^]-FY<?+(U`'OLG[)GAO4X[
MAM2U#Q!K5Y=):1W-Y=W^;B?[-)=/'ED"[2#>3#Y<8&T#&T5SW@/_`()^_#_X
M>>';S2['^UGAOK2]LY3)<H&,=VMHDN`B*JG%C;@$*/NL3DL37CNH?MH?%?PM
MJ3:7IOA5;E;7PI=WP6_T2^=S?1VDMQ"PG,Y,L+,BQ%"$<ON`8[:Z#QW^T3\8
M/AK\6+/P_:Z/HVL0WFOK:7VJRZ5?K:7*K9Z2?*@432?9VD:YNBI)=0;=CL8B
M1@`3?#__`()AV-E/XLA\5^)!KUAKFN?V]8"#2XK>XT^ZWW9,C22>:)<QWDJ;
M&4H-SL`&<D?1'C'1X/#WPEU*PM5\NVLM)F@B7/W46%E`_(5R'[)_Q<\0?%[P
MCKEQXEMX8;[3-9FL8WM])GL+66)8XW4Q>=(TDR@N4,C+$2Z.IC4J<]O\2_\`
MDGVN?]@^X[?],FH`V/V5O^39_A__`-B[8?\`I-'7?5P/[*O_`";/\/\`_L7;
M#_TFCKOJ`/$OVJO^1Z\(?]>6I?\`H5G7BGQE\#K\0?"+:>NGK>W1+-:2M=O:
MBQF\MU6;S(SYBE0QQL!.3VZCVO\`:J_Y'KPA_P!>6I?^A6=<!0!Y7X4_9^U?
MPS\8=)\32>,-6U2*UTV[M;J.Z2VW322&UV@;8`_E_N"2&DW!E3!(+YZ2U^"N
MF6_BFSUAKF_DO+41M*"R>7>2)]H*R2#;G=NNIS\I4'>!C``'844`<7=?!"QO
M-=UZ\DU763%XEF66^M`8!"^VW6WV*?*\Q5,:@'#Y)SS@XKE]%_9[N(OB%>27
M6HZPVGV-KI/]E7YEMOM2RV?VL$,HBV%2ESMRR$DESP0I/KE%`'E]G^RCHMC'
M;JFL>(F:U@L((6:2WW1?8[M[N%A^YP6WR.#G(*G&,C-;WPZ^'[>'/&GBS6)H
M3`VM7J-!&90_[M(8T:7`&$:1U9F"\$*A.&)`[*B@#1^'/_);/!/_`&$;C_TW
M7E?3=?,GPY_Y+9X)_P"PC<?^FZ\KZ;H`*^5=1_Y'/Q-_V';W_P!'-7U57RKJ
M/_(Y^)O^P[>_^CFH`Y_XD?#C3?BIX9;2=5$_V5IX;@&&3RY%>*59%PW;)4`^
MH)'>L'7OV=]!URT\71++J%F?&CPO?/;R)F+RT1`(@R%4!"`G@Y))],=Y67XW
M\22>$/"=_J45G)J$MG$9$MHV"M.W0*">YSV!/H"<`@'(M^SCI)U35;U=5UV.
MXU@WBW+K)!EHKH1"6(?NL!?W$9!`W@Y^;G%5X?V;]'T+5VU2WFU:[,%Y/J$6
MFNT'V>1WL4LO)^:/(3RHU`!;J2236;I_[4L>HW0C738V7S]+B+)=NC+]MU">
MQ.5DB1U>)X&+(R@\XX(K'\`_M!:MX:\&:?;ZAI=WKUY<0W-U#<0W3332QIJ'
MV=O-01EE(612JQB0LL;@`;<4`=AX+_9]T6+X7Z'I/B#2=/U+4-/L&MY+B=1<
M30-(FV81S,-X&#L##:=JK4MW^SGHFJZ?)'?7FK7\TD5C"MW++&LZ16DC20JK
M(BCDR2!C@LPD89Z8Y?2OVBFU^^OK6SCDN+C5I(OL3M>A;.!&TN.[)CD\E9!P
M<@,K,6+'Y5&U<;X;_M)3:#\.K6XU.6;4M2C\-:/>B.XN687TLMA+<2E!'`SA
MR('9BVY<#=E`#D`]#L/V>-%TB'18[&ZU2SBT&\N[RV2-XV7=/%)%L.Y#\D<<
MFQ%&,*B@YQ69I'[)/A?2M"N--\S4+FUO--CTRX,PMVEE1+06@D$GE!T<PJBG
M857*`[>6S3F_:8OGM]4U&W\.6\F@Z+'97%]>2ZF4EMX+B."5I3$(2,1QRL[?
M/TB/J*]*\(ZY-XE\/6U_-;K:_:P98T60R;HB?W;$[5P63:Q7'REB,G%`&;X&
M^&\/@;5-8O5U+4M2NM<EBFN7N_*^_'$D0*B.-`,JBY&,9&1CFMZ?_D,>'_\`
ML8=)_P#2^"IJAG_Y#'A__L8=)_\`2^"@#ZRH-%%`'FGC+]K[X>_#[Q3>:+J_
MB`6VJ:>RK<0)97,WE$J&`+1QLN<,#C/>LS_AN_X5_P#0S2?^"J]_^,U@?"@9
M^,_Q<]?^$AA'_DE;U+X=_:1\)^(_%6K:0MU>6<VC+=R37%]:26MHZ6LP@N72
M=P(V6*1E5B&XW#WP`;7_``W?\*_^AFD_\%5[_P#&:/\`AN_X5_\`0S2?^"J]
M_P#C-31?$[PU/+91KKVCM)J5NUW9J+V,M=0J,M+&-WS(`"2PR`!G.*SKOXZ>
M$X=6T6Q@US3;^\\03F"RAM+J.9Y=HDW/@-G8IB=2PR`PQ0!;_P"&[_A7_P!#
M-)_X*KW_`.,T?\-W_"O_`*&:3_P57O\`\9K/^)7Q_P#"/PH\/ZUJ&K:UIZMX
M?A2:\M4NHC<Q"0A8@4+C:79E"[B`21SC)J?Q/\:?#O@Z#1_[1OHK>[UQX$M+
M(S1FZD\UT0$('RRJSJ&9<@>IH`L_\-W_``K_`.AFD_\`!5>__&:/^&[_`(5_
M]#-)_P""J]_^,U''\9O"9T[[3-XBT6S1(H9I5N;Z.&2W68`Q>8K,"I?(`SU/
M`J/Q7\<_!?@:\:WU?Q1H>GW"74%G)%+>()(99_\`4JZYRN_!(W``@$].:`+'
M_#=_PK_Z&:3_`,%5[_\`&:/^&[_A7_T,TG_@JO?_`(S3Y_BKX6M8[]Y?$6A1
M+I4OV>^+ZA$OV.0@D))\WR,0"<'!X-6])\<Z'KUPT-CJ^FW<RS26QCANDD82
MQX\R,@,?F3(W#J,C/44`4?\`AN_X5_\`0S2?^"J]_P#C-'_#=_PK_P"AFD_\
M%5[_`/&:P?"W[3O@WQ3?:U#_`&A/I:Z#O:ZN-4MI+&V*)<26S2)+*%1T$T;I
MN!QD#U%:MQ\:O#EIXA_L^:^6';;37;W,A"6J11);R,YD)`V[;J(@],$\\4`6
M?^&[_A7_`-#-)_X*KW_XS1_PW?\`"O\`Z&:3_P`%5[_\9K0TSQEH^LB$V>J:
M?=+<NL<1AN4D$K-'YJA<-R3'\X`ZK\W3FM39_GF@#F_^&[_A7_T,TG_@JO?_
M`(S1_P`-W_"O_H9I/_!5>_\`QFNDV?YYHV?YYH`YL?MW?"PG_D9I/_!5>_\`
MQFO0/AQ\3-%^+7AF/6?#]\NH:;*[Q+,(WC^93M8%7`8$$="*P9%PE<S^Q/Q\
M-=?'_4UZO_Z5O0![%1110`4444`?._[%XS^R]X._Z\C_`.C'KU#;7EW[&'_)
MKW@W_KR/;_IH]>GX_P`XH`=BH;V]@TVU>>XFCMX8QEI)'"JO;DFI,?YQ7G/[
M57P.NOVB/@]=>%[74+'3FNKFWGD:\LVN89DCE5S&RJZ.,XX9'5@0,'K0!WG]
MMV)N##]KM_."[RGFC<%XY(SG^(?F*Q=)^+&BZY;7UQ9W$ES;Z?J<>DRR0P22
MC[0YB"@;%)*_OHR7^XH)+$!6(^=;;_@F/#!X*>R_M[3?[<EL(]-EU?\`LC=-
M-;IX?CTGR7_>;FA,B>>8R^#DKPWSUU5E^S'K?@#X1P>'+&VT6ZGU;QYIOB*Y
M&AV*Z3IVD0PWUI=3%87E9L8M6`V;F:25255=S*`>XW/C'3;2ZMX_M2N;B=[8
M-$&D2)TC:1A(R@K%A4/+E1G"]2`8U^(&A-XCL='75M/;5-2MYKNUMEG#27$,
M+(LKJ`>55I$!],_6OEZQ_P""8MU%X#OM'D\3:'!)<Z8-(\VPT$VR72)IFI6*
MW5ROG'S;N0ZAOEER-X@1<#J/1O`O[%]A\-OC?H_BK1T\,VMCI<FKI'8IHRQM
M9P7PM6"6SJP$)26W<G"E66YF&`6+$`]HFURPB1=]Y:H)-NPM*OS;\[<<\[MI
MQZX/I6//XH\)_"_08X6O-%T/3;>YBLUC1D@BBFGE"1IM7`5GE?'098GWKYG\
M<_\`!+2/QK'&MUXEM[R.UU.46=O<VUU'!9Z3MVVEFHM[F)_,M@TOER;@,3.-
MH."-[6_^"<]E=V&H-:W'A<ZEJ&I/JUQ+>:")H;Z?^WO[5B-P@=3+LC+VV2P.
MQVQ@$I0!])SZW8VL1DEO+6.,9)9Y551@[3R3V/%-;7]/19&:^M%6%UCD)F7"
M,V-JGG@G(P#R<U\\7/[!U]XCU]E\0:]H.L>'+?5SJ%KISZ(V7B;6O[5>*<O*
MR2G<3&"$4`#<022*Y:Y_X)?20Q>+&L]=\/\`V_Q%K0U2"_O=+NKR2V'FWD@+
MPO=&WED3[657,8C(W[D.X;`#ZJO/%=AI^KRV=Q-Y$D$"W,C2JT<01BX&)"`C
M']VV5#%E`!(`()GEUJQAA:22[M5C7<"[2@*-HR><]AR?05Y1\9_V3+/XV?%;
M3=>U:;3;W2K/[#Y^E7M@+B*Z^S#4,;MQV\M>JPRIP8>^1CRSQ'_P3%D\0>#V
MT>3Q<K6T.CZ;;6T+6<JQ"^M_L*W-PY2979+B+3K:/:&#('G.]O,P`#Z<\1_$
M+0?"&G?;-4U?3[&US"/-FG55_>R+%&<YZ-(RJ#TR:O-KUA&LS->VJBW"M*3,
MH\H,,J6YXR.F>M?*[?\`!,_99-:PW_@]+1=%L;!()]!FO5FN+6YM;B-I&N+F
M23R`;8Q^5&R924!BQC4U0\3_`/!+)_$5_P",KIO$6F?:/$VIC4AOMK[9*IN_
MM1MKA$O%1H8S\L0C5"@2,DMAE8`^O8;ZWFN&ACFA>5%5V17!8!NA(]\''KBI
MMM>'_L[?LBR?`/XD76KV]]HK:?-HEGI/V>VT^87,KV\%O")9+B>:60J%@"A%
M*J007WNN]O;L?YQ0`[;1MIN/\XHQ_G%`#MM8?Q+&/A[KG_8/N/\`T4U;6/\`
M.*P_B7_R3[7/^P?<=O\`IDU`&Q^RM_R;/\/_`/L7;#_TFCKOJX']E7_DV?X?
M_P#8NV'_`*31UWU`'B/[51_XKOPA_P!>6I'_`,?LZX'</5?SKZ4\6_#SP_X^
M6W77=#T?6EM2QA%_9QW`BW8SMW@XS@9QUP*Q?^&=/A]_T(G@W_P2VW_Q%`'@
MNX>J_G06`_G7O7_#.GP^_P"A$\&_^"6V_P#B*\GU#X*^#?&7[6UGHUGX1\,P
MZ/X-T=[_`%..'2X$BN;JZ/EP12`*`P6-9)`#G!8&@#G=P]5_.C</5?SKWK_A
MG3X??]")X-_\$MM_\11_PSI\/O\`H1/!O_@EMO\`XB@#P7</5?SHW#U7\Z]Z
M_P"&=/A]_P!")X-_\$MM_P#$4?\`#.GP^_Z$3P;_`."6V_\`B*`/%?AR<_&S
MP3_V$;C_`--UY7TY7,^'O@OX/\):Q%J&D^$_#>EW\`(CN;33(89H\@@X95!&
M02#ST-=-0`5\J:@P/C/Q-R.-=O>__39J^JZY75?@3X'U[5+B^OO!OA6]O;IS
M)-<3Z3!)+,QZEF9"2?<T`?/NX>J_G45[:0:E9R6]Q'#<03+M>.10R./0@\$>
MQKW_`/X9T^'W_0B>#?\`P2VW_P`11_PSI\/O^A$\&_\`@EMO_B*`/G*;P=HU
MTT!ETO2Y/LJ".'=;)^Z4$$*O'`!`.!C&*3_A"M%\FYC_`++TOR[QQ)<)]GCV
MSMG.YACYCDD@G)!-?1W_``SI\/O^A$\&_P#@EMO_`(BC_AG3X??]")X-_P#!
M+;?_`!%`'S@W@C19?-W:5ILC3LDDA-K&S2.@PK'CE@.`3R!TQ40^'7AV/(71
M=)56*$C[)%SL&%S\O\()`]`3C%?2;_LY_#YEQ_P@O@W_`,$MM_\`$5Y-\)?@
MUX/\"_&CQ-X%UOPGX;ODN<Z[X?N;O2X)7DM)&Q+;[F4D^3)T&<A)%["@#SS7
M/A?H^K>&]1TNUACT6'5H1;74FG0PPRRQ8*E"Q0\%25Z9`/&#@UT,:K%&JKL5
M4`50.@`X`KWS_AG3X??]")X-_P#!+;?_`!%'_#.GP^_Z$3P;_P""6V_^(H`\
M%W#U7\Z@G.=9\/\`3_D8=)_]+[>OH'_AG3X??]")X-_\$MM_\14UA\`_`NDZ
MA;W=KX+\)VMU:R+-!-#I-O')"ZG*LK!`0P(!!'((H`ZRBBB@#P/X3_\`)9?B
MY_V,$/\`Z0V]>=W/[!ZS>*?$>K1:UI-E<:S?3:C"]MH"QS33/J$-^@U"3SC]
MMCCDA6-4Q%B-G7.6R/0_A3S\9/BY_P!C!#_Z0V]>-R_M6ZQX'US6=0;Q-;^*
MFM]4URUU#PY*;2$>'K:UN)HK>Z:2&,2PPY2)9&F\TD3;EQM(8`V+W]@>;4?$
MNDZA-XOF2.PCO))[6WL9(;>6YNFOFEDBB6X\M$S?,`LBRN!$@$BY<OU>G?LD
M1Z-\1_#^M6FK6<.G:)]CE-E_9*&9YK:UGM4\N8./*A*3EB@0G>,A@&8'D;+]
MNF\N-5TVS.G>%I'DNDMY)+?7#)'K*O>_9=VEGR?]*9/O2`[0IPN3G<.1?_@I
MW=Q_#*X\5+H&@R6?]J"SMH3JLD$DD:V_GS`F:&-?-3*H`N5D(8QF0"@#T_6/
MV-(]>\5ZE>7.M0R6-Q<W-U9PC2T%Q"]S=07,XFGW_ODW0!8U")L4C)?:NW9^
M)O[,S_$#XI6OB*/5[>TMU&G_`&BVDTM9Y2UE<331&*;>#$&\^17&UB<+@KA@
MT?PY_:1N_$?CR\LM<T_1]#T=I[Z#3+S^T2TEPUKJ0T_9*CQHJO+*\6Q49\EL
M=2`:/BK]H*30?'WC31&UBT%_INJ:+#IVG+-!'=>1<M:I*X5E9F3=,V3M)QD!
ME."`#`\1_L`V>L?#N'18M;:*[@U*VU#[4T$\:W'E:5'IIBE%O<0RLIC1G&)5
M`9@"&4$-OVW[)5QI.F7-C8ZUI:6<6JPZQI@N=$\^XM95N5GD2>7SP9XFP50`
M(R*0"S[17`^'/VQ?'%I86%YJ<?@.^\S0M2NWM+;4I(Y9[VUNEB\H9C)4J'7>
MN"4&21P`=+Q!^VYXC\$>']5N-<\-^&[2YMVNH;'R]:D:&XEMM22PF$CO!&(E
M9Y%:,DXX(8IF@#H?#7[$]OI/B6POK[6+:_M]'O8IK*W&EK$7ACFGF"W+[V^T
M3;YR1+A/NYVAF9FZ?X1?L_7GPKOYI&UC3[NUFO[F[2VATLQ+;)*B!8XF>61H
M^5+/@A&+85(U`%<C\+?VR[SQ[?:-J%]HVCZ/X4U2*W,U]+JN9;*671AJI+@Q
MB/R4CWH7\P$D!MH&:7XW?M$:[\(?CE(R_P#$Q\*_V':0II\<"EFU.\EO4M&\
MP#=B22UCMP"=N^Y0X[D`QT_X)_RVB>)&L?$FGZ3<:[=37`ETW17L9+@2ZA]M
M/VZ2&Y62YD0YBCD1X61&<<AC5JY_X)_6MUX"AT3_`(2B_4VMA;6D,XADC;?;
MQZ6J.QCF23:3I:%@CJQ$K*'7`8\QI7[<FO?#F_\`#WAG7H]-\3:S<6^J27]\
M+A+&5Y+:34O+V6X0`HRV!4["Q7.6V\;^KU/]L76O#*WBZMIO@RSO=/TB'49;
M.37WCFF:=2Z/$K0`M:QJ5\V8@;=LQ"GR\,`2^%?V3-6^'7C.POM!O;&-=+T)
M;:`SB62`ZF\LBO>^7(\LFY+>65!OE<N)%4L-NZOH",?NUSG..:^>]$_;@AG6
MWM=2A\.PWU[>6]C8R6NL":UUAGU064KVDC(IF2-&5SM7(8E3TW'M/V=?VCX?
MC9IETUY%I^D7T-V]I!:"\$DMZ(XHG>XC!"EH7\U7C8#YHGB<X+[0`>I8HQ3?
M\]*,?YQ0`2CY#7+_`+%'_)-O$'_8UZO_`.E;UT\GW/\`ZU<Q^Q1_R3;Q!_V-
M>K_^E;T`>Q4444`%%%%`'@_A7]B[5?`WAZUTG1_BAXJL=-L5*6\`L[-O*7).
M,F(D]3R:T/\`AEGQ-_T5KQ9_X`6/_P`:KVBB@#Q?_AEGQ-_T5KQ9_P"`%C_\
M:H_X99\3?]%:\6?^`%C_`/&J]HHH`\7_`.&6?$W_`$5KQ9_X`6/_`,:H_P"&
M6?$W_16_%G_@!8__`!JO:**`/%_^&6?$W_16O%G_`(`6/_QJC_AEGQ-_T5KQ
M9_X`6/\`\:KVBB@#Q?\`X99\3?\`16O%G_@!8_\`QJC_`(99\3?]%:\6?^`%
MC_\`&J]HHH`\7_X99\3?]%:\6?\`@!8__&J/^&6?$W_16O%G_@!8_P#QJO:*
M*`/%_P#AEGQ-_P!%:\6?^`%C_P#&J/\`AEGQ-_T5KQ9_X`6/_P`:KVBB@#Q?
M_AEGQ-_T5KQ9_P"`%C_\:H_X99\3?]%:\6?^`%C_`/&J]HHH`\7_`.&6?$W_
M`$5KQ9_X`6/_`,:H_P"&6?$W_16O%G_@!8__`!JO:**`/%_^&6?$W_16O%G_
M`(`6/_QJC_AEGQ-_T5KQ9_X`6/\`\:KVBB@#Q?\`X99\3?\`16O%G_@!8_\`
MQJH=0_9+\1:I83VMQ\6/%DEO=1M%*OV&Q&Y6&"/]5W![5[=10!B_#GP3;_#;
MP#HOA^UEEGM]$L8;&*27&^18D"`MCC)"UM444`%%%%`$5]<I9V<DTC+''&I9
MF;HH'4UY)^Q];-XC\,^(/'-PK_:/'NK3:C#O^\EFA\FU3Z".,,/]\U=_;!\2
MW6E_!JYT?39/+U;QA<0^'K'_`*Z73>6Q]?EC\QL]MM>@^$/#5KX.\*Z;I-F@
MCM-+M8K2%1V1%"K^@H`TJ***`"BBB@`HHHH`****`"BBB@`HHHH`*\J_:H\)
MWO\`PC.G^,M#A:;Q!X$N3JD$2_>O+;&+JW_X'%NP/[RK7JM-D19$*LH8$8((
MZT`9W@WQ;9>//"NGZSILRSV.IVZ7,#C^)'4,/QP:TZ\9^`CM\'_BCX@^&LY*
MZ<2^O>&\]/L<KGSK<?\`7&8G`Z[9%[5[-0`4444`%%%%`'@?PG./C+\7/^Q@
MA_\`2&WK8LOBEX)N/$%]IMIKWARXU:*[2QOK2VNXI+B*=]^R.9%)96;8^`X&
M=IK&^%'/QD^+F/\`H88>O_7E;UYU??LH^(_%/BV\M[_^R=-\%RZ]'JITJVUN
M[N/M)\^>6:8$P1M;-+Y@W0([Q,S.<C+;P#W7Q#=Z/X7T&2^U(V=EI^FQEVFE
M4*ELN,$_[/%8'PO_`&?_``A\'K.XA\/Z3]GCNC&7\^YFO"%C#"-$,SN4C0,P
M5%(1=S8`R:\!U7]B_P")7B"]EAO_`!+87%C-X13P[*3K5UFX?[)#&S.IMS)N
M\]))!*)^0X/E!][M]"?!CX>W'PO\*7&DRW'G6\>HW<UDOVB6?R+:29WBCW2?
M-\JL!C)`Q@'`%`'0:EX<L=76$7-I;S?9YA<1;XPWER`[@P]PW.?4`]1FIGTJ
MUDNO/:WA:;`'F%!NP.G/6IL?YQ1C_.*`(3I5J3G[/#P68?(."WWC^/?UITNF
MV\Z,LD$+JV<AD!!R<G\SS]:DQ_G%&/\`.*`*>K>&M/UW2IK&\L[>XL[E2DL+
MH"DBD;2I'<%>".XXZ5:^QQ'&Z-6(V\D>AR/R/(IV/\XHQ_G%`$3:7;/*KM;P
MLZ@J&*#(!ZC/O2OI]O))O:&)G"&,,5&=I_ASZ>U28_SBC'^<4`0_V5:[8E^S
MP[81B,;!^[^GIT'3TJ$^&K`ZQ!J'V.W%[:PO;Q3B,!TC<H60'L#Y:9`Z[1Z5
M<Q_G%&/\XH`=BC%-Q_G%&/\`.*`"4?(:Y?\`8H_Y)MX@_P"QKU?_`-*WKIY/
MN?\`UJYC]BC_`))MX@_[&O5__2MZ`/8J***`"BBB@#RO5?VUOAEH>L7FGW7B
M>-+S3YWMKA$L;F01R(<,NY8RI((QP3R*@_X;I^%?_0T_^4V\_P#C5<Q^S(=O
MA/Q)_L^*M7'3_I\DJMX"_;"\$^-M"U35+B^/AG3]*CMYY;K77ALX&BN&D6&0
M2>84`=HG`5B'&!E1N7(!V'_#=/PK_P"AI_\`*;>?_&J/^&Z?A7_T-/\`Y3;S
M_P"-56N_CGX)L+NXMY_%WAB&XL[)=3N(GU.!7@M&VXN'&[*Q'<N'/RG<.>:I
MZ=^T)X1\0?$'3_#.DZ]I6L:MJ-H]\(K"\AN#!"$21))`KEE61)$*-@A@<YQB
M@#5_X;I^%?\`T-/_`)3;S_XU1_PW3\*_^AI_\IMY_P#&JY;Q]^UIX$\#6N5\
M0Z+K%XNKV^AM8V&J69N(KR9RJQ/YDJ)&P"NQ#L#A&P">*O\`C[]HOPG\._%%
MOH5YJUE-K4J2326,-W;_`&BVA2WEN#-*CR*4C*0L`Y&,D=`<@`VO^&Z?A7_T
M-/\`Y3;S_P"-4?\`#=/PK_Z&G_RFWG_QJJC?'OP.E\+7_A,?"OVIK\Z4(?[5
M@\PW@./LVW?GSO\`IG][VJC<?M-_#VV\5Z?H?_"9>&9-6U+4)-*AM8M1ADD^
MUQJ6>!@K';(.FUL')`QD@4`;/_#=/PK_`.AI_P#*;>?_`!JC_ANGX5_]#3_Y
M3;S_`.-50L?VA?`.IVUO-;^-O!]Q!=W9T^"6/6+9TFN1C,"L'(:3YE^0?-\P
MXY%:7AGXI^&O&UK'-HFOZ+K44T#W43V%Y%<K+$CF-G4HQ#*'!4D<!A@\\4`,
M_P"&Z?A7_P!#3_Y3;S_XU1_PW3\*_P#H:?\`RFWG_P`:KC/AW^V3X&\>^#3K
MMSJ'_"*Z?YEO&C^()(;%93<1":':YD*,70YVAMPP<@5M3_M'>$M+U358=4U6
MRT.VT>-9+F^U&\MX+-"US/;!/-,F`_F6[_*V",J#\V5`!L_\-T_"O_H:?_*;
M>?\`QJC_`(;I^%?_`$-/_E-O/_C57-)\=:'KUW'!8ZQI=Y--YWEI!=)(TGDL
MJR[0I.=C.BMC[I90<$C/*?$+]HK2?`&K:M:-INO:H/#]DU]JMQ86BR0:>OE-
M*D;LSK^\=4)"KG:&4OL5@2`;_P#PW3\*_P#H:?\`RFWG_P`:H_X;I^%?_0T_
M^4V\_P#C5<\O[2WA.^T;3=0TW5+76[759H[>*33KJWN`LC7-M;%3MDZI)=1[
M\9VC.>=H8T;]J?P#K7B+4+"'Q5X?*V,]M9_:SJ5O]EGN9S*$MHW\SYIQY+9C
MX;E<`\T`=!)^W9\*HT9F\5!549).FW?`_P"_5>H>'?$-GXLT"RU33KA+K3]1
M@2YMIE!"RQN`RL,\X((/-><_$;CX?ZY_V#Y^W_3-JU/V5#G]F7X??]B[8_\`
MHA*`-3Q/\<O!7@G5I-/UGQAX7TG4(@&>VO=5@MYE!&02CL#@@Y''-9__``T_
M\-_^BA>!_P#P>VO_`,<K\]?^"F[8_:[UO;_SZ6G;_I@M?/\`O;_(H`_8K_AI
M_P"&_P#T4+P/_P"#VU_^.4?\-/\`PW_Z*%X'_P#![:__`!ROQUWM_D4;V_R*
M`/V*_P"&G_AO_P!%"\#_`/@]M?\`XY1_PT_\-_\`HH7@?_P>VO\`\<K\I?!G
MP-\2>/\`P_;ZGI<%I-:W>H#28=UU'&TET4+B(*S`[BHR,\'US6+KG@W4?#FE
MQ75XL$*R7,UIY7G(TT<D1`</&#N7!/4@9H`_73_AI_X;_P#10O`__@]M?_CE
M'_#3_P`-_P#HH7@?_P`'MK_\<K\D?!/@+4O'YU3^S_LY.CZ?-J=P)9`A\F(9
M<KZGIQ[_`%QAEV_R*`/TT\9_'KP-XZ_:K\*B;QEX37P_X1TNXU873:O;BVGO
MIF\B./<7VETC\Q\`DC<.G%>JK^T[\-U'_)0O`_\`X/;7_P".5^.P;'I]=M&]
MO\B@#]BO^&G_`(;_`/10O`__`(/;7_XY1_PT_P##?_HH7@?_`,'MK_\`'*_'
M7>W^11O;_(H`_8K_`(:?^&__`$4+P/\`^#VU_P#CE'_#3_PW_P"BA>!__![:
M_P#QROQUWM_D4;V_R*`/V8\-_'?P3XQUB+3])\8>%=5OILF.VL]5@GF?`).%
M5R3@`GIT%=->W\&FV<EQ<31P6\*&2261@J1J!DL2>``!DD\"OR$_98U:XTCX
MY:#/;RM%*)F7<IQP48']#7ZI_$-VN/@AK[-RQT6YY_[8-0!3;]I[X;`_\E"\
M#_\`@]M?_BZ/^&G_`(;_`/10O`__`(/;7_XY7XZ[V_R*-[?Y%`'[%?\`#3_P
MW_Z*%X'_`/![:_\`QRC_`(:?^&__`$4+P/\`^#VU_P#CE?CKO;_(J2R@DOKN
M.%656E8*"WRJ,G&2>P]S0!^PW_#3_P`-_P#HH7@?_P`'MK_\<H_X:?\`AO\`
M]%"\#_\`@]M?_CE?E3XS^`GBCP'9ZM<:A9P^7H,T4&H^3<),;-Y5#1[PI)PP
M(PPXSQG/%<7O;_(H`_8K_AI_X;_]%"\#_P#@]M?_`(Y1_P`-/_#?_HH7@?\`
M\'MK_P#'*_'U=.NVTQKT6\WV-91`9_+/EB0@L$W=-V`3CK@57WM_D4`?IM^U
M'\;_``1-H.E>,/#_`(V\'WGB7P/=B_M;>VUJV>:^MV^2YM@%?+;XB3@`G<BX
M!->G:=^U3\-;[3X)E\?^"XUFC5PLFM6R.N1G#*7!!]01D5^/98L/_K4!B!_]
M:@#]BO\`AI_X;_\`10O`_P#X/;7_`..4?\-/_#?_`**%X'_\'MK_`/'*_'7>
MW^11O;_(H`_8H?M/_#;O\0O`_P#X/;7_`.+KM+&_@U.TCN+::.X@F4/')&P9
M74C(((X(([U^(.YC_P#JK]8OV)-:N=8^!FEO<2O*T<2("QS@!1B@#%^$W_)9
MOBY_V,,/_I%;UZ)BO._A.<?&7XN?]C##_P"D5O5,?M?>"?\`A,VT$S:XMXM\
M=/\`,.A7GV4R"Z^QL1/Y?E;!<%8B^[:&=>>:`/4,48KR&;]N'X=Q:??7"ZAJ
MTW]FW\NG7,,.BW<EQ#+%"T\A:)8RZHL:.Q8@`;2,Y&*T-5_:Z\#Z1XEUK1Y+
MW4)-5T-8&FM(=+N)9I_/=(X_)54)ERTD8^3(^8'IS0!Z=BC%>.6O[>7PQN[D
M0+KLXN#I*:UY)TZX\T0/`MRHV;-WF&!TD\O&_:P.*DN/VY/AWI^BZAJ%[J&K
M:9;Z;D2?;]$O+1I'$XMWCC62-3(Z3,J.$SM+#.*`/7\48KQO5OVX_`MMH%Y?
M:?+K&KK;Z:VI1?9=*N/*N@+,WHA64IL\UH`7V$[@%.0,5Z1HOCBWU?1M#NQ9
MZM'_`&]CRDDL)5>W/E-)^^!7]SPI&9-H+%5^\P!`-S%&*\I\4_M1V/A+X;WG
MB6YTZ9[>RU35].-K$6EN+C^S_MI8Q!4(+.+-FPQ4*&/S$@!J]I^V+X=34-1M
M[S2?&%FU@]I"@?0+IY+N6YA,R1QQK&6+A0<KC(P2<`<`'KV*,5Y#-^W'\.;;
MP6GB";4]2MM)DN(+=9[C1KN'(FB\Z*7#Q@^2\?*R8VG!`)((K9A_:A\(W4?B
MEHYM2'_"(6UY=WK2Z;/#'+':2/%<&!W54F\N1"IV,1DCGF@#T7%&*\.\0_M.
M^*O!VK^%=.UGPCX=TN^\73R_94E\0S.L4*>3PYCLG/VC,V#'CRP5.)2*W_`7
M[05]XM\7:1%=>'5L/#_BIKI-!U!-0$UQ<F#<3Y\'E@0B1$=XRLDF57#^6Q"D
M`]2Q1BO(/AK^U!_PGOQW\2>$9+'3+6TT6X-E!<QWK2S3W`4N$*&,)\R),X\M
MWV>0ZOM<;1Z\1@__`%J`$E'R&N7_`&*/^2;>(/\`L:]7_P#2MZZ>3[G_`-:N
M8_8H_P"2;>(/^QKU?_TK>@#V*BBB@`HHHH`^??V8QGPIXD_[&O6/_2R2N'\$
M?L%6?P_2&XTOQ/<6>L:?-!+8W5OI5K%&AB2YC#3Q!<7$C)=S*TDAS]TKM(.>
MV_9H;;X1\3'T\5:P?3'^F2=Z\A\-?M07GA;X:Z9JDWCC2[[Q+K$D$7B"#7WB
MBT[P7=&WN)GM72&-)8F:2/[.B3.6)"'YF.)`#IX/^"?.B6NNB?\`X2;7YK*+
M2(]'M[.X$4B01K%;1G'R@`'[,'VJ`H:64XP5"]WH'[.\/A[XRW'BU=;OI8))
MKFYATQX(?+@EN8X4F;S-OFL#Y"%06PNYAR-@3S*__:M\9C0I_$4WAN&SL[&Y
M>*+2L2_:RZZ"^HNMP2IP%E98\(N1Y9)SG97H-E\:#XF^!>OZA8Z]X=UC7M/T
M2YU!;K0F\VT9?](2":,,7R"T#C&YANC89(P2`4_!?[(ECX4UBRNW\0:EJ`TB
M6V73HY(84^RVT$DTB0LRJ&D):=LNY)PJ]"6+)X__`&0[7Q]XNUS4)?$FJ6]G
MKCS7$E@L$+)'<2Z;_9S2+(5WX\D(0N<!@2<Y`7R[P_\`M3ZKX.TC=IWC+1_%
M/AV\6Q">*M?>-M/L;Q[>[EN;0S6J1I(<P6ZJ/O*]R5)9@L9L>(/V_=8T"SU:
M^O-'T;2UL;`7$^E7<DO]I:'F*V<7-VH`'V=GG*+M"EM@PV2PC`/0/%O[$FA>
M+;GPY+-J-TKZ!J&IWA4PQO'=)?WPO)HV4C&0Z(JMS@`Y!)R+EG^RA]FT'2=+
MD\4ZE-IVA74GV*(VD"LEG)!-`]LSJH9CLG;$N0P*J<$Y)\EM?^"@^O1W/A>W
M_L_P[J\NNZ%>ZM))I\BB(^7#?S0/&#<&0H19HCA8W"O*0SQL%1O<O@M\7[[Q
M;=ZAI/B1=)L]>M;HI;Q6)D,=W!]EM+DNH?YLQ_:TC8]R`0!NVJ`8?@K]D2S\
M,:S:ZC?>(+W6-2M;=K-)IK.WC'D"U^RQIY:H$RL>XDE3N+$8"@(.D^#_`,$Y
MOA/X>BTUO$6H:O;1P2Q;;B&-1'OD+C80-R1HIV+'N*JH`'08\`T;X[^-)]8B
ML]%\46/BS5+/7I7N+UKF.YT2:$Z;J<PM@+>*.2*1&MTWV\A=HR83YC;N9_%/
M[:/B;QYXJU'PYH-A;Z?<0C2+NWF+@20/)?Z8DD4RK(TOENEVXW-#&&5&V&0$
ML@!M#_@F=I2_"I_"T?BW4[&WF@M[.9M.L+:SAN((;:>W7S(8U"R3%;AF:5]Q
M9DBR"$`KJ/'?[#&C^-%FD;7-0M[IK[^T(7\I&2.0S7TA!3C<I6_E7&01M0YX
M(/3>'?BMXQUCP)I=];^$+?6M0DFN[74%MM02TBBDM[AH-R"7+%7V%@.JC@DF
MN5_:%^.?B/P1\1/#,>EV&K-I>BQQ:IXG%I##+#%;SS"`+,[$,$CC%W/^Z!8M
M;Q_PL00#2\#?LR7GP\^(^J:OHVI1V-C<G3K6SBP)/LMK#%&MV$38%1KGR+=&
M"Y`$6\$,<#:\=?L[2>+-<\236?B;4=)TOQA:-;:OIZ6T,R7#_9VMQ*CNNZ-C
M'Y:L`2"(EQM.XMX<?VMO&WPN\/ZI<7L^C:LD.FZ9/9VUWY5O<VXGN)XI;N>2
M:>%&@0HJDL\:@M&-X.=W:Z7^TK\0/%,-NUEHGA>P:^U&QTN*.YEDN?(DFTI+
M^61I(CLD1&8HNPX?&=PZT`=?J'[)&D7OB%M074;R)FN8;GRDC14!C;2R!P,X
M/]EQC_MJ_H*P-'_8@71[*PC3QEK+2Z:;"*WNEL[:*Z@M[-)8XXTD1`59HY2K
MOSN!<%2K;!Y[K_[=_BKQ!+K&FZ-8Z7I%]!X.3Q"MQ<QK-_9\WV>TN'#1^:)'
MC\NX<*YA5,Q-AW*NB>D?`W]I[6OBA\>==\)W6F:2-,T:S$R:A;7<!:Y($!6=
M(1.\Q@F$KLC-$JA4&'D+':`>A7UEJFG?!C4X=9O%O]373KAIYDC$:,Q1CA0`
M/E&<#(R0`3R:ZG]E/_DV3X>_]B[8?^DZ5F?$;_DGVN?]@^?M_P!,VK3_`&4_
M^39/A[_V+MA_Z3I0!^?/_!389_:[UO\`Z]+3_P!$+7@&*]^_X*;_`/)W>M_]
M>EIV_P"F"U\__P">E`#L48KMK7]G;Q5J&E65Y;6=K<IJ5A)J=JD5U$TL]O&<
M.RINR=ISE>O!P#6'X]^'FH?#C4;.UU(6XEOK**_B\J02`Q2C*'([D=J`/6_@
M)\9M"^'WPLTO3[S5+:WOK?QC%K,\3V<DS?9%MS$^Q@A"RG.%(((Z[AUJSH7Q
M4^'%N?#LUY:Q36]KK^IW=Q;RV9FGCMYTQ:M,Q7$QC8`L"SDX'7D5\_X_SBC'
M^<4`?0/A#XQ^$M!TM5>\MUUQ?".IZ7=ZF+239J-U.X-L"-F6V*`"SJ.N.0*N
MV_Q.^'*_$2#Q!_:-HMU'9Z5'<0C3)%L[HH0+W<HBR9"`-N,*V?F/`KYRS@?_
M`%J3O_\`6H`]GU'XQ^&+;P1XDL;6&/\`M"QUBXG\-S0VQC5K6Y$D;*^0"/*4
M[D!Y#-QP.+WBGXI^#KZXT2/2(/#-MH7GZ=+/:W>F7#7^G&(`3X;:T3K)\Q8\
MLY921D9'AA8G_P#53>@^GM0![-\=?B%X5\9>!M6@TVXTV34%\6W5[IWDZ<UN
MZZ9(OR(&\I?X^2I.?KW\;Q6JG@K4FAU1YH5M6T>));J*Z=;>95=E"[4<AF)W
M*<*"<'/3FLC'^<4`.Q1BMKPW\/M0\5^'-<U2T%O]E\/6Z7-WO?:P1G5!M'4_
M,P_SBL,<C_ZU`'>_LU\?&?0O^NY_]!-?JUX\_P"2&:]_V!;G_P!$-7Y2?LU?
M\EGT+_KN?_037ZM^//\`DAFO?]@6Y_\`1#4`?C5BC%7O#'ARY\7>(;+2[/R3
M>:A.EO`)'$:O(YVJ-QX&6('/<BNSL/V7?%^HZS#91V=GNFU671#+]J1HXKR)
M2SPN5)VL%5CR.0#C-`'GV*FTT)_:-OYDBQ)YB[G;.U!D9)P">/8&HIX&MIGC
M;&Z-BIX[@XIG^>E`'O?Q+_:'TC5_V@IYUF75/`.I:G9W^HVT-J8WOEBC1-LH
M=59@I4D*?E(QWS5OPG\6?`-IXLT!M5;2[YK/4=3N+F_?2BR&TE5A;6^SR]Q9
M9#N&%VQKP#U%?/1.?_U4'G_]5`'L]E\6-$\4_""TT/7-8:QFA\31W5\MG:,H
MNK#R(828E$?E[@49]CA0222"3BNRT_Q'X-\;:]I?V.;1+J30]/U@7M[+93Q^
M3"V?LD[/Y!RZ;EYV':V=H'RD?,V<#_ZU3Z?J=QI%SYUK<36TP!&^)BC8/!&1
MZ]*`/H[Q%XU\/>&M;O[B^;PPFI:IIFFW&@WXBN;JQ$4,A699`L:2QO,T1+$1
MX8,0=RDD_/?B[45UGQ/J%XD.GVZW5S)*(["-X[5,L3B)6^94]`>0,5'%;7WB
M:]D95NKZY*/,^%:60JB[G8]3@*"2>P!-/U3PO=:1HFFZA,;7[/JJR-`(YTDD
M`1MK;T4EDYZ;@,CD9H`H8HQ2`9./4XZ5M^(/A]J'AGPIH>M72V_V'Q$DKV;(
M^YF$3A'R.V&X_"@#%4?-7ZK_`+"/_)"-._W%_P#017Y4+]X?X5^J_P"PC_R0
MC3O]Q?\`T$4`9_PH&?C+\7/^QAA_](K>KMU^S]X5NI?,DLY=S7#W'_'P_P!]
MK];]CU[W**WI@;?NY%4?A2,_&3XN9Z?\)!#_`.D-O7A?CV+XI1:)X[T.Q_X3
MAH]>O=6U^PU*%[C[1IJ6EQ.J6<$@^9%E*:>8HUQO26Y*\+0![-X5_8S\!^#+
M"6UL=/O_`")E>/;-J4\PC1K9[78NYSM40R,H`P!G/7FN7^,'_!/OPG\1?#6L
M6NFR2:7>:U*DD[7C3ZA9.HGCG=#;^=&%#R1*Q\MT.X#G`VG%TWXS?%SQ5\5?
M$VB0Z7+I.D1:Y;65A?W'AZY)@MC-=QS,=ZI$XV0PNKI)*H$JEB-WE+#KGQV^
M)EMH%Q+''JL5[]ONH[A(O`=_=?V8\8E,%L@7'VF*4K&#<IF-><LGF(4`/1?"
MW[(/AO1M.C&H3ZEJE_-IL.GZA-]JEMX=0:.&.$3-`C>6'\N)%!P3M5<DD9K3
M\6?LN>#?%ULR7EG>*WFW,R2P7TL,L,D]XM[(Z,K`JWGHK`CH,K]TD5YOJGQ_
M^)C/>6%MX6U)?$&GP74S6W]B7#64\WVBQ%I;K=[?**R)-<*\BL?*",[8$9!Z
M+Q#\2M9\<_LX736*^(%\36`TT:_'8Z?+:7UJLC6TU['!'RXF6UDEV*A9P2N"
M6P2`=6/V;O"+6$EK-:SW$,SEY?.O9':1OL)L#N8MN)-NQ4Y/)^;KS72:?X(M
M=)TS1;6.[U9X]!_U+RZA+(TX\MHOW[%OWW#D_O-WSA6^\H-?-_B6]U;3O%VD
MW'P]?XEZQYVD7-OI^GZU'K]O'83D796[FFN_W,WSE%,5Y\ZJD31D?*K<]XV;
MQ'<_#[6(/"<?Q4GTR\M]+6]?Q);ZW<O%?+</)+^X*F[>!T1(9TM!Y6)E*8`<
MT`?0Q_9>\)S2Z@UPNK7=MJ5W=7SVL^ISR6T,MTEPEPT49;;'YBW4^0N!E@>H
M%7-(_9]\.Z1K]IJBR:Q<7EF+9E:YU.:99'MXWCCE<,Q#2;)&!<\M\N<X%>8:
M#\3_`!=I'[&=O>Z7H_B32O$&CM'IZ6NL:/>:AJC0QR*BN\:1L\LLD`#!PICW
MMAF7#%<%?'_Q6^'^E>*-0MM/U.]M]4FU&YL[270+B6XTV07EE'&S;#*SH4N;
ME]J(Y"6^424JP<`]-\1?L4?#_P`2Z/9V-UI^H+!96L%A'Y&IW$#>1#!]G6-B
MC@LOEX!!SG'.376:9\$_#>D-+LL5D6>*^MYHY9&DBD2]N/M%PK*Q(P\A/T!P
M,#BO#/A9\2?B3;>*-/\`%OB:&;3=%O+"P7Q!:2Z1<K';[;2_DFN$>3:8@KQ0
M9!C'^LPW)4+W'Q'U7^UOC+H=SK"^/X_#-QIEO-I']@PZDD8OVG8RB]%H,J!&
M;?"W($6#-D9!P`;=E^RIX;L)-+:'5/&27&BL_P!CF/B:]>6"-Q&IA#-*3Y9$
M2?(3@XR<GFM;P1^SUX9\`^+3K.GQZA]H43_989M1N)K73_/??-]GA9S'#O89
M^11@9`P"17@?A/PGXJ\)_#7PK-XVN_B%<:3K%W/=:R-'N]=FU6W;R6\A)5CF
MDN8H]V_<MLL:;O*RH7(/T#^S\FL)\'-!77VU!M4$+;C?_->&+>WD^?W\[RO+
MWYYW[L\T`96B?LI>#_#WQ,A\76MOJD>L6D]Q<6S'5;EH;8W#.\Z)$7V".1Y&
M<IC;N.0!7I!&:;C_`#BC'^<4`$H^0UR_[%'_`"3;Q!_V->K_`/I6]=/)]S_Z
MU<Q^Q1_R3;Q!_P!C7J__`*5O0![%1110`4444`?/O[,0W>%?$G_8UZQ_Z625
MV3>-]+3Q2^B_:D_M.-(I&@P=P602E#G&.1!+W_A]QGC/V95W^$_$H_ZFO6.@
MY_X_)*\@TO\`80\26_A#4M/.I^']/NK[3OL,MS9&X5M0E&G:C:->3D@'SII+
MR.5\9P4;YF;#$`^J-Z_WEZXZU0LO[+3Q!?BWDL?[4V1->*C)YX0[A%Y@'..)
M-N>N&QT-?/'BG]AC49_BAXFU;1=2T_3])U+3DM--LE/DQV\2Q01FPD2.(,;6
M1HI';$N`;A\1%LLTVK_L7W4^HW]]8>'?AW8MJ>GZ9#=:?'#(MM<?9+AW:Q=A
M%EK1XVC'*X#0(#$R?*`#Z0#*#UQ^-9?C+PAI7CSPW<Z7K%K!?:;=*#-#)]UM
MI#*<CD%6`8$<@@$<BOGK4/V%]0E^'VK6C2:!JFN7MI8VEI/>;S!91PN9&A`D
MCEW0AO+Q&RL'6%`V"%=/=_`OA.X\-Z3J$-Q'IL<UY<-,7LU=5G)15,CALX<D
M'(!(QB@#(^`/C'P'XF\#);^`+[2;C1=/<J([)_EC:3]Z6(/S$R;RY8_?+ELD
MDD]B=)M9=42^\F%KN.-H%F*@NJ,5+*&ZX)1<C.#M'H,?(-C_`,$Z_%W_``J>
MQT&;7--B^R?V?'/9#5+J]AOC;6<UL9S<744KQMF2)XXEC*0FW'EE&;>O=^+_
M`-A1?%7AK5K>2XTZ74M1FU>Z^W3>:9GGN%<6,KN/F+6[-O!_A;+)AN:`/HL%
M3W'KUHPHKYKU_P#8GUQ?B%X9NM#U#0M.\.^&_$)U:TLUAVRV,+36TDD43>4S
M#S!%,K*CQC]Z22X)4=5\)OV7M0^$?PWU[1]+OM/L[[6?#MK8BX6-Y(O[3CAF
MCEO9%."Y<O#DYW$1`$\"@#VH;0.P_'K65>^-M*T[4=0M;B\ABDTNQ34KL.2!
M#;L90LA.,8S#+WXV'VKYR^'_`.P9K&@:-HZ:EJ&CR7&@S37.F1PY\K3))+VT
MN`8@D42`A8)DW)&F?.;@!W!Z?X2?LGZQX$L?'D=Y)H"W/BK14TD75FLHEU"9
M6O";VZW#_72?:5W;=W*'DC``!ZM8?&#PSJO_``C/V?6]-E'C*-IM$VSAO[31
M8?.9HO[P$0W?2K'B'XCZ/X5URSTV^NTM[W4-GV:)E?,VZ18A@@$<NZ+S_>],
MUX7<?L0:X^^.W\3V]C#I[7<.@R0Q.)M#@NM.OHIBC<9D-Y>B08V@16T*C!6J
M_@W]A_7M`\,:7:#6K/39[-G8_97\Q;0M<V\V8-L,*+_J2^T1J-[DG))8@'TS
MA5/]<_A2XVGTKY=MOV#-0U+PO<V>H/X:LU:UND@L+`SFRANVLE@COOF&?/,H
M\YCC*LJ,"SJ7/T3-X8N)_$=CJ']KZI'%9P-"]@IB^RW+'^-P8R^X=!M<#U!H
M`/B,/^+?:Y_V#Y__`$6U:?[*?_)LGP]_[%VP_P#2=*S/B-_R3[7/^P?/V_Z9
MM6G^RG_R;)\/?^Q=L/\`TG2@#\^?^"FPS^UWK?\`UZ6G_HA:\`Q_G->_?\%-
M_P#D[O6_^O2T[?\`3!:\=7X;:P_A&TU[[+&-)OKO[!#<&>,!I\9V$;MP('))
M``'/2@#T;Q?\<X]*^&7@FS\-ZO`NIZ?HMQI6HNEM(LT"RRLY5'=``"IVEDYZ
MX.#SU'B_XM^!_%GA2^TN]U.SN(_^$=T>RM'739&FAN;=@)RCM$"#L!`).#G!
MZFO"?&O@G4_AWXCN-(UBU%GJ5KCSH-ZR&(D`@$J2,X(.,]Z=-X%U.W\"P^)&
MMX_['FO&L$F$J$^<%WE2H.X?+SR!0![M)\2_AO;^)/![?;-+N[/P_KLTDTTN
ME2&:;3BB>4)/W(5G!5@5`P"1CY>:R_`?QD\.:?I^H-J5QH:WW]O:>UNXT<D-
M80LPFZ0G&Y"ORG!)!.`3SY;9?![Q%JECH5U;V*S1^)#<#3RL\69_(_UH/S?+
MM_VL9QQ7,=O_`*U`'T+K?Q`^&_BBXL5NM0M+..Q\1:C=026.DF-XK)US:I_J
M<;`X&1M+*#P`>D.M?$3P#K-[J$B76EZ?K5]X9M;2'5(=.E%O:ZA&W[]ROE[Q
MYB`!9%0L.<X).?`!P?\`ZU:NC>"=4\0:7/?6]J/L-O(L4ES-(D,*R-]U-[D+
MN(R=H.<`G&.:`/59/BMX93X8B*UA\*C7I/[0CU:.]TVX,6HF9]T4UNT:X4HN
M`@D"[".,9.='Q-\3O`M]X3UF>SDTZ'4-0T?28K2"/2VBN+2YMW0W`WK&%4/C
M(*O@X.<<9\-UG1[GP[J]U8WD?DW=G*T$T>0VQU)5AD$@X(/()!JN3D?_`%J`
M/?OB)\5?"/BWQ5\3-1DU6UOH?$5G#_8PDL9O.MR)49X@QCS&=JL.&V\CGTJZ
M[XT\#ZS\2S<VNK6NG^%_LYGTRSBTV1)M,N4MPB13?NF'EL_+-&78DEN#R/"L
MX'_UJ`<?_JH`]]\7?%3P=>6GQ`_LV^L;<^)?#MA:PQ16<\2RWD;Q//QY>%R4
M;#'`.1ZDUX&%P,>G%(3N_P#U4F/\XH`[W]FOCXSZ%_UW/_H)K]6O'G_)#->_
M[`MS_P"B&K\I/V:O^2SZ%_UW/_H)K]6_'G_)#->_[`MS_P"B&H`_(KX2ZG:Z
M#\4/#^H7UQ':V=AJ-O<S2NKL$1)`QX4$G@=A7KN@?M$V=K^TU]LFUJ&+P/#X
MCO-=C\NU=?,:42!790GF-)M90<\#YOJ?`,?YQ1_GI0![Y/X_\"ZYIOARZN]6
ML;?7])TF_BDGBTMTCFNS-FV$V(26C$98952PX&0"<R>*_BYX+M;WX@7^AOH:
MW6J2Z=<Z,AT<\-'@W*_-%A=Q!XR`2<\9S7@!.[_]5)C_`#B@#Z&;XP^#[?P>
MUK!=:$MQ'X.MK2+.BG*ZO'.7:4'R>#M/WQ@$_G6A8_$CX7V?Q?O]>CU"S^S7
ME]9+-:/I3_8Y;3R`MP53R21)YH)P<(5)/+8Q\TX_SBMJX^'^K6G@BW\1/:H-
M'NKEK2*<31G=*H!*[-VX$`@\CH1ZB@#TC4/&GA"V\`:/;Z9-I\,EC<W":U9R
M6<OF:O&\ZLCQ2[",B,;0'*%>W).>ID^-/@>V^+VCW!M_"UQX1CU&:Y41Z//]
MNL(9+?RUB=9!Y91&V-B,L=REAR2#\\S6LULL?F1NBS*)(\K@2*>`P]1P>?:M
M/QEX#U3P#=V<.J6\<$E_9Q7\`65)0\,HRC90D<CMG-`'MWA;XJ^#O"5II5I;
MZO90W"^&-4T>[O[2PFB074KL8)6_=!F&T@;@K,.XZU1\(?$'P!I^D>"X=8EL
M;F^T^SU2*^N8M-9_(NIFS;7+J47S@B@>K`XX.*\(SQ_]:D_STH`][^$7C[P5
MX<OVN/$>LZ?J5U-<?9+]&TN26TN[,6AC21`80[2^9RYDV]"0"QR8-&^*OA?2
M_`W@>SN+C3M5DT.SU.WN[>:*YC\LW$X9&BD$>4D"9(<!MI&,="/#"=W_`.J@
M';_^J@#H_BM?:7J7Q'U6?0YKJYTF2;-K+<(J2R+@#+!0!G.><`D8)&2:_37]
MA'_DA&G?[B_^@BORH7[P_P`*_5?]A'_DA&G?[B_^@B@"A\)N?C-\7/\`L88?
M_2*WKT,H&Z\_6O._A0VWXR?%PGH/$$/_`*16]13_`+6_P^MM`\7:M)KQCTGP
M/YHUB_:PN1:P&)VBE6.7R]EPR2(T;+`7*N-A&[`H`]*"@4WRU]*\SNOVQ?AO
M9^)O#>DR>)HOM7BZTLK_`$IULKAK:XAO7:.S=IQ&8H_/=66,2.I=A@`GBO3/
M\]*`';::L*J3A0-QR<=^U&/\XHQ_G%`"A<#BE"XIN/\`.*,?YQ0`NP4I7/O3
M<?YQ1C_.*`!X5D5E90RMPP/0T;%]*,?YQ1C_`#B@`,:D=*=BFX_SBC'^<4`.
MQ1BFX_SBC'^<4`$H^0UR_P"Q1_R3;Q!_V->K_P#I6]=/)]S_`.M7,?L4?\DV
M\0?]C7J__I6]`'L5%%%`!1110!\]_LU;_P#A#?%'EE5D_P"$IUG:2,@'[7)U
MY'\Z\T3_`(*$IX(\$MKWC;PS>:;;1ZF?#[PV,D+3+>VJD:C,JS2QF2UBE_=J
M8@TC>6QVD,M>F_LQC/A7Q)_V->L=O^GR2KWC#]G#P#\0K);'6?#.EZA##=W&
MH".6,\37+EYW.#D^8Y)8'@D`X^48`/._AM^W7I.O?%/3O`FI:=JDOB+4=0U"
MW-S86P:PLXXK^_M[?S2TGFAG2R.65&0,1DH"!70>)_VD[KP_KFN6K6-JT.C^
M-+3PSD.=[PRZ9;7K2?[X,[`#I@`FNHT?X(^!8O&L?B"QT72UUS29)HS<PG]Y
M"\CRS.'`."VZYE<;@2IG<C&\YL:A\`O!FJ_$0^+;CPYI<WB)EP;XQ?O&/E&$
M.><&3RF,8?&\(=N=O%`'E6C?\%!-!UW3=,U230/%.BZ?<;)9X=0M[?STM98+
M>XCO"8[AD2$0W`D?)+JL;@HI7!K:A_P4X\!V.L:G:KH_C"ZCTG3[S4IKF"RA
M>%H[>&:X`7]Z&_?6\)EB8J(V66(%U=]@]:/[//@EM/:U/AK2S;261TYHC$=K
M6QMQ;&(C/*^0HCQ_=&*IS?LM_#V>8.WA/2?^02-#*+$5C:S$1A$14'!`B9D!
M(W!6*@X.*`.-UG]LR*T\176C'PCXJTO6K&73T>ROOL'G77VIXE$<(6\^8@S(
MIF'[D/N`=F1E#O@G^VQI_P`4=/\`!=MJ7ACQ!X;\2>,;"POX=,G:WG\N&ZM[
MJ=9A)'*P,(6SF!8X8$Q@HK.%KT*[^!/A"_\`&UQXCGT"PFURZ>)WO'0M(#$T
M;H5R<+AHHB=H&[RDSG:,9?A']F7PEX$\=:'KFDZ<E@_AK2+K1-+MH@!#9V]Q
M/%/*%R"W+1(`-VU%!"J,F@#SFS_;T@\-OXOC\4>'=7A;P_J&IQ6$]L;6&VU>
M&TU"&SV1--=+^_#7-N")1$KLY$98@BNN^#?[87A[XW>(;*QTS2]>LH]0T"#Q
M#;W.H+;P1S0R!"41/.,LC1[P'=$:)6ROF;N#TGB+]G7P1XML+BUU'PWIMU#<
MO/*X9&!WS7$5S(X((*L9X(9-P((:-2,$4_P1^SWX*^&^M6^H:%X=TW3+RUL1
MID#PQD>1;#8/+09PHQ'&#@`D1H#D*,`'CNI_\%!&U/5/":^'_`WBR]_MR>&X
M;3Y8[-;W4-+N-.U&ZMKRU)NUB4.U@V5F9)%5&!C#,F;>N_\`!2SP5H>CS7PT
M3Q9=0M)9)IZ11VB3:P+JVDNHWACEN$=8Q%%*?,F6)6*,(S(017>']C/X6G0G
MTT>"=%CL7N1=B)(2HCD6-XEV$'**L<LB*BX55D<``,0;&I?LE?#?5I+QYO".
MDM)?-"[NL;1M$80PC\IE(,.`S<1[0=[9SDY`.//[?WA>&VU"^F\/>,;;1;$O
M"FIS6L"0WMRNG#4?LL4?G>?YQ@/`>)07^3.[BJ6@?\%%/#/BS7+G3=*\)^.=
M0OX=931((8K>T7[=,3<AFC=KE454-I*&\QD;&TA2K!J]5O?@1X-U'2/[/N/#
MFES6/]IP:R(&AS&MY!Y?DS@=`R>3'CMA`.F:AT7]GOP7X=UV74K'P[I]M?3:
MA_:K2(C#%U^]S,JYVJQ,\S':`"TK,<DYH`[3%&*;C_.*,?YQ0!C_`!&'_%OM
M<_[!\_\`Z+:M/]E/_DV3X>_]B[8?^DZ5F?$;_DGVN?\`8/G[?],VK3_93_Y-
MD^'O_8NV'_I.E`'Y\_\`!389_:[UO_KTM/\`T0M<U9>.=)MOV9-!T7[5IL^K
M0^)I+V6UF5B886B5!(3P/O`]R<<XKI/^"F__`"=WK?\`UZ6G;_I@M?/_`/GI
M0!]'_$GQ_P"!?%?Q*\9:I#>:+=7VI:SI]S9W=]:>?;RV*JBSH`\9VMD9(*@E
M00I/=MCX[^&,FE6MC-(J^%QX[GU,Z<R2&2.P:W$:,1C.W>`2N=VSC!KYR_ST
MHQ_G%`'TIIGCKP9=7GP[L=:U3PS?Z?H-WJYU*-;'_1%CF(>';&8P#G"]%X(.
M:ROAOXB\"6'ASP?8ZP?"S?Z)JT6N/)I\<DNXKBS(D$98-D##*<COBO!]-TZ7
M5M0@M8%5IKB18XPS!`6)P.20!^)K;N/A3X@M/'K^&)-.9==B8H]KYL99&52Y
M!8-MR%!/7MZT`>S:YX5TJT^!LMMI^E^$Y-:?PS:7$Z.\!O+7:[3372EU\QFD
MC=!MR`!]TD8!XVU\3Z'XV_9PTWPO)JUKH>M>']4GO@+I)/)U&.50.'16Q(I&
M,,`-O?M7G=YXNU74=/6UN-4U":U6-85ADG=D$:_=3!/W1V'08'I1H7A?4/$L
M=_)8V_GKIMLUY='(7RHE(!;D\\L.!D\T`>N^"O$?P]L/#_A_^U!IUXL$&IIX
MB$EH7NK^9L_9GA=DW@'Y<8*[2&W=>=5/%O@6T\(>3'_PB+7D?@Z'86TN$R?V
MRMP6.6,?.8^N24(P.<5\_P!Q:R6I7S(V3S%#KE2-RGH1['UJUX9\.7GC#Q%8
MZ7I\:S7VH3I;6Z,ZQAY'.U5RQ`&20.3WH`^C;^'PG?6/Q$UOP[:^$VL[.719
M+6>?3H9+>U,C;+E0CH0JLRME0,$'CK532=;^$LWBW7+Z&XTN#1]7NKN%--N]
M.4?9(_LV(986\EY$#3<@+)'L&`5/2O"[K5M>\#+JWAW^T+ZR@:=H;^SBN&$,
MSQL5.]5.UL$'!.?:L0\G_P"M0![YX=U_P*/!VCZ?>'POYLGA2_@OY#I\?FKJ
M.YC;$R^7O#8*_,K8XYZ5SOQ7US0[KX/>&=2L=+T^TUS7+5;.]2+3XHT3[)(Z
MM.A"\-,6CRRXYB<=#BO)1P?_`*U6]4UZ^UQ+5;V\NKQ;&$6]N)I&D$$0)(1<
MGY5!).!QR:`.Q_9KX^,^A?\`7<_^@FOU:\>?\D,U[_L"W/\`Z(:ORD_9J_Y+
M/H7_`%W/_H)K]6_'G_)#->_[`MS_`.B&H`_&K%&*;C_.*,?YQ0`[%&*;C_.*
M,?YQ0`[%>K6>IZ/K_P"SAX=\.3ZW8V-Y%XDGO;D2;F:VMWB1-Y`'S<JWR@D]
M/6O)\?YQ70>#OAKJWCRPU"YT^.W:WTE8WNGEG2$1"1Q&I^8C.78#CIGG`YH`
M]FU+QOX&\4ZQH\E[?:*RP^!TT^S\^P)CT_5DC`S,OEG<F=VW[ZY(...>3_:`
MUC1?B#=:5>V>O:4TFC>%=/M&C2*5?M-S&`DD48\L!=N2V3A<#CT'-ZI^S[XJ
MT@1?:K&&%Y-6_L+RS<QF1+SKY;*&)&1R&/RD<@UC^*/AQJGA#0=,U.\6U^PZ
MP9A9RPSI*)O*?8Y&TG@-QD]:`,/%&*;C_.*,?YQ0`[%&*;C_`#BC'^<4`.4?
M-7ZK_L(_\D(T[_<7_P!!%?E0OWA_A7ZK_L(_\D(T[_<7_P!!%`&=\*D\SXQ?
M%U?^I@AZ?]>-O7A_B7_@G'KWBGQ]X@OK?QQ:^$]!\4:[9ZQJ6DZ!IK+!<R6U
MY)>BY,5U)/`MU)*+82.L0218Y-Z,S@K[E\)O^2S?%S_L88?_`$BMZ]#)S_\`
MJH`^)?#_`/P2@US0_%GA&9O'UM<6?@Z.PL].O)-.E74K:TL=7N+^W5#'*D)<
MP2K;.6B*;59E09`'VTJ;%Q28_P`XHQ_G%`#L48IN/\XHQ_G%`#L48IN/\XHQ
M_G%`#L48IN/\XHQ_G%`#L48IN/\`.*,?YQ0`[%&*;C_.*,?YQ0`[%&*;C_.*
M,?YQ0`2CY#7+_L4?\DV\0?\`8UZO_P"E;UT\GW/_`*U<Q^Q1_P`DV\0?]C7J
M_P#Z5O0![%1110`4444`?/G[,PSX2\2X_P"ALU?M_P!/DE?*G[0ME\8/@%\%
M=!U)[KQ;J&L:WI^FV&M7<&J0K>07A3499P+C($44<GV4@!U1R/+#$R,&^K/V
M8O\`D5O$G_8UZQV_Z?)*](*Y_P#K<4`?%MY^S%\1O%?@+QM<:;?>-?LGCNPN
M)DL[O4DL+B9O[*TL6LCHQ#P73W$%Q&Y9@1E@YV[2/L+PA"\'A338Y(=0MY$M
M8U:*_F6:ZC(4?+*ZLZM(.C,&8$Y(8]:T,?YQ1C_.*`'8HQ3<?YQ1C_.*`'8H
MQ3<?YQ1C_.*`'8HQ3<?YQ1C_`#B@!V*,4W'^<48_SB@!V*,4W'^<48_SB@!V
M*,4W'^<48_SB@#'^(P_XM]KG_8/G_P#1;5I_LI_\FR?#W_L7;#_TG2LSXC?\
MD^US_L'S]O\`IFU:?[*?_)LGP]_[%VP_])TH`_/G_@IL,_M=ZW_UZ6G_`*(6
MO`,5[]_P4W_Y.[UO_KTM.W_3!:^?\?YQ0`[%&*;C_.*,?YQ0!H^%&CB\3Z<T
MDB0QI<QL[N<*@#`DGV%>XW&L^#-=_:VU3Q1JFL:'?>&[[5)9!%<0&>.:%H9,
M2,K*2,2",8QD[CVS7S[C_.*4''_ZJ`/H'X?^(_`FG^#_``W::E_PBK7*Z9JR
M:JTVGQ22FX)_T/\`>;"V>F"#T^]4.H:YX$O?MEQN\,I<W7@2.)ECLD1%UL$!
MF153:C;=WS*`O/KS7E/A+X0>(?'.CMJ&EV"75HMU'8[_`+1%'^_D_P!7'AF!
MW-VXYINJ_"+Q%H>B1ZA>::;6TEOFTT-++&K+<J2&B92VY6&.0P&!S0![-K?C
M;P#XM\:M=7U]I,D,OA*"STMFM"L5C>I#$C+,OE$=G"DJZ@\XZ8B\#>/?`UGK
MRZOCPWH6M6?BNQO9C';R36_]G1JOF"U)C.UO,5F("KU&T@#%>/\`BCX2>(/!
MFA?VEJ-G'!8_;'L/-6YBE'VA/OQX1B=RX.>.,5S6/\XH`Z#XJ:C!K/Q+\07E
MM*D]M=:C<312(?ED1I&92/J".M8.*;C_`#BC'^<4`.Q1BFX_SBC'^<4`=[^S
M7Q\9]"_Z[G_T$U^K7CS_`)(9KW_8%N?_`$0U?E)^S5_R6?0O^NY_]!-?JWX\
M_P"2&:]_V!;G_P!$-0!^-6*,4W'^<48_SB@!V*,4W'^<48_SB@!V*[[X,?%.
MS^'.@>)K:Y6Z\_6H+>&"2*WCG6$QW"3%BLA`;[N`/7GM7G^/\XI2<C_ZU`'K
M>J_M)PW-_P"/I(-):.W\53K>V"23F1M.NEROGY_O&-Y>1T9EQP!7*^-O'UCX
MC^%G@W0[>.\6Z\.+=K.\JJ$E\Z7S!@AB?EZ<@9KC<?YQ1C_.*`'8HQ3<?YQ1
MC_.*`'8HQ3<?YQ1C_.*`'*/FK]5_V$?^2$:=_N+_`.@BORH7[P_PK]5_V$?^
M2$:=_N+_`.@B@#/^%/\`R63XN?\`8P0_^D5O7DFK?MF>*?AA]N\0>(+31-<\
M,S:KXATRRTO2+.2VU:U&F37*I(\LUP\4ZR+;[20L(1YHASN)'KGPG&?C+\7/
M^QAA_P#2*WJY8_`3X>67B'6[BW\'^$X]4\0*YU>5-,@%QJ2R/O?SVV[I`S?,
M=V<GDT`1_$_QIXLT[X)WFJ>&]#@;Q<D4)32[F1+C[.[/&)5PLL:S.D;.PC\V
M,2%57>N[</'I/^"DNA^%X+.VO=/U7Q%*FAW>HW>IZ9IKV=L+FUM[J>6U:"9V
M:VF*V<P$4LA<,,?,N7'NOB[X8^#]7\,Z];ZYH7A^XT?695OM8BO+.)K>]DC2
M-1-.&&UF5(8AN;D").?E&,D?LP?#66XM[@>`?!IFM;!M+MY1HUN&BM&C>(P*
M=F1$8Y'7:.-KL,8)H`\N3]NAQ\9O#?A_4-!OM$?5CJ-A<Z?=S6^ZWNK<V4PD
M:Y60PB,6D\DF-V68!1DU?^#7[>MI\<=>TG3=)\&^)([K4+^YM9_M31VZ6D,,
M%E<&Y^=E:2-H[^$J8PVXABNY,.?6M2^#GA/6+J2:\\-:%=332"9WEL8W9W#0
ML&)(^]NMX#GKF&,]5&*_@+X#>!_A4(_^$9\'^&?#WDM(Z?V;ID-KM:01K(1L
M4<LL,0)[B)`?NC`!XEXW_:Z\1Z?KNM7$-_H>EZ59WVLZ/I^G/X?O;Z[N+JPM
M9Y=TUZDP@M6D,)ECBDB.^$`A\L-MC3O^"@@TWP9YNJ^!_$*ZYI-C/J6L64=Q
M9@VUE;6=A=SW2GSMC_N]0M\1*Q8L7'1=Q]7U+X-_#;Q%XE7Q==^&?!M]K%]!
MY*ZO)I]O)<7,3QF/'G%2S*T3,O7!1L=#BKFM_`+P+XM6W.I>#O#&H+;W$=Y!
M]HTN&;RIDB2))%W*<,(XHT!'.V-1T`H`\2^)/[?&H>&O%")I_@W6)H=%U'48
M=4L)9+:*\N+.VL[F<74:R2*41OL[,A(/F*1M_CV>I?'GXF:WH'A'PT_A&ZT6
MUU+Q)KEGI:7&IV<E[;VT<P9F9H8YH69MHQCS%QG//2M6Q^"?P_MM3U);?PKX
M5AO-2EEN;_9IT"S7+S(R2O)@98R([*Q;[P<@Y!.77W[/7@G6?"=YH>I>&='U
M?1[Z_?5)[34;9;N&6Y9BWF%9`1E>`O\`<5548"@4`<+^SM^U3J'Q9\3R>';[
M05%]H\$S:KK%I<(NFETU"_L(S"CN92)7L)'`^8*'4%V/)R?C%^V!JWP=_:!U
MKP[=:?IUSHIT"W;0R`Z75YKDSW`AL6;<5(G6([,*"IC?).X`>M1?";P?I^F+
M8Q^&_#\-DT-M9K`+&)8C%;NTEO$%QC;&[,Z+T5F)`!R:L:MX*\,:_P"(HY;[
M2=%NM65X;R-IK>-K@-;LPBE4D;OW32N%8?<,AQC=R`>%_!_]M;7/$NF^'].U
M#05USQ5K5A;7,MKI*+96\0,3/<RA[BX.44@;4)W_`#`9(#.*&A?\%$KCP_\`
M#74K_P`2>$-8GU:QF)LX+$Q.VMPM>7\"M!%&[R;D2PE9DVEMHWD*N\I[;=_`
MCX=^*;=;*X\(^$[^/2[B&18)-,MY!9RQH3$0I4[65)25Z$"3T-3:_P#L^>`_
M%FCMI^J>#/"^I6+!0UO=:7#-$=LDD@^5E(X>65OK*YZL<@'B\_\`P4,M_&^K
M3Z;X7\,>*H(X;O28QK=[I<@TR07-YIT<T/FCY!((K[`PQ^9'XPJEOIA.5[UQ
M]C^SWX#TW7)-3M_!GA>WU&:."%[J+2H5F>.`Q&!2X7)$9@A*C.%\I,8VC'8`
M8'_UJ`"4?(:Y?]BC_DFWB#_L:]7_`/2MZZ>3[G_UJYC]BC_DFWB#_L:]7_\`
M2MZ`/8J***`"BBB@#Y]_9BX\*^)/^QKUC_TLDK+T7]L_PMKO@SPUK,-EKBKX
MGUN+0H;-X8Q=6DLDJQK+,H<JD1\R)MP9CMGB.,MBM3]F/GPKXE_[&O6.<9_Y
M?)*R="_8P\+^']3ANX;K6&FMX=,BC#S(55K*X@G$@&P#?-]EM8Y#W2W0#:02
M0#H+W]J7X=:=HSZA-XR\/QV<=TUD96NU"^<JAV4?1#OSTV_-G`)%S6/VA/!6
M@/K"WGB;2+>3P^8QJ"O<`&V+OL4'U)<A<#.&P.O%><^#/V`/"_@K1-2LH]7\
M07G]JI=)//.;597^T6@M'9C'`F]_+&3(X9V<DNS=*P/C'_P3^D\0G7M6\+^)
M-8M?$6NW44TDLMZEE+%&MP)]D=Y#;M.I5@%1I/-VQCRU"C!4`]=A_:=^'\UO
MYO\`PE^@K']@34R[7BJJVK*C+,2>BE9$;GHK`G@@U'I?[4WP[UK2]0O;7QCH
M%Q;:4L;7;QWBM]GWN8U##KN+@IMQG=QC)`/G_A']@C0M-O/[6U*>%M>O-.M+
M6^>STZTCA\V"WMX-\,C0F>-"EM&OEB39M!PH)R-CX@?L1^&?B/I9M;ZZU$*M
MQ>7<3-';7"QRW.HF_<^7+"\;@2%E`=6&QN<L`P`-_P`3?M;?#SPM8:I/-XIT
MF9M(TQM7FM[:Y6:8VPA6<.JJ?FW1LK#'53GIDC3UGX_^&-&\!:EXC^W-?6&E
MPQ2RI:(9)W:94,$2IP3)+YD85>Y<5RZ_L:>&5\,S:2LVH1V=SO5T@6"!45M)
M&E$(D<2HB^3\VU5`#]`%`6NB\0_!+_A-/AWJOAS6_$&NZI#J4<`6\;R(;JSF
MBV,L\1BB15D$L8FY5E#]`%PH`*^F_M*:#;W6D:?XF63P-XAUR4Q6FB:Y=VHO
M9#O"(?W$TL1#L0JXD.YCM^]D53M/VQ_AO=Z=<:@OBO1FT:WAAE&I"\C-O,97
ME140!M[-F)OX<8S@G:P7)U#]CY?$'B.UU36?''C+6+AC8C4UN$T^./6$L;M[
MRS258K5-@BFD<YA\LL&(<N`!4'_#$6C6.G>%UTOQ%XET74O!NG6.G:5J-L;6
M2XMUM8KN%7*RP/$[/%>W"-N3&&!4*PS0!UOQ-_:+T+X5W-LMZMU=QW6ESZM&
M]FHFWQ1RV\**@!^=Y9;J%(POWBW4"N7N?VSK#1_'^D^&=9\'^*?#VK:E9-J,
MT>I7NDQC3[=7=#(^V]8RC$;-BW$S!1R`>*T_BQ^S;'\5?%EE<W5]<1V2Z#<Z
M/=2QN([P2&XM+FVNHV"E5DAEMBPRI4LX)!`VFA-^R*=4\:V>O:MXY\4:W>1V
M!TN]%W9:7MU*U,COY3[+13$,2.N83&Q!Y)/-`#=%_;/TK4OLWVSPOXLT%;^.
MQN[%M4BMX_[0LKJZBM5NXQ'-(51))X2Z2B.5%D4E!G%>R*=P_#/6O"9/V+VM
MM!AM3XKUSQ#-;KI^G6LNM-`3INF6][!<R6\7D01[FE%O&C22;G.U"6^7!]?\
M"Z-J6@>%K.UUC4_[9U)$)N;PPB$2N6+':B\*HSM4<G"C))R2`;.*,4W'^<48
M_P`XH`Q_B,/^+?:Y_P!@^?\`]%M6G^RG_P`FR?#W_L7;#_TG2LSXC?\`)/M<
M_P"P?/V_Z9M6G^RG_P`FQ_#W_L7;#_TG2@#\^?\`@IL,_M=ZW_UZ6G_HA:\`
MQ7W]^VK^P+K'QI^+5QXJTO5/FOHHHWM3:Y$7EH$R'W\YQGI7C/\`PZ_\9?\`
M/Q'_`-^A_P#%4`?,^*,5],?\.O\`QE_S\1_]^O\`[*C_`(=?^,O^?B/_`+]?
M_94`?,^*,5],?\.O_&7_`#\1_P#?K_[*C_AU_P",O^?B/_OU_P#94`<Q^SK\
M1M(\$?"VXM[J_P!)COF\3:=J,<-VK-MAA)+R84'[N>!U)Z`U+I?QQ\,VEQ\1
M;6>2_OM.GU0>(_#KW:^9++?)(P!?_?5P3N_A0YYIOCO]B.X^&$L<?B#Q1HFC
MS3)YD<=U+'%(ZYQN"EP2,C&:K^`/V-9OBI-)'X?\2Z9JK0G#^0`^T_@U`&'X
MC\7Z?J7[*.B:0-0BFUJW\07-_<6Y),HCDC"AR<8)+`\9SWQ7E^*^F?\`AV#X
MRQ_Q\1_]^O\`[*D_X=?^,O\`GXC_`._7_P!E0!\SXHQ7TQ_PZ_\`&7_/Q'_W
MZ_\`LJ/^'7_C+_GXC_[]?_94`?,^*,5],?\`#K_QE_S\1_\`?K_[*C_AU_XR
M_P"?B/\`[]?_`&5`'D7[-?'QGT+_`*[G_P!!-?JUX\_Y(9KW_8%N?_1#5\4?
M"3_@G;XM\#>/M-U2:2.2.TF#LHCVY&"/[WO^E?=6O>&)-?\`A_>Z/YHMVO[&
M2T,FW=Y>^,IG&1G&<XS0!^*^*,5]3>(/^"6'BC3-6EAL]26\MT.$E:V$>\?3
M><?G5'_AU_XR_P"?B/\`[]?_`&5`'S/BC%?3'_#K_P`9?\_$?_?K_P"RH_X=
M?^,O^?B/_OU_]E0!\SXHQ7TQ_P`.O_&7_/Q'_P!^O_LJ/^'7_C+_`)^(_P#O
MU_\`94`?,^*,5],?\.O_`!E_S\1_]^O_`+*C_AU_XR_Y^(_^_7_V5`'S/BC%
M?3'_``Z_\9?\_$?_`'Z_^RH_X=?^,O\`GXC_`._7_P!E0!\SXHQ7M7Q&_8Y;
MX27D-OXB\4:/I-S<)YL<,Y59'3)&X`MG&01GVJKX'_90A^)&J"RT/Q9H^I71
M&?*@VNP&<=`V:`/'U'S5^J_["/\`R0C3O]Q?_017R"O_``3`\9$C_28_KY73
M_P`>K[@_9;^&M_\`"[X7VNE:AM\^`!21WP`*`.-^%!`^,WQ<!;;_`,5!#_Z1
M6]>&>(_A%X[\+Z!XYA\._#V9/'FI:O=W*^-;2XL/M&J6%QJ8F2%)#=071:*V
M*)Y4CP1@6P"2GY`?I[Q9^Q_X/\9>+]2URY_MZVU#5Y%ENC9:S<VL<KJBH&*(
MX7.U0.E41^Q!X+'_`"]>,/\`PI;W_P".4`?'H\*?'CXFZ5K7AO4E\376I6_A
MY--U9I]0LXM(GEF\-!9H!'OWO.^HR1.)%S&H$@\Q?F5^RT3X<?'CQ'\6/%-K
MJU[X@T3PA?:]:FUDLM1MT>*Q2>\$Q@D%Q(X5[<VF<10,&)"J63SF^CO^&(/!
MF/\`CZ\8?^%+??\`QRE_X8?\%_\`/UXP_P#"EO?_`(Y0!X1\7?#GQTG^%OPA
MMO#[:A+XBL8+>3Q5<1W=ON-S']F#B4?:(4=''VG<R>:H8*!"P</'GW'PU^-F
MDVL\DVH>,]8L]2O([C4;.SUBRAODC6\U`".RD=DCBQ"VG,P9ANCCD&3(6#?0
M_P#PP_X+Q_Q]>,/_``I+W_XY0/V'O!8_Y>O&'_A27O\`\<H`\!\3?`'6(_@%
M\"-)USX=_P#"Q/\`A"H(X=<T1GT^;;)_9,UMO/VJ2.%@LSKED);G(4XXZG]E
MKX:?$#X.6K1^*)M8UT01:9I-E;1ZK')96-NME;BYF4.0[[+A95+-F1P,A?F;
M/JI_8?\`!9_Y>O&'_A27O_QRC_AA[P7_`,_7C#_PI;W_`..4`?+'Q`_9E^(A
M_:R^(7C'PMH=]::AJLEU-IFLN^F16AB;PY;VD0CE1OMXG%]`HV2C[,J!GP'V
MM71^-_A1\6OCY9^*EU)O%/A/2]4T778].TO^VK:)UN9K>QBLHYVMWD&W/VT_
M*Y52V3GY:^A/^&'_``7_`,_7C#_PI;W_`..4?\,/>"_^?KQA_P"%)>__`!R@
M#P?X]?!7XB_%+P9X"A\,V/\`9\W@JR77HHO$MX+F[EU>)HS;0M+#,REU59U>
M1F:,BX&"V#CBO&?PG^/6K>)=>US2X_$MGK$RW-H9Y[^QN4DM)-6AF2*PB2Z@
M,9^Q(B-YDT!WQ/AMQ$DGU;_PP_X+/_+UXP_\*6]_^.4O_#$'@O\`Y^O&'_A2
MWO\`\<H`^8W^`?QL_LS59K?7O$%CK%QI\E[]NL[BSM)=2U./2])@MS-'OE0#
MSH+L,NYD)4[F*LNZ_?\`@+X^:)\3/"=IIUUK5WX;T?5KL7%]<:A!/)=V+WLV
MP7&;B,[A;&':WE7#'&/W#J6D^B_^&'O!?_/UXP_\*2]_^.4O_##_`(+_`.?K
MQA_X4M[_`/'*`.)_9(\&>._`GAB>U\<ZIJ^K7,]II]QYVHW<5S)'=M:1B]16
MCX$8N`Y51\HR=I(KU[C_`":Y?_AA_P`%_P#/UXP_\*2]_P#CE)_PP]X+_P"?
MGQA_X4E[_P#'*`.HE^X?\:Y?]BC_`))MK_\`V-6K_P#I6]'_``P]X+'2Z\8#
MW_X26]_^.5WWPK^%6D?!SPL-&T2*>*Q$TEP?.N'GD>1VW,Q=R6))/<T`=)11
M10`4444`?/O[,HSX3\2]O^*KUC_TLDKX\^%?[6GQ9^'?PYU*^0S>(Y[QM*BE
MN]4>ZU*P\/3.+XW#3AUM2DCE+6,P)*8XC(C;LMM?[#_9C&?"OB3_`+&O6.W_
M`$^25Z,(5#;N=WKSS0!\N:C^T3\9K[1[JZL],\):9,^I_P!GP6ESH][<FV6/
M0#J4SNZW$1DWW&($PD>W&3O8A1A>*/VW?B?X*N?#NG77A_2[S4K_`%^WM;J2
MVT*[^S2V4MOI<[(C&YS'/'_:$J[]L@<6DKF.,*P7[!*`G/\`C2&%6ZCWZ4`>
M.?LP_&+QO\2?$FL6_BZST>WM?L,&HZ=]AL9[9H`]W?6[0RM+(XD8+:Q2;E"8
M\[&T@!F\^^)?Q,U/_A:&O6NO^(O$GAOP9!XKGL+^]TN20/8B/2;"6S@:1%8P
M13/-/,77;N<)&6^;:_U,$"_ATSFJMIH-E87UY=06L$-UJ#*US*D85[@JH12S
M#EB%`49Z``=!0!\1_%'XM?%K1_"/Q/T+1=2\774GB!-3U7PWKGV,B;1(-/B<
MW$7^K`0RA+-(E*[C)>3D#$9`[>/QMX@\0?&;^SIO$OC2W\03^)M4T_5M&5)(
M--L?#ZQ77V>[5@@6/,:VDJ7"R;S-(8\\%%^K1"JGI^>34.I:1:ZSIUQ9W=O%
M=6EU$T$T,J;HY8V!5E93P002"#U!H`Y7]G#Q3J'CK]GWP/K>K[CJNL:#8WMX
M67:6FDMT9SCMEB3CWKM,5';VT=I`D42+'%&`J*JX"@#``'8#IBG8_P`XH`=B
MC%-Q_G%&/\XH`=BC%-Q_G%&/\XH`=BC%-Q_G%&/\XH`Q_B,/^+?:Y_V#Y_\`
MT6U:?[*?_)LGP]_[%VP_])TK,^(W_)/]<_[!\_;_`*9M6G^RG_R;)\/?^Q=L
M/_2=*`._HHHH`****`"JNL:S:^']+N+Z^N(;6TM8VEFEE8*D:J,DDG@`#FK1
M.!7YZ_\`!3+]J_6/$/C>\^'MC#>Z5HNELIO3(IC?4W^\"/6$=1V8C/84`>?_
M`+>'[6,/[3/Q#MX-*M8X_#^A,\5C,T0%Q>,Q`:0GJ$.!M3Z$\\#U+_@F%\(?
M%'A;XB7>LZGI5W8Z;=0*L33+@/GYLCU'(_7TK"_8$_8BF^(FK6WBKQ);M'I-
MNP>UMW&/.(_B(/\`G^GZ&Z=IL.E6<<$$:QQQ*$55&``*`+%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`?GC_P5GT&^USX^:;+:V-U<V^F^
M'8I;B2*)G6!3<7'+$#`''?TKQ/\`90^.R_L]_%:'5IK=;BQF*QW&1DH,]17Z
MW:AH-GJI;[1:V\_F+L;S$#;EYX.>W)_,U^=?[?7["LGP7U&X\6>%K>23PI=2
M;KJV09.E.?\`VD3T/\)X]*`/T`^''Q%TSXF>%[75-+N([BWN$#`JV<9[5T%?
MEC^Q+^UKJ7P'\:VNE3O-=:'J4HB\C.YH6)QP/3V[5^HFCZDFKZ9;W,88+.@<
M9'J*`+5%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110!\^_LQMM\*>)/^QKUC_TLDJ5OVM_AF/`E]XH_P"$Y\,?\([IMU%97&I&
M_3[+'-*RI&N_.T[V90I!(.>#5;]FQ6?P;XH6/;O;Q3K(7<.,_:Y.OM7S7/\`
M\$PO&WB_PBG@Z^\3Z'H'PZ6]N+N#PU%-=:[;:4C:=)9+!;M<B)A"6N)YA&<+
M`\<.P-S@`^L$_:$\%R?%@^!?^$FT=?&`_P"80UR!=']SY^`G<^5\^!SMR<8!
M-=EFOC/X0_\`!/[XC:#^T?X9\>^*/$/A^\O])N-/O=0O[6_O)FO)(-".E3HM
ME(@MU:9CYAN<^:JY0<,:^RO\]*`'9HS3<?YQ1C_.*`'9HS3<?YQ1C_.*`'9H
MS3<?YQ1C_.*`'9HS3<?YQ1C_`#B@!V:,TW'^<48_SB@!V:,TW'^<48_SB@#'
M^(W_`"3[7/\`L'S_`/HMJT_V4_\`DV3X>_\`8NV'_I.E9GQ&_P"2?ZY_V#Y^
MW_3-JT_V4_\`DV3X>_\`8NV'_I.E`&]\6?B##\*/AIKGB2>WDNX=$LY+QH48
M*TH09V@GIGUKS*U_:7^(%[:QS1?!^]:.90Z-_P`)+9#((R*Z3]L?_DUCQ]_V
M!;C_`-!I?"O_`"+&F_\`7K'V_P!D4`<[_P`-'?$3_HCM[_X4UC_C1_PT=\1/
M^B.WO_A36/\`C7(:/\>M6N_BQXLT6YGTF.U\,ZR+!((]+N7N+R`Z=#?%A*KF
M-9`LK+M*_-Y?&"P`E3]M3P6W@Z/6F76H[>:&.ZCA?3V6>2![*2^\T+G[HMXI
M6(.&)C*A2Q4,`=5_PT;\1/\`HCM[_P"%-8_XUQ'Q2DU3XR:G87WB+X"/?7NF
M$_9IV\1V6^,'J"01D=\'(!Y&#S6Q=?M>^#[/Q%-I,C:FNH"&":W@>S,<EYYT
MUM!&$5B"N9;N!`9`BDN2"0CE:<?[;_P]:VM+B34[BWM[BU>[EDFMF3[$B1SR
M$S(?G4;;>;Y@I4;5!8;TW`'0:%\<?'/AS2X;.R^"]U#;PJ%14\26(`%6_P#A
MH[XB?]$=O?\`PIK'_&N8\&?'^_\`$.A?%*^OK)M+C\#WS06BRV#^<(1I=I>!
MI8UE;S&#7#<(4RH`PK9K2^''[2V@^/\`Q!;Z+#_:']H.6@,TEBT%O/.EM!<N
ML98DX\J='!Y&`1N)'(!J_P##1WQ$_P"B.WO_`(4UC_C1_P`-'?$3_HCM[_X4
MUC_C7GWBW]KZ3PS\0IK631+R'0M'U/4--U*0P+//.+;3H[WSX3'*0J!7.5D7
M<05`PV5KNO"'[1/A;QYX]G\.Z5>->7T,$EQOC3=$PC:)9%R"2K*TT8PX7=EM
MN[8^T`G_`.&COB)_T1V]_P#"FL?\:/\`AH[XB?\`1';W_P`*:Q_QKSJ__:]$
MNA>'WTOR;^YN-=LK'5ICI[PP6-O<7TELH</*&CEVQN0?G`*995$B5I1?MU>!
M;FQ:XMVUB^B\N>=7M;$S1R0Q6HNVD#J=F/))8`D/E&4J'&V@#L_^&COB)_T1
MV]_\*:Q_QH_X:.^(G_1';W_PIK'_`!KSSQ?^V5'H[:Y)9Z->,F@S:C$D4L2-
M_:_V734O08I%DVPY#J<2#)7.!N!`M?#+]J*:Y.KV?B5?MFM6ET633M(T:9;B
MVM!:V=P[LGG2^=Y8O(LO"3N\Q51"V00#N?\`AH[XB?\`1';W_P`*:Q_QH_X:
M.^(G_1';W_PIK'_&N4U#]L'03XYC\.Z=INM:AJHU:'2[B%8$C:V647NVX8.X
M.PFPGPN`Y`5@NUT8L\&?M@>&]2\#Z#J-]<7%T=0MK07%Y::;(EM'=W%HMU'`
M8RS21O)&RLJ'=CS(U+;G4$`Z[_AH[XB?]$=O?_"FL?\`&C_AH[XB?]$=O?\`
MPIK'_&E^$GQQT/XT:9+=:.M]&L,5M.4N[8PR&*XA2>&3:?X61\\X(*D$#C/.
MR_M>^%4\6W&@K;ZY-K$%]%IXM8[$F1Y)?M8B)YPBN;*X`,A3A58@(ZL0#H?^
M&COB)_T1V]_\*:Q_QH_X:.^(G_1';W_PIK'_`!KCKC]J^R\4^(_`,?A13J.E
M>)]3MK6^NI;1MMLEQIDM_#'G>I28QK"Y!1@%D`.UF7/L9'/_`-:@"M\!_CC<
M_&$Z];W_`(?N/#>I>';U;.ZM9+N.ZY:)900\?RGAQ7H5>*_LL_\`)4/BU_V'
M;?\`](H*]JH`XWX[?%O_`(4G\/9M=_LV75I%N+>UBM(Y5A::2:58E&]N%&6'
M)KAA^T=\0R/^2.WI]_\`A);+_&K?[;PS\$H_^P[I7_I=#7%_MD_MF^#_`-AC
MX7:?XN\:1ZS+I>H:O;Z+$NF6?VJ;SI@Y4E=P`4!&).<\8`+$`@'4_P##1WQ$
M_P"B.WO_`(4UC_C1_P`-'?$3_HCM[_X4UC_C77PR+/$KK]UP&&5(.#[4['^<
M4`<=_P`-'?$3_HCM[_X4UC_C5;5OCOXZUW39[.\^"]Q<6MU&T4T4GB.Q9)$8
M8*D'@@CC%<7^T_\`M>-^SMK>I69T74-2,'A2[UZV>UTVZNT$\+A52=H8V$,)
MSDR.548ZU3\4_MQ:?:ZK'96.DZI:YU>.SCO]1@C^Q:E!#J]MINH/!Y<IE!@D
MG"CS43<2&42+DT`<+\./V;YOAK\09=?M?@[JES^_::WMKCQ/8NEH"<A%[X'8
MG)QU-?0$'[0_Q!MXU6/X.7BHHPH'B6Q``KRSPO\`M]PZIXBQ?^$?$FFZ3JEU
MI=KI37,=I#(%O8GD2XGD-SY2QL-FQ`WG%FV^67RHZ/XA_ML>&?A[\8IO`[:;
MX@U;6[>P>^?^SK>&6-2MO+<B##2J_F-%"Y!V^6"54N&8`@'9_P##1WQ$_P"B
M.WO_`(4UC_C1_P`-'?$3_HCM[_X4UC_C7F&M?MX:;K_PYUG6O!F@ZYK,=GX9
MN/$D.HRP0II\,&V[^R2R@S+,T=PUG(4$:,P4J7\O<*W/%W[:OASP9X>EU"32
M_$%_Y/VW=%;16Z8^R:BFGS%GEF2.-!*^[?(Z((U+,RGB@#L_^&COB)_T1V]_
M\*:Q_P`:/^&COB)_T1V]_P#"FL?\:\ZO?V]/"?AF/56UE=2MULKAA`8K5&^U
M0++(DSQXD8R?9TB:64CHA4J&)VUM?#O]LGPU\1/A%<>-8]/US3M)L]6@TBZC
MNXH?-MGED@C$K&.5XVB47$;LZ.VU0X(W(R``ZO\`X:.^(G_1';W_`,*:Q_QH
M_P"&COB)_P!$=O?_``IK'_&O+M,_X*+>#_%&C6MUH.@^,M>DN;1[[[+9V=ND
MT<49N/.+^=,BAHEM]S)NWD30[0Y?`;K7[?&FQW5K?6.AZQ)X92^N;&2^E@AW
M:K*ENTD<=FOG!MS.8DS,D:GS0`>&*@'J?_#1WQ$_Z([>_P#A36/^-'_#1WQ$
M_P"B.WO_`(4UC_C7'^"_VJHW^$=UXN\6Z5=^&[2'Q+<:%-%*L1DTQ5O6M8FN
M"DKI]_8K-&[J2XQD<USNG_\`!0[POKL>G76FZ3XDNX;RS5C:&QCCNS>R36,,
M5A\\RJEP)+^%'5R%4R`F10K&@#U+_AH[XB?]$=O?_"FL?\:/^&COB)_T1V]_
M\*:Q_P`:\H^$W_!0#2?%_CK1/".LZ/K%AXFUR[O(S%%;Q&+3$2_O;:W2X_?,
M_F.+-PS1"2-6Y+(K+G4US]L7_A#OB?X@T'4-)N=2DL]2?3M*L]+A3[5J#[-+
M")OFF2(.9-0.=Q1`J9++M.X`]#_X:.^(G_1';W_PIK'_`!H_X:.^(G_1';W_
M`,*:Q_QKS#5?^"BOA'3?%NM:(WA_QBVI:#';BXABM+>0O<S26L7V08G.V5'O
M(@2^V,X?8[[36E_PW=X;31]0U";P[XMM['P_I=QJFOSO!:[=`$,EW$89P)R7
MD:2QN$'D"5,A26565B`=[_PT=\1/^B.WO_A36/\`C1_PT=\1/^B.WO\`X4UC
M_C53X-?'[3_CG\)Y/%FBZ3K$<<;SQ?V?<K`EVTD)(**RRM`Q;`VL)2GS#+#G
M'C_P@_X*%?;_`(2Z!K7C3PUK=K>:CIL.HZA<V%E;I8:9)<6TEY;6A!O)9&D>
MW5"'&4)DC+^0S^4@![7_`,-'?$3_`*([>_\`A36/^-'_``T=\1/^B.WO_A36
M/^-<AX[_`&Q-/^'7PV\/^)-0\(^,G_X2*"XO(=-AALVO+:W@@:XDFE_TCRU4
M0(T@42,YX7;YAV5G^(OV[O#GAV[O%;0/%EU:I/+9Z==V]K;M#K=Q#>P6,\-N
M#.'#1W%PB$S+$IPY0N%-`'H`_:-^(>>?@]>+[GQ+9<?K7:_`?XOM\:_!,FK2
M:5-HMQ;WMQ87%I).LQBEAD*-\Z\,,CJ*Y;X6?$FU^+?@.WURUL[[3EGEGMY+
M2]5%N+2:"9X)8G\MW0LLD;J2CLIQE6(()C_8H/\`Q;;7_P#L:]7_`/2MZ`/8
MJ***`"BBB@#Y^_9B_P"15\2?]C7K'_I9)7I.:\T_9F./"?B8_P#4UZQV_P"G
MR2O,/"'[<VN:/H'AR^\7>&8+YO&VEV^J:%;^&9!)<N9KNTM1;2I<O&BN'O;<
MB3S`K#S<A?+RP!]-49KB_BQ\3)_ASX,L]4CM%EDNM8TK3&BF8#RUO-0M[1V)
M4D;D$Y8`$@E,9Q7CNN_\%#8;B?PU+H?@SQ5>PZM/%=O9O;6HO-0TJXT[4KNV
MO;7_`$D1A7;3WRL[I(%5@8U9DR`?2V:,UY-\-_VN]!^*?Q*D\-Z9I7B!0T;F
MWU6>WB73[MTM[6Y:),2&7<(KR!LM&J\N`Q*D#C/#/[=,FHW/BZ:Y\.W5U:^%
M/$;^%1:6!C.H:G>OJ<MG;&%)GC00E40M*SA2[2J"!"Q(!]&9HS7A=Q^WEX9A
MO+6W71?%$D\EY'I]X/*M(X](G>YO+8I<RR3I$K+)8S_*KL6S&$#F10<WPW_P
M4"TLV_A-/$GA3Q!X;U#QAK5UHUI;R7>G7'E&*]%FDSB.Y+F-Y61<QHY5M^X!
M`'8`^ALT9KPF;]MO2?`_PO\`A7K'BFTF_M#XE6UDRIIQ@"6LDXMU+F.:996C
M$EQ&#Y0D90W(Z&DTC]O+0]?#0V?A/QM/J5U/##I5C]FM%FUH2?;OWD!:Y"*B
M#3KQF\UHV(A!56WIN`/=\T9KY];]I?QMX@\&?#"ZT+2O"S:KXR\)3>*;^+4I
MIK>W3R8K)V@C9=YCW-=D;WW[0N2&KN?V>?VDM/\`VCM/O+S2]#U[3K.QCM2]
MU?QP)%-+/:PW1BC"R&0M''/%N+1JN6P"2&``/2<T9KYYOOVTI/#WBR]U#6O[
M%T;P39WFM62M+!>SZA<_V4ET;F0/'%]GC;=:3,L+MO>*,R`Y.P3>'?\`@H9X
M7\3Z6EY:^'?%GDQV&H:G?-*+"*+3(+/RO,:29KH1-N,T04Q.XRYW%=C[0#Z`
MS1FO`-!_X*&^%?%7A^'4-/\`#?C&ZA:R-W,(XK)FMG-]-I\=LQ^T[6EENX6B
M3RV=#N5BZIN9?0OV=?BGJ'QC^'LVLZGI<FBW2ZOJ>GFRE5?.MUM;Z>V02;'=
M?,VQ#<5=E+9*G&*`.C^(W_)/M<_[!\__`*+:M/\`93_Y-D^'O_8NV'_I.E9G
MQ&'_`!;[7/\`L'S]O^F;5I_LI_\`)LGP]_[%VP_])TH`J?MC_P#)K'C[_L"W
M'_H-.\*_\BOIO_7K'_Z"*;^V/_R:QX^_[`MQ_P"@TOA7_D5]._Z]8^W^R*`.
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M_+6OX>_8Y\-CP]]EUIM4U`7NE-HVH6AU*;['>VO[U8XI(U*K)Y4<SQH[*&VX
MSR%V^):E^V-K>N6GA?QA-)H=Q+:-?SVVEZ->W#,V-*EDEM;R#)!GMYE!90"Z
MC'R1DX;I_%O[8_B[0=:U.UMKKP+=6]M8:Q<Z5?\`DR^1XDDM(--FACM@)^KM
M>RVY"M(?,@W#O'0![5H'[/FB^'_#?BC38[K6;D>,%"ZG<7-\\LTN+5+4$$\*
MWDQHI8`$E022>:J>#OV9-`\#^);/5;2YU>2ZL;F2[3S;A61I'M(K0EAM&?W,
M,8QQR">I)KQ?Q=^W#XI\+Z?XCNWD\$K_`&+8>);Y+1XI/.W:4]N4A8^?R\BS
ME3@<%=P!!V#0U']LSQ)>>)-1AL;CP'9V=IXDM]`:"Z>:2^L_,U-;19)4#JNV
M:W<7,1)7*C`$@)=`#U3Q7^RQX9\8ZUJ5Y<R:I&^K274US%#=;8W>XLULI6`(
M.,P(!QP#SUK4^'?P'T/X5ZQ>7VER:LCWP&^&74))+99-J*\J0D^6DCA%+%5&
M3N/!9B?.?V</VA];^+?CO5);Z^TB:Q7PK8:C;6%C"1YES]MU*WN)(V,C$J?L
ML7RG.WS$&[@EN&\3_M.:[\4/!VBQR7N@Z7I^M7OAJ6:>-7C-NUY>LEUI,X,P
M;SHUC^<@J2K,#&G4@'K=A^QGX+L"I7^V"IN(+FY3[>\:7LL%S)<Q-(%QDK+(
M_3&Y3M;<%4!R_L;^$E\-VFD1W'B$Z?I]O<V=O'-JLEP8+>>`VY@5I-Q6-8B5
M101MZ\GFN-^.OQE_X0Z7Q-X`MM4T[1+?2?"K7$"WUW<KJFHVQM+H&>UN/,WD
MP20Q!W.YAEF9T)4MYUI7[9>K^`=-\1-I]_X1O;?2=(U/6I&NY9YY;UK+3='F
MC0,;DJAD%U(AV`+NCWA"Q<,`>^:K^R+X5UJ.X62;6%2Y\_SE2[P)&FL5L9&Z
M'#-`H'&.23@&G-^R+X6FUU=6:;Q`=4CN%N#=QZE)!(X%M#:O&QCV[HI(K>`.
MA^4F)6P",UYKX*_:NFA^(M]X=34/"]B)==O_`"9KJ2XF76!'>K'+;6Q\URMP
MD+"0HH93O4B-$#$9/P:_:BN_CE\8?!K7U_IMO-;ZO/;PPV%P\4=];RZ'!=J\
MD)E<$B61E!/(V<JC;UH`]=TC]C_PAH'B%=5M/[6AO(9HYX6%\Q6`QS7<R!0<
M\!KZ[ZY)$QR<A2%\,?L@>#O">F0V=E'J*V\,-O'Y;719))+>'R+>=E/!FBB"
MH&Q_!&6#%%(XC]J_]I3Q)\-I_%FCZ*UC9S6_A2]U+3[M8%NYHKN&SN+@K*@F
M5XEVQ`HYB:-B"#('*QMSWB[]O>]\)^-=:L9-0\%_V/IT0(U&8F!8`E[86\TK
M(T^701W;RHO[O=Y8"LZL'(![Q\+/@=I'P?6X729=09;BUM+1A/-YFV.UA\F+
M'`Y"#D]2>37.:5^QUX3T/Q/%JUE+KEK>07,=S'MO=T:&.6\E10K`C`>_NCSR
M?-.22`1POP=_:\\0_$CQ[X5T>27P&_\`:EC#J%VEM=L\M]!(EQNEL2CR)(L4
MB1H_+!2),LI*`_1R\CMUQTH`\K\)?L=>#_`\NAG3_P"V88]`EL[BWA74)!%)
M-:6ILX)9`"-SK;8B/9U1-X8J#7JJC`I,?YQ0/\\4`<?^RS_R4_XM?]AVW_\`
M2*"O:J\5_99_Y*?\6O\`L.V__I%!7M5`'D'[;O\`R1./_L.Z5_Z70UT%[IUO
MJD"QW-O#<1JRN%D0.H93E6P>X(R#V-<_^V[_`,D3C_[#NE?^ET-=*.G_`-:@
M!V:,TW'^<48_SB@##\5?#/0?&DE[)JFEVUXVH:;+I%R90?WUI(<R0MS]UCU[
M^]<_9_LR^`['Q!?:I'X:TU;_`%*Y6[GDP3NE6X6YW*I.U-TZB1]H&]P&;<1F
MI/B7X4\=ZSJGVCPOXNTS0[5;<*+2XT079DE!;YO-\U2H.5&-IQC//2OG73?A
MC\?/$OA>.UFU3QOH3+%YES]IU?37O9;]=.NM[QR1%D6SDOC9F./Y67;)E(XR
M5H`]VTC]C?X:^'[:UCL_">G6L-K=072(KR!&>$`1!E+89$`4*C910B`+A%QJ
M^)O@7X'^('BR^U/4-)LKS5I+4Z;?.L[*9(61AY<J*P!/ERN`6!8+*0"`QSXA
MK?AOXQRRZPUU9^/[B2754:\.DZSI=O#?:9\QCBTX22J8;A28_.,IB#`2['8L
MF.:N?A3\>M+T6XN(_P"VI-8UB`337.DZCI]O-_:BZ7IT-K<W1D*H]K%)%=K,
MD8)=@I6)UP``?1%Q^RG\/KR_:Y/AG35EEAN;=_++(LL=RTS2HRJ0K*6N)V`(
MPIFD*[2QS%J?[)7PYU34=6N9O#-DMUKV\WTL<LD;S[Y%E?E6!4-(H=@N`S%B
M<EFS\D^%?C7\6]3\8_%+5;.;Q7-K7A;7([32-*N90VEZG&^I75DJ[%&;=C%/
M;,L;J&;[*LF2)'Q]!?&CX4>/KZ\\%V?AW5-3*V>F0:7J^MPS6\-^R_VGIAN)
M`S@D,UK%>,=H//3YME`'H$WP`^'NFW6E33>'-!C;3S=PZ?YL2XA^UQA+F-%/
M&)(TVLH&"J],9JWH_P`!O!^E?#/4/!L&CPR>%]5AD@N]/EE>:.XCD38RLSL6
MP4PH^;A0`,``#YB\6?!KXT^*-:T.UU:#Q'K$>E0L;:=M4T[[!M6TU"#_`$J,
ML))+IY)+=MZJ4VG!92'5M+QGX.^.B^`/$5EI=KXQ_P"$BN+R.&"Z@U/3O[-2
MR&3%]D@^TP2"1`(EE#R0AB796F4+&0#W/5?V1OAKK&FSV-UX2T9K6\OFU&:)
M4,?G3M`L#,=I!PT"+&R_=91A@036KJ_[/?@O7]#GTV\\.Z7<:?/+<SR0-'^[
M,EPFR9@,\%E..,8[8/-?-]O\&/C-IZZ]J%G%J\GB[5+F#5X;V]U&RFL(+@^%
MI+1A#$7?R9$U%0K8CV%)(B"Z!P-.R^''QNU"YAN;?4/&^DZ;I[7=YI=CJ.L:
M?/?EA)I?DV]])&SI*IVZHP"NP$<B!F#!5`![S)\"?`^D_"6[\%7&CZ6/">IR
M,D]C<-NAN9)I=QW%CEI'E.<D[F<YZU#J'[+WP_U*QOK:;PMH_E:G<W-Y=!8R
MIEFN)899I<@Y5VDMX6W#!5HD*D%<UXGXA^&?Q0\6?`SQ)INK67BV_P!2A\<Z
M=JVG$ZCI\.I7-C!?VMQ(;<><\$.%241AI%SM!*1%MHP%\+_M'R^+=)$LGB.U
MTJ/P_>V\\L5UIMU<*[V]X;;>6NHXVO4D^QJQ$1C=E9OM*H64`'T;X7_9I\"^
M"M>TS4M)\/V5A>Z+&\5L\#,FU&>60AU#8DP\TS#?G:TKE<%C3_$WP#\!?$2]
MU634-#TV_N;N8_;)`Y$R2_Z.V=RL&CD!MK9@1AAY2$8KYJC\$_M-3:U%/#J6
MJ:3!#X8N(K2TD:QNXS=FVN5C6XG:\RDYF-O)E;>Y10JH9R-Y;N?!/P^^(GAK
M]GWQPNFZ?XKLO$&L>)XM0MK>^U2PEUN73C]A2X07".UN+DV\5PD;,_#",EQ]
M^@#U6R_9>\!6&JS7D/AVT6:X2W67$C['\@PM"Q3=MWJ;>#Y\;CY2`D@4FK?L
MQ_#_`%?5)+N\\.Z9)-);W,$P;(2>&X:=YED3.V16:YN#AP0IFDQC<<^1?#CX
M>?&D^*](U35-6\30V.FS6*P:=<ZC92>9;2:I?_:%O/+)66>+3FL0S*Q!D4E6
M=@2<3]H7]GKXH>//B9XZ\4:?I6CW5GXCT+5/!L%B;A$O&TZ33V\ERS.(=IOU
MW@'YU2X.>A``/ISP9X1T/X9>&H='TM8[.QCW-&DEPTK$LQ))>1BS$G/))KE5
M_99^&UWJ%E.OAG1I)-*TY-)MPI)6*V6!X$0KG!*PO)&K'+*LC`$`G/S[=_L0
MZMJ\7BC1?$'A70_%&CZ5?>%;7PI=:C]GN9#IMIJ1GN(R)261H;65H&SS*D(^
M\7*UVOPN_8XUCP+\6?%WC/1+CPWX6UBXO+NTT2/^P8YK;[%(UKS<_9YH9)P$
MM]L49EC$.XG:W`H`]R\1_"7P]XNTNSL]2TFUO+>PMI;.W2121%#+"8)$'/1H
MBR'V-8L'[+_@.W\0WVJKX9TT7^I2)+/*%/+I-'.&5<[49I8878J`7:)"V=HQ
MW<881+O*LP&"54@$^PR<?3)^IZTN/\XH`S_#_AFQ\(Z4]GIUM':VS32W!C3H
M9)96ED;ZM([,?=C6/^Q1_P`DV\0?]C7J_P#Z5O73R?<_^M7,?L4?\DV\0?\`
M8UZO_P"E;T`>Q4444`%%%%`'S[^S(-WA/Q*/7Q7K`_\`)R2IO!W[*WP^\!PL
MNE>&K&W#3VTX=GDE=3;2^=;JK.Q98XY/G6-2$!).WDYK?LUY_P"$.\48&X_\
M)5K'&.O^F2<5\O0:+\:/A!\,&TKX<^%_%&GQQZL)X]2NK.P35-5VP+N74(7>
M996:3"O=1M"7*DE<@.X!]AZC\%O"^J6=A;W.DV\T.EZJVM6L<CL5BO&F:<S8
MW<MYKLX!RJM@@`JN,?PM^RS\/_!(3^RO#.FV?ESF>/8I;RCY$UN%3)^6-8KB
M9%C7"()&VJ,YKP_QQ+\?M#T#Q!<6-YXFU*XUBYNUM8;>STM9-!ACUEH[=K<-
M`?-#V&QV67>QQD,AS4>F>)/CQ<>$[R75D\<0:\VF:,5@TVQTA[..)H]-.IRQ
MM(&<Z@LAU()&Q,.%3"'Y20#Z,\,_!CPOX,U"WN]+T>SL;BU+/$\><H6AAA8\
MD]8[>%?I&/>H#^S_`.#VU2&^70;!;J"X:Z20`AO-:\-\6//S'[2SRC.0&=\8
M#,#\]N_Q^7P)K^HR7WC#[9:Z7:PZ19QV^DI<W#2ZM>I)=3CR74W4.G+92/%'
MM0N755#,"OT!^SC>>*-0^!'A.;QM'+'XM;38O[666.-)/M`7#EEB_=AB1DA/
MER>.*`,D?LD^"[J^\07&H::NI2>)->'B*\$QVHUPMO#;J-J;0T?EPIE'#!B2
M6!)S4C_LE_#Z37K75&\,VGVZQU!]4@D\V7$=R\ZW#2;=^T_OE$@4C:KY8`$L
M3Z-C_.*,?YQ0!POB#]FCP/XILO#5O?>'[6>'P>BQ:.NYE^PHK1,J#!&5#00L
M`V1NB0XRH(CU?]ESP'K^FK9WGAK3YK>-8410&1HA$\SQ[&4@KAKFXY4C*S.I
MRIQ7?8_SBC'^<4`<'XK_`&8/`?C;1-"TS5/#=G=:=X9M#8:=:[Y$A@MBL:M`
MRJP$D3+%&#&^Y2$`(K;LOA1X?TS48[JUTNWMYH=0;54:/*XN6MS;&3`.,F$E
M,8P!T`(!'0X_SBC'^<4`<%J/[+W@/5_&EYX@NO#.FW&I:AYAN6=28IVD@:W>
M1HL^6TC0,T1D*[RC%2=IQ3K/]F7P/8^'YM+7P_;RV-Q8SZ;*EQ+).\MM,RM)
M$SNY<@F-",G(V+C```[O'^<48_SB@#@=._9;\!Z3X4OM#@\-6*Z;J5HUE<Q,
M7<S1F>6Y.69BV[SII9-^=V]RV<\UTGP]^'6B_"KPO#HOA_3XM-TN&265+>,D
MJ'DD:21LL22S.[,22222:VL?YQ1C_.*`,?XC?\D^US_L'S_^BVK3_93_`.39
M/A[_`-B[8?\`I.E9GQ&'_%OM<_[!\_;_`*9M6G^RG_R;)\/?^Q=L/_2=*`*G
M[8__`":QX^_[`MQ_Z#3O"G_(KZ;_`->L?_H(IO[8_P#R:QX^_P"P+<?^@TOA
M4?\`%,:=_P!>L?;_`&10!>:1$&6VC;W/;_.*!(C'/R_7(KYH\>>"_BY%XU\5
M7'AE/$4::AJ.H_8'GUV)K1+9M.M?)\N)IF\HM>)/L(CW)NSPAJJWP\^*&AK:
MW%C;_$"^@O)=.N'MK[Q':_:]/$>LB>YBE*W(B(:T=XP$>7<B!'8X%`'U`'C!
MXQSSP>M8NH^`=(U'QUIOB2>.1M8TNVGLK.7[5*J1Q3F,RKY88(VXPQG+*2#&
MN",&OG72OA/\5K7P;';1R>+8-6O-/NWAN+CQ)Y[:5J@N_P#1I;@-<,DEM]G6
M+,<>\?)+NC+R$F]J7A+XL6VK7RW-GXFU;P[>:N[M]@UN*PU8031W2J8RUT8@
MD$I@(*-#YB$9@+1$2@'T5HGB+3]>2?[%=6US]EG>VF$3AO+E0X=#Z,IZCM5X
MR*O)*_7(KYCL_`'Q6O?B-&EZWC:+P[_;D\\,EIX@M=T*B[20&<O+N>UEAWQJ
MBJ73#`)%N#KE^&/!WQ@T/0M#@O\`3?'&I6":5HJZY;CQ/;_VE<W"PZG'>FWG
M:[&QUD?392?,C5UA<`LVX,`?5ZRJWW2O7L12EU49/`]Z\3^"7@_QUIWQAU6Z
M\33>)O[.@ADAMWDU.WGTR^B?R&A*Q*?,6XB"2([>7&K;G.7W#9S&@>$_B;+I
MFEKK6F^+F>.Y:V\2):^)H4;4G6WN%%[8LLZF"!Y6B<Q%XB`$Q$!&WF`'TF67
MOBD9E,G.-R^O4=Z^6=%^%OQ8M);/^VI/&&I72ZE"-1N;+Q$D%M=VP\-^3*8X
MQ<(45M54/@*I'+`*K-GF_A];_%CQM#XDL=&U;6K7QUX=N88+R:]UN.?3[6>3
MPM;[K9X5E<;CJ,BR@I&4!5RK#YD8`^RR5(SQ]?\`/T_2C*YYQZ\G_/I^E?+O
MC'X<_%:;3]5O-%A\81VE];7T.GZ1)XD0WNG2RZ6BQN\QN=I5;Q"5/F,\98LN
M%.%AU+P;\9H[[7+O1K/Q1#<W\NH>4M]KT$D,4#V%F8U1?M#"-S<QW`1@N49A
MDB/%`'TOX?\`%NE^*1?+I][9WG]FW3V5T(95?[/.@&^-L=&7<,@\C-)XJ\(6
M/C33([2^2X\J.:.=&@NI;:2-T8,K*\3*RD$=C@]"",BOG/P;\-?B%X9\?M=:
M5I'B+3=)NO%S:A<6NIZQ'.MQ8R1V"/+)-'>/)YD8BG*JXF5E5D*IO21?IY>1
M_P#6H`IZ#H-MX;TQ+.U2188R6'F2-(Y)))+,Q+,Q))))))-7OPIN/\XHQ_G%
M`#LT4W'^<4#_`#Q0!Q_[+/\`R4_XM?\`8=M__2*"O:J\5_99_P"2G_%K_L.V
M_P#Z105[50!Y!^V[_P`D3C_[#NE?^ET-=,.E<S^V[_R1./\`[#NE?^ET-=*.
MG_UJ`'9HS3<?YQ1C_.*`./\`'_Q^\)_#'Q5INAZUJJV>J:MY?V>$PR/E9)1"
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ML#P17&SS-OELXBGB?:K%MKAL8Y'(Q_L`^"_^$TT'7II]2N[[PW-(]D;N"RN?
M+A-PUS';JTEN7C2*5W9'C9)<-AY'``KIOAG^RIX;^%<VFR:;)JC-I,XN(/.F
M5\N-.M].Y`4<>1;1G''S;CT.*`-SQO\`'?PK\./%-IH^M:F+"^O[>2YB#V\K
M1.B)([9D"F-6V0RD*S!F$;;0<5PWC/\`;X^'/AWX7:CXFLM976([6.Y:"UAM
MIUFNGA@CG(VF/<D;1S0,)F`B(N(B&(=<V_C%^Q7X3^-OQ?TWQIK$VJ+JFF6!
MT^)(3#Y80QW,>X,\;2(=MU*"(W57^0LK%$*T_%W["OA;Q9%-MU;Q/I<MY;26
M%W+97<:-<VDMI9VDMLVZ-AY<B6%JS$8?='D,`2I`.D^+/[3_`(;^$GBC1=#O
M+@3:UK5U90);*'_<1W,_DK-)($*1CY)&`=E+B%PN=IQ%H/[8'P\\1V%Q=6?B
M*WDAMX)+ERT$T;/&A@!=%9`S@FZMRI4'>)XRNX,#3/B5^RIH'Q0\?PZ_?7VN
MP9CLHKO3[>X1;/419S2S6QE#(7^1II?N,H8/\P)52O+^!_\`@GA\/_`.@>']
M+LX[W[+X9UJ+6[39':VIE>)%6.&;[/!&)H@8XG/F;G=XD9W8CD`VI_VU/`;W
MEHUGJMO=Z8TLZWE^1)#'9I';/<+*%=`98Y`A"/'E7(.TMBK]K^V-\.;JZTN%
M?$4:S:M((88Y+.XCDA?S_L^V93'FWQ-B,^;MP[*IY90>,\,?\$V_AWX0\(OH
MFGQZC:V(F::W%LEK:RVA\HQQ8DB@1I#%N+(\YDD+`;W<<4X?L&Z?-\1(=6N?
M%'B2\LI(4?5(I)8A+X@N5O1=A[IEB5=@9(@%A6+`3;]PLI`-OQC^W;\-_#'P
M]UCQ!#KB:E_9J2E+:&VG\R\98'G5D'EDF!DC8BX`,.%9M^!FO1?$'Q(TGP?X
M`_X236;A=-TU88YI'=6D*F3:$154%G=F9555!9F(`!)`KQ31?^"9_@/PKX,D
MT31;S7-#MY#-")=-6SM9Q9RPF"2S=TMP98VC./,EWSY`/FY&:]?^(/PDT_XC
M?#=?#5U<:A9V\+VL]M=6DH2ZM)[6:.>WF1BI7>DL4;C<K*2N&5@2"`>;^+O^
M"@W@/PY#?-9G5=36QL['4)IDT^>.V2*XU$V#!I#'A)HI5DWPN%<%2N-P8+TZ
M_M@_#ES8C_A)+=?[0M9+N+?;S+Y:(90XER@\E]T$ZB.7:[-#(H!*D#(M?V*_
M#=JB_P#$T\22M,(FU#?/"QU::/4VU19YOW0PXNI)FQ%Y:;9F7:`J;<W5_P#@
MGMX!UOQPWB*:.\_M*6"\MIG>&UF:1;B:[G.V22%I82DE[.5,+Q[@5#[PHP`=
M=KO[5W@+PUX%TGQ-?:Q);Z-KPD.GS&PN=]VJ*S.RQ^7YFP(K/OV[=@+YV_-5
M?5/VR?AQHJZBTWB)-FF71LKEX[.XF02*C2/ADC(98XU+R,I*QJ59RH8$T_C-
M^RROQ9MO!=A#XBU;0=.\*K/#+)8,BWES#)9O:F/>R,JY5R"VW=R2I5L,(=4_
M8L\,S^&8-+TW4O$>@I;W-Y*LVGW:+,(;M0EQ;9DC<>4RA1TWJ44JZL,T`:&H
M_MF_#72+K4H;CQ/;QMHX8W3+;S/&")HH&6-PFV1A)-""L99AYJ$C#*2ZV_:]
M\#B>W@N]3:SNKR>6"&W-M-))\DC1KO54S$TCJ41)`K._R*"^5KD/"/[`NAZ5
MJM]<:EK.L75NNJR7^D:?#*L5GHZ&[MKD+&NW>S%K.!6+NPPK;`A=BVS>?L.>
M"KWXQ:?XX>&X;6]/O9+T-)#:3>:7N9+I5#2P.\02:5V4P-&QW89F``H`N>#O
MVV?`'C#P?X;UG^T-0TF#Q7I;:O8QZEI=S;OY"Q23,')CV*XCAE8+N)=8V9-Z
M\UO>"/VEO!OQ%>S72-86XDU"Z^QVT3V\T,DTAMVN5PLB*=K0H[A\;"!P2>*\
MUD_X)L^![S5_#EW=:GXEOG\*Z,V@V!N'M6>.U,%U;H@?R!(OEPW<B#:P#A8V
MD$CJ&KN-#_9ML-&_:!M/'"S$G3?#,/AZV@.225E=C,_\.\(0BL`#AY`200``
M>F2G]W7+_L4?\DV\0?\`8UZO_P"E;UT\GW/_`*U<Q^Q1_P`DV\0?]C7J_P#Z
M5O0![%1110`4444`>,R_L4:+'J6H7%CXN^(>DQZE>37TEM8:UY%NDDKEWVH$
MX!9B>]*O[&%BO_-0/BI_X41_^(KV6B@#QH?L8V(_YJ!\5/Q\1'_XBE_X8QL2
M,?\`"P/BIC_L8F_^(KV2B@#QK_AC"Q_Z*!\5/_"B;_XBE_X8RLO^B@?%3_PH
MF_\`B*]DHH`\;_X8SLO^B@?%3_PHF_\`B*/^&,[+_HH'Q4_\*)O_`(BO9**`
M/&_^&,[+_HH'Q4_\*)O_`(BC_AC.R_Z*!\5/_"B;_P"(KV2B@#QO_AC.R_Z*
M!\5/_"B;_P"(H_X8SLO^B@?%3_PHF_\`B*]DHH`\;_X8SLO^B@?%3_PHF_\`
MB*/^&,[+_HH'Q4_\*)O_`(BO9**`/&_^&,[+_HH'Q4_\*)O_`(BC_AC.R_Z*
M!\5/_"B;_P"(KV2B@#Q>Z_8ITZ^M9(9O'OQ2DAF0HZ-X@+*ZD8((*8(([&O4
M_`O@^S^'O@O2=!T_S?L.C6D5E;^:VY_+C4(NX]S@#FM6B@#S7]L?_DUCQ]_V
M!;C_`-!IWA4_\4OIW_7K'_Z"*;^V/_R:QX^_[`MQ_P"@T[PJ/^*8TW_KVC[?
M[(H`Y4?M'>#X=3U:SN-8M;&71=2_LJY^UY@`N/*CDPI8#*A9DRP^4;ASR,M'
M[37P]:)Y/^$P\-^7#<O:22"_C,<4J2>4ZLV<+MDPA)P`S`'DC/#_`!7_`&,O
M^%FWGB'_`(J:XL[7Q!>RWTELUH)8XI9+:U@W_?&YD^R(RY&!YDG!.QEYWQ_^
MR9XC<Z#;V-S9ZDEG=ZS?S7+6FV-Y+_4DO_*EB-U&Q@$N20'DR$3,9(#4`>N:
MY^T=X.\.ZS;:?+K5I)>W5]%IXA@)E9)9/-VEMH.U,P3#>>`87'52*A\"?M(>
M$?&MOIL<>O>'UU74+>&<V=OJ4=SY1EA:9`'7A@T:.RGC<J$C@''(>%_V-;?P
MEJ$5U:ZQ;BXL=:_M>QE_LB%9(T+3,8)I%*O.H^T2!69@5`3(8ABV1I/[%>H>
M%M!LX[?Q!9ZE/I$=E]GBFT_RUNS:6MS;QH[%W"AQ<$LVU@,#Y2,@@'LWA'XH
M>'O'UA=7&AZQI^K16+!9_LLPF:$L@==RKR-R,K+Q\RL",@@UQ?P\_:W\,?$7
MQ7;V-O-':V>IZ/INL:3=7$OE-J"7LETB((V`96#6IZ]2ZXZC-?\`9*^#NL?!
M[P;?6.K;2]U+#*&DA\NY=TMXX,R,+FX#+Y<42+\X(5,8`P*P--_8JDT_2]-L
M1XF\RSTRRT#3HPVG;9'@TBYGGARPE^_)YVUV`Q\H("]*`/6=,^+'AO6=$U34
M+;6]+FL=%!-].+E?+M%\L2[G.<!3&RN&Z%2""00:Y5?VI_"\WC_3='AO]/GT
M_4K><KJ4=VK1Q7<=W;6GV-UQE93+=1+AB"&.TC)KF[']E:3X??LV>*/!^DS6
M6K7FKZ6VEPS-I]O9N\(C,49EV!1-,J$DNQ7>P&#$#D8OA?\`8_U36;*QGU;6
M([&ZT]Y9K=?[/W3/,VIV6IB:X/VJ;>QN+-<@2'<DA&Y3C`!Z8G[3/@N779=/
M76K=I(;874D@5C%@W+V@0/C!D-Q&\6P9;<,8SC,D?[2O@&:XBCC\7>'YI+I8
MGB6*\21I1-$9H<`$Y,D2ET'5P"1GI7!V/[&UUI\=UY?BRZ62^E,MPQLU"S`Z
MO-J?E$*RGRRUQ-$R@Y9"/F'.Z'X>?L4S?#BVT&&U\36\T7AZ33#;B32B"T=C
M;3VZ*VV8#YEG).``"O`P<4`=YXG_`&H?`OA'PY>:I/XBTZ:WL]);6C]FD\YY
M;581-O0+G=F,JX`YVL&^Z<U;UW]H3P1X7E9-4\3:'IKQB,E;JZ6%AO>.-!AL
M?-OEB7'4&1`<;A7CQ_X)XI/X5LM)N/%UU<06.@R^'HG-@/,BMY-,_LXA/WA"
MC:!*1@DR%LDKL5.BO/V,$NM:U*^76K-)K_6+36D=M%A::":*^MKZ5!,&65HI
M)K5"$+'8'89;";`#M-7_`&E_!]LD<=CXB\.W]])/:0K;-J<4+.L]S%;[E+?>
M(:0#:H.7PG#$5U'ACQ_HOC2ZO8-*U*SU";365+E8)0QB+9VDCT.U@&Z$JV#P
M<>!Z7^RCXCUCQUXCFO+BUTNSU#5FU&&1K7[1Y835HM0C6$BY^59#$#*/)B+,
M0278;Z]:^!'P>N/@MX5BT637+C6[+3H8[#3#/;)'+:V<61#"[+S*R*=N\XR`
M.`=Q8`[K-&:;C_.*,?YQ0`[-%-Q_G%`_SQ0!Q_[+/_)3_BU_V';?_P!(H*]J
MKQ7]EG_DI_Q:_P"P[;_^D4%>U4`>0?MN_P#)$X_^P[I7_I=#73#I7,_MN_\`
M)$X_^P[I7_I=#72CI_\`6H`=FC--Q_G%&/\`.*`/%?V@_P!H#Q)\-/B99Z3I
M=OIOV<Z--J4%K<V%S<7/B6X7S/\`0;22-U2&1`B.S.LF1*OR@*S5XKX4_:0^
M)?Q=G\(ZM>1RV8EO$A:/1#);VU_$-7T($R)YLJJP2>[A;=(WRK(3LW/&OUG\
M0?B?H?PRM[.76;V.W;4+NWLK:+.9)Y)IXH$VIG+`/*FXC.T')JAXG^./A?PI
M<6L5SJ(F:XNI[0?8T-T8YH8FED1A'N*L$4G;C/3(H`\'^)'[:GCOPI\89O#]
MGX5LGN[73K>\/AAK>6YU:_\`.CO2S1W4,IMXUB^S1D@HY82@95MN['\%_MC_
M`!;\9>`IM532?":R:?H.NZXS#3KJ1=0^QQV1@@18[IA"[2W4J-EY2?LQPJEB
MJ?3D>L^%-(U635A>:+:WFK16R/=&9$DO(\N+<%LY926D"#G)9L=ZO)XUT.>[
MNH%U;2Y)K)6>YC%TC-;JN`Q<;LJ!QDG`H`^7?&/[6GQ@^&=EX@_M#0_#.LR6
M`NX+:33M)NX5B:&XTQ3=2B2Y(:%8=0D<H&3_`(\G;S0'(CY7XB?MO?$W6/#[
M:##H\-G>:SX)U&[DN=,LIA+#<K87TT%U:S)<.?+9K>(!!&^'F"B=B`#]@77Q
M.\,6OC&X\/SZWIL&M65@NJ36<DXCDAM<NOG$$CY`8WR>V,GL:M7OCC1[.QTV
MZ>^A>SU1MMM<QDR0,!&\NXR+E579&QWDA>`,\@4`?(7B;]L/XCZ3:/KVGV]I
MKD>FP76G17UMIUU;:-=JUSHR_;WMIIU;]Q]HNH6)G4%H)6WQKN"^N_$O]I+Q
M%X*_9E\"^*;MO#_A_6/%%S86E_<7=M/>V.F_:(W9YA''(CNJE0<>8!M)RX`W
MCU"Y^-?@^T\0:=I<GB;1EO\`5+:YN[*(7:G[1%;,BSLI!Q\C.H/.>O\`=;$E
M[K_A/Q;+;1S7V@ZA)IX&K0*9HY&MPA91<*,Y7:=PW^N1G-`'R7=?\%"OB=IY
MUBXO/!^C:;;Z1X7CUAHKRTN(Y9I#917!N4'F^:;<S.T'E>5N4J<REAY=:4O[
M4'Q(UC55N&UC19=$DT;5?L0L?#]W:KXCN+6[B5+BVD:X9X1Y4GW#O#"*4AB'
M5E^D/B/\1/!1^'6J7FM7>EZMHD>DS:I/;@I<_:[.)2\CI&"?,0`=0",XK0\-
M?%/0?%VAW5]:WBK;V=W<6LHE'EL)(;F6W;@GH989`I_BQQF@#Y$\0?MK_$O1
M->\3:U:0:;<>2+/3C9RZ5=I9^%B;O45D-V))XTFFVQ6ZM(DD*_Z1$<;0N_W3
M]FC]H/Q/\5?B=K^B^(K#3;`6&EZ??1V]C:S.MG)-"C2Q2W#O\S^8S;4,,?R*
M&#2Y;9Z)X5^+7AGQ?X=L]6M-6LDM[RPM]359ITCEB@G4/$\BELIN##KW..M2
MW?Q6\+Z3XITO0YM<TN'5-;M);^PMS,-UY!%Y?F2ISAE'F(<]P<C(!P`?.WC'
MXIZB_CVZC\0^+/$WA7PG-XBUNVO+W32VZSN+6.QBT^T+A)/*2:$W%SM``DDP
M,G?L;GM8C^,>H>&O%VN6FM:S_9NH>*?[%L+0ZT\=S=JWB>"V1X\6N;&-;,3Q
MLR&7>LJOM4H,_56F^*/"-B\U[::EH,;:\QO)+B*XB_TXI%L,I93\^V*#;NYP
ML6,X7A\WQ8\+Q:7]N;Q#HK6;0S72S+>1LKQ0_P"M=2"<JF#N(X'>@#Q;P-=_
M$3P6?%WA_5_$7]H>)=/\"VFHI<RYO8+.]>?4DCXQ%YI,<<2L0(_,-ONVJ7P/
M-?#_`.U'\2O@[X#CT7R+'Q)J/A_P\\[07EAJ<E_?D:&=1&IM<27$A-N;O%D8
MB6;S,XD7Y8A]7>"O%/A+Q?<IJV@WVBWMUX@L8;L36TB&:]M5W+&YQ\S(I9E&
M>`68=<UTHB4#I^E`'SG^V9\8O'OPB^!%G;6M]I=OK^M:;J"7&LV^D7C6Z7$=
MH[PP6T44YDBFE?`C=Y'P4)VN2JUE>(?VNO&WPR\%ZIKFL6>E/I,=YJFE:5$F
MDWDEQYMI:RO;^=(LK>8UQ*BH`L:#A@&9G`7ZA>)9.O\`*D,"GM^G2@#YW_9@
M_:VUWXZ?M'^,O#5U)X>M]'\-I/%%:16K1W[S171A9Q(UPWFQ@#+$6\81I43<
MWWG^C,US/ACX->$_!7BW4=>TCPWHNFZWJY8WM];6:1W%UN;>V]P,G<WS'/4\
MG)KI,?YQ0`2_<-<O^Q1_R3;Q!_V->K_^E;UT\GW/_K5S'[%'_)-O$'_8UZO_
M`.E;T`>Q4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`'FO[8__)K'C[_L"W'_`*#3O"I_XI?3?^O6/_T$4W]L?_DUCQ]_V!;C
M_P!!I?"H_P"*8T[_`*]8^W^R*`/-/$_[7&E^&?$NM::^E7DC>'+VT@U(M*D+
MVMO<2I%]M,;D,ULK."9%!7"N<Y1@,?XE?MK6_@?PQJUQ%H<O]IVWAN]\1:?;
MW=RD$>IPP)/(#$Q_UF4A5F"9=%F3<J@Y':^./@5I/B^WU);5;>UDUN.2SU.:
M9&NC+9S$?:88T=]L/FX&XJ,$@$JQ'&CXA^!GA7Q=N_M/1X;R.2U>S,$C/Y'E
MO"]NP$8.P,899(]P&X([+G!(H`X?6_VQ[71-4N+=?"'BJ_BM;V/3)+NU@3[+
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M8]VS/]G79VD#`"9QN(7VS4/`.CZ]XRL?$$T,QUC2[6>QMITGE3RX9BAE3:K!
M2&,<9.1G*)W`KEC^R9\/FTZ&U;P^LD-K!:6T!>[N&>WCM#*;<1L9-R>7Y\P4
MJ0<2N.C$$`N>)?CK;Z+;Z"EMHNKZAJ7B#39=6@TY42&ZCMHA"92RR,H$BFXB
M79G))]`2.3U;]M31],:T,>@ZY?PZO)LTF2V:`C4%74K?396&Z1=FV>ZA.&P6
M1\XR&5>_\7_!SPQX[BT==6T>UNE\/R>;IP&Z+[*=NPJI4CY&7Y60_*R\$$51
MD_9Z\&W"7&-%CC6[NOMS>5/+&$F^T)<EDVN/+W7")*P3:&=0S`L,T`<//^VU
M8V9ACF\*:\MQ<7KV$4*S6Q+R1ZQ%I$IR9``JW,T>"<%E).!BFO\`MQ:/%K>G
MZ:^@ZQ]NN[VXTV:!'A9[>XADNXBN-_W6>S<*Y*J?,CYSO":WQ!_9%\,^+](C
MATU6TFZ2^CO#=&>YN#C^TH=2G0*9EP9KB%69@0V22"#@C:O/V8O`^H7-K--H
M2?:+4*(Y8[J>*1BLDT@=F5P7??<W#%VRQ-Q+D_.V0#D=#_;>TO4]+TW4+KP_
MJVDZ??/9_:+F[G@V:='=V9NK9Y2K,,2$>3A22)&0'ALUT7CO]I:U^'VB6MQ?
M:'J;7K:%<>([VPBDC,]C96XB-P3E@'D3SD`12=Q#<],NN?V:?#T%G#8Z;;Q6
M>CR/9#4;.57NQ?1687[+&#*[!%0HG0'*C'7!'4>,?A=X?^(=Q:3ZQI<-[+9Q
MRPQ,Y8$0RA1+"Q4C?$X5=\;91]B[@=HP`>(/^V=JGA'P/JDUYI,VM7C:KJUO
MI%TSQV]O=1VVH"%48+EE*Q2(<E1N\N0$J=I;=U[]L"UF\5W?A^VT_5[?4--U
M?3[.62W^SW$<ZS:@UFR$LX509(RIP2ZK*C%5;*KZ%=_`+P??_P!I^=HL#_VP
M)A<@O)C]\ZR2F,;L1%Y$1V,>TLR*QR0#6</V6O`8U9KU-#,=TUP+HR17UQ&3
M(+DW8;"R`<7#-+TQO=FZLV0#DM`_;@TO7]%TB5?#?B"#4O$%CIVH:;IYC6XF
MN(KV"\GBSY)?:P2PN21SC:G][B.R_:?O/B!\1OA_;Z'I^J:9I.J:W)I.LKJ$
M,<<\4W]B7&HBV:,DR1R1D0AB,#<KKSP3UD_[)7P]NM)AL9/#ZR6]K;V=K;!K
MRX+6D=GYOV41/YFZ+RA-,%*$$"5QG#$5J6O[/?@VP\2VFK6^A6T%[8W"7<!B
M:1(HYTMC:++Y8;89!;L8MQ7.S`S@#`!2^'7[0VG?$3XH^(/"<%C>V]YX?C\Q
MYG>-XIE%Q-;M@JQPP>%CMZ@,NX*<J/0:Y7PI\%O#/@CQ7>:YI6EK9ZGJ'FB>
M5)I2'$LSSR#86*@--)))@`?-(YZLV>H'^>*`./\`V6?^2G_%K_L.V_\`Z105
M[57BO[+/_)3_`(M?]AVW_P#2*"O:J`/(/VW?^2)Q_P#8=TK_`-+H:Z8=*YG]
MMW_DB<?_`&'=*_\`2Z&N&_;4_:O;]COX4Z?XG3P7XI\=-?:S:Z1]@T&V\ZXA
M$Q;]\PP?E&W;[NZ+QNR`#V#-%1POYT*OM9=P!PR\CZT[_/2@#QCX^?LDR?&O
MXIZ+XB36M+L8M/;3C<0WFAB_G`LM02^C-K,9D^S.[*4=MDFY=G`V9/G'@3_@
MES9^"/!UQI,/BI6DD9T%X;2\FFGB^RSVT?F_:+V5/-`G9F:%88V(XC7C'K'Q
M$^(_B"X^.]EX2T76M!\-VUGHRZ[=SZE8F[?4D-P83%$/-C"*FW,CY8@SP].<
M\S8?MPKXHU/POI^@^&?[2U+Q5'IKQ1OJ4<4=H;R'4IB)&"L1Y::=)G`RQ=0`
M,'(!QOQ(_P""6^G_`!$^U?:/%331MK,]S:6]Q:W<=O9:9(DP33P+2\MI&$3W
M-R8Y/,`"S%&C8`5O>*OV%(HY?"L.ER6IW>,;_5O$=W';K#)?:9=W,M_)9R?,
M3(K3Q6,18DDI&3\H)%0Z%_P4+FU77?"-C)\/]<_XJR"&_#VC27JV%E//]GAG
ME>.$QIF19&<2.@2-00SN?+$?AO\`;F\4>/+CP*NG^![#2X_%5[;&Y%]K`DD@
ML+K2;C4()H_+CP9L0.&C/`V;=WS[D`.T^/7[(S?&7QM?:U:ZMH^F27^DV5A,
MEWH8OB\EEJ`OH"S>='N@9MT<T)'[Q"`'CP2<OQ!^P^OB/]GZU\$/X@M;22.[
MUF_N+JUTGR[9I=2M]0BD6*V\T^5%&U^65#(QQ$%+9)8._9?_`&N9_C'_`&)X
M?U'37C\21Z%#JNL3JZ^5$LEM92PS;0OW;C[4^T#[IMIUR2AKC=&_X*6S^*/!
M4>M:7\./$#PWGF75D+YWT]+FR2RGO#*KS0IN<1V[KMC#IO>,"0@LR@&YXS_X
M)YV.MS:LNDZIHNCVFKV&MZ6;<>'UD6SM]2LK.W(@VS((VCDLQ)G!#+-*NU2W
MF"C\2?\`@F]'XZ^*FK:]:^)[/2M-O=);2[32X]'=H;13!!$$9%N4@E@+P[V4
MP"5A(Z&79L"OU#_@HO&NL^+4L?"<E[IOAIDM8KG[7*\UU>/=);I;M!!;RNK,
M3(RA/,<K'G8,D#+_`.'HNGW=O)?6?@_4+K2;/P[!KU[(ERS75J9[2TN(83`D
M+'#&]AC#%@Q99<(=@W`%GQ+_`,$TT\9^.;SQ!J'B+18=0U#0[C3'73](O+.V
MLIY;6[MO.MK=-0^SK'LNF8QRQRN6WD2J7XZ*?]A_4H?%C7EGXRLX=-O-1CU#
M4;271#++.8=7O-3A6*47"B/#7CQL2C[@BL-G*G&3]NC6/&.H^&;#3_"EUX?N
M+S4M*BU@ZHYMYK2.ZU.XLPD=O/%'-()%LYFW,D;*LD9VYW;-WXL_MFW7PF\?
M>)-*C\-S:]%H?VJ[F9;J.U^RVEK86%U.V2&\Q\7AVK\N2H4E02P`.)TS_@EP
ML7BM[[4/&=OJEBVD6.CFUET63][%;2Z5(1(#=-`RM_9FT!85?$YWO+L4'UCX
M_P#[+3?&+5]-O-,U72_#]Q8^'M6\.>9)HJWS1P7T<*J\/[R,1M$\"$`AE9&D
M7"E@ZX?[1/[6-]\,OB+9Z!I>FQM;VEQHT^KWSW$>^*"]NYHECB@(+2LR6LV6
M!!3*$!OFV\[X&_X*-Q>+_#6E:C=>!M?T8>(IEM-$6\66W&JW$OV0VT*>=#&Q
M,B73.652@%K,59U`<@'+ZO\`\$W=2\#?`;Q!I^BZIIFO>*+C1[K3M.DET]@M
MH;G4Y+Z4QM=W,[D!9"FR68^9M4/(`25;\%O^";%Q=W'A3Q!XONM/L]4TS39;
M&_TZ"*Y$;,9[]UN(UAO%M4DD%\[2QO#<1@DI&56M#2?^"E<GBG1='\26_A77
M-)T*>1Y$BOK9[;^V(9;9WM2DD\<80^8%#LI>)001(XSCJ%_;[EA\0+IEUX0$
M-QI]S';:RR:Q$\=H7U%=/S`=@-S^\DC.`$."P(5U$;`%SX3?L9:Y\)O%NDZU
M8^*O"\-YIV@6^A2FT\+20K>B)XOWCAKUU7]TCJ!&$;=(6=Y%58Q]`@;1WKY>
MT?\`X*)-8^$FU34_"EY-I=GIHFFU**[B1I[K^Q?[7\I8"/E4PJZEB_#[0`P)
M*]QH_P"UA<3_`+,-Y\1M0\/1V)2[:TL["*[ENEU`F\^R0/$Z6_F.LSE3'LA=
MF5T*JQ8"@#VK-&:Y'X$?%>W^.?P@\/\`BZWLY["'7K1;I;:8'S+<DD%#D*>"
M#U53Z@=*ZS'^<4`.S1FFX_SBC'^<4`$OW#7+_L4?\DV\0?\`8UZO_P"E;UT\
MGW/_`*U<Q^Q1_P`DV\0?]C7J_P#Z5O0![%1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`>:_MC_\`)K'C[_L"W'_H-.\*_P#(
MKZ;_`->L?_H(IO[8_P#R:QX^_P"P+<?^@TOA7_D6--_Z]8^W^R*`/E/Q-XDU
MSX:?'CQEJ&A^'KRXC?5;^X:6#0Y)IXXVM=`2>>W<1_.VQ+M_+4GSGM\88KBM
MWQ9\:_B/!?36NEW6K/;V^CS:E87\_A>X5M9C\N[QN3R=L4\;+:G#21EQDB$^
M:JI]/Y_3VI#S_P#JH`^9;#X[?$2*YAC:#4=5BM]:M(Y5CTIK>YN;:6RT^5_*
MW0F-U2>:Y4H7C8JAQ(6B97[S]E[X@>+OB/9ZU=>*4N+%XUA3[%-ILML^FW0\
MP7$2R211K-&"$V%?,&,GS9`Z[?7AQ_\`JH_+\J`/C+X1ZMXS\!:?J%]HZZS<
M2R:;'J>J%_#R_;KYVU6YAFD=_)5IG@M7$R18+L50#*L5/3^,OC-\4=%O=06U
MO+UK&QL[^ZTVX&@&1M56*\LDMS(JH-I9)KI"J!2ZP>8NT'-?4QY__52_YZ4`
M>/Z%H+?M%?`WQEX=\9?;)8/[4U+2X[M[3[/<^1',WV>Y0;5&]5V,K(H!*@\\
MUY?XC^(OC+P1^S/9^,-`TVZ?Q_XAM[F?4Y+7P](/M4UI8S^3`T;([QJSQ1*J
M[27+,H:/=O'U>>?_`-5*#@__`%J`/E#X>>//%WASXE2Z+H6G7NE:+K'BN\OQ
M<-HMP\-YNOD-Q"W[DB/,#%TD=XE+,6RX1D/J/Q&TR#1/VF?"_B+4M/FFTEO#
M6JZ9+=)8R72B=Y[%XHW5%8_-&MR%R.<NN<MAO71P?_K4N?\`.*`/ES3O&7C'
MX?:CI_AR&.ZM-!LXM-L&L4T,O%`DVEW4DY+JAW;+B.$D@X!?:V=PPWP-XV^*
M7A3X49ATW4+B/3_"VGZ]810:/'!;Q*;(0RZ6L*1>9YL4Z23A5&XH8XQD]?J8
MMDY[_2FCY3_]:@#Y?TGXH_$^_N=2:/6;B2WL]'BU&Q$V@S6RWIEO[B())(UJ
M71E@\G+"W&U@LIB\O<K9NA>*?&WC+XJ>'[A)/$OA;^U+O38]4G71(5G;S-&U
M+/VA_*99%2Z2WVG.U3,H^7*@?61Y_ETJ'4M,M]8T^>TNHEGMKJ-HIHG&5D1A
MAE([@@XH`\]_9H\0>*O%OA&:\\5/-'?64ITB6(K$(YKBT+0W-U&44'9-,KE5
M/1$0X4L5'I6:IZ)H=GX;TFWL-/M8+.RM(Q%#!#'LCB0#`4`<``5:Q_G%`#LT
M4W'^<4#_`#Q0!Q_[+/\`R4_XM?\`8=M__2*"O:J\5_99_P"2G_%K_L.V_P#Z
M105[50!Y!^V[_P`D3C_[#NE?^ET-=,/NUS/[;O\`R1./_L.Z5_Z70UTHZ?\`
MUJ`'49IN/\XHQ_G%`&+XO^&_AOQ]<:;+KV@:)K4VCW`NM/DU"RBN6L9@1B2(
MN#L<$##+@\57T+X3>$?"M_->:9X9\.Z;>3W+7TMQ:Z?##+).1(#,S*H)D(EE
M&\\_O7&?F.?,_P!IO]GSQ9\6M?U/4/#VO7FCS1^%Y].TLPZM<6:Q7TDOS2,B
M`IEH2T8E9':,ON5<BO)[C]CWXQ0^&;*QTSQ/?6]Y'X<O-/DOM1\8W5U+;RR3
M74D<<(CMHT5]LL4?VAUD*(J[4+1*[`'U-=_"?PG?7NCW%QX9\/37'AO<-)DD
MTZ%GTLL`#Y!*YBR`!\F,@51\7>#O`_A[PXMYK&C^%[72M$,%TDEU:0B&Q-L"
M()%)7"&(9"$8V=L5\Q6_['_QHL];\%_9O$URFGZ)IEY;W37/BVXFGWS_`-H8
MC<"W5)E7SK/RV"QL@B;)DV1D;OC']C'QCJOAW5O#\4TFHV.I>%$TFUO[OQGJ
M:R:;<-#*MR&@(87'FRR;Q.[[UR``/*2@#Z*\+?"O0_!_BK4=;TVSCM;S4[.T
MTZ0Q@*D=M:^9Y$*(/E5$,TI``ZN?:J^@_#+P'INH:I::7X>\)6]U+,]YJ,-M
M8VZR-+/&R-+*JC):2/<I9N64L#D9KR/XH?!SQ9X/_9FN/#>A_P!K:U?2>,K6
M2R@CUZ]CG.ER:S%(T,EZ-]Q&BVS.K-\Q5`1R!7F?CG]FOXOVECX<TG[1>:Y'
M?-)"]M%XNU*SATM!:Z@8EEO(T\UUA:6T0.XS,UNK'#8R`>R1?L:?!_X8>-/$
M?BW4M%TB63QG)]DU`:J4FL[AKBYCD$120;6W3I%M#[MA`5-BG;5K0/V+?A7=
M_%"3XAZ?HNGW-YJVGK;IY1633Y;9[1+8*L8^1H6MU51'S%@[@H8[J\O\.?L=
M_%9/B'K%]K_C*\UZ"XU#3KJ.2?6F^R3+!J%I<`K9_9QY$D<4$B`B9@Q<DC+Y
M1DG[&GQ63P?J$EMXTOK?Q1?:=_9SW(\1WK1&$:580[%5@R1.UY!<OYRQ[U\[
M?\Q)6@#Z1T[X'>"-(FTB6U\'>%;:3P\GE:5)%I4"-IB;Q)MA(7]V-V&PF!D`
M]::Y\%>(?'.J:-)!X=OO$$=H)M1MGBBDN/L\P$691C.UUA53NX81*.0M>1I^
MSWXZLOV7O#'ADWUYK&K:5JC76J6E[XIN()=4M"]P5MCJ,$*2KL,L+C$8R(!&
M25)8GP2_91\6?#7PGXZDFU\_\)EXLT2TL8=7.H7-YY%S%IZP"4B3&=DHSOP&
M<*"W)P`#V";PMX/\=^,SJ$VD>'M4\1>&)%M!=26D,UYICE8YQ&'(+QY5HY``
M1U4^AIWA[X/>$/"-G##I/A;PWIMO;7S:I$EKIL$*17;*5:X4*H`E*NP,GWB&
M(S@U\V_#K]B?QI;ZA?3W]PWAVWNFU"ZBM;3QCJ>I-#=R:;IEK;2R3.(WGV26
MEP^U\JN],`GIP?Q]\"_&F+Q9X1_M;3=:FL=4U<7%[9^&M2U34%B2"#1X403P
M+"L,TC07K`W*_9PL\FX[FR`#[,T_X,>"])M;^&U\)^&;>'5)9I[Q(M-@1;N2
M9"DSR`+AVD0[6+9+#@YK)L?V:/`&F^,-)UJW\*^'X;SP]:K9Z4D=C"L.E*)&
MD#6\87;$^Z1OF0*<&O+?C3\`/B)XK\6?$"XT9H9O^$@@MH]'OG\6W]B=/M@M
MHMQ9BUC0PAV,5U*LYW?-,JLK("IYGPM^Q[\6;30--GNO&EU:^)[#28--AN_^
M$AO+J&V(L=0AD=H]J1S-YTUD^]HP[&#=D%0*`/;O%?PX^&_Q0T'7?`UU9^'\
M7D,MG>V-IY=O=1`VD<3%=N'5EMKF)<CI',B_=8`U_@U\`/ASX&^"-QX/T33=
M*U7P6]Q<I<VEXD=W:RRB9A.KHP\O"RHP*!0JLAX!S7AFB_L>_$[2M$UIK%[3
M1?[6O#=S:6GC/4;PW4>W0T>!KZ2,3*TL>GWL8D"YB%R-O4XJZ+^Q+\4%\5>%
M+674+/2_"=C#JT6HVEIXJOYB4O9-58QOOC!N2OVNT(E+1OF)RQ8B/`!]?>&=
M'TWP]H-K9:/:V-CIEO$HMH+.-(H(X\9`15PH7G(P,<U>#9KXT\-?L5_%+2;_
M`$D?VWJ6FZ3I_A'^QH=,TWQK/%#:3_8IX&0%[21GW3.LZS95D.T;2(E5_IGX
M`>%M<\%?!_0=*\1FU;6+&`QW'V>ZGNX\[CM_>S$R.0NW)/&<X`&!0!V>:,TW
M'^<48_SB@`E^X:Y?]BC_`))MX@_[&O5__2MZZ>3[G_UJYC]BC_DFWB#_`+&O
M5_\`TK>@#V*BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`\U_;'_Y-7\??]@6X_\`0:=X5&WPQIW!_P"/:/\`]!%2?M;*'_9B
M\>[@&_XD=T>1Z1M7Y'CQKK$:JJZMJ:JJ@`"Z?`X^M`'Z^9HS7Y!_\)QK7_08
MU3_P*D_QH_X3C6O^@QJG_@5)_C0!^OF:,U^0?_"<:U_T&-4_\"I/\:/^$XUK
M_H,:I_X%2?XT`?KYFC-?D'_PG&M?]!C5/_`J3_&C_A.-:_Z#&J?^!4G^-`'Z
M^9HS7Y!_\)QK7_08U3_P*D_QH_X3C6O^@QJG_@5)_C0!^OF:,U^0?_"<:U_T
M&-4_\"I/\:/^$XUK_H,:I_X%2?XT`?KYFC-?D'_PG&M?]!C5/_`J3_&C_A.-
M:_Z#&J?^!4G^-`'Z^9HS7Y!_\)QK7_08U3_P*D_QH_X3C6O^@QJG_@5)_C0!
M^OF:,U^0?_"<:U_T&-4_\"I/\:/^$XUK_H,:I_X%2?XT`?KYFBOR#_X3C6O^
M@QJG_@5)_C1_PG&M?]!C5/\`P*D_QH`_4K]E@_\`%S_BU_V';?\`](8*]JKY
M%_X)$74M]\)?%$\\DDTTFM?/([%F;$,8&2>3BOKJ@#Q_]MYL?!./_L.:5_Z7
M0UTX/%<#_P`%)#L_9&\1N.&CDM65AU4BXCP1[U^8DGCC6O,;_B<:IU_Y^I/\
M:`/UZS1FOR#_`.$XUK_H,:I_X%2?XT?\)QK7_08U3_P*D_QH`_7S-&:_(/\`
MX3C6O^@QJG_@5)_C1_PG&M?]!C5/_`J3_&@#]?,T9K\@_P#A.-:_Z#&J?^!4
MG^-'_"<:U_T&-4_\"I/\:`/U[Z]J,9'2OR$_X3C6O^@QJG_@5)_C1_PG&M?]
M!C5/_`J3_&@#]?,T9K\@_P#A.-:_Z#&J?^!4G^-'_"<:U_T&-4_\"I/\:`/U
M\HS7Y!_\)QK7_08U3_P*D_QH_P"$XUK_`*#&J?\`@5)_C0!^OE-VC=NV\^M?
MD+_PG&M?]!C5/_`J3_&C_A.-:_Z#&J?^!4G^-`'Z^9HS7Y!_\)QK7_08U3_P
M*D_QH_X3C6O^@QJG_@5)_C0!^OF:*_(/_A.-:_Z#&J?^!4G^-'_"<:U_T&-4
M_P#`J3_&@#]?*,U^0?\`PG&M?]!C5/\`P*D_QH_X3C6O^@QJG_@5)_C0!^OF
M:,U^0?\`PG&M?]!C5/\`P*D_QH_X3C6O^@QJG_@5)_C0!^O4G*5R_P"Q/_R3
M;Q!_V->K_P#I6]?E:OCC6MP_XG&J=?\`GZD_QK],/^"9#M+^REI<C$M))>73
7NQ.2[&5LDGN3ZT`?0E%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>